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Abstract 
This thesis aims to describe the uptake and coverage of HIV testing and counselling 
(HTC) services in a community cohort study in rural Tanzania between 2003 and 
2010, and to investigate the impact of HTC on changes in sexual risk behaviour and 
HIV incidence.  
Paper A uses data from three HTC services (community outreach HTC (CO-HTC), 
walk-in HTC (WI-HTC) and antenatal HTC) linked to the community cohort data to 
compare the characteristics of services users, and found that while WI-HTC was 
most likely attract HIV-positive individuals, the overall proportion of infected persons 
diagnosed was greatest at CO-HTC.  
Rates of repeat testing are important to understand given potential HIV treatment as 
prevention approaches. Paper B found that small proportions of cohort participants 
repeat tested between 2003 and 2010, although this improved over time. 
Paper C presents a quantitative analysis of the impact of CO-HTC on changes in 
sexual behaviour and HIV incidence, and found moderate associations between 
HTC use and reductions in some risk behaviours among HIV-negative participants, 
but no impacts among HIV-positive individuals or reductions in HIV incidence, 
possibly as a result of small sample sizes and a declining background incidence in 
the study area.  
Paper D presents findings from a qualitative study exploring the effectiveness of HIV 
prevention counselling messages, which showed that relationship dynamics 
constrained the extent to which HIV-negative women felt able to control their HIV-
related risk, and imbalanced client-counsellor interactions limited communication 
during counselling sessions.  
Overall, the findings from the thesis reveal that provision of different HTC models 
increased the uptake of services, but the proportions of individuals repeat testing 
were low and there was limited evidence for an impact of HTC on sexual risk 
reduction. Future research should explore the effectiveness of different HTC 
modalities in encouraging repeat testing among high risk HIV-negative individuals, 
influencing sexual behaviour change and linking HIV-positive people to care and 
treatment. 
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1 Introduction 
 
1.1 Background 
Southern and Eastern Africa remains the region most affected by the HIV pandemic, 
accounting for just over 5% of the world’s population but approximately 50% of all 
people living with HIV, corresponding to 17.1 million of the estimated 34.0 million 
people living with HIV in 2011 (1). In Tanzania, 1.4 million people were living with 
HIV in 2013, and prevalence among adults aged 15-49 was estimated at 4.9% 
(range 4.6-5.3%) (2). The vast majority of new infections in sub-Saharan Africa are 
acquired via heterosexual transmission (3).  
 
HIV testing and counselling (HTC) services are promoted as the gateway to HIV 
care and treatment services, and offer the opportunity for specially-trained 
counsellors to encourage avoidance of high risk sexual behaviours among both HIV-
negative and HIV-positive individuals. Since the mid-1990s, the traditional model of 
HTC service delivery in Tanzania and elsewhere in sub-Saharan Africa has been via 
client-initiated voluntary counselling and testing (VCT), with the emphasis originally 
being on counselling for HIV prevention, or linkage of positive persons to palliative 
care and other social support services, in the absence of widely available 
antiretroviral therapy (ART) (4-6). 
 
Since the start of ART rollout across sub-Saharan Africa in the early to mid-2000s, 
in response to low initial rates of testing uptake as well as in recognition that many 
opportunities to diagnose individuals attending health facilities were being missed, 
policies and programmes for provider-initiated testing and counselling (PITC) in 
clinical settings have been increasingly adopted (7). In 2007 the WHO and UNAIDS 
published guidance recommending the scale-up of opt-out PITC alongside 
traditional VCT services, although by this time approximately 50% of African 
countries were already offering PITC - mainly in antenatal clinics, but also in clinics 
providing diagnosis, care and treatment for tuberculosis and sexual transmitted 
infections (STI), and other health facility settings where patients presented with HIV-
like symptoms (8). In Tanzania, guidelines recommending the introduction and 
scale-up of PITC were published in 2007 (9), following a national programme for 
provision of free ART which started in October 2004. 
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Over the past ten years, other alternative and innovative options for HTC service 
delivery have evolved across sub-Saharan Africa, including mobile VCT, home-
based VCT and VCT services offered to individuals in their local communities or 
places of work (10). These services have been associated with considerable 
increases in the uptake of HIV testing (11), although they have usually been offered 
as part of research or other projects, and have not generally been taken to scale as 
part of national-level policy.  
 
In line with trends in other African countries, the number of facilities providing HTC 
services in Tanzania has increased substantially over the past 20 years. By the end 
of 2012, there were 2,168 sites across Tanzania providing HTC services, and PITC 
programmes (primarily antenatal testing of pregnant women) had been implemented 
at all hospitals and approximately 50% of health centres (12). Impressive as this roll-
out is, it is worth remembering that more than 80% of the population in Tanzania are 
served by health centres and rural dispensaries (12) – that is they do not live in 
areas that can directly access hospital services. Nevertheless, the increase in the 
number of facilities providing HTC has seen a corresponding rise in HTC coverage 
rates. The proportions of men and women aged 15-49 in Tanzania who had ever 
tested for HIV increased from 15.4% and 15.2% respectively in 2003-2004 (13) to 
27% of men and 37% of women in 2007-2008 (14), and 47% of men and 62% of 
women in 2011-2012 (15). However, in 2011-2012, the proportions of men and 
women reporting recent HTC (in the last 12 months) - a better indicator of 
knowledge of current HIV-status compared to reports of ever testing - were just 
25.0% and 29.5% respectively (15), and Tanzania is among the countries with the 
poorest overall coverage of antiretroviral therapy (ART) in sub-Saharan Africa, with 
less than 60% of those eligible for treatment receiving it based on 2010 WHO 
treatment guidelines (1). Challenges to the uptake of HTC in Tanzania include low 
utilisation of services in rural areas (12), fear of HIV-related stigma and 
discrimination (16), a perceived lack of confidentiality associated with HIV testing 
(17), and fears surrounding disclosure of sero-status to partners and others (18, 19). 
Challenges to service provision include a lack of trained healthcare workers, a weak 
health system infrastructure and poor drug distribution systems leading to frequent 
stock-outs of HIV test kits and other supplies (12). 
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A note on terminology 
A wide variety of terms are used to describe HTC services. The WHO and other 
international public health organisations use HTC as an umbrella term to refer to all 
types of testing and counselling services, whether they take the form of client-
initiated voluntary counselling and testing (VCT), or opt-in or opt-out provider-
initiated testing and counselling (PITC) (20). Client-initiated VCT can be further 
distinguished as services provided at clinics attached to health facilities, at stand-
alone centres, or as temporary outreach services provided within villages or places 
or work. In this thesis, HTC is similarly used as an umbrella term, while the more 
specific terms are used to distinguish between types of services where relevant. 
 
1.2 Rationale 
HTC services are hypothesized to contribute to HIV-prevention by encouraging 
changes in sexual risk behaviour among both HIV-negative and HIV-positive 
individuals, following the development of an individualised risk reduction plan under 
the guidance and support of a trained counsellor (5, 21). However, previous 
quantitative and qualitative research in sub-Saharan Africa has provided mixed 
evidence for sexual risk reduction following HTC use. Quantitative studies provide 
moderate evidence for reductions in some sexual risk behaviours following HTC, 
such as changes in condom use or reductions in numbers of sexual partners, but 
suggest that changes in behaviour may be greater among individuals testing HIV-
positive compared to those testing negative (22-24). However, there is considerable 
heterogeneity in study findings, and not all studies have stratified results by HIV-
status. Furthermore, there is uncertainty regarding the extent to which the 
availability of treatment may affect patterns of sexual risk behaviour in sub-Saharan 
Africa (25), and whether any impacts of HTC on sexual behaviour may differ before 
and after the widespread availability of ART. A limited number of qualitative studies 
have explored understandings of and responses to HIV prevention counselling 
messages among individuals completing HTC, however many of these have 
focussed on HIV-positive individuals (26-29), despite the fact that HIV-negative 
individuals comprise the majority of the population and it is their behaviour that 
represents an opportunity for the primary prevention of HIV. Further qualitative 
research may help to shed light on the factors influencing sexual behaviour following 
HTC use, particularly among individuals testing HIV-negative. 
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Interest in the widespread use of ART in order to prevent HIV transmission by 
reducing viral loads in treated patients (treatment as prevention or TasP) has grown 
in recent years, following greater availability of ART across sub-Saharan Africa, and 
data from observational research, clinical trials and modelling studies which have 
demonstrated potentially great reductions in HIV incidence associated with TasP 
(30-32). In 2013, the WHO revised its treatment guidelines to recommended earlier 
ART initiation for several groups of patients, including all patients with a CD4 count 
≤500 cells/μL, and immediate provision of ART for all sero-discordant couples, 
pregnant women living with HIV, people with HIV and tuberculosis or HIV and 
hepatitis B co-infections, and all HIV-positive children under five years old (33). 
These revised guidelines (compared to earlier guidelines which recommended 
treatment initiation at CD4 counts  ≤350 cells/μL – (34)) will lead to substantial 
increases in the number of people eligible for treatment and requiring access to HTC 
as the point of diagnosis. Some countries in sub-Saharan Africa are beginning to roll 
out forms of TasP, while several countries are already implementing Option B+ 
(immediate ART for life for HIV-positive pregnant women) (35). In Tanzania, 
guidelines on the implementation of Option B+ were published in 2013 (36).  
 
TasP strategies advocate regular repeat testing among high-risk individuals in order 
to diagnose HIV-positive patients and link them to treatment services as soon as 
possible after infection, reducing the period in which the risk of HIV transmission is 
greatest (30). As the numbers of people accessing HTC services increase, there is 
therefore a need to understand rates of repeat testing in sub-Saharan Africa. There 
is also a need to monitor and evaluate the relative success of different HTC service 
delivery models in attracting clients with high-risk behaviours known to be 
associated with HIV acquisition (such as greater numbers of sexual partners (37), 
unprotected sex (38) or early sexual debut (39)), as well as in improving early HIV 
diagnosis rates. Previous research in African settings suggests that overall, uptake 
of HTC is lower in rural compared to urban areas (40, 41), and that outreach HTC 
strategies such as mobile or home-based HTC result in greater uptake of HIV 
testing compared to health facility based services (11). However, the relative 
success of different testing modalities in attracting high-risk individuals or those at 
early stages of HIV infection is less well documented.  
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1.3 The research setting 
This PhD research was conducted within the context of the Kisesa HIV community 
cohort study, a collaborative research project (‘TAZAMA’ - Tanzania AIDS 
Monitoring Activities) between the Tanzania National Institute of Medical Research 
(NIMR) in Mwanza, northwest Tanzania and the London School of Hygiene and 
Tropical Medicine (LSHTM), UK. The TAZAMA project aims to monitor the HIV 
epidemic in Kisesa and to describe incidence, prevalence and HIV-related mortality 
and their demographic correlates. The project has also been monitoring the 
implementation of an HIV treatment programme in Kisesa since it started in 2005.  
 
The Kisesa cohort study is funded by the Global Fund to Fight AIDS, Tuberculosis 
and Malaria, and the principal investigators are Mark Urassa and John Changalucha 
at NIMR Mwanza, with technical assistance from Basia Zaba and others at the 
LSHTM. The primary research activities conducted by TAZAMA include rounds of 
demographic and serological surveillance (sero-surveys) which have been 
conducted in the study area since 1994 (initially a collaboration between the 
Tanzania-Netherlands Support programme on AIDS – TANESA, funded by the 
Royal Dutch Tropical Institute). Mobile or community-based outreach HTC services 
have been provided to sero-survey participants in temporary purpose constructed 
huts during all sero-survey rounds since 2003-2004. Further details of the research 
activities conducted as part of the Kisesa cohort study are provided in Chapter 3.  
 
In addition to the research activities, a partnership also exists between TAZAMA and 
government-run health facilities in the study area, including HTC clinics (a voluntary 
client-initiated walk-in HTC or VCT clinic, as well as PITC offered primarily to 
pregnant women attending the antenatal clinic), and an HIV care and treatment 
clinic (CTC) located at Kisesa Health Centre. The project also partners with a CTC 
at Bugando Medical Centre, a zonal referral hospital in Mwanza city, and three rural 
dispensaries which are located in the study area. Recent goals of the TAZAMA 
project include monitoring the demographic impacts of the HIV epidemic, and the 
linkage of the community cohort research datasets to data from the Kisesa-based 
health facilities, in order to monitor the use and impact of HIV services.  
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Long-term observational HIV cohort studies such as that conducted in Kisesa offer a 
unique opportunity to explore trends in HTC uptake as well as risk factors 
associated with service use, given the availability of data on HTC use, HIV-status, 
and other socio-demographic and behavioural characteristics over extended periods 
of time. In addition, the linkage between the routinely collected HTC clinic datasets 
at government-run health facilities and the research datasets allows for comparisons 
in rates of testing uptake and risk factors associated with use of different types of 
services to be made, in addition to estimations of service coverage at the community 
level. Kisesa is a rural ward that can be considered typical of many rural settings in 
Tanzania, thus the research findings are expected to be applicable elsewhere in 
Tanzania and other similar contexts across sub-Saharan Africa. 
 
1.4 Aims and objectives of the research 
The overall aim of the analyses presented in this thesis is to understand the role of 
HTC services in HIV prevention in Kisesa. The specific objectives cover two broad 
areas of research (see Figure 1.1). The first of these relates to describing the uptake 
and coverage of different types of HTC services, with uptake being defined as usage 
of testing services, while coverage refers to the proportion of the population who 
have ever accessed testing services. Quantitative research methods are used to 
investigate these topics.  
 
The second area of research involves investigating the role of HTC in sexual 
behaviour change, using both quantitative and qualitative methods. The quantitative 
analyses investigate changes in reported sexual risk behaviours and HIV incidence 
before and after using a community-outreach HTC service, while the qualitative 
research adds depth to the quantitative findings by exploring perceptions of HTC 
services, and how HIV prevention counselling messages might influence attitudes 
and intentions regarding sexual risk reduction following HTC use.  
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Figure 1.1 Broad research aims of the thesis 
 
 
The specific research objectives are as follows: 
1. To explore the uptake and coverage of different types of HTC services in 
Kisesa between 2003 and 2010 (community outreach HTC (CO-HTC), client-
initiated or walk-in HTC (WI-HTC) and antenatal testing of pregnant women 
(ANC-HTC)), by describing the proportions of individuals using each type of 
service and the socio-demographic, behavioural and clinical characteristics 
associated with service use. 
2. To investigate trends in characteristics associated with CO-HTC use 
between 2003 and 2010, and to explore rates of repeat testing among HIV-
negative and HIV-positive individuals, as well as risk factors for repeat CO-
HTC use. 
3. To synthesize the evidence for an impact of HTC on sexual behaviour 
change and HIV incidence in sub-Saharan Africa. 
4. To quantitatively evaluate the impact of CO-HTC on changes in reported 
sexual risk behaviours among HIV-negative and HIV-positive individuals, as 
well as changes in HIV incidence, before and after the widespread 
availability of ART.  
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5. To explore perceptions of HTC services, and to understand how HIV 
prevention counselling messages might influence attitudes and intentions 
regarding sexual risk reduction. 
6. To develop policy recommendations to improve the uptake, coverage and 
impact of HTC services among rural populations in Tanzania and elsewhere 
in sub-Saharan Africa.  
 
Table 1.1 below summarises the research objectives as they were investigated in 
the thesis, showing the methods and data sources used for each.  
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Table 1.1 Summary of research objectives, methods and data sources 
 Research objectives Methods Data sources Chapter 
in thesis 
1 To explore uptake and 
coverage of different types of 
HTC services in Kisesa (CO-
HTC, WI-HTC, ANC-HTC) 
between 2003 and 2010 
Quantitative 
statistical 
analysis 
Community 
cohort 
(demographic 
surveillance & 
HIV sero-survey) 
data linked to 
HTC-use 
datasets 
Chapter 4 
(Paper A) 
2 To investigate trends in 
characteristics associated with 
CO-HTC use between 2003 
and 2010, and to explore rates 
of repeat testing among HIV-
negative and HIV-positive 
individuals, as well as risk 
factors for repeat CO-HTC use 
Quantitative 
statistical 
analysis 
Kisesa cohort 
and linked CO-
HTC use 
datasets 
Chapter 5 
(Paper B) 
3 To synthesize the evidence for 
an impact of HTC on sexual 
behaviour change and HIV 
incidence in sub-Saharan 
Africa 
Systematic 
review of 
quantitative 
evidence 
Bibliographic 
databases 
(Medline and 
Embase) - 
existing literature 
Chapter 2 
4 To evaluate the impact of CO-
HTC on changes in reported 
sexual risk behaviours and 
HIV incidence before and after 
the widespread availability of 
ART in Kisesa 
Quantitative 
statistical 
analysis 
Kisesa cohort 
and linked CO-
HTC use 
datasets 
Chapter 6 
(Paper C) 
5 To explore perceptions of HTC 
services, and to understand 
how HIV prevention 
counselling messages might 
influence attitudes and 
intentions regarding sexual 
risk reduction 
Qualitative 
study in 
Kisesa 
Transcripts of in-
depth interviews 
and participatory 
group activities, 
field notes 
Chapter 8 
(Paper D) 
6 To develop policy 
recommendations to improve 
the uptake and impact of HTC 
services among rural 
populations in Tanzania and 
elsewhere in sub-Saharan 
Africa 
Synthesis of 
all the 
research 
presented in 
the thesis 
Systematic 
literature review 
(Chapter 2) 
 
Papers A-D 
(Chapters 4, 5, 6 
and 8) 
Chapter 9 
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1.5 Conceptual framework for the thesis 
Figure 1.2 below shows a conceptual framework for understanding the role of HTC 
services in HIV prevention in Kisesa, incorporating the measured outcomes under 
the two main areas of research, namely i) describing the uptake and coverage of 
HTC services in Kisesa, ii) investigating the impact of HTC on changes in sexual risk 
behaviours among HIV-negative and HIV-positive individuals. Based on a review of 
the literature as well as findings from previous studies in Kisesa (42, 43), the 
hypothesized influences on the research outcomes (uptake of HTC, or sexual 
behaviour change) are summarised. Hypothesized influences and measured 
outcomes which are highlighted in blue represent those which will be investigated 
using quantitative methods. Hypothesized influences and outcomes highlighted in 
green will be investigated using qualitative methods, while influences which will be 
explored using both quantitative and qualitative methods are highlighted in purple. 
The ultimate aim of the research is to understand how to maximise the contribution 
of HTC to HIV-prevention efforts in rural Tanzania and other similar settings in sub-
Saharan Africa. 
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Figure 1.2 Conceptual framework for understanding the role of HTC services in HIV prevention in Kisesa 
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1.6 Structure of the thesis 
This thesis is presented in research paper style, including four published or 
submitted academic papers (Papers A-D) and five additional chapters including this 
introductory chapter. A short introductory section is provided before each research 
paper, briefly outlining the rationale for the paper and linking it to findings presented 
in preceding chapters.  
 
Chapter 2 reviews the literature that is relevant to the research presented in this 
thesis, including a brief history of HTC service provision in sub-Saharan Africa, a 
review of HTC service provision modalities and the characteristics of users of 
different types of services, and a systematic literature review of the quantitative 
evidence for an impact of HTC on sexual behaviour change and HIV incidence in 
sub-Saharan Africa. Chapter 3 summarises the quantitative research methods, 
including further details on the research setting and a description of data 
management and preparation for the primary and secondary data sources used in 
Chapters 4, 5 and 6. 
 
Chapter 4 is a research paper (Paper A) submitted to Tropical Medicine and 
International Health, and investigates risk factors associated with the use of different 
types of HTC services in Kisesa (CO-HTC, WI-HTC and ANC-HTC), as well as 
trends in the overall uptake of testing services between 2003 and 2010. This is 
followed by another paper (Chapter 5 – Paper B, published in PLOS ONE) which 
adds to these analyses by exploring trends in risk factors associated with CO-HTC 
use over the same time period, as well as rates of repeat testing and risk factors for 
repeat CO-HTC use between 2006 and 2010. 
 
Chapter 6 (Paper C), published in BMC Infectious Diseases, is a quantitative 
analysis assessing the impact of CO-HTC use on changes in reported sexual risk 
behaviours and HIV incidence in Kisesa between i) 2003/2004 and 2006/2007 
(when ART was available in Mwanza city, but not within Kisesa itself) and ii) 
2006/2007 and 2010, when ART was available at a local CTC within the study area.  
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Chapter 7 provides details of the qualitative research methods, including a 
description of the data collection tools used during a period of fieldwork in Kisesa in 
2012, the sampling and recruitment strategies used, and methods of data analysis. 
This is followed by Chapter 8, a qualitative paper submitted to AIDS and Behavior, 
which explores perceptions of HTC services and the factors which shape attitudes 
and intentions regarding sexual risk reduction following HTC use in Kisesa. 
 
The thesis concludes with a discussion (Chapter 9) of the main findings from the 
PhD research, including a blended synthesis of findings from both quantitative and 
qualitative analyses. The strengths and limitations of the research are also 
discussed, as are programme and policy recommendations which will be relevant to 
policy makers in Kisesa and other similar rural settings in Tanzania. 
Recommendations for future research are also highlighted. The appendices include 
all the study tools, ethical clearance certificates, and disseminated work including 
posters and slides presented at international conferences. 
 
1.7 Role of the candidate 
I contributed to the design and framing of the overall objectives and research 
questions for this study. Because the research was conducted within the context of 
the TAZAMA Project, colleagues at the LSHTM and NIMR Mwanza were also 
involved in ideas and design for the study. My role in the quantitative and qualitative 
analyses completed as part of this thesis are outlined below. 
 
1.7.1 Quantitative data collection and analysis (Papers A, B and C) 
The quantitative analyses presented made use of both primary and secondary 
datasets. The secondary data came from rounds of demographic and serological 
surveillance carried out in the study area between 2003 and 2010. I was responsible 
for linking the demographic and sero-surveillance datasets, extracting, generating 
and cleaning the relevant variables, and designing and conducting the analyses. 
Although I was not responsible for the design or management of the sero-surveys, I 
provided feedback on the Sero7 and Sero8 questionnaires, particularly with 
reference to the questioning on HTC. I also attended two ALPHA (Analysing 
Longitudinal Population-based HIV/AIDS data on Africa) workshops in 2010 and 
27 
 
2011, which provided me with training on methods of data management and 
analysis techniques. 
 
The primary dataset used in this thesis constituted data from a walk-in HTC clinic at 
Kisesa Health Centre which was linked to the Kisesa cohort research dataset. Part 
of the WI-HTC clinic data (up to June 2010) had already been entered, however I 
coordinated further work to update the data entry to cover the period 2010 to 2012. 
The additional data entry was overseen by a senior data manager at NIMR 
(Clemens Masesa), however I identified the relevant logbooks for data entry, 
advised on the design and creation of data entry screens as well as the 
development of edit checks, and I merged and cleaned the final WI-HTC clinic 
datasets used in analyses. The design of the algorithm to link the HTC clinic data to 
the cohort research dataset was initially led by an IT consultant at NIMR (Benjamin 
Clark), however I was involved in various stages of model development (further 
details of my role in the data linkage project are provided in Chapter 3). 
 
I wrote the manuscripts for Papers A, B and C, incorporating feedback from co-
authors and peer reviewers. Advice and guidance on the analyses was also 
provided from statisticians on my advisory panel at the LSHTM and NIMR including 
Jim Todd, Emma Slaymaker and Georges Reniers. 
 
1.7.2 Qualitative research (Paper D) 
I designed and led the qualitative study which was conducted in Kisesa in 2012, with 
advice and guidance from senior social scientists on my advisory panel at NIMR 
(Joyce Wamoyi) and the LSHTM (Shelley Lees). This included obtaining ethical 
approval for the study, designing the sampling frame using the demographic and 
sero-surveillance datasets, developing and piloting the data collection tools, training 
four research assistants with the support of senior social scientists, and analysing 
the data. I wrote the manuscript and developed the conceptual framework for Paper 
D, incorporating feedback from co-authors. 
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1.8 Ethical clearance 
The research included in this thesis was approved by the ethics committee of the 
London School of Hygiene & Tropical Medicine and the Tanzanian Medical 
Research Coordinating Committee (see Chapters 3 and 7 for further details, and 
ethical clearance certificates in Appendix 11.1). 
 
1.9 Funding sources 
I was awarded a three year studentship from the UK Economic and Social Research 
Council which covered the cost of my research degree fees as well as an annual 
stipend and part of my fieldwork costs. I was awarded a £5,000 grant from the 
Gordon Smith Travelling Scholarship of the LSHTM which covered additional 
fieldwork costs and the costs of my travel to Tanzania. The ongoing TAZAMA cohort 
activities are funded by the Global Fund to fight AIDS, Tuberculosis and Malaria, 
with additional funding from the Bill and Melinda Gates Foundation (via the ALPHA 
Network) and the US National Institutes of Health (via the East Africa IeDEA 
(International Epidemiologic Databases to Evaluate AIDS) consortium). 
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2 Literature review 
 
This chapter summarises the literature that is relevant to the research presented in 
this thesis. The first section provides of a brief history of HTC service provision in 
sub-Saharan Africa. This is followed by a section exploring the relative success of 
different HTC service delivery models in increasing the overall uptake of testing, and 
the socio-demographic, behavioural and clinical characteristics of users of different 
types of services. This informs the analyses presented in Chapter 4 (Paper A), 
which investigates risk factors for HTC service use in rural Tanzania. Section 2.3 
explores rates of repeat testing in sub-Saharan Africa, which are important to 
understand given recent interest in TasP strategies, as well as the characteristics of 
those who return to test more than once - topics which are investigated in Chapter 5 
of this thesis (Paper B).  
 
Previous reviews of the impact of HTC on changes in sexual risk behaviour and HIV 
incidence have focussed on developed countries, or on developing countries 
including those outside of Africa, and only include studies published up to 2010. 
Section 2.4 presents a systematic review of the quantitative evidence for an impact 
of HTC on sexual risk reduction and HIV incidence in sub-Saharan Africa, 
incorporating studies published up to the end of 2014. This review informed the 
analyses presented in Chapter 6 (Paper C), which explore the impact of community-
based outreach VCT on sexual risk behaviours and HIV incidence in Kisesa. In 
section 2.5.1, a brief overview of theories of behaviour change are presented. This 
is followed by a summary of qualitative findings relating to perceptions of HIV 
prevention counselling messages among individuals completing HTC in sub-
Saharan Africa, in order to contextualise the qualitative research presented in 
Chapter 7 (Paper D). 
 
2.1 A brief history of HTC service provision in sub-Saharan 
Africa 
The first antibody test for HIV became widely available in industrialised nations in 
the mid-1980s. Initial approaches to HIV testing emphasized that it should be client 
initiated and done voluntarily, and were shaped strongly by activism in the Western 
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world which underscored the need for protection of the human rights of those 
infected with a highly stigmatised and untreatable condition (44). Counselling was 
proposed as a critical component of the VCT process. During pre-test counselling 
patients could be reassured that test results would remain confidential and fully 
informed consent could be obtained. Post-test counselling provided an opportunity 
to offer emotional and psychological support, to help clients understand the 
significance of their test results (whether negative or positive), and to plan for the 
future including reducing the risk of acquiring or transmitting HIV (45). 
 
There is a paucity of evidence to guide the design of VCT interventions in 
developing countries and in sub-Saharan Africa specifically, however, these have 
generally evolved from the same set of principles guiding VCT service provision in 
developed countries (46, 47). A key hypothesis underscoring HTC service provision 
globally is that it can contribute to HIV-prevention by helping clients to initiate or 
maintain safe sexual behaviour (4, 5). However, policy documents have 
acknowledged that the impact of HTC on sexual behaviour change may be difficult 
to measure, due to the complex nature of sexual behaviour and partnerships in 
many high prevalence settings (21). 
 
With the advent of antiretroviral therapy (ART) for the treatment of HIV in the mid to 
late 1990s, policy documents began to highlight the importance of HIV testing and 
counselling (HTC) not only for HIV prevention, but also in linking HIV-positive 
individuals to treatment and care (47). By the early 2000s, international 
organisations were examining ways to rapidly increase the number of people 
accessing HTC services and to scale up ART provision in sub-Saharan Africa, 
where the burden of HIV infection is greatest. Debates ensued about ‘opt-in’ versus 
‘opt-out’ approaches to testing, coming respectively from human rights and public 
health perspectives (44). However, in recognition that many opportunities to counsel 
and diagnose individuals attending health facilities were being missed (7), in 2007 
the WHO and UNAIDS published guidance on PITC to be offered by healthcare 
workers within existing clinics and health facilities (48). The PITC guidelines 
supported the continued scale-up of client-initiated VCT, but recommended opt-out 
PITC for patients attending health facilities whose clinical presentation might result 
from underlying HIV infection (irrespective of epidemic setting), and as a standard 
part of medical care for all patients attending health facilities in generalised epidemic 
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settings. The guidance noted that PITC should be accompanied by a package of 
HIV-related prevention, treatment, care and support services, and implemented 
within the framework of a national plan to achieve universal access to ART for all 
those who need it (48). 
 
Subsequent to a number of international policy declarations which sought to reduce 
the impact of the global HIV epidemic and to dramatically increase the number of 
HIV-positive patients accessing treatment (49-51), by the mid-2000s vast resources 
had been mobilised to increase access to HTC and ART in sub-Saharan Africa (1). 
Alongside traditional stand-alone VCT services and PITC approaches, a number of 
alternative models of HTC service delivery have evolved, including VCT provided as 
temporary mobile or outreach services, or to people within their homes or places of 
work (7, 10). At the same time rapid testing technologies emerged, allowing for 
same day delivery of test results using simplified approaches such as finger-prick 
blood or oral fluid specimens (52). 
 
In recent years, there has been renewed enthusiasm for expanding access to HIV 
testing and treatment services in light of research which has shown that HIV-positive 
individuals are significantly less likely to transmit infection to their sexual partners if 
their viral loads are suppressed as a result of receiving ART (31, 53). One modelling 
study hypothesized that the TasP approach could contribute to dramatic declines in 
HIV incidence if all adults aged 15 or older in high prevalence settings tested 
regularly (once per year), and if those testing positive initiated ART immediately 
after diagnosis (30). The success of TasP, if implemented at policy level, will 
ultimately depend on the ability of health systems to achieve near universal rates of 
HTC uptake, and to ensure strong systems for linking and retaining HIV-positive 
individuals in treatment and care. 
 
2.2 Scale-up of HTC service provision: types of services and 
characteristics of service users 
While there have been dramatic and encouraging increases in the numbers 
accessing HTC in sub-Saharan Africa in the last fifteen years, there is considerable 
regional variation in uptake. Data from Demographic and Health Surveys (DHS) and 
AIDS Indicator Surveys (AIS) carried out between 2006 and 2011 show that the 
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percentage of adult men and women who have ever tested for HIV ranged from less 
than 30% in Uganda to more than 70% in Rwanda (1). In Tanzania, data from an 
AIDS Indicator Survey in 2011-2012 showed that 47% of men and 62% of women 
reported ever having tested for HIV (15). This represents an encouraging increase in 
uptake from 27% of men and 37% of women reporting ever having tested in 2007-
2008 (14). However, at least 38% of women and more than half of men in the 2011-
2012 survey could not have been aware of their status, as they had never tested for 
HIV. In Tanzania and elsewhere, further substantial increases in the uptake of 
testing are required in order to maximise the potential prevention benefits of HTC, 
and to further increase the number of HIV-positive patients receiving treatment. 
 
Several reviews have noted that PITC has contributed to substantial increases in 
HIV-testing across sub-Saharan Africa, with much of this attributed to the testing of 
pregnant women in antenatal clinics (8, 54-56). Some studies have highlighted 
concerns that opt-out testing during PITC can lead to coercion, with clients 
reportedly being unable or unaware of the right to decline testing (57, 58). However, 
other studies have found that rates of client satisfaction, consent and confidentiality 
did not differ between VCT and PITC services (59), and that PITC may help to 
‘normalise’ HIV testing by eliminating the stigma associated with self-identifying 
oneself as at risk of HIV infection (60). 
 
Mobile and community-based outreach VCT services have also been found to 
substantially increase the uptake of HIV testing in comparison to standard facility-
based VCT services, and have been met with high rates of acceptability (61-64). 
Such services help to reduce the logistical (such as time and transport) and financial 
barriers to accessing testing (65, 66), and some studies have reported that they 
compare favourably with facility-based VCT services in terms of cost-effectiveness 
(64, 67). Studies assessing the usage of home-based VCT have also found high 
rates of acceptability and uptake (68-70), and this type of service can reduce 
concerns relating to confidentiality and stigma, as testing is provided within the 
privacy of the home (71, 72). 
 
Recently there has been growing interest in self-testing for HIV (73). As a new and 
emergent technology, its feasibility and acceptability as well as ethical aspects 
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relating to its use are not well understood, particularly in African settings. However, 
one study in an urban setting in Malawi found an oral-swab self-test to be highly 
accurate (99.2% accuracy – two false negative results) and acceptable (all 
participants who agreed to test opted to use the self-test (followed by standard VCT 
with a trained counsellor), and 98.5% of self-testers rated the self-test ‘not hard at all 
to do’).  This notwithstanding, participants articulated that counselling support was 
still needed following testing, and alternative counselling options such as a 
telephone helpline, information leaflets, or availability of a local community health 
worker were not considered acceptable substitutes (74). Globally, very few countries 
have adopted policies regarding self-testing (although Kenya is one of them – (73)), 
and there is a lack of evidence surrounding its efficacy and appropriateness for use 
in a rural African setting such as Kisesa. Nevertheless, initial studies in African 
settings have indicated that self-testing warrants further exploration as a potential 
way to make progress towards meeting universal access goals (74, 75). 
 
A number of studies have reported on the general socio-demographic, behavioural 
and clinical characteristics of individuals who report ever having tested for HIV (40, 
41), however few have compared the characteristics of individuals who use different 
types of testing services. Some studies have suggested that mobile or community-
based VCT may help to reach comparatively older and less educated clients 
compared to health facility-based VCT or PITC (76-79). However, one study 
reported that the age distribution of clients using six stand-alone VCT centres 
compared to three different types of mobile VCT services were similar (64). Several 
studies have reported that men are less likely to use health facility-based HTC 
services compared to women (77, 79, 80), although few have reported which 
strategies might be most effective in promoting couples-testing.  
 
Some studies have found VCT use to be associated with higher risk sexual 
behaviours (42, 81), however there is a lack of literature to compare the sexual risk 
profiles of individuals across different types of services. A number of studies have 
reported that HIV prevalence is higher among individuals testing at health facility-
based services compared to outreach VCT services (64, 67, 69, 77, 79). While there 
is some evidence that mobile and home-based VCT services may help to diagnose 
HIV-positive individuals at earlier stages of infection (67, 77), this has not yet been 
widely documented, and relatively few studies have explored which types of HTC 
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services attract first-time and previously undiagnosed testers (64, 67). Further 
research is required in order to understand which HTC service delivery models are 
most effective at identifying HIV-positive individuals and those most at risk of 
infection, as well as whether different types of services help to increase the 
coverage of testing among different socio-demographic groups. 
 
2.3 TasP and repeat testing 
TasP approaches advocate regular repeat testing among individuals testing HIV-
negative, in order to identify new HIV infections soon after sero-conversion (30, 82). 
However, few studies have explored rates of repeat testing in sub-Saharan Africa, or 
the characteristics of those who return for a second or subsequent test. One study 
offering home-based VCT in Uganda reported that only 24% of individuals accepted 
a repeat HIV-test during rounds of annual demographic and health surveillance (83). 
However, in another HIV cohort study in Malawi, a substantially larger proportion of 
participants (73.4%) accepted repeat home-based VCT during two surveys in 2004 
and 2006 (84).  
 
A small number of studies have explored the socio-demographic characteristics of 
individuals who have tested for HIV more than once. Some of these are similar to 
the characteristics of those who report ever having tested, with rates of repeat 
testing being greater among women (85-87), those aged 25-44 (43), those living in 
urban areas (43) and those with higher levels of education (85, 88). Other studies 
have shown that repeat testers have similar or increased sexual risk behaviours 
compared to those who have never tested (83, 88). This is encouraging in terms of 
the potential of HTC to pick-up those at greatest risk of HIV-infection, although does 
not lend support to the hypothesis that HTC encourages sexual risk reduction. One 
study in South Africa reported that median CD4 counts were significantly higher 
among HIV-positive individuals being diagnosed on their second or later HIV test 
compared to those diagnosed at their first test, providing some reassurance that 
repeat HIV testing may help to shorten the period between sero-conversion and 
diagnosis (86). However, further research is required in order to better understand 
the characteristics of those who repeat test, including whether these individuals are 
at higher risk of sero-conversion than those who don’t test or who test only once. 
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2.4 Systematic review of the impact of HTC on sexual 
behaviour change and HIV incidence in sub-Saharan 
Africa 
A number of early reviews assessed the evidence for an effect of VCT on sexual risk 
reduction in developed countries, mainly among men who have sex with men and 
intravenous drug users (89-91). These studies found that VCT was associated with 
decreases in sexual risk behaviour among HIV-positive individuals and sero-
discordant couples, although evidence for an impact among HIV-negative 
individuals was less clear. More recent quantitative reviews have included data from 
low and middle-income countries (22, 23, 54), although none have focussed on sub-
Saharan Africa specifically. A systematic review was conducted in order to 
investigate the quantitative evidence for an impact of HTC on changes in sexual risk 
behaviour and HIV incidence in sub-Saharan Africa. 
 
Database searches were conducted in Medline and Embase, including studies 
published between 1st January 2000 and 31st January 2015. Both MESH term and 
keyword searches were used and the results were combined in order to maximise 
the number of potentially relevant results. The following search terms were used:  
(‘Counselling’ OR ‘VCT’ OR ‘(counsel?* adj3 test*)’) AND (‘HIV’ OR ‘human 
immun#deficiency virus’ OR ‘human immun#-deficiency virus’ OR ‘AIDS’ OR 
‘acquired-immun#-deficiency-syndrome’) AND (‘Sexual Behavior’ OR ‘(sex* adj3 
(behavio?r* or risk* or practice*)’) AND (‘Africa south of the Sahara’ OR ‘Africa’ OR 
‘Senegal’ OR ‘Gambia’ OR ‘Guinea’ OR ‘Sierra Leone’ OR ‘Liberia’ OR ‘Cote d-
Ivoire’ OR ‘Burkina Faso’ OR ‘Ghana’ OR ‘Togo’ OR ‘Benin’ OR ‘Niger’ OR ‘Nigeria’ 
OR ‘Cameroon’ OR ‘Gabon’ OR ‘Congo’ OR ‘Angola’ OR ‘Namibia’ OR ‘Lesotho’ 
OR ‘Swaziland’ OR ‘Botswana’ OR ‘Zimbabwe’ OR ‘Mozambique’ OR ‘Malawi’ OR 
‘Zambia’ OR ‘Tanzania’ OR ‘Kenya’ OR ‘Uganda’ OR ‘Rwanda’ OR ‘Burundi’ OR 
‘Ethiopia’ OR ‘Somalia’ OR ‘Djibouti’ OR ‘Eritrea’ OR ‘Sudan’). In addition to the 
searches in Medline and Embase, the reference lists of articles meeting the review 
inclusion criteria were screened for relevant articles. Previous reviews and meta-
analyses provided relevant background information. 
 
In total 765 articles were retrieved from the database searches, as well as two 
additional articles from the review of reference lists of other papers. 722 articles 
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were excluded after review of the title or abstract, while 45 papers were reviewed in 
detail, 24 of which were found to meet the review inclusion criteria. One article was 
subsequently excluded as it reported earlier results included in a subsequent 
publication from the same study site, leaving 23 articles in the final review.  
 
Studies were included which measured the impact of an HTC intervention (defined 
as HIV testing including receipt of results and pre and post-test counselling – 
whether this was provided in a VCT or PITC setting) on self-reported sexual 
behaviour outcomes (e.g. number and type of sexual partners, condom use) and/or 
the incidence of HIV or other sexually transmitted infections (STIs). The review 
included articles which made comparisons between participants before and after 
using HTC services, or between individuals who had and had not used HTC, in 
cross-sectional studies, cohort studies or randomised controlled trials (RCTs). 
Studies which made comparisons between individuals who received more and less 
intensive versions of HTC interventions were also included. Papers reporting 
attitudes towards risky sex and/or condom use rather than reported behaviours were 
excluded, as were studies where HTC was part of the study design but it was not 
possible to distinguish its effects from other study interventions. Qualitative data 
were not included as part of the systematic review, however a review of the 
qualitative literature exploring perceptions of or responses to HIV prevention 
counselling messages among individuals completing HTC in African settings is 
presented in Section 2.5.2 below. 
 
The 23 studies included in the review are summarised in Table 2.1. The studies 
assessed the impacts of the following types of HTC interventions: i) VCT services 
provided to individuals at free-standing centres or within clinics attached to health-
facilities, ii) outreach VCT services provided within mobile units, the home or the 
place of work, iii) health-facility based VCT services provided to couples, iv) PITC 
services offered to pregnant women or attendees at outpatients clinics. The findings 
from the review are synthesized below. 
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2.4.1 Studies assessing the impact of health facility-based VCT 
services 
Three prospective studies recruited individuals from VCT clinics at health centres in 
Mozambique, Kenya and South Africa. These studies included both HIV-negative 
and HIV-positive individuals (but did not stratify results by HIV-status - (92, 93)), or 
HIV-positive individuals only (94), and found statistically significant reductions in the 
number of sexual partners and levels of unprotected sex reported four or six months 
after testing. A further prospective study assessed changes in sexual risk behaviour 
among initially HIV-negative participants returning for repeat testing at a free 
standing VCT clinic in Tanzania, with a mean period of 94 days between first and 
second tests (95). This study reported significant increases in the proportion of 
clients reporting no concurrent sexual partners (83.3% at first test versus 89.7% at 
second test, p<0.0001) or any condom use in the past month (15.3% reporting any 
condom use at first test versus 21.0% at second test, p<0.04).  
 
2.4.2 Studies assessing the impact of outreach VCT services provided 
within the community, home or place of work 
Four RCTs assessed the impact of community-based VCT interventions on changes 
in reported sexual risk behaviours and/or HIV incidence. The earliest of these 
recruited individuals and couples in Kenya, Tanzania and Trinidad between 1995 
and 1998, and assessed sexual behaviour outcomes among participants 
randomised to receive either immediate (intervention arm) or delayed (control arm) 
access to VCT (96). Participants in the control arm received a health information 
intervention at baseline (a 15 minute video and participation in a discussion about 
HIV transmission and condom use), and were offered VCT at first and second 
follow-up at seven and 14 months respectively. 
 
The trial found that among participants recruited as individuals (rather than as part 
of a couple), VCT had a significant impact in reducing unprotected sex with non-
primary partners (OR 0.68, 95% CI 0.56-0.82, p<0.0001). Among men, this effect 
was greater among HIV-positive compared to HIV-negative individuals (in 
intervention arm, 4.8% of HIV-positive men reported unprotected sex with a non-
primary partner at first follow-up compared to 20.6% of HIV-negative men, 
p<0.0001. This finding was maintained at second follow-up when 6.1% of HIV-
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positive men reported unprotected sex with a non-primary partner compared to 
16.5% of HIV-negative men, p=0.006). Among participants who were recruited into 
the study as couples, VCT resulted in reduced levels of unprotected sex with 
enrolment partners (but no differences in unprotected sex were found with non-
enrolment partners), and this effect was greater where one or both members of the 
couple were HIV-positive. In the trial, the reductions in sexual risk behaviour 
achieved in the intervention arm were replicated in the control arm once this group 
had access to VCT at first follow-up. The validity of self-reported sexual behaviour 
data was also assessed by analysing the agreement of reports made by different 
members of the same couple, who were interviewed separately. This revealed high 
rates of agreement: 91% in the case of reports of coital frequency, and 88% in 
relation to reports of unprotected sex. 
 
In another randomised trial, Coates et al investigated the impact of outreach VCT on 
HIV incidence (primary outcome) as well as on increasing the uptake of testing and 
reducing sexual risk behaviours among young people aged 18-32 in four countries 
(Tanzania, Zimbabwe, South Africa and Thailand) (97). In the intervention arm, 
outreach VCT was provided in easily accessible mobile units provided within the 
community and was accompanied by community mobilisation and post-test peer-
based social support groups for both HIV-negative and HIV-positive individuals. 
Control communities received standard VCT services at existing district hospitals or 
health-care facilities. Although the intervention increased the uptake of testing by 
25% (p=0.0003), there was only weak evidence for a statistically significant 
reduction in HIV incidence in the intervention arm compared to the control arm (RR 
0.86, 95% CI 0.73-1.02, p=0.08). However, the reduction in HIV incidence was 
significant among women aged 25-32 (RR 0.70, 85% CI 0.54-0.90, p=0.008). In 
analyses conducted at the community level (including all residents in the target age 
group, not only those who had used VCT), there were no effects of the intervention 
on the reported number of unprotected sex acts. However, among HIV-positive 
individuals there was a significant reduction in the number of sexual partners, which 
was reduced by 8% in the intervention compared to control arm (95% CI 1%-3%, 
p=0.034). This effect was particularly strong among HIV-positive men, who reduced 
the number of partners by 18% (95% CI 5%–28%, p=0·009).  
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Two further cluster RCTs investigated the impact of workplace-based VCT in 
Zimbabwe (61) or home-based VCT in South Africa (98). The Zimbabwean study 
found no impact of workplace-based VCT compared to offsite VCT in reducing HIV 
incidence (adjusted relative risk (aRR) for sero-conversion: 1.49, 95% CI 0.79-2.80), 
although the uptake of testing was significantly greater in the intervention compared 
to the control arm (mean uptake per site 70.7% in workplace-based VCT arm versus 
5.2% in offsite VCT arm, p<0.001). The South African study similarly reported 
significantly higher uptake of VCT in the intervention compared to control arm 
(prevalence of HIV-testing 69% in home-based VCT arm compared to 47% in 
standard VCT arm, prevalence ratio 1.54, 95% CI 1.32-1.82). Results were not 
stratified by HIV-status, but the authors reported that the proportions of individuals 
reporting more than one partner or any casual partner in the past three months were 
significantly lower in the intervention compared to control arm (prevalence ratio for 
reporting more than one partner in the past three months: 0.45, 95% CI 0.33-0.62. 
Prevalence ratio for reporting any casual partner in the past three months: 0.55, 
95% CI 0.42-0.73). However, there was no evidence for an impact of the 
intervention on increasing the proportion of respondents reporting condom use at 
last sex (prevalence ratio 0.86, 95% CI 0.65-1.15). 
 
Four articles assessed the impact of HTC services using data from cohort studies, 
comparing outcomes among individuals who had and had not used HTC in Rakai, 
Uganda (83, 99), Manicaland, Zimbabwe (100) or KwaZulu-Natal, South Africa 
(101). The Rakai papers reported no impact of home-based VCT on self-reported 
sexual risk behaviours or HIV incidence among HIV-negative individuals, even when 
participants had received repeat VCT on two or more occasions. In Manicaland, 
Cremin et al found no impact of reported VCT use on sexual behaviour change 
among men, although they found that women who had previously tested either HIV-
negative or HIV-positive reported a reduction in the number of new sexual partners 
in the last year as compared to women who didn’t test, and women who tested 
positive also reported a reduction in the number of visits to a bar or beer hall in the 
last month (an activity associated with risky sexual behaviour). However, an 
adjusted analysis taking into account background declines in sexual risk behaviour 
over the study period (1998-2005) revealed no impact of VCT on sexual risk 
behaviour among HIV-positive women, and that women testing negative increased 
their bar attendance and numbers of partners in the last month compared to women 
who didn’t test. However, the increases in both indicators were small and driven by 
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modest changes among a small number of HIV-negative women (Ide Cremin, 
personal communication June 2011). The South African cohort study reported that 
in adjusted analyses which took account of differences in underlying HIV risk, the 
hazard of HIV acquisition was significantly lower among young people aged 15-24 
reporting previous HTC compared to those reporting no HTC (0.59, 95% CI 0.45-
0.78) (101). It was reported that this effect was similar in the first 1.5 years after 
reported HTC use as in the next 3 years after HTC, among men and women, as well 
as among those aged less than 20 or aged 20 or older.  
 
An additional cohort study evaluated the impact of HTC as part of a broader 
investigation of hormonal contraception and HIV, and found that women testing HIV-
positive were twice as likely to report that all acts of sexual intercourse were 
protected 12 to 16 months after testing compared to before diagnosis (aOR 1.99, 
95% CI 1.12-3.53), although among HIV-positive women reporting at least one 
unprotected act, the overall proportion of unprotected acts did not change (7% 
reduction, 95% CI -18 to +6%). Furthermore, there were no statistically significant 
reductions in reported sexual risk behaviours among women who tested HIV-
negative (102). 
 
Finally, three observational studies explored the impact of outreach VCT services in 
Zimbabwe, South Africa and Uganda (103-105). One of these reported that women 
who sero-converted during a reproductive health trial were more likely to report 
consistent condom use, and less likely to report having more than one sex partner, 
after diagnosis compared to before (104). The other two studies reported changes in 
some but not all sexual risk behaviours among individuals testing HIV-negative 
(103) or among both HIV-negative and HIV-positive participants (results not 
stratified by HIV-status (105) - see Table 2.1). 
 
2.4.3 Studies assessing the impact of HTC on sexual behaviour 
change among couples 
Three studies in Rwanda and Zambia recruited couples who were either married or 
cohabiting or had been in a relationship for at least six months (106-108). In the 
situation where at least one member of the couple tested HIV positive, all three 
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studies showed a statistically significant impact of VCT in reducing sexual risk 
behaviour. None of the studies included an untested control group and all were pre-
post analyses of the intervention, with follow-up at either six or 12 months post-
testing. However, one of the Zambian studies assessed the validity of self-reported 
sexual behaviours using biological markers (107). This corroborated the finding that 
VCT was associated with increased condom use, although also indicated that 
overall, at least half of all unprotected sex acts were not reported. 
 
Two of the studies included an additional element provided alongside the VCT 
service. In the study in Rwanda, an extra focussed counselling session was 
provided for men (as they were considered to be the primary decision-makers in the 
relationship) (106). The study reported that the mean rate of unprotected intercourse 
decreased where one or both members of the couple tested HIV positive, but no 
statistically significant reductions in sexual risk behaviour were observed where both 
participants tested HIV negative. 
 
One of the studies in Zambia recruited HIV-positive concordant or sero-discordant 
couples. Women received three additional risk-reduction counselling sessions after 
undergoing VCT, while men were randomised to receive either one or three 
additional risk-reduction counselling sessions (108). Reported consistent male 
condom use over the last seven days increased significantly in both arms of the 
study at 12-month follow-up. In couples where the male partner had tested HIV 
negative, reported consistent condom use increased more for men receiving three 
risk-reduction counselling sessions than for those who had received one. 
 
2.4.4 Studies assessing the impact of PITC on sexual behaviour 
outcomes 
Three studies assessed the impact of PITC offered at antenatal clinics in Kenya, 
Cote d’Ivoire and South Africa, while one assessed the impact of PITC offered at the 
outpatients department of a rural hospital in Uganda.  
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In the South African study, pregnant women attending an antenatal clinic were 
randomised to receive an enhanced or standard PITC service (109). The enhanced 
PITC intervention included a 15 minute video priming women around decisions 
relating to HIV testing and risk reduction, enhanced pre- and post-test counselling 
(using interactive techniques such as role-plays) and access to legal and support 
groups. Women in the control arm received standard PITC in accordance with South 
African national guidelines. The study reported no statistically significant effects of 
the intervention on incident STIs (Trichomonas vaginalis, Neisseria gonorrhoea or 
Chlamydia trachomatis) at 14 weeks post-partum among HIV-negative or HIV-
positive women (results were stratified by HIV-status). The authors reported that 
across both treatment and control groups there were substantial reductions in past 
30 day inconsistent condom use at 14 weeks and 9 months post-partum, among 
both HIV-negative and HIV-positive participants. However, the effect of the 
enhanced PITC intervention on inconsistent condom use was only statistically 
significant among HIV-negative women at the 9 month post-partum follow-up visit 
(RR 0.72, 95% CI 0.59-0.88, p=0.001). 
 
Two observational studies assessed the impacts of PITC and the role of partner 
involvement on the uptake of HIV-prevention interventions among pregnant women 
in Kenya (110) and Cote d’Ivoire (111). In the Kenyan study, among 871 pregnant 
women who were sexually active between PITC and two week follow-up, the 
prevalence of reported condom use increased from 14% before testing to 38% at 
the follow-up visit (p<0.001) (110). However, there was no statistically significant 
increase in reports of condom use among 170 male partners who were also tested 
and returned at two week follow-up (16% before testing versus 19% after testing, 
p=0.6). Among HIV-positive women, couple counselling was associated with a trend 
for increased condom use (OR 6.5, 95% CI 0.77-55, p=0.07), however the opposite 
effect was seen among HIV-negative women who were counselled as part of a 
couple (OR 0.2, 95% CI 0.1-0.43, p<0.001) (97% of these women and their partners 
were concordant HIV-negative). 
 
In Cote d’Ivoire, 710 women accepted PITC at seven different antenatal clinics 
(111). Among both HIV-negative and HIV-positive women, significantly larger 
proportions reported having ever used condoms with their regular partners at 18 
months post-partum compared to before testing (HIV-negative women: 36.4% at 
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baseline versus 58.7% at follow-up, p<0.01. HIV-positive women: 23.2% at baseline 
versus 48.8% at follow-up, p<0.01).  However, increases in the proportions of 
women using condoms consistently were much lower (statistical significance not 
reported).  
 
Finally, one study assessed PITC among individuals waiting to see a clinician at the 
outpatient clinic of a rural hospital in Uganda (112). Results were stratified by HIV-
status, and the study reported that among 215 participants who accepted testing 
and returned at three month follow-up, the percentage of both HIV-negative and 
HIV-positive people who reported engaging in risky sex (defined as unprotected sex 
with a partner of unknown or sero-discordant status) decreased at the follow-up visit. 
However, at three month follow-up more than 50% of all participants still reported 
engaging in risky sex, and among individuals who reported at least one risky act, 
only HIV-positive individuals decreased their average overall proportion of 
unprotected sex acts. There were also low rates of behaviour change reported by 
married or cohabiting couples in this study. 
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Table 2.1 Studies included in systematic review of impacts of HTC on sexual risk behaviour and HIV incidence in sub-Saharan Africa 
 
*Number of individuals contributing to analysis of impact of HTC, unless stated otherwise 
† Where outcome measures assessed at >1 follow-up, key findings reported for longest period of follow-up, unless stated otherwise   
Author & 
Ref Setting and study design Intervention & sero-status of participants
Outcome 
measures
Contro
l grp N*
Follow-
up† Key findings
Mola et al 
2006 (92)
*Pre-post analysis of adults aged 18+ 
attending VCT clinics in Mozambique 
between 2002-2003                                                                                                                                                   
*Controls attended outpatient clinics 
(general medical care or antenatal clinics) in 
same cities
*Government run VCT clinics                                                                                                                                                                                                                                                                                                                                                                                                                                                         
*HIV-ve & HIV+ve participants (results not 
stratified by HIV-status)                                                                                                
*No further details on VCT service provided                                                                                                                                                                                                                                           
Condom use Yes 622 VCT 
users, 598 
controls
4 & 6
mths
*VCT clients reported using condoms significantly
more often than non-users of VCT in unadjusted 
analyses.                                                                                                                                                
Arthur et 
al 2007 
(93)
*Adults aged 18 or older, or married, 
recruited at health centre based VCT clinics 
in Thika & Nairobi, Kenya in 1999.                                                                                                                                                              
*Pre-post analysis 
*Government run VCT clinic                                                                                                                                                                                                                                                                                              
*HIV-ve & HIV+ve participants (results not 
stratified by HIV-status)
*Counselling sessions included personalised 
interactive counselling, risk assessment & coping 
strategies. Use of rapid tests. Condom 
demonstrations & free condoms provided.
Reported #
of partners, 
condom use, 
STI 
symptoms
No 540 6 mths *Significant reductions in # of clients with multiple
partners, # reporting STI symptoms, levels of 
unprotected sex.                                                                                                                            
Peltzer et 
al 2010 
(94)
*HIV+ve adults aged 18+ accessing 13 VCT 
clinics in Mpumalanga, South Africa in 2008-
2009.                                                                                                                                
*Pre-post analysis
*Government run VCT clinics                                                                                                                                                                                                                                                                                                    
*HIV+ve participants only                                                                                                        
*VCT with lay counsellors from local communities 
who had 2 wks training in HIV counselling.                                                                               
*Participants also received 3 x 30 min motivational-
skills building risk reduction counselling sessions at 
~0,1, 2 mths after VCT
Reported #
of partners,
coital 
frequency
condom use
No 488 4 mths *Significant reductions in # individuals with mutiple
sex partners, unprotected sex, use of alcohol or drugs 
in the context of sex, transactional sex.                                                                                       
*Significant increase in sexual abstinence during the 
last 3 mths
Fiorillo et 
al 2012 
(95)
*Pre-post analysis among HIV-ve adults 18+ 
attending for repeat testing at VCT clinic in  
Tanzania between 2003-2008                               
*Structured questionnaire administered to 
clients attending 2 consecutive HTC visits
*Freestanding VCT clinic operated by a 
community group                                                                                                           
*HIV-ve participants only                                                                                           
*VCT provided according to Tanzanian national 
guidelines using rapid HIV tests                                                                                                             
Abstinence, 
concurrent
sexual
partners, 
condom use
No 951 94 days 
(range 
24-
1920)
*Reduction in proportion of men and women 
reporting concurrent partners                                           
*Increase in proportion of men and women reporting 
condom use in past month                                                                                                                      
*No change in abstinence in last year
Voluntary 
HTC 
Efficacy 
Study 
Group, 
2000 (96)
*RCT of individuals & couples aged 18+, or 
married, from 3 study sites in Kenya, 
Tanzania & Trinidad between 1995-1998                                                                                  
*Participants randomised to receive VCT or 
health information
*Standard VCT (intervention arm) vs health 
information only (control arm)                                                                                                                                                                                                                                                                                 
*HIV-ve & HIV+ve participants (results stratified)                                                                                                                                            
*Test results & post-test counselling  2 weeks after 
blood sample.                                                                                                                                                                                                                                                         
*Health information arm included 15 min video & 
discussion about HIV transmission. Participants in 
this arm offered VCT at 1st & 2nd follow-up at ~7 
& 14 mths
Condom 
use, incident
STIs
Yes 3,120 
individuals
586 couples
7 & 14 
mths
*Reductions in unprotected sex with non-primary 
partners significantly greater in intervention arm                                                                                                               
*Couples in intervention arm reduced unprotected 
sex with enrolment (but not non-enrolment) partners 
significantly more than couples in health information 
arm                                                                                                      
*Reductions in unprotected sex greater among 
HIV+ve individuals or where ≥1 member of couple 
was HIV+ve
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Table 2.1 continued 
 
*Number of individuals contributing to analysis of impact of HTC, unless stated otherwise 
† Where outcome measures assessed at >1 follow-up, key findings reported for longest period of follow-up, unless stated otherwise 
Author & 
Ref Setting and study design Intervention & sero-status of participants
Outcome 
measures
Contro
l grp N*
Follow-
up† Key findings
Corbett et 
al 2007 
(171)
*Cluster randomised trial of intensive (on-
site) vs standard (off-site) VCT at 22 
businesses in Harare, Zimbabwe between 
2002-2004                                                                                 
*Participants were initially HIV-ve indivdiuals 
consenting to repeat testing at end of 2 yr 
intervention period
*Workplace VCT with same-day results 
(intervention arm) vs pre-paid vouchers for 
external VCT centres (control arm)                                                          
*HIV-ve participants                                                                               
*VCT was provided according to WHO guidelines
HIV 
incidence
Yes 2,966 2 yrs *Uptake of VCT significantly higher in intervention vs 
control arm, but no significant difference in HIV 
incidence between arms in crude or adjusted analyses
Doherty et 
al 2013 
(98)
*Cluster randomised trial, participants aged 
≥14 in 16 communities in KwaZulu Natal, 
South Africa                                                                                               
*Communities randomised to home-based 
VCT or standard VCT at local clinics between 
2009-2010                                                                                                 
*Home-based VCT (HB-VCT) vs standard VCT (S-
VCT) at local clinics                                                                   
*HIV-ve & HIV+ve participants (results not 
stratified by HIV-status)                                                                       
*Intervention arm included community 
mobilisation & HB-VCT delivered by lay 
counsellors.                                                                                                                                 
*S-VCT included services at local clinics & some 
non-governmental organisation mobile outreach 
VCT
# & type of 
partners, 
condom use 
at last sex
Yes 16 
communities 
(4,154 
participants)
x-
sectional 
surveys 
at 
baseline 
& 18 
mths
*Significantly lower proportion of men & women in 
intervention arm reporting >1 sex partner or a casual 
partner in past 3 mths compared to control arm                                                                                            
*No effect of intervention on condom use at last sex
Coates et 
al 2014 
(97)
*Cluster randomised trial between 2004-
2011, participants aged 18-32.                                                  
*34 communities at 4 sites in Africa (South 
Africa, Tanzania, Zimbabwe) & 14 
communities in Thailand                                                                                                              
*Communities randomised to community 
based VCT or standard VCT at district health 
facilities
*Community based VCT (CB-VCT) vs standard VCT 
(S-VCT) at health facilities                                                             
*HIV-ve & HIV+ve participants (results stratified)                                               
*CB-VCT included easily accessible VCT in mobile 
units, community mobilisation & post-test peer 
based social support groups                                                                            
*S-VCT consisted of services at existing district 
hospitals or local health-care facilities
HIV 
incidence, 
avg monthly
# 
unprotected 
sex acts, #
partners
Yes 34 
communities 
(HIV 
incidence) 
48 
communities 
(sexual 
behaviour)*
x-
sectional 
surveys 
at 
baseline 
& 36 
mths
*Borderline significant lower HIV incidence in CB-VCT 
arm compared to S-VCT arm. Highly significant lower 
HIV incidence among women aged 25-32                                                                              
*No effect on # unprotected sex acts among men or 
women. Significant reduction in # sex partners among 
HIV+ participants
Matovu et 
al 2005 
(99)
*Open HIV cohort study offering VCT in 
Rakai, south-west Uganda.                                                                                                                                                                                                                                               
*Pre-post analysis of adults (15-49 yrs) who 
were HIV-ve in 1999 and also attended a 
sero-survey in 2000
*Home-based VCT                                                                                                                                                                                                                                                                                                                           
*HIV-negative participants only                       
*Pre-test counselling on benefits of individual & 
couple counselling after providing blood sample 
for research purposes.                                                                           
*Results and post test counselling available in ~1 
month. Post-test counselling provided in the home 
or other venue of the partipants' choosing
# partners,
condom use,
HIV 
incidence
Yes 6,088 12 mths *No impact of VCT on subsequent risk behaviours or
HIV incidence                                                                      
Matovu et 
al 2007 
(83)
*Open HIV cohort study offering VCT in 
Rakai, south-west Uganda.                                                                                                                                                                                                                                                                                                
*Pre-post analysis of impact of repeat-
testing among all HIV-ve adults (15-49) 
providing an interview & blood sample at 
two or more annual surveys from 1999
*Home-based VCT                                                                                                                                                                                                                                                                                                                           
*HIV-negative participants only
*Pre-test counselling on benefits of individual & 
couple counselling after providing blood sample 
for research purposes.                                                                           
*Results and post test counselling available in ~1 
month. Post-test counselling provided in the home 
or other venue of the partipants' choosing
# partners,
condom use,
HIV 
incidence
Yes 6,377 12 mths *Individuals accepting repeat VCT less likely to change
risk behaviour compared to those i) not using VCT ii) 
using VCT only once                                                                              
*No difference in HIV incidence between repeat-
testers & those i) not using VCT ii) using VCT only once
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Table 2.1 continued 
 
*Number of individuals contributing to analysis of impact of HTC, unless stated otherwise 
† Where outcome measures assessed at >1 follow-up, key findings reported for longest period of follow-up, unless stated otherwise 
& Adjusted analysis found no impact among HIV+ve women, & that HIV-ve women increased bar attendance & # of partners in last month, but this was driven by modest changes among small # of women 
Author & 
Ref Setting and study design Intervention & sero-status of participants
Outcome 
measures
Contro
l grp N*
Follow-
up† Key findings
Cremin et 
al 2010 
(100)
*Open HIV cohort study offering VCT in 
Manicaland, Zimbabwe                                                                                                                                                                                                                                                          
*Pre-post analysis using data on reports of 
previous VCT use from 3 survey rounds 
(1998-2000, 2001-2003, 2003-2005) 
including men aged 17-54 & women aged 15-
44 (first 2 rounds), or all adults aged 15-54 
 
*Mobile village based VCT clinic                                                                                                                                                                                                                                                                               
*HIV-ve & HIV+ve participants (results stratified)                  
*Free VCT after completing survey questionnaire. 
Test results & post-test counselling 2 weeks later 
(first 2 rounds) or rapid testing with same day 
results & post-test counselling (last round).
# partners, 
visits to beer
hall, condom 
use
Yes 1,759 2-3 yrs *No impact of VCT on sexual behaviour change among
men (HIV+ve or -ve)                                                          
*Reduction in # new sex partners in last year among 
women (HIV+ve or -ve)&                                                              
*Reduction in # visits to beer hall in last mth among 
HIV+ve women&
Rosenberg 
et al 2013 
(101)
*Cohort study assessing impact of HTC on 
HIV incidence among youth in South Africa                                                                                                                                                                             
*Study participants were HIV-ve, aged 15-24 
and attended at least 2 rounds of an annual 
HIV survey between 2006-2011                                                 
*Study assessed HIV acquisition comparing 
those exposed and unexposed to HTC
*Reported previous HTC (any type of service - 
walk-in VCT, outreach VCT or PITC)
*HIV-ve participants                                                                        
HIV 
incidence
Yes 3,959 Annual 
surveys 
between 
2006-
2011
*In adjusted model, HIV incidence signficantly lower 
in HTC exposed compared to unexposed youth                                                                                                                                                
*Reduction in incidence sustained up to 4.5 yrs after 
HTC, & similar among men & women 
Turner et 
al 2009 
(102)
*Study on effect of hormonal contraception 
on HIV acquisition & HIV genital shedding 
that included HTC data                                                                                                                                                 
*HIV-ve women aged 18-35 recruited from 
FP clinics (Uganda, Zimbabwe) & from sex 
workers, military wives & STI clinic 
attendees (Uganda) between 1999-2004                                                                                                                                                                                                                                                                                                                                                
*W  ff d VCT  3 th  f   t  
*VCT offered as part of the study                                                                                                                                                                                                                                                                                                                   
*HIV-ve & HIV+ve participants (results  stratified)                                                                                                                             
*All VCT sessions included pre- & post-test
counselling & instructions on condom use. 
Counselling sessions for HIV+ve women slightly 
longer (45 mins) than HIV-ve women (30 mins)                                                                                                       
*Test results were usually received with ~10 days.                                                                                             
*P ti t  i f d t  ld i  f  
Condom use No 801 6 & 16
mths
*HIV+ve women twice as likely to report that all sex
acts were protected 12-16 mths after diagnosis 
compared to before                                                                                                                    
*No change in the proportion of unprotected sex acts 
among HIV+ve women who used condoms 
inconcsistently                                                                                                                                         
*No significant reductions in unprotected sex among 
 t ti  HIV                                                                                                                                                                                                           Matambo 
et al 2006 
(103)
*Pre-post analysis among HIV-ve 
participants receiving VCT at their workplace 
(11 business in Harare, Zimbabwe) between 
2002-2004                                              
*Questionnaire & risk assessment at time of 
VCT & 3 mths later
*Workplace VCT with same-day delivery of 
results                                                                                                                                    
*HIV-ve participants                                                                                            
*VCT provided according to WHO guidelines
Any high risk 
behaviour, 
unprotected
sex, STI 
symptoms
No 388 3 mths *Borderline significant reduction in proportion 
reporting sex with a partner known or thought to be 
HIV+                                                                                                                       
*No reduction in proportion of participants reporting 
unprotected sex
Venkatesh 
et al 2011 
(104)
*Nested cohort study in Zimbabwe & South 
Africa                                                                                                                                                                                                    
*Participants were women aged 18-49 sero-
converting during an RCT between 2003-
2006 on effectiveness of diaphragm & 
lubricant gel in preventing HIV acquisition                                                                                                                      
*Analyses compared sexual behaviours 
reported at visits pre & post seroconversion
*HTC offered quarterly to all women as part of 
the RCT                                                                         
*Impacts of HTC assessed among women who 
sero-converted                                                                                                         
Being 
sexually
active, coital 
freq,
condom use, 
>1 sex 
partner
No 327 12-24 
mths
*Women less likely to report >4 sex acts in past wk, 
>1 sex partner or anal sex at visits post- compared to 
pre-seroconversion                                                                  
*Women more likely to report consistent condom use 
at visits post seroconversion                                                                         
*Weak evidence that women less likely to report 
being sexually active after seroconversion
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Table 2.1 continued 
 
*Number of individuals contributing to analysis of impact of HTC, unless stated otherwise 
† Where outcome measures assessed at >1 follow-up, key findings reported for longest period of follow-up, unless stated otherwise 
Author & 
Ref Setting and study design Intervention & sero-status of participants
Outcome 
measures
Contro
l grp N*
Follow-
up† Key findings
Nuwaha et 
al 2012 
(105)
*Pre-post analysis - serial cross sectional 
surveys in 2004 & 2007 among adults 18-49 
yrs before & after implementation of home-
based VCT in Bushenyi, Uganda
*Home based VCT                                                                           
*HIV-ve & HIV+ve participants (results not 
stratified by HIV status)                                                                              
*VCT offered to all adults & children at risk of HIV 
(mother infected or dead) within all households in 
Bushenyi district over 2 yr period                                               
*Programme also provided community 
mobilisation & education in relation to HIV, and 
        
Sex in past 
12 mths, 
condom use, 
type of 
partners, 
reported STI 
symptoms
No Baseline: 
n=1,402  
Follow-up: 
n=1,562
Two x-
sectional 
surveys 
at 
baseline 
& 24 
mths
*Reduction in proportion of individuals paying or 
receiving money at last sex, reporting STI symptoms 
in past 12 mths                                                                                                                        
*Increase in proportion of individuals using condom 
at last sex where money was exchanged                                                                              
*No change in proportion of individuals reporting any 
sex or sex with a non-regular partner in past 12 mths, 
or using condom use at last sex (any partner type)
Roth et al 
2001 
(106)
*Married or co-habiting sero-concordant or 
sero-discordant couples from prenatal or 
paediatric clinics in Kigali, Rwanda                                                         
*Pre-post analysis in 1991-1992
*Couples PITC in antenatal or paediatric clinics                                                                                
*Sero-concodant (-ve or +ve) & sero-discordant 
couples                                                             
*Men received additional risk-reduction 
counselling session designed to heighten 
awareness of HIV risk & illustrate safe sexual 
practices
Condom use No 684 couples 12 mths *Mean rates of protected sex increased among all 
couples except those who were concordant HIV-ve
Allen et al 
2003 
(107)
*HIV sero-discordant and sero-concordant 
HIV-ve cohabiting couples recruited in 
Zambia between 1994-1998. Women were 
aged ≤ 48 yrs, men were ≤ 65 yrs                                                                                                                                        
*Couples VCT                                                                                
*Behaviour change following VCT assessed 
among sero-discordant  couples                                            
*Same day VCT service including free treatment for
syphilis, free condoms & condom skills training
Condom use No 818 couples 3, 6, 9 & 
12 mths
*Couples reported an increase in condom use after 
joint VCT (<3% of sex acts protected prior to VCT 
compared to >80% at 12 mth follow-up)                                                                                               
*Biological markers corroborated this finding but also 
indicated at least half of all unprotected sexual 
contacts were not reported
Jones et al 
2009 
(108)
*HIV+ve sero-concordant or discordant 
couples aged 18+  recruited from VCT clinics 
in Zambia between 2003-2006                                                                                                                  
*Pre-post analysis
*Couples VCT                                                                                                                                                                                                                                                                                                                                                
*HIV+ve sero-concordant or sero-discordant 
couples                                           
*All women received 3 risk reduction counselling 
sessions after VCT. Men randomised to receive 1 
or 3 additional risk-reduction counselling sessions                                                                                                                                                                                                                                  
Condom use No 83 couples 6 & 12 
mths
*Significant increase in consistent male condom use in
both study arms at 6 & 12 mth follow-up                                       
*Where male partner HIV-ve, increase in condom use 
greater among men receiving 3 risk-reduction 
counselling sessions vs those receiving 1
Farquhar 
et al 2004 
(110)
*Pregnant women attending their first 
antenatal visit at a city council clinic in Kenya 
between 2001-2002                                                                          
*Pre-post analysis 
*PITC for pregnant women                                                              
*HIV-ve & HIV+ve participants (some but not all 
results stratified by HIV status)                                                            
*Women provided with information on tesitng, 
encouraged to inform partners about tesitng & to 
return within 7 days for individual or couples HTC
Condom use No 871 2 wks *Condom use increased from 14%-38% by 2 wk 
follow-up (p<0.001)                                                                                          
*Among HIV+ve women, partner notification of status 
associated with significant increase in condom use                                                                                  
*Couple counselling associated with increased 
condom use among HIV+ve but not HIV-ve women
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Table 2.1 continued 
 
*Number of individuals contributing to analysis of impact of HTC, unless stated otherwise 
† Where outcome measures assessed at >1 follow-up, key findings reported for longest period of follow-up, unless stated otherwise
Author & 
Ref Setting and study design Intervention & sero-status of participants
Outcome 
measures
Contro
l grp N*
Follow-
up† Key findings
Desgrees-
du-Lou et 
al 2009 
(111)
*Pregnant women attending 7 antenatal 
clinics in Abidjan, Cote d'Ivoire between 
2002-2003                                                                           
*Pre-post analysis
*PITC for pregnant women                                                       
*HIV-ve & HIV+ve participants (results stratified)                                                                      
*Partners were encouraged to come for testing
Condom use 
at sex 
resumption 
after delivery
No 710 18 mths *Significant increases in proportions of HIV+ve & -ve 
women ever using condoms in 18 mths following HTC                                       
*Increases in consistent condom use were much 
lower (statistical significant not reported)                                                                                                                                
*HTC associated with higher levels of communication 
with partners about sexual risks
Maman et 
al 2014 
(109)
*RCT of enhanced PITC  vs standard PITC 
among women recruited from ANC in South 
Africa between 2008-2010                                                                                    
*Participants were aged 18+ & had a 
primary partner for ≥6 months
*RCT of enhanced PITC vs standard PITC among 
pregnant women                                                                       
*HIV-ve & HIV+ve participants (results stratified)                                                                    
*Enhanced PITC included 15 min video priming 
women around decisions relating to HIV testing & 
risk reduction, enhanced pre & post-test 
counselling using interactive techniques (eg role 
plays), access to legal & support groups                           
*Control women received standard PITC according 
to South African national guidelines
STI 
incidence, 
condom use
Yes 1,480 14 wks 
& 9 mths 
post-
partum
*No effect of intervention on STI incidence among 
HIV+ve or HIV-ve women                                         
*Increase in consistent condom use among HIV-ve 
women at 9 mths post-partum. No effect among 
HIV+ve women, or among HIV-ve women at 14 wks 
post-partum
Kiene et al 
2010 
(112)
*Outpatients aged 18+ recruited from rural 
hospital in Uganda in 2008                                                  
*Participants were not tested for HIV in 
previous 3 mths, never tested HIV+ve, had 
sexual contact in last 6 mths                                                                                                
*Pre-post analysis
*PITC at an outpatients clinic                                                                                                                                  
*HIV-ve & HIV+ve participants (results stratified)                                                                                     
*Patients approached & asked whether wished to 
receive HTC. Rapid testing with same-day receipt 
of results & post-test counselling. Testing referral 
cards provided to encourage partner(s) to test
Unprotected
sex with
partner of 
unknown or 
sero-
discordant 
status ('risky 
sex')
No 215 3 mths *Non significant decrease in total number of risky sex 
acts among HIV+ve & -ve participants
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2.4.5 Summary of findings 
The studies assessing the impacts of HTC on reported sexual risk behaviours and 
HIV incidence used different study designs and assessed different outcome 
measures at different periods of follow-up post-intervention, making it challenging to 
synthesize findings. However, in general, studies tended to show reductions in at 
least some sexual risk behaviours, particularly among HIV-positive individuals. 
Findings were mixed among HIV-negative individuals, with some studies reporting 
statistically significant findings and others not, although reassuringly studies 
generally did not find any increases in sexual risk behaviour associated with HTC 
use. The reported sexual behaviours most commonly investigated included condom 
use and numbers of sexual partners, while six studies measured HIV or STI 
incidence following HTC use. 
 
Condom use 
Twenty-one of 23 included studies assessed the impact of HTC on condom use 
behaviour (see Table 2.1). In total, two-thirds of these (14/21 studies) reported 
reductions in levels of unprotected sex or increases in condom use following HTC. 
However, in six studies this was restricted to situations where participants or their 
partners had tested HIV-positive (94, 102, 104, 106-108), while in two studies the 
measures of effect were stronger among individuals testing HIV-positive compared 
to those testing negative (96, 110). In addition, some studies reported increases in 
condom use with some but not all partner types (96, 105) or increases in reports of 
ever having used a condom but not of consistent condom use (111). 
 
Numbers of sexual partners 
Nine of 23 studies assessed the impact of HTC interventions on reported numbers 
of sexual partners. Two RCTs reported associations between HTC use and 
reductions in numbers of sexual partners 18 months (results not stratified by HIV-
status) (98) or 36 months (HIV-positive participants only) (97) post intervention. 
However, evidence for an impact of HTC on numbers of sexual partners from 
observational studies was mixed. Four observational studies reported significant 
reductions in numbers of sexual partners, of which two were conducted among HIV-
positive participants (94, 104), one included both negative and positive participants 
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(results not stratified by HIV status) (93) and one included HIV-negative participants 
only (95). Three other observational studies found no impacts of home-based VCT 
or self-reported prior VCT use on numbers of partners, with two of these including 
HIV-negative participants only (83, 99) and one being undertaken among positive or 
negative participants (results stratified by HIV status) (100).  
 
Incidence of HIV or other STIs 
In total six studies investigated the impact of HTC on the incidence of HIV or other 
STIs. One community cohort study among young people aged 15-24 in South Africa 
reported an association between HTC use and a reduction in HIV incidence (101). 
Two cluster RCTs found no overall impact of HTC on reductions in HIV incidence in 
Zimbabwe (although the study was not powered to detect a difference in HIV-
incidence) (61), or among community members in South Africa, Tanzania and 
Zimbabwe (HIV-incidence was the primary outcome of this study) (97). However, the 
multi-country study did report reductions in HIV-incidence among the sub-group of 
women aged 25-32 (97). Two additional observational studies in Uganda and one 
RCT among pregnant women in South Africa found no impact of home-based or 
enhanced HTC on HIV (83, 99) or STI incidence (109), respectively. 
 
2.4.6 Conclusions 
Overall, the findings of the review suggest that HTC is associated with some sexual 
risk reduction among HIV-positive individuals. However, its impact among HIV-
negative individuals is less clear, with a number of studies reporting no statistically 
significant reductions (or increases) in sexual risk behaviour among this group. The 
measurement of sexual risk behaviour is subject to recall and social desirability 
biases, and it is difficult to assess the extent to which this may have affected study 
findings, particularly given the nature of the intervention. Only a few studies reported 
measures taken to attempt to minimise social desirability bias, such as the use of 
confidential voting systems in Zimbabwe (100) or audio computer-assisted self-
interviewing in one study in Zimbabwe and South Africa (104). A few studies 
included an assessment of the validity of the sexual behaviours reported, including 
correlation of reports made by different members of the same couple (96, 107) or 
the use of sexual diaries and biological markers (107). Encouragingly, these 
assessments generally corroborated the studies’ findings. Many of the studies 
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reviewed were conducted in the early 2000s prior to the scale-up of ART, and those 
which recruited individuals at later time periods did not investigate whether changes 
in sexual risk behaviours might have persisted after the widespread availability of 
ART. Furthermore, of the 23 studies included, only six evaluated study outcomes 
one year or later post implementation of the intervention, and longer term studies 
would help in understanding whether any changes in sexual risk behaviour following 
HTC use can be sustained over time.  
 
The findings from this review are largely in agreement with two previous meta-
analyses which investigated the impacts of VCT on sexual risk behaviours in low 
and middle income countries and included data up to 2010 (22, 23). The first of 
these reported that participants were significantly more likely to report condom use 
after VCT (pooled random-effects OR: 1.69, 95% CI 1.25-2.31, p<0.01), but that the 
significant effect was found primarily in studies which included HIV-positive 
individuals or sero-discordant couples (22). The second review found weak 
evidence for an overall positive impact of VCT on levels of condom use (pooled 
random-effects OR 1.39, 95% CI 0.97-1.99, p=0.08). This effect was significant 
among HIV-positive individuals (pooled random-effects OR 3.24, 95% CI 2.29-4.58, 
p<0.001), but could not be meta-analysed among HIV-negative individuals, as only 
one study provided results separately for HIV-negative participants (23). With regard 
to numbers of sexual partners, the first review found no overall impact of VCT on 
reductions in numbers of partners (pooled random-effects OR: 1.22, 95% CI 0.89-
1.67, p>0.05) (22), while the second review reported that VCT use was associated 
with a reduced likelihood of reporting an increased number of sexual partners 
(pooled random-effects OR 0.69, 95% CI 0.53-0.90, p=0.007), but when stratified by 
HIV-status, this result remained significant only among HIV-positive individuals (23). 
Both reviews reported considerably heterogeneity in the studies included, with some 
articles reporting statistically significant findings and others not. 
 
2.5 HTC and sexual behaviour change: qualitative 
perspectives 
This section reviews theoretical frameworks for understanding processes of sexual 
behaviour change. It also synthesizes qualitative literature on clients’ experiences of 
using HTC, and their perceptions of HIV prevention counselling messages from 
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studies undertaken in sub-Saharan Africa. Such studies may help to explain 
quantitative findings by shedding light on the processes which mediate sexual 
behaviour change. 
 
2.5.1 Theoretical frameworks for understanding sexual behaviour 
change 
Various theories have been proposed in an attempt to understand the underlying 
constructs of health behaviours, including models which focus on factors operating 
at the level of the individual, as well those which take account of broader structural 
or environmental determinants of behaviour (113, 114). Although individual level 
models of behaviour change have some key limitations in attempting to understand 
sexual behaviour change, primarily because they do not take account of socio-
cultural or other environmental influences on behaviour (115, 116), HTC is in itself 
an intervention targeted at the level of the individual (or within the unit of a couple, 
where couple counselling is offered). As such, it seems appropriate to explore its 
role in HIV prevention within the framework of an individual level model of behaviour 
change. 
 
Many individual level models of behaviour change such as the Health Belief Model, 
the Stages of Change Theory or the Theory of Reasoned Action were developed in 
Western settings, and are based primarily on psychological theory (113). The Health 
Belief Model (HBM) was originally developed by social psychologists at the United 
States Public Health Service in an attempt to understand the lack of public 
participation in health screening programmes (117). Since then the model has been 
adapted to explore various health behaviours including sexual risk behaviours and 
HIV transmission (118). The HBM incorporates four core constructs: perceived 
susceptibility to illness, perceived severity of illness, and perceived benefits and 
barriers to taking a particular course of action. The model also acknowledges that 
self-efficacy (belief in one’s ability to change behaviour) and physiological or 
environmental cues also play a role in influencing behaviour (117).  
 
The applicability of the HBM has been tested mainly in developed country settings 
(118), however some studies have assessed its relevance with regard to sexual risk 
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behaviour in developing countries. Studies in Benin (119) and Ghana (120) reported 
that the strongest HBM construct predicting condom use was perceived barriers, 
followed by perceived benefits, perceived susceptibility and self-efficacy. However, 
neither study explored the specific barriers which inhibited condom use, stated by 
Hounton et al simply as ‘problems using condoms’ (119). In another study testing 
the applicability of the HBM in Zimbabwe, external cues and the perceived support 
of friends and partners were found to be the most consistent factors associated with 
sexual risk reduction (121).  
 
The Stages of Change Theory (SOC) was originally developed to assess smoking 
cessation behaviour (122). It consists of five stages along a behaviour change 
continuum including pre-contemplation, contemplation, preparation, action and 
maintenance. ‘Decisional-balance’ is central to this model, which assumes that 
individuals construct a ‘balance sheet’ of pros and cons in relation to performing a 
specific behaviour, and this helps to predict movement across the stages. The SOC 
theory has been most frequently evaluated in developed country settings (123-125). 
However, its individualistic and rather ‘rational’ approach doesn’t take into account 
the dyadic and complex social context within which sexual behaviour occurs, 
particularly in African settings.  
 
The Theory of Reasoned Action (TRA) proposes that intention is the strongest 
predictor of behaviour, and that intention is in turn influenced by individual attitudes 
(positive or negative feelings towards performing a specific behaviour) and 
subjective norms (beliefs regarding how other people view the behaviour, as well as 
how other people interpret one’s own behaviour) (126). As with other models, 
individual agency is a core construct within the TRA, which assumes that behaviour 
is under volitional control and that beliefs about potential consequences help to 
predict behaviours. The model pays some attention to the influence of societal or 
external factors in the form of subjective norms, although the focus remains on 
individual willingness or unwillingness to conform to these. Van Landingham et al 
did a comparative analysis of the utility of the HBM and the TRA in predicting sexual 
behaviours among young men in Thailand (127). They found that the strongest 
predictor of consistent condom use was perceived peer norms about condoms and 
motivation to comply with these, and that the TRA better explained their findings 
when compared to the HBM. However, they also noted that the model did not take 
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account of other important social influences, such as group behaviours (visiting 
commercial sex establishments together with friends), and participants desire to 
partake in and conform to these. 
 
Fishbein proposed an adapted version of the TRA which takes some account of 
external factors in the form of ‘environmental constraints’ (128). This integrated 
model, which draws on aspects of the HBM and social-cognitive theory, proposes 
that there are three primary determinants of behaviour including individual intention, 
the skills an individual possesses in order to perform the behaviour, and 
environmental constraints. Environmental constraints are not specifically defined, 
but might be taken to represent socio-cultural, socio-economic or other 
environmental factors which influence behaviour. The model further posits that 
intentions are influenced by individual attitudes, subjective norms and self-efficacy. 
Fishbein emphasizes that the relative importance of each of the constructs in this 
model will vary depending on the specific behaviour and population under 
consideration, and that as such the model is adaptable and relevant to a broad 
range of socio-cultural settings. However, few studies have assessed its utility in 
predicting sexual risk behaviours in African settings. 
 
The individual-level models of behaviour change discussed above provide some 
potentially useful frameworks within which to assess the role of HTC in sexual 
behaviour change, although they generally place great emphasis on individual 
agency and the ability to enact behaviour change once the required knowledge, 
skills, attitudes and intentions have been acquired. While these concepts may apply 
in developed country settings, they may translate less well to African settings where 
individual agency is less prized and identity is linked strongly to cultural values and 
practices (115).  In the context of HTC use in rural Tanzania, Fishbein’s integrated 
model (128), which attempts to take some account of ‘environmental’ influences on 
behaviour, may prove most useful. As such, this model was used as a starting point 
to develop the conceptual framework which guided the qualitative analyses 
presented in Chapter 8 (Paper D). 
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2.5.2 Responses to HIV-prevention counselling messages among 
clients using HTC 
Several studies have explored HIV-positive clients’ perceptions of HIV prevention 
counselling messages (26-28, 129), however very few have focussed on the 
experiences of clients testing HIV-negative (130). Some studies among HIV-positive 
individuals have reported increased motivation to reduce sexual risk behaviour 
following HTC (28, 29, 131). In one study, reasons given for this included wishes to 
ensure children were not orphaned and were cared for, desires to protect partners 
from physical or psychological suffering, and a sense of moral obligation to prevent 
the spread of HIV infection (29). However, other studies have reported barriers to 
sexual risk reduction among HIV-positive individuals, including wishes to have 
children which were perceived as a barrier to condom use (27), or that sexual 
desires returned as ART led in improvements in health (26, 131). Many studies have 
reported preferences for sex without condoms, particularly among men (26, 28, 
131), or that sex without condoms symbolised a committed and intimate partnership, 
and thus their use within marriage was difficult (26, 132). One study exploring 
responses to HIV prevention counselling messages among individuals testing HIV-
negative found that most participants reported having changed or reduced their 
sexual risk behaviour prior to attending for VCT, and that counselling served to 
consolidate pre-test decisions about risk behaviour rather than to initiate them. This 
study also found that HIV-negative individuals reported a need for greater support in 
the period after testing, such as additional counselling and regular reminders to 
safeguard their negative status (130).  
 
A number of studies have explored the issues surrounding HIV sero-status 
disclosure among individuals testing HIV-positive (129, 133, 134). Fears of stigma 
and discrimination, or of blame for bringing HIV into the relationship, act as barriers 
to disclosure among both men and women (129, 133, 134), while women also fear 
abuse or loss of economic support (135). However, some studies have reported 
positive outcomes after disclosure of HIV-positive status, for example that it led to 
increased support within the relationship, particularly with regard to accessing 
treatment (131). In another study among HIV-positive pregnant women in Tanzania, 
Kilewo et al reported that while almost half of women who did not disclose their 
sero-status feared that it might lead to divorce, nearly all women who did disclose 
their results reported that their relationship continued afterwards (136). 
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A few studies have reported that clients in sub-Saharan Africa may view the utility of 
HTC primarily as a diagnostic tool rather than an opportunity to discuss HIV-related 
risk (137, 138). In an early study exploring community perceptions of a VCT 
programme in rural Uganda, many participants felt that VCT did not lead to any 
changes in sexual risk behaviour or to increases in condom use, which were 
generally viewed in a negative light because they reduced sexual pleasure or broke 
easily (137). Nevertheless, participants expressed a need for VCT services and felt 
that they were useful because they gave clients better knowledge about HIV/AIDS 
and might lead to less stigmatisation of people living with HIV. A number of studies 
have highlighted that behaviour change processes are likely to be iterative, and that 
a single counselling session is unlikely to be sufficient in influencing behaviour (26, 
137), suggesting a need for continued or ongoing counselling.  
 
2.6 Conclusions 
This chapter summarises the findings from studies that have assessed the uptake of 
HTC services in sub-Saharan Africa, as well as their impact in reducing sexual risk 
behaviour and HIV incidence, and clients’ perceptions of HIV prevention counselling 
messages. While it is clear that there have been dramatic increases in the uptake of 
testing in the last ten to fifteen years, there is considerable heterogeneity in uptake 
between countries, and the relative success of different strategies in attracting 
different types of service users and in identifying HIV-positive individuals is less well 
understood. Furthermore, the impact of HTC on sexual behaviour change and HIV-
incidence among HIV-negative individuals is unclear.  
 
Community HIV cohort studies can play an important role in investigating the uptake 
and impact of HTC services as they provide information on HTC use and HIV status, 
as well as other socio-demographic and behavioural characteristics, over extended 
periods of time. As such, they can be used to document the characteristics 
associated with service use and provide estimates of coverage with HTC, as well as 
to investigate the potential impacts of HTC on sexual risk reduction, using both 
quantitative and qualitative methods. 
57 
 
3 Quantitative research methods 
 
This chapter describes the research setting including the demographic surveillance 
activities, community HIV-cohort study and HIV services available in the study area. 
It also describes the methods of data management and preparation for primary and 
secondary data sources, and gives an overview of the statistical methods used in 
quantitative analyses. 
 
3.1 Context 
3.1.1 The research setting 
Kisesa ward is an administrative unit within Magu district in Mwanza region, 
northwest Tanzania (Figure 3.1). It lies approximately 20 kilometres east of Mwanza 
city, the regional capital and Tanzania’s second largest city, and includes seven 
villages, each of which is divided into a number of sub-villages. For the analyses 
presented in this thesis, sub-villages are categorised as being located in rural areas, 
along a main tarmacadam road which runs through the study area, or surrounding 
the study area’s trading centre (Kisesa trading centre). The ward had a population of 
approximately 32,000 people in 2012, the majority of whom belong to the Sukuma 
tribe, Tanzania’s largest ethnic group. The study area is predominantly rural in 
nature with economic activities revolving around small-scale farming and the petty 
trade of agricultural products such as milk, tomatoes, maize, fish and rice. Per capita 
income is low, estimated at approximately 340 US dollars per year in 2011 (139). 
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Figure 3.1 Location of Kisesa ward and study area 
 
 
3.1.2 Kisesa cohort study activities 
The primary research activities conducted as part of the Kisesa cohort study include 
ongoing rounds of biannual demographic surveillance (the demographic surveillance 
system or DSS), and serological surveys (sero-surveys) which are conducted once 
every two to three years. Each of these activities are described in detail below. 
 
Demographic surveillance system (DSS) 
The DSS constitutes a census of the entire population (i.e. including all children and 
adults) of the seven villages which make up Kisesa ward, with 28 rounds of the 
survey having been completed between 1994 and 2013 (see Figure 3.2). At each 
round all households in the study area (including any new households appearing 
since the last round of demographic surveillance) are visited by trained fieldworkers. 
A single individual (usually the head of household, or another well informed 
household member if the household head is not present) responds on behalf of all 
household members, reporting information on residence status of each individual 
(whether alive or dead, whether still living there or moved house within the study 
area, or out- migrated from the study area), any new or returning household 
members, spousal and parent-child links within households, pregnancy among 
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women of reproductive age, births, deaths and, since the fifteenth round of the DSS 
in 2003, number of years of schooling for those aged 5 to 25 (see Appendix 11.2.1 
for an example of the household enumeration form used at DSS round 28 in 2013). 
Response rates during DSS rounds are generally very high (≥98%; households are 
re-visited several times if nobody is present to respond at the initial visit).  For the 
research presented in this thesis, data from DSS rounds 16 to 27 were linked to the 
sero-surveillance data (see below), and these data were used as the denominator in 
quantitative analyses. 
  
Serological surveillance 
In addition to the DSS, seven rounds of serological surveillance (sero-surveys) have 
been completed between 1994 and 2013 (in 1994-1995, 1996-1997, 1999-2000, 
2003-2004, 2006-2007, 2010 and 2013; Seros 1 to 7, respectively, see Figure 3.2) 
as part of the Kisesa cohort study (data from sero-survey rounds 4, 5 and 6 are 
used as part of this thesis). Eligibility for sero-surveys is based on having been 
resident at the most recent round of demographic surveillance (for existing 
household members, having responded ‘yes’ to DSS question ‘Still live here?’, or for 
new or returning members of the household, classified as ‘resident’ – see DSS 
enumeration form in Appendix 11.2.1) and being aged 15-44 (Sero1), 15-46 (Sero2) 
or 15 or older (all subsequent rounds) at the time of the sero-survey. During sero-
surveys, eligible individuals are invited to a central location within each village in 
order to participate. Transport to the sero-survey site is provided free of charge for 
all study participants. Separate consent is provided for each element of the study 
(i.e, participants may choose to participate in any single element of the study without 
being required to participate in other parts of the study), including completion of a 
structured interview questionnaire with a trained researcher, provision ofa finger-
prick blood sample for research HIV testing, and since Sero4 in 2003-2004, optional 
use of a voluntary mobile or community outreach HTC serviceAll study participants 
are also offered free medical treatment for any health problems present at the time 
of the sero-survey, for themselves and any accompanying family members. 
 
During sero-surveys, study participation occurs in the following chronological order: 
registration, completion of the interview questionnaire, provision of a finger prick 
blood sample, visit to the study clinician or nurse for a medical consultation, and 
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participation in HTC. Each element of the study takes place in a separate purpose 
constructed hut or room (making use of existing village infrastructure where 
possible) in order to ensure privacy. Interview questionnaires are administered by 
trained, same sex researchers in Swahili or in the local language Sukuma if 
appropriate, and cover topics on family planning and sexual health, HIV and ART 
knowledge, partnerships, sexual behaviour and use of HIV and other health services 
(see Sero6 questionnaire provided as an example of a typical sero-survey 
questionnaire in Appendix 11.2.2).  Data from the DSS can be linked to the sero-
survey data using unique identifiers assigned to study participants, providing access 
to additional information on spousal links between those attending sero-surveys, 
recent changes in marital status, or periods of in and out-migration from the study 
area..  
 
Research HIV testing during sero-surveys is anonymous and based on informed 
consent without results disclosure. During Sero1 whole blood was collected by 
venepuncture. From Sero2 onwards all samples were collected as dried blood spots 
on filter paper. HIV testing is performed at the regional reference laboratory at the 
National Institute for Medical Research (NIMR) in Mwanza city, with serologic 
diagnosis based on two ELISAs (Enzygnost HIV1/HIV2 (Behring, Marburg, 
Germany) and Vironostika HIV-MIXT (Organon, Boxtel, the Netherlands) for Seros 
1-3, Enzygnost HIV1/HIV2 (Behring, Marburg, Germany) and Uniform 2 
(BioMerieux, Boxtel, the Netherlands) for Seros 4-7). At all rounds blood samples 
with reactive results for both ELISAs were considered to be HIV positive, with 
Western blot tests used in the case of discordant results at Sero1, and repeat 
testing of samples using the two ELISA tests from Sero2 onwards. 
 
Participation in sero-surveys has declined over time, from approximately 85% at 
Sero1 (5,642/6,672 of all those eligible participating) to 55% at Sero6 (6,511/11,946 
of all those eligible participating). Table 3.1 below shows the distribution of 
participation in sero-survey rounds 1 to 6 by sex and age-group. Declines in 
participation have been greatest among men aged 25-54 living in roadside villages 
or in the trading centre (140), likely as a result of out-migration for work (the 
implications of declining participation for the study’s results are considered in the 
thesis discussion). 
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Table 3.1: Distribution of participation in sero-survey rounds 1-6 by sex and age-group 
 
*Note that all Sero6 figures are preliminary – the final breakdown of Sero6 participation by sex and age-group is not yet available, although the pattern is not 
expected to change significantly from the figures shown here.
Sero1 Sero2 Sero3 Sero4 Sero5 Sero6*
Eligible Attended (%) Eligible Attended (%) Eligible Attended (%) Eligible Attended (%) Eligible Attended (%) Eligible Attended (%)
Men
15-24 1600 1328 (83.0) 1750 1371 (78.3) 1826 1204 (65.9) 2148 1593 (74.2) 2307 1629 (70.6) 2150 1084 (50.4)
25-34 979 806 (82.3) 1054 819 (77.7) 1093 702 (64.2) 1297 859 (66.2) 1241 658 (53.0) 1026 428 (41.7)
35-44 562 455 (81.0) 670 503 (75.1) 756 508 (67.2) 913 600 (65.7) 863 468 (54.2) 808 367 (45.4)
45-54 31 19 (61.3) 102 81 (79.4) 434 289 (66.6) 506 331 (65.4) 594 357 (60.1) 606 282 (46.5)
55+ 2 0  (0) 7 3 (42.9) 527 375 (71.2) 639 481 (75.3) 643 442 (68.7) 688 364 (52.9)
Overall participation 
men 3174 2608 (82.2) 3583 2777 (77.5) 4636 3078 (66.4) 5503 3864 (70.2) 5648 3554 (62.9) 5278 2525 (47.8)
Women
15-24 1584 1395 (88.1) 1720 1488 (86.5) 1751 1345 (76.8) 2206 1691 (76.7) 2336 1786 (76.5) 2089 1277 (61.1)
25-34 1223 1066 (87.2) 1338 1163 (86.9) 1474 1154 (78.3) 1695 1260 (74.3) 1714 1212 (70.7) 1561 924 (59.2)
35-44 669 561 (83.9) 804 682 (84.8) 953 736 (77.2) 1187 889 (74.9) 1150 777 (67.6) 1223 727 (59.4)
45-54 15 11 (73.3) 116 92 (79.3) 558 441 (79.0) 689 509 (73.9) 764 520 (68.1) 825 460 (55.8)
55+ 7 1 (14.3) 11 5 (45.5) 672 516 (76.8) 798 579 (72.6) 909 684 (75.2) 970 598 (61.6)
Overall participation 
women 3498 3034 (86.7) 3989 3430 (86.0) 5408 4192 (77.5) 6575 4928 (75.0) 6873 4979 (72.4) 6668 3986 (59.8)
Overall participation 
men and women 6672 5642 (84.6) 7572 6207 (82.0) 10044 7270 (72.4) 12078 8792 (72.8) 12521 8533 (68.1) 11946 6511 (54.5)
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3.1.3 HIV testing and counselling services during sero-survey rounds 
During Sero3 in 1999-2000, a voluntary HTC service was provided by a trained 
counsellor who followed the sero-survey team, however less than 1% of study 
participants used the service. Since Sero4 in 2003-2004, a mobile voluntary 
community outreach HTC  (CO-HTC)clinic has been set up within pre-existing 
buildings or temporary purpose constructed huts within each village, and routinely 
offered to all study participants. The CO-HTC service is offered for the duration of 
the sero-survey - i.e. for approximately one month in each village. The clinic is 
located close to the main sero-survey site where interview questionnaires are 
completed. CO-HTC services are provided according to Tanzanian national VCT 
guidelines (6) by trained counsellors who come from outside the study area. 
However, some counsellors providing HTC services during sero-surveys also 
provide HTC at a walk-in clinic at the study area’s main health centre (see Section 
3.1.4 below). The study numbers of those using the CO-HTC service are 
anonymously linked to the main sero-survey questionnaire data using unique, 
numeric participant identifiers. 
 
At Sero4, venous blood was collected from CO-HTC clients and transported to the 
NIMR laboratory in Mwanza for testing, with diagnosis based on two ELISAs as for 
research tests. Clients were asked to return for their test results and post-test 
counselling one week later, at the same location where testing had been performed. 
During Sero5 in 2006-2007 and Sero6 in 2010 venous blood was again collected but 
rapid HIV screening tests were used (preliminary test using Capillus, confirmatory 
test using Determine. If the preliminary test was positive and the confirmatory test 
was negative, the sample was sent for testing using two ELISAs as for research 
tests. Quality control was performed on a 5% sub-sample of rapid tests using two 
ELISAs as for research tests, at the NIMR laboratory in Mwanza). Where rapid HIV 
tests were used (i.e. from Sero5 onwards), results and post-test counselling were 
usually delivered to clients within 45 minutes of the test being performed.  
 
During post-test counselling, clients with an HIV negative result were counselled 
about risk reduction and HIV prevention strategies, and encouraged to repeat HTC 
three months later for those potentially in the window period for infection, or 
otherwise at a later date in the future. Clients with a positive test result were advised 
on strategies to reduce the risk of onward transmission and on healthy living with 
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HIV. During Sero4 in 2003-2004, which was before free availability of ART in 
Tanzania, individuals testing HIV-positive were informed that treatment would 
become available in the near future through the Tanzanian national ART 
programme, which started at the end of 2004. With their prior agreement, these 
individuals were subsequently traced by the HTC counsellors and referred to an HIV 
care and treatment centre (CTC) at the zonal referral hospital (Bugando Medical 
Centre) in Mwanza city 20 kilometres away, which opened at the beginning of 2005. 
Individuals testing HIV-positive at Sero5 were referred for follow-up care at one of 
two Mwanza CTCs (either Bugando Medical Centre or Sekou Toure regional 
hospital), while those testing positive at Sero6 were referred directly to a local CTC 
which opened within the study area’s health centre at the end of 2008 (see Figure 
3.2).
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Figure 3.2 Timeline of Kisesa cohort study activities and availability of HIV services in the study area 
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3.1.4 Other HIV testing and counselling services in the study area 
The study population is served by a government-run health centre located in Kisesa 
trading centre - Kisesa Health Centre (see Figure 3.3). A voluntary walk-in HTC (WI-
HTC) clinic opened at the health centre in March 2005, with services delivered free 
of charge and according to Tanzanian national guidelines (6), as during sero-
surveys. The WI-HTC was initially based in NIMR field offices but subsequently 
transferred to a purpose-built clinic in June 2006. The WI-HTC includes two 
dedicated counselling rooms and a waiting room and is usually staffed by one or two 
trained counsellors dependant on financial resources, some of whom also provide 
the HTC services offered during sero-surveys. Rapid HIV tests are used to test 
finger-prick blood samples, with results usually available within 30-45 minutes of 
tests being performed (preliminary test using Capillus until April 2006, Bioline 
thereafter. Confirmatory test using Determine. A third discriminatory test (Unigold) is 
used in the case of discordant test results). 
 
Between 2005 and 2008, clients testing HIV-positive at the WI-HTC clinic at Kisesa 
Health Centre were referred to CTCs at Mwanza city hospitals (Figure 3.2). Since 
the end of 2008, clients have been referred directly to the CTC located within the 
health centre. At this time, Kisesa residents already receiving HIV care at Mwanza 
city hospitals were given the option of transferring to Kisesa CTC if they were stable 
on ART and wished to do so. Services provided at Kisesa CTC include CD4 counts 
(since 2012) and prescriptions for opportunistic infections and ART, which is 
prescribed in accordance with Tanzanian national protocol, based on WHO 
guidelines. 
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Figure 3.3 Images of Kisesa Health Centre  
(Images reproduced with permission from Annabelle Gourlay) 
   
 
     
 
   
Top left: Kisesa Health Centre WI-HTC (labour and delivery ward in background). Top right: Kisesa 
CTC. Middle left: entrance to Kisesa WI-HTC. Middle right: WI-HTC waiting area. Bottom left: 
Counselling room. Bottom right: entrance to Kisesa CTC. 
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Since the roll out of a prevention of mother-to-child transmission (PMTCT) 
programme at Kisesa Health Centre at the end of 2008, provider-initiated testing 
and counselling (PITC) has been routinely offered to all pregnant women attending 
the health centre antenatal clinic (ANC) (Figure 3.2). Prior to this, smaller numbers 
of pregnant women were referred for antenatal HIV testing at the WI-HTC if they had 
symptoms suggestive of HIV infection, or if they requested to be tested. As part of 
the PMTCT programme, pre-test counselling usually takes place in a group rather 
than individual format, but delivery of test results and post-test counselling are 
conducted individually, in accordance with national guidelines (9). Pregnant women 
who do not wish to receive PITC may opt out, although in practice many women 
accept testing (141). While antenatal PITC is usually conducted at the ANC by 
trained nurse counsellors, women are sometimes referred to the WI-HTC, 
dependant on staffing and test kit availability at the ANC. 
 
In theory PITC has been offered to patients attending out-patients clinics at Kisesa 
Health Centre since 2010, including a sexually transmitted infections clinic and a 
tuberculosis clinic. In practice the numbers of patients who have been offered these 
services are very small, with reported reasons for this including high patient volume 
resulting in lack of time to provide PITC, lack of training for clinical staff and 
inadequate HIV test kit supplies (Denna Michael, personal communication August 
2014). 
 
In addition to the services provided at the health centre, the population in Kisesa is 
served by three small dispensaries located in the rural villages of Igekemaja, 
Welamasonga and Ihayabuyaga. These provide basic outpatients and maternal and 
child health services. Since mid-2009 antenatal PITC is usually offered to pregnant 
women attending the rural dispensaries, dependant on the availability of test kit 
supplies, however HTC services for the general population are not available. Figure 
3.4 and Figure 3.5 show the locations of the health facilities in Kisesa ward. 
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Figure 3.4 Map of Kisesa ward showing clinics and locations of households 
Clinics in Isangijo, Kanyama and Kitumba are only available temporarily during sero-
survey rounds.  (Map reproduced with permission from Jocelyn Poppinchalk). 
 
Figure 3.5 Map of Kisesa ward showing mean distances to sero-survey clinics 
and percentage of population classified as rural. 
(Map reproduced with permission from Jocelyn Poppinchalk). 
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3.1.5 HIV prevention activities and support for HIV-positive persons in 
Kisesa ward 
Since the start of the Kisesa cohort study in 1994, various HIV prevention activities 
linked to district level HIV prevention programmes have been implemented (142). 
These include the establishment of village AIDS committees, school interventions 
and education campaigns to reduce high-risk sexual behaviour, and the provision of 
periodic outreach testing campaigns within villages or at community events, e.g. on 
World AIDS Day. 
 
Between 2005 and 2008, a community-based organisation, TUMAINI, provided 
home-based care and related support services to HIV-positive persons in several 
wards in Mwanza Region, including Kisesa. A community volunteer was usually 
available to escort clients testing HIV-positive to CTC sites in Mwanza city for their 
first appointment, and to act as a treatment support partner for some clients. The 
TAZAMA project also provided a transportation allowance for HIV-positive patients 
travelling to attend appointments at CTC sites in Mwanza city (2,000 Tanzanian 
shillings or approximately £0.80 per appointment), until the CTC opened at Kisesa 
Health Centre at the end of 2008, when patients could access services locally. 
 
3.2 Data entry and management 
3.2.1 Demographic surveillance system and sero-survey data 
(secondary datasets) 
Demographic surveillance system and sero-survey data were double-entered using 
CSPro 4.0 (143). Geographic identifiers were constructed for participants of the 
demographic surveys based on their current place of residence, and linked to 
unique study numbers assigned to sero-survey participants. Data on HIV research 
tests and CO-HTC attendance were anonymously linked to sero-survey data using 
unique participant identifiers. 
 
Data on socio-demographic characteristics collected during sero-surveys included 
sex, date of birth, ethnicity, religion, marital status, income generating activities 
performed and level of education. Sexual behaviour variables included age at first 
sex, numbers and types of sexual partners and condom use with different partner 
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types (see Sero6 questionnaire in Appendix 11.2.2). Information on marital status 
was also collected during recent DSS rounds allowing for the construction of marital 
status change variables, which represented marital status at the DSS round 
preceding a sero-survey compared to marital status reported at the sero-survey. The 
unique identifiers of spouses were also recorded during DSS rounds; these could be 
linked to sero-survey data to anonymously identify spousal HIV and HTC use status 
at each round. Sero-survey questionnaires also captured information on participants’ 
previous use of HTC services within or outside the study area. Further details 
relating to preparation of data for the analyses presented in this thesis can be found 
in each of the individual results chapters. 
 
3.2.2 Newly collected data (primary datasets) 
A major component of the analyses presented in Chapter 4 (Paper A) involved the 
entry and linkage of data from the WI-HTC clinic at Kisesa Health Centre to the 
cohort study datasets. Few research sites in Africa have implemented systems to 
link population-level data from DSS sites to health facility datasets. Methods for 
retrospective record linkage (i.e. after the time point of clinic access) are still in 
development but are largely based on matching records on personal attribute data 
that are common to both datasets (e.g. name, date of birth, sex, residence 
information) (144). However, records corresponding to the same individual rarely 
match exactly on these identifiers, due to spelling errors, use of nicknames, masking 
of real names, change in last name after marriage, interchanging middle and last 
names, poor recall of date of birth, or change in place of residence. The procedure 
for matching records must therefore employ a probabilistic approach whereby 
match-scores are calculated which represent a measure of the similarity between 
individual identifiers in each of the two datasets (the alternative deterministic 
approach relies on an exact match on personal attributes, or a unique identifier 
between datasets). Weights, representing the relative importance of a match on 
each individual identifier (in terms of maximising the sensitivity and specificity of 
matching) are then applied and used to generate an overall match score for each 
pair of records. 
 
The aim of the record linkage work between the WI-HTC clinic data and the Kisesa 
cohort study dataset was to automate the matching procedure given the large 
volume of records (in the order of 30,000 DSS records and 18,000 WI-HTC clinic 
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records), and to make the process as reproducible and objective as possible. The 
process of preparing the datasets for linkage and implementing the linkage 
algorithm consisted of several steps including: i) Entry and cleaning of the WI-HTC 
clinic data; ii) Creating a gold standard dataset and designing a scoring and 
weighting scheme (the linkage algorithm) which could be used to match the clinic 
and DSS records using Structured Query Language (SQL) iii) Testing the linkage 
algorithm developed to ensure it was running correctly, which involved viewing the 
results of the matching and then refining the algorithm and re-processing the 
matches (numerous iterations); iv) Validating the final match set produced by the 
linkage algorithm, including resolving cases of multiple matches (multiple DSS 
records chosen as a match for one clinic record and vice versa). The scoring 
scheme for the linkage algorithm was initially designed by a senior data manager 
based at NIMR Mwanza (Benjamin Clark), however, I was involved in various stages 
of model development. These steps and my role in each of them are described in 
further detail below. 
 
3.2.3 Entry and cleaning of data from the WI-HTC clinic 
Since July 2009, two TAZAMA-designed registration books have been completed by 
counsellors at the WI-HTC clinic (in addition to the standardised government 
logbooks which have been used at the clinic since it opened in 2005. Counsellors 
receive a monthly salary supplement from the TAZAMA Project in order to complete 
the TAZAMA registration books, as well as for completion of TAZAMA-designed 
referral forms which are used to monitor access to CTC services among HIV-
positive individuals). The first TAZAMA WI-HTC (or VCT) registration book includes 
a unique numerical identifier (ID) which is assigned for each test visit, information on 
personal identifiers (client name, age, sex, village of residence) and data on a 
number of socio-demographic variables (marital status, occupation, religion, level of 
education), with standardised codes used to categorise data (see registration book 
template in Appendix 11.2.3). In the case of repeat testing visits at the WI-HTC, 
counsellors attempt to record the unique ID number corresponding to a client’s first 
test visit in a second identifier field, as a means to link repeat visits by the same 
client together. However, this is dependent upon the client presenting a test card 
which contains the ID number corresponding to his or her first visit (see client ID 
card template in Appendix 11.2.4), or by the counsellor tracing back through the 
registration books to find the entry corresponding to the reported date of the first 
visit, if no ID card is presented. This system is unlikely to capture all repeat visits 
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made by individual clients at the WI-HTC, although the extent of missed repeat visits 
is unknown.  
 
HIV test results are entered into a second book, for which a standard template has 
not yet been designed and rule-lined ‘counter’ books are used (see Appendix 
11.2.5). This book contains fields for the VCT client ID number (referred to as 
‘sample number’ in older versions of the tests results books (up to June 2009). The 
unique test visit ID number should be entered into this field, but sometimes the 
repeat test visit ID is used), test date and rapid test results.  
 
Data from the main WI-HTC registration books covering the periods March 2005-
June 2009 (government logbook data) and July 2009-June 2010 (TAZAMA 
registration books) had already been entered as two separate datasets. I undertook 
further work to coordinate entry of the TAZAMA registration books covering the 
period July 2010-November 2012, and to merge all the WI-HTC main registration 
data together to obtain one master dataset. The entry of the TAZAMA registration 
books covering the period July 2010-November 2012 involved the creation of a new 
CS-Pro data entry tool in order to standardise WI-HTC data entry with other data 
entry systems used by the TAZAMA Project, and was managed by a senior clinic 
data manager based at NIMR Mwanza (Clemens Masesa). I oversaw the data entry 
process and provided administrative and technical support, identifying the relevant 
logbooks for data entry, developing the edit checks, and advising on initial data 
cleaning procedures. I carried out further extensive cleaning on the merged WI-HTC 
data, relating particularly to issues around client ID numbers (unexpected duplicates 
within the field which should have contained a unique ID number for each test visit 
(this sometimes represented the same client and sometimes different clients). 
Erroneous duplicates where the second ID number recorded against repeat testing 
visits actually represented different clients). I also coordinated the entry of all the 
HIV test results books, none of which had been entered before, including advising 
on the creation of CS-Pro data entry screens, edit checks and data cleaning 
procedures. I subsequently linked these test result data to the main WI-HTC 
registration books.  
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Linkage between the main WI-HTC registration data and the test results books was 
achieved using the unique test visit ID number (where this had been recorded in the 
test results book), or otherwise a combination of the repeat client ID number and 
date (where the repeat client ID number was recorded in test results book), or a 
combination of repeat client ID number, date, age and sex (where there were 
erroneous duplicates on repeat client ID number and date (clients cannot test more 
than once on the same day; these records represented more than one individual)) 
(see Table 3.2). I also manually reviewed approximately 2,600 records in the main 
WI-HTC registration data for which no matching test result could be found. These 
steps resulted in a matching test result being found for 81.7% (14,514/17,775) of the 
main registration data (Table 3.2), while for the remaining 18.3% (3,261/17,775) no 
matching test results were found. 
 
Table 3.2 Steps taken to match test results to WI-HTC clinic main registration 
data 
Variables or methodology used to 
match records 
Number (%) of WI-HTC 
main registration records 
for which a matching test 
result was found 
Unique test visit client ID number 11,558/17,785 (65.0%) 
Repeat client ID number, date 1,258/17,785 (7.1%) 
Repeat client ID number, date, age 
and sex 1,343/17,785 (7.6%) 
Manual review of remaining 
unmatched main registration and test 
result data 355/17,785 (2.0%) 
Total number (%) of main 
registration records matched 14,514/17,775 (81.7%) 
 
3.2.4 Linkage of records from the WI-HTC clinic to the cohort datasets 
Creation of a gold standard dataset and development of the linkage algorithm 
The gold standard dataset was developed by the senior data manager manager 
based at NIMR Mwanza and contained known or deterministic links (i.e. based on a 
unique identifier) between those who used the CO-HTC service provided during 
Sero6 and their corresponding cohort record, and also contained the same set of 
personal identifiers reported in each dataset (i.e. in the main sero-survey 
questionnaire and in the HTC register). There were 3,718 record pairs in the gold 
standard dataset, 338 of which were true matches. The remaining 3,380 records in 
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the gold standard dataset represented intentionally mismatched pairs, which 
included the top ten closest (in terms of total score) non-matches from the cohort 
data for each CO-HTC user. The intentionally mismatched pairs were chosen in 
order to train the linkage algorithm to distinguish between true matches and other 
similar high-scoring records which were not correct matches. The gold standard 
data were used to train and develop a scoring scheme and weights to be used by 
the linkage algorithm, using the solver tool in Microsoft Excel. In consultation with 
the data manager, I reviewed the output of several iterations of the scoring and 
weighting scheme in order to maximise the sensitivity and specificity of the linkage 
algorithm. This involved plotting the ranges of scores obtained for true-matches, true 
non-matches and mis-matches (false positives, false negatives) for each of the 
matching variables, and tweaking the match-scores and weighting schemes used in 
order to try and pull apart, as far as was possible, the distributions of scores for true 
matches and true non-matches. Details of the final scoring scheme that was used 
and the weights applied by the linkage algorithm applied are provided in Appendix 
11.3. 
 
I undertook a similar process of review and feedback of the linked datasets that 
were produced by the data manager after running the linkage algorithm in SQL. I 
helped to scrutinize the performance of the algorithms, including assessing the total 
number of linkages made (linkage rate) and number of DSS records matched to 
each clinic ID, and alerted the data manager to any possible errors in the code that 
were preventing the algorithms from running correctly. After dropping erroneous 
repeating HTC client IDs which represented different individuals, the final linked 
dataset outputted by the algorithm contained a total of 10,289 HTC clinic IDs which 
had been linked to at least one DSS record. This represented an overall linkage rate 
of 93.6% (10,289 of 10,994 Kisesa resident clients covering the period March 2005-
November 2012). However there were a number of issues to resolve including large 
numbers of potential DSS matches for each clinic ID, and cases where the same 
DSS record had been matched to more than one clinic ID. 
 
Validating the match set produced by the linkage algorithm 
I carried out all of the validation steps described here. The vast majority of clinic ids 
(10,146/10,289 or 98.6%) had more than one potential DSS match in the final 
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dataset produced by the linkage algorithm. Many of the multiple matches would 
likely reflect the same individual who had moved residence within the study area 
and been assigned a different DSS identifier in the new household. However, for 
some records, particularly those with very large numbers of low-scoring multiple 
matches, there was likely to be a considerable number of false positives. A series of 
steps was therefore implemented in order to reduce the number of potential 
matches for each clinic record and select the best match. These steps are described 
briefly below and in detail in Table 3.3. 
 
First, residency episode and event data were merged in from the DSS in order to 
drop match-pairs where the matched DSS individual was last seen in the study area 
before 2004 (more than a year before WI-HTC clinic opened in March 2005), or 
where the matched DSS individual was reported as having died before the date of 
the clinic visit. Next, a distance variable was created which represented the closest 
overlap (in number of days) between periods of residency in the study area and 
clinic visit dates (zero where the clinic visit overlapped exactly with a period of 
residence in the study area, otherwise the number of days between the clinic visit 
and date of entry into the study area (if clinic visit date before date of entry) or date 
of exit from the study area (if clinic visit date after date of exit)). Cases of multiple 
DSS matches per clinic ID were dropped by keeping a single top-scoring DSS 
match for each clinic record. If match-pairs were tied on top-score, the DSS record 
with the closest distance between the clinic visit date and period of residency in the 
study area was chosen. For a small proportion of records which were tied on both 
top-score and distance, the best match was selected at random. 
  
The resulting one to one linked dataset (one DSS match per clinic record) contained 
cases where the same DSS individual had been chosen as a top-scoring match for 
more than one clinic ID number. It was possible that different clinic ID numbers 
represented the same person, if counsellors were not always successful in recording 
the original unique test visit ID number against new ID numbers for those with return 
or repeat visits. Alternatively, the different clinic ID numbers may have represented 
different people, with the requirement that just one be chosen as the best match for 
the DSS record. Due to the large volume of cases in which one DSS record had 
been linked to more than one clinic ID (4,824/10,264 or 47% of all records in the one 
to one linked dataset), it was not feasible to manually review records to attempt to 
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identify whether different clinic IDs linked to the same DSS number represented one 
or more than one person. For these cases, a single best clinic ID-DSS match pair 
was kept, using the same approach as described above for eliminating multiple DSS 
matches per clinic ID (top-scoring match pair kept. Match-pair with closest distance 
between clinic visit and period of residency in the study area chosen if records were 
tied on top-score, or selected at random for a small proportion of records which were 
tied on both top-score and distance variable).
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Table 3.3 Detailed description of steps taken to validate the final match-set outputted by the HTC clinic-to-cohort linkage algorithm 
 Validation step Overall 
linkage rate 
(% of 
Kisesa 
resident 
HTC clients 
retained) 
Number (%) 
of linked 
HTC client 
IDs 
retained at 
each step 
Number of 
linked 
clinic-DSS 
record 
pairs 
retained 
0 Full linked dataset containing all HTC client IDs between March 2005-November 2012 which were matched by 
the algorithm to the cohort dataset (n=10,289), and all potential DSS matches for each WI-HTC client ID 
(n=2,140,196 record pairs). 
 
10,289/ 
10,994  
(93.6 %) 
10,289/ 
10,289 
(100%) 
2,140,196/
2,140,196 
1 Merged DSS residency episode data into linked dataset.  
(i) Dropped record pairs where matched DSS individual last seen in the study area before 2004 (more 
than a year before the WI-HTC opened).  
(ii) Dropped record pairs where matched DSS individual reported as having died before date of HTC visit, 
with buffer of six months around date of death in order to account for reporting inaccuracies. Where 
client had >1 HTC visit, date of most recent visit used to complete check for this and subsequent 
steps. 
 
10,264/ 
10,994 
(93.4%) 
10,264/ 
10,289 
(99.8%) 
1,688,608/
2,140,196 
2 Created a one to one linked dataset: chose a single best DSS match for each individual HTC client ID. 
(i) Created a ‘distance’ variable representing closest overlap between periods of residency in the study 
area and HTC visit date. Distance is zero where HTC visit date falls within a period of residency in the 
study area – i.e. after date of entry into study area and before date of exit from study area. Where 
clinic visit date falls outside a period of residency, distance represents number of days between HTC 
visit date and date of entry into study area (if HTC visit date before date of entry) or number of days 
between HTC visit date and date of exit from study area (if HTC visit date after date of exit).  
(ii) Eliminated multiple DSS matches per HTC clinic ID by keeping top-scoring DSS match for each clinic 
ID. Where top-scoring DSS match was tied, kept the match with smallest ‘distance’ between HTC visit 
date and closest period of residency in the study area. Where DSS matches tied on top score AND 
closest distance, best DSS match selected at random. Dataset now contained one DSS match per 
HTC clinic ID. 
10,264/ 
10,994 
(93.4%) 
10,264/ 
10,289 
(99.8%) 
10,264/ 
2,140,196 
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 Validation step Overall 
linkage rate 
(% of 
Kisesa 
resident 
HTC clients 
retained) 
Number (%) 
of linked 
HTC client 
IDs 
retained at 
each step 
Number of 
linked 
clinic-DSS 
record 
pairs 
retained 
3 Resolved cases where same DSS individual matched to more than one HTC clinic ID. 
(i) It was possible that different clinic ID numbers represented the same person, if counsellors were not 
successful in recording original unique test visit ID numbers against new test visit ID numbers for 
those with repeat visits.  
(ii) Alternatively, the different test visit ID numbers represented different people, and one had to be 
chosen as the best match for the DSS record. 
 
Without performing a manual review, it was not possible to determine whether cases fell into scenario (i) or (ii) 
above. Due to the large volume of cases involved (47.0% of all record pairs), only one HTC clinic ID-DSS match 
pair was kept for cases where the same DSS individual had been matched to more than one clinic ID. Same 
procedure used for selection of best clinic ID-DSS match pair to keep as described in step 2 above (top scoring 
match pair was kept. Where match-pairs tied on top score, pair with closest residency episode overlap was kept. 
Where match-pairs tied on top-score AND residency episode overlap, best match-pair kept at random). 
 
6,927/ 
10,994 
(63.0%) 
6,927/ 
10,289 
(67.3%) 
6,927/ 
2,140,196 
4 Manual review of every 100th match-pair, sorted in order of descending match-score. This revealed a score 
threshold below which the validity or accuracy of match-pairs was in doubt, and so records below this threshold 
were dropped. The final linked dataset contained 4,046 HTC clients linked to a DSS record (1,955 (48.3%) of 
whom were sero-survey attendees). 
4,046/ 
10,994 
(36.8%) 
4,046/ 
10,289 
(39.3%) 
4,046/ 
2,140,196 
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After de-duplication the linked dataset contained 6,927 unique clinic IDs linked to 
one DSS record. This dataset was sorted in descending match-score order and 
clerical review of every 100th record-pair was undertaken. The review revealed a 
total match-score below which the validity or accuracy of the match-pairs was in 
doubt, and so records below this threshold were dropped. The final linked dataset 
available for analyses contained 4,046 unique clinic IDs which had been linked to a 
DSS participant, representing a linkage rate of 36.8% (4,406 of 10,994 Kisesa 
resident clients contained within the HTC clinic dataset covering the period March 
2005-November 2012). Of the 4,046 HTC clients linked to a DSS record, 1,955 
(48.3%) were sero-survey attendees. 
 
The final linked dataset had low sensitivity, estimated at 17.8% based on the 
proportion of correctly matched gold standard links contained within the dataset, but 
a positive predictive value (PPV) of 68.9%. At the expense of further loss in 
sensitivity, the PPV could be increased to 78.5% and 85.0% by placing additional 
restrictions on the parameters for final match-pairs accepted. These restrictions 
included i) accepting match-pairs only where the distance or overlap between the 
clinic visit date and the closest period of residency in the study area was not greater 
than one year (PPV 78.5%), or applying this restriction and also only accepting 
match-pairs where the match-score for sub-village was at least 0.4 or higher (score 
range 0 to 1. Sub-village was found to be a good discriminator between true-
matches and true non-matches in the gold standard data. PPV 85.0%). 
 
3.3 Statistical analyses 
All statistical analyses were conducted in Stata 12 (StataCorp, Texas, USA). All 
statistical tests used were two-tailed and interpreted at the 5% significance level. 
 
For the analyses which looked at the uptake of HTC services (either CO-HTC use 
during sero-surveys, or clients testing at the WI-HTC or via ANC-HTC), explanatory 
variables were prepared using questions from the sero-surveys and linked 
information from the DSS. HIV status was based on sero-survey research test 
results. Socio-demographic, behavioural and clinical risk factors for service use 
were investigated separately by sex using a priori hypotheses, drawing on factors 
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identified in the literature or associated with access to other HIV services in Kisesa 
(42, 43). Data were first analysed using cross tabulations and chi square tests to 
explore associations between exposure variables and HTC use. Logistic regression 
models were used to compare the characteristics of those who tested and didn’t test 
in crude and adjusted analyses. Multivariable models were fitted using a forward-
stepwise approach and including all variables significant in univariable analyses at 
the p≤0.10 level. Likelihood ratio tests were used to assess the inclusion of variables 
in multivariable models (variable retained if it significantly improved model fit at the 
p≤0.10 level). Interactions were explored between HIV status and other 
characteristics found to be strongly associated with HTC use in this setting (area of 
residence, level of education and previous HTC use), and retained where 
statistically significant. 
 
The denominator for analyses which explored CO-HTC use during sero-survey 
rounds included all sero-survey attendees. For the analysis of risk factors for WI-
HTC and ANC-HTC uptake using the linked clinic-cohort dataset, some cohort 
participants were initially matched to a WI-HTC or ANC-HTC clinic record but then 
dropped during the validation procedures which created the final linked dataset. The 
analyses assessing risk factors for WI-HTC and ANC-HTC use among sero-survey 
attendees therefore used case-control methods, because the dataset did not contain 
the full denominator of all sero-survey attendees. For WI-HTC use, cases were 
defined as Sero6 attendees who were linked to a WI-HTC client with a clinic visit 
occurring within two years after participation in Sero6 (Sero6 was in 2010 and WI-
HTC clinic data were available up to 2012. Given the potential for reverse causality, 
as sexual behaviours are hypothesized to change as a result of attending HTC, 
explanatory variables from the sero-survey and DSS were taken as measured prior 
to the time of HTC service use. Only clinic visits occurring up to three years after 
participation in a sero-survey were considered, in order to ensure that data had 
been recently collected). Controls were defined as Sero6 participants who were not 
linked to any WI-HTC clinic record. 
 
For the analysis of risk factors associated with ANC-HTC use, women attending 
either Sero5 or Sero6 were included in order to increase sample size. Cases were 
defined as either i) women who participated in Sero5, reported a pregnancy 
between 2007-2010 and were linked to an ANC-HTC client with a testing visit within 
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three years of Sero5, or ii) women who participated in Sero6, reported a pregnancy 
between 2010-2012 and were linked to an ANC-HTC client with a testing visit within 
two years of Sero6. Controls were women who participated in either Sero5 or Sero6, 
reported a pregnancy between 2007-2010 (Sero5 attendees) or 2010-2012 (Sero6 
attendees) and were not linked to any ANC-HTC clinic record. 
 
Trends in coverage, i.e. the proportion of persons repeat testing or testing at 
different service types, were assessed using data on known HTC use (i.e. linked 
CO-HTC or clinic based HTC use) or on reported HTC use as indicated in 
responses to sero-survey questionnaires. The analyses which investigated risk 
factors for repeat testing relied on known CO-HTC use during sero-surveys, due to 
variability in completeness of reporting of previous HTC use during sero-surveys, 
and in identification of repeat testers at the clinic HTC services. 
 
For the analysis which explored the impact of CO-HTC use on sexual behaviour 
change, nine indices of behaviour change were created by comparing sexual 
behaviours reported at one sero-survey round to those reported at the next. In order 
to explore any potential differences over time, analyses were carried out separately 
for those a) attending both Sero4 and Sero5 and using the CO-HTC service at 
Sero4, b) attending both Sero5 and Sero6 and using the CO-HTC service at Sero5. 
Multinomial logistic regression was used to assess associations between HTC use 
and three outcomes: an increase, decrease or no change in sexual risk behaviour, 
stratified by HIV-status. Crude associations were adjusted for potentially 
confounding socio-demographic variables (age, sex, marital status, area of 
residence, level of education and reported previous HTC use) in multivariable 
analyses. Poisson regression models were used to calculate crude and adjusted 
HIV incidence rates comparing those who used and didn’t use CO-HTC. 
 
3.4 Ethical considerations 
3.4.1 Cohort study activities 
Ethical approval for successive rounds of demographic and serological surveillance 
has been granted by the Tanzanian Medical Research Coordinating Committee 
(MRCC) and the Ethics Committee of the London School of Hygiene and Tropical 
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Medicine (LSHTM) (see ethical clearance certificates in Appendix 11.1.1). During 
the first four sero-survey rounds, verbal consent was obtained directly from all 
participants (including those aged less than 18) due to low literacy rates among the 
study population. Consent was witnessed and documented for each participant on 
their survey questionnaire, by a member of the sero-survey team. During Sero5 in 
2006-2007 and Sero6 in 2010, consent was again obtained directly from all study 
participants including those aged less than 18, however the option of written consent 
was introduced for those who were able to provide it. During Sero7 in 2013 (data not 
included as part of this thesis) additional written consent was obtained from parents 
or guardians of participants aged less than 18. 
 
During sero-survey rounds, temporary field sites are constructed at central locations 
within each village, with purpose constructed huts or private rooms ensuring 
confidentiality during questionnaire interviews and medical consultations. Research 
HIV testing is based on informed consent without results disclosure. However, the 
benefits of knowing HIV status are set out in the informed consent procedure, and 
CO-HTC services have been systematically offered to all participants at a 
confidential site near to, but separate from, the main sero-survey site since Sero4 in 
2003-2004 (following the announcement of government plans to make ART 
available through a national treatment programme). Community opinion has 
indicated that if receipt of test results were made a condition of participation in sero-
surveys, participation rates would be expected to fall markedly. In addition, it has 
indicated that people who had previously tested and were already aware that they 
were infected would be unlikely to participate in further surveys if this involved 
another round of counselling, leading to under-estimation of prevalence based on 
research tests, and very little information from people living with HIV/AIDS in the 
behaviour survey. 
 
3.4.2 Linkage of clinic and cohort study datasets 
Ethical approval for the entry of the WI-HTC clinic data and subsequent linkage to 
the cohort datasets was initially sought from the Tanzanian MRCC and the ethics 
committee of the LSHTM in 2010. Two amendments to these applications were 
submitted in February 2012 and November 2013 in order to cover work on an 
additional project using PMTCT data, and on a development phase of the linkage 
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algorithm. Approval for these amendments was granted by the ethics committee of 
the LSHTM in January 2014 and by the MRCC in April 2014 (see Appendix 11.1.2). 
 
All data entry systems for the WI-HTC data were developed and stored on secure 
servers at NIMR Mwanza, while HTC logbooks were retained securely in a locked 
office at NIMR before being returned to the WI-HTC clinic. Client names were 
encrypted during the data entry process such that they were only seen by data entry 
clerks, who underwent ethical training. The resolution of discrepancies in client ID 
numbers in the merged WI-HTC dataset and the development of the linkage 
algorithm necessitated viewing of names and other personal identifiers in the gold 
standard and interim linked HTC datasets. All researchers and data managers 
involved in this process, including myself, participated in ethical training. The gold 
standard and interim linked datasets containing names were stored on secure 
servers at NIMR Mwanza (primarily), LSHTM, and on my personal laptop, all with 
password restricted access. Prior to using the linked results for statistical analyses, 
all personal identifying information, including names, were stripped from the 
datasets, leaving only numerical scores and ID numbers. 
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4 Paper A. Risk factors for service use and trends in 
coverage of different HIV testing and counselling 
models in northwest Tanzania between 2003 and 
2010 
 
Introduction to the paper 
As modes for HTC service provision diversify, there is a need to understand which 
testing modalities are most effective at identifying HIV-positive individuals and those 
most at risk of infection, as well as whether different models of service provision 
help to increase the uptake of HTC among different socio-demographic groups. A 
small number of studies have compared the basic socio-demographic 
characteristics of individuals testing at community outreach or health facility-based 
HTC services (76-79), however few have explored the sexual risk profiles of 
individuals using different types of services (76), and only one study in Tanzania has 
explored the uptake of different types of HTC (a comparison of uptake of opt-out 
versus opt-in VCT among young people) (145). Paper A (submitted to Tropical 
Medicine and International Health) makes use of the linked clinic-cohort dataset 
containing information on usage of three different types of HTC services in Kisesa 
(community outreach HTC, walk-in HTC at the Kisesa Health Centre and antenatal 
testing of pregnant women) to explore the socio-demographic, behavioural and 
clinical characteristics associated with service use, as well as trends in coverage of 
different types of HTC services by gender, age-group and area of residence. 
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Submitted manuscript 
 
4.1 Abstract 
 
Objectives: To investigate the relative effectiveness of different HIV testing and 
counselling (HTC) services in improving HIV diagnosis rates and increasing HTC 
coverage in African settings. 
 
Methods: Patient records from three HTC services (community outreach HTC 
during cohort study rounds (CO-HTC), walk-in HTC at the local health centre (WI-
HTC) and antenatal HIV testing (ANC-HTC)) were linked to records from a 
community cohort study using a probabilistic record linkage algorithm. 
Characteristics of linked users of each HTC service were compared to those of 
cohort participants who did not use the HTC service using logistic regression. Data 
from three cohort study rounds between 2003 and 2010 were used to assess trends 
in the proportion of persons testing at different service types. 
 
Results: The adjusted odds ratios for HTC use among individuals with increasing 
numbers of sexual partners in the past year, and among HIV-positive individuals 
compared to HIV-negative individuals, were higher at WI-HTC than CO-HTC and 
ANC-HTC. Among participants at each survey round, a higher proportion had ever 
used CO-HTC compared to the other services, and CO-HTC also diagnosed the 
largest numbers of HIV-positive persons. 
 
Conclusions: While the odds of attracting high-risk or infected individuals was 
greatest at WI-HTC compared to CO-HTC or ANC-HTC, the overall proportion of 
infected persons diagnosed was highest at CO-HTC. Further research should 
compare the effectiveness of the three services in effecting sexual behaviour 
change, and investigate which services most effectively link HIV-positive people to 
treatment services relative to the total cost per diagnosis made.  
87 
 
4.2 Introduction 
HIV testing and counselling (HTC) serves as the point of diagnosis and entry into 
care for HIV-positive individuals. It may also confer prevention benefits as a result of 
changes in sexual risk behaviour in HIV-negative and positive persons (23, 146), 
and via viral load suppression if HIV-positive individuals can be successfully linked 
to HIV care and treatment (30, 147). 
 
The traditional model of HTC service delivery in many countries in sub-Saharan 
Africa has been at dedicated voluntary counselling and testing (VCT) centres, 
provided either as stand-alone services or at clinics attached to health facilities. In 
response to a need to increase VCT uptake in sub-Saharan Africa (148), and in 
recognition that alternative models of service delivery may help to reach 
underserved groups, there has been a drive to diversify strategies for HTC service 
provision (8). These include HTC services offered routinely to pregnant women at 
antenatal clinics (ANC), or to attendees of out-patient departments such as sexually 
transmitted infection or tuberculosis clinics (provider-initiated testing and counselling 
or PITC) (7, 8). Additional options for service provision include door-to-door testing 
provided to people in their homes, or temporary or mobile VCT units which are often 
provided in remote or rural communities (‘outreach’ testing) (64, 70, 149).  
 
Little is known regarding the relative effectiveness of different HTC models in 
attracting people with risky behaviours or HIV infection, or in identifying the greatest 
absolute numbers of HIV-positive individuals at an early stage of infection – the 
latter group being particularly important to identify for treatment as prevention 
programmes (147). We use community cohort data linked to facility records from 
three different HTC services in northwest Tanzania (community outreach testing 
(CO-HTC), a walk-in HTC centre at a health facility (WI-HTC), and an antenatal 
testing service (ANC-HTC)), to compare socio-demographic, behavioural and 
clinical factors associated with HTC service use. We also assess trends in the 
proportion of persons tested at different service types between 2003 and 2010, by 
HIV-status and socio-demographic characteristics. 
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4.3 Methods 
4.3.1 Study setting 
The Kisesa HIV community cohort study includes six villages and has conducted 28 
approximately half-yearly rounds of demographic surveillance since 1994, collecting 
information on residence and survival status of household members, pregnancy, 
births and migration. Seven rounds of serological and behavioural surveillance 
(sero-surveys) have been completed every two-three years over the same period, 
with eligibility defined as being resident at the last demographic surveillance round 
and aged 15 or older at the time of the sero-survey. Participants are invited to a 
central location in each village to give finger prick blood samples for HIV research 
testing without results disclosure, complete an interview questionnaire on health and 
HIV-related knowledge and behaviours, and are offered free medical treatment for 
health problems (142, 150). 
 
4.3.2 HIV testing and counselling services in the study area 
Three HTC services are available in the study area: i) a community outreach HTC 
(CO-HTC) service operates within each village for the duration of the sero-survey, 
since the fourth round in 2003/4; ii) a walk-in HTC (WI-HTC) clinic has been 
available at the main health centre in the study area’s trading centre since 2005; iii) 
PITC has been routinely offered to pregnant women attending the health centre 
ANC since the roll out of a prevention to mother-to-child transmission (PMTCT) 
programme in 2008. Antenatal testing (ANC-HTC) may be carried out in the ANC or 
WI-HTC building, dependant on the availability of staff and test-kit supplies. All HTC 
services are provided free of charge. 
 
4.3.3 Data sources – cohort data 
During three sero-surveys in 2003/4 (Sero4), 2006/7 (Sero5) and 2010 (Sero6), data 
on participants’ socio-demographic characteristics, sexual and health-seeking 
behaviours and reported prior use of any HTC services were collected. HIV-status 
for all study participants was determined using research test results. 
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4.3.4 Data sources – HTC data 
Data on CO-HTC use were obtained by linking unique anonymous identifiers 
assigned to those using the service to their research study record. Data from the WI-
HTC, including data on ANC-HTC which occurred within the WI-HTC building, were 
double-entered for the period 2005-2012 (partial data for 2012). A probabilistic 
record linkage algorithm was developed to match users of the clinic HTC services 
(WI-HTC and ANC-HTC) to cohort study participants, based on measures of 
similarity (‘match-scores’) between personal identifiers (name, sex, date of birth, 
village) in the two datasets (151). The CO-HTC dataset was used as a gold 
standard to train the record linkage algorithm. After validation procedures, 36.8% 
(4,046/10,994) of Kisesa resident clients using WI-HTC or ANC-HTC at the health 
centre between 2005 and 2012 were matched to the cohort dataset. The final linked 
dataset had low sensitivity (estimated at 17.8% based on the proportion of correctly 
matched gold-standard links) but a positive predictive value (PPV) of 68.9%. 
 
4.3.5 Statistical methods 
The investigation of risk factors for CO-HTC use compared the characteristics of all 
those who used the service compared to all those who did not use the service 
during Sero6 (Table 4.1). For the analysis of WI-HTC and ANC-HTC use, cohort 
participants who were matched to a WI-HTC or ANC-HTC client but with a low 
match-score below a cut-off threshold were dropped from the dataset, because the 
accuracy of the match could not be confidently ascertained. The analyses assessing 
risk factors for WI-HTC and ANC-HTC use therefore used case-control methods. 
For WI-HTC use, cases were defined as Sero6 participants who were linked to a WI-
HTC client with a clinic visit occurring within two years of participation in Sero6. For 
cases with repeat WI-HTC (18/187), only the first testing visit was used. Controls 
were defined as Sero6 participants who were not linked to any WI-HTC clinic record 
(Table 4.1). 
 
For the analysis of risk factors associated with ANC-HTC use, women attending 
either Sero5 or Sero6 were included in order to increase sample size. Cases were 
defined as women who participated in Sero5, reported a pregnancy between 2007-
2010 and were linked to an ANC-HTC client with a testing visit within three years of 
Sero5, or women who participated in Sero6, reported a pregnancy between 2010-
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2012 and were linked to an ANC-HTC client with a testing visit within two years of 
Sero6. For cases with repeat ANC-HTC (3/153), only the first testing visit was used. 
Controls were defined as women who participated in either Sero5 or Sero6, who 
reported a pregnancy between 2007-2010 (Sero5 attendees) or 2010-2012 (Sero6 
attendees) and who were not linked to any ANC-HTC clinic record (Table 4.1). A 
proportion of controls (11/78) (but no cases) participated in both Sero5 and Sero6; 
these were randomly assigned as a control for one or other round. 
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Table 4.1 Methods, data sources and definitions for analyses of factors associated with CO-HTC, WI-HTC and ANC-HTC use 
Testing 
service 
type 
Method 
of 
analysis 
Data 
source 
Definition of case Number 
of cases  
Definition of control Number 
of 
controls  
CO-HTC Cross 
sectional 
All Sero 6 
participants 
All those who used CO-HTC at Sero6 2,040 All those who did not use CO-HTC at Sero6 5,968 
WI-HTC Case-
control 
Sero 6 
participants 
Sero6 participant linked to a WI-HTC 
client, with WI-HTC visit within two 
years of Sero6 participation 
187 Sero6 participant not linked to a WI-HTC 
client 
815 
ANC-
HTC 
Case-
control 
Sero5 and 
Sero6 
participants 
Female Sero5 participant, reported a 
pregnancy between 2007-2010 and 
linked to ANC-HTC client with ANC-
HTC visit within three years of Sero5 
participation 
 
OR 
 
Female Sero6 participant, reported a 
pregnancy between 2010-2012 and 
linked to ANC-HTC client with ANC-
HTC visit within two years of Sero6 
participation 
153 Female Sero5 participant with reported 
pregnancy between 2007-2010 and not 
linked to an ANC-HTC client 
 
OR 
 
Female Sero6 participant with reported 
pregnancy between 2010-2012 and not 
linked to an ANC-HTC client 
76 
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Logistic regression models were fitted separately for men and women to identify 
characteristics independently associated with CO-HTC, WI-HTC or ANC-HTC, using 
a forward-fitting approach and including all variables significant in univariable 
analyses at the p≤0.10 level. Likelihood ratio tests were used to assess the inclusion 
of variables in multivariable models (variable retained if it significantly improved 
model fit at p≤0.10 level). Interactions were explored between HIV status and other 
characteristics previously found to be strongly associated with HTC use in this 
setting (area of residence, level of education and previous HTC use) (43, 152). 
Trends in the proportion of persons testing at different service types were assessed 
using data on actual or reported HTC use among participants of Sero4, Sero5 and 
Sero6, by HIV-status and socio-demographic characteristics. All statistical analyses 
were carried out in Stata 12 (StataCorp, Texas, USA). 
 
4.3.6 Ethical statement 
Ethical approval for the activities carried out as part of the Kisesa cohort study, 
including linkage of WI-HTC and ANC-HTC clinic data to the research study dataset, 
has been granted by the Tanzanian Medical Research Coordinating Committee and 
the Ethics Committee of the London School of Hygiene and Tropical Medicine. 
Participation in sero-surveys is based on informed consent without disclosure of 
HIV-research test results, with a free CO-HTC service available since Sero4 in 
2003/4 (just prior to the start of the Tanzanian national antiretroviral therapy 
programme). Verbal consent was obtained during Sero4, due to low literacy rates 
among the study population. This was witnessed and documented for each 
participant on their study questionnaire, by a member of the sero-survey team. 
During Sero5 and Sero6 written consent was introduced (either a signature or a 
thumb-print, depending on the participant’s writing ability). 
 
4.4 Results 
The analysis of CO-HTC use among Sero6 attendees included 811 men and 1,229 
women who used HTC, and 2,320 men and 3,648 women who did not use HTC. For 
WI-HTC there were 75 male and 112 female Sero6 participants who were linked to a 
WI-HTC client (cases), and 425 men and 390 women who were controls. For ANC-
HTC, 153 pregnant women were tested and linked to a Sero5 (85) or Sero6 (68) 
participant, and 76 pregnant women were controls (58 in Sero5 and 31 in Sero6). 
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4.4.1 Characteristics of HTC users 
In adjusted analyses, men and women aged ≥55 had significantly lower odds of 
using CO-HTC and WI-HTC compared to those aged 15-24 (Table 4.2 and Table 
4.3). Among women, increasing educational attainment was associated with both 
CO-HTC and WI-HTC but not ANC-HTC (Table 4.3 and Table 4.4). Men and women 
living in roadside villages or in the trading centre had significantly higher odds of 
using all types of testing services compared to those living in rural villages, with the 
exception of WI-HTC use among women, where uptake was more equitable by area 
of residence (Table 4.2, Table 4.3, Table 4.4). 
 
Self-reported prior HTC was strongly associated with use of all three testing service 
types. The odds of testing also increased significantly with increasing numbers of 
sexual partners in the past year for men and women using WI-HTC, but this was not 
the case for women using CO-HTC or ANC-HTC (Table 4.2, Table 4.3, Table 4.4). 
 
There was some evidence that HIV-positive individuals were more likely to use WI-
HTC compared to HIV-negatives. Among men, the results did not quite reach 
statistical significance (Table 4.2), however women who were HIV-positive <3 years 
since first positive research test had higher odds of using WI-HTC compared to HIV-
negatives (Table 4.3: aOR: 4.14, 95% CI 1.27-13.52). The result was just short of 
reaching statistical significance for women HIV-positive ≥3 years since first positive 
research test. In contrast, HIV-positive men and women were not more likely to use 
CO-HTC or ANC-HTC compared to HIV-negative individuals (Table 4.2, Table 4.3, 
Table 4.4). For CO-HTC use, there was an interaction between HIV status and 
previous HTC use. Men and women HIV-positive ≥3 years since first positive 
research test who reported previous HTC were significantly less likely to use CO-
HTC than HIV negative individuals (OR men: 0.30, 95% CI 0.12-0.74. aOR women: 
0.18, 95% CI 0.09-0.36). However, these individuals were not significantly more or 
less likely to use CO-HTC if they reported no prior HTC (OR men: 1.98, 95% CI 
0.75-5.24. aOR women: 0.68, 95% CI 0.27-1.72. p values for interaction: men 
p=0.01, women p=0.06). 
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Table 4.2 Risk factors for community outreach HTC or walk-in HTC among men attending Sero6 in 2010¶ 
 
¶ All characteristics as reported at Sero6, $ Cross sectional analysis, + Case-control analysis, cOR crude OR, CI confidence interval, aOR adjusted OR 
N
% 
using cOR 95% CI aOR 95% CI N
% 
using cOR 95% CI aOR 95% CI
Total 3,131 25.9 500 15.0
Age 15-24 1,494 19.7 1 1 167 16.8 1 1
25-34 458 37.6 2.45 1.95-3.08 1.14 0.84-1.54 43 23.3 1.5 0.67-3.40 0.58 0.21-1.61
35-44 417 35.7 2.27 1.79-2.88 1.14 0.83-1.58 60 35.0 2.67 1.37-5.21 1.3 0.54-3.11
45-54 313 32.6 1.97 1.51-2.58 1.03 0.73-1.47 48 12.5 0.71 0.28-1.83 0.4 0.13-1.22
≥55 447 21.3 1.1 0.85-1.43 0.67 0.48-0.94 182 5.5 0.29 0.14-0.61 0.24 0.10-0.59
Area of residence Rural 1,772 15.8 1 1 278 11.2 1 1
Roadside 763 36.3 3.04 2.50-3.69 2.61 2.09-3.26 124 20.2 2.01 1.13-3.58 2 1.04-3.85
Trading Centre 596 42.8 3.98 3.24-4.90 3.43 2.72-4.33 98 19.4 1.92 1.03-3.58 1.27 0.62-2.61
Education None 453 18.1 1 138 6.5 1
Primary 1-4 324 25.3 1.53 1.08-2.17 60 6.7 1.02 0.30-3.46
Primary 5-7 1,563 26.7 1.65 1.26-2.14  213 22.1 4.06 1.92-8.59
Secondary or higher 777 29.1 1.86 1.40-2.47 89 16.9 2.91 1.21-6.97
Religion Catholic 1,107 28.2 1 171 18.1 1
Other Christian 1,416 27.0 0.94 0.79-1.13 193 17.6 0.97 0.56-1.65
Traditional 530 15.8 0.48 0.37-0.63 121 5.8 0.28 0.12-0.65
Muslim 75 44.0 2 1.25-3.22 15 20.0 1.13 0.30-4.24
Marital status Never married 1,466 20.1 0.55 0.46-0.65 176 16.5 1.41 0.82-2.44
Married monogamous 1,325 31.5 1 253 12.3 1
Married polygamous 128 37.5 1.3 0.89-1.90 26 34.6 3.79 1.56-9.24
Widowed 46 13.0 0.33 0.14-0.77 23 8.7 0.68 0.15-3.05
Separated/divorced 97 33.0 1.07 0.69-1.66 18 16.7 1.43 0.39-5.23
HIV status Negative 2,947 25.9 1 472 14.2 1
<3 years since first 
positive research test 111 29.7 1.21 0.80-1.84 18 27.8 2.32 0.80-6.73
≥3 years since first 
positive research test 50 24.0 0.91 0.47-1.74 5 40.0 4.03 0.66-24.57
Reported any 
previous HCT No 2,005 19.2 1 1 386 8.8 1 1
Yes 863 45.5 3.52 2.96-4.19 2.13 1.74-2.61 111 36.9 6.06 3.60-10.22 5.15 2.79-9.50
Has an HIV positive 
relative No 2,133 24.3 1 1 337 15.4 1
Yes 479 38.8 1.97 1.60-2.43 1.28 1.00-1.62 60 21.7 1.52 0.77-3.00
Don't know 274 29.2 1.28 0.97-1.69 1.25 0.92-1.71 103 9.7 0.59 0.29-1.21
Community outreach HTC (CO-HTC)$ Walk-in HTC (WI-HTC)+
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Table 4.2 continued¶ 
 
¶ All characteristics as reported at Sero6 in 2010, $ Cross sectional analysis, + Case-control analysis, cOR crude OR, CI confidence interval, aOR adjusted OR 
γ Participants reporting 'never had sex' at Sero6 reassigned to  'don't know' category for WI-HTC analysis, because these testing visits happened after the time of data collection 
*Omitted because of colinearity, α First/main spouse among men with more than one spouse, β First reported regular partner among those with more than one 
N
% 
using cOR 95% CI aOR 95% CI N
% 
using cOR 95% CI aOR 95% CI
Spouse HIV & VCT 
use status at Sero6 No spouse identified 2,444 24.9 1 1 354 17.0 1
Spouse HIV neg no VCT 484 19.4 0.73 0.57-0.93 0.56 0.42-0.75 112 6.3 0.33 0.14-0.74
Spouse HIV pos no VCT 29 31.0 1.36 0.62-3.00 0.72 0.30-1.72 7 28.6 1.96 0.37-10.34
Spouse HIV neg used VCT 163 58.3 4.22 3.05-5.84 2.26 1.55-3.28 23 21.7 1.36 0.49-3.81
Spouse HIV pos used VCT 10 60.0 4.53 1.27-16.10 2.82 0.73-10.88 3 33.3 2.45 0.22-27.45
Age at first sex <15 256 21.5 0.54 0.40-0.74 0.64 0.44-0.92 45 15.6 0.82 0.35-1.92
>=15 1,782 33.5 1 1 293 18.4 1
Never had sexγ 825 11.2 0.25 0.20-0.32 0.32 0.23-0.44 - - - -
Don't knowγ 237 27.4 0.75 0.55-1.01 0.82 0.58-1.16 158 8.9 0.43 0.23-0.80
Number of sexual 
partners in last year None 322 21.1 0.58 0.43-0.78 0.65 0.46-0.91 59 10.2 0.85 0.34-2.15 1.17 0.41-3.34
One 1,315 31.6 1 1 247 11.7 1 1
Two or more 640 36.2 1.23 1.01-1.50 1.12 0.89-1.42 91 31.9 3.52 1.96-6.32 2.77 1.41-5.46
Never had sexγ 825 11.2 0.27 0.21-0.35 * * - - - - - -
Don't knowγ - - - - - - 98 11.2 0.95 0.45-1.99 0.87 0.33-2.28
Had a casual partner 
in last year No 1,799 30.4 1 346 14.7 1
Yes 476 35.3 1.25 1.01-1.55 54 24.1 1.83 0.92-3.66
Never had sexγ 825 11.2 0.29 0.23-0.37 - - - -
Don't knowγ - - - - 98 11.2 0.73 0.37-1.46
Frequency of condom 
use with spouseα Consistent 4 50.0 2.1 0.30-14.98 1 100.0 - -
Inconsistent 106 43.4 1.61 1.08-2.41 12 50.0 6.48 1.97-21.30
Never 1,241 32.2 1 247 13.4 1
No spouse 830 30.2 0.91 0.75-1.10 113 19.5 1.57 0.87-2.84
Never had sexγ 825 11.2 0.26 0.21-0.34 - - - -
Don't knowγ - - - - 98 11.2 0.82 0.40-1.70
Frequency condom 
use with regular 
partnerβ Consistent 39 33.3 1.12 0.57-2.19 0.62 0.30-1.28 6 33.3 2.94 0.52-16.42
Inconsistent 53 49.1 2.16 1.25-3.73 1.98 1.05-3.73 5 40.0 3.91 0.64-23.97
Never 116 30.2 0.97 0.64-1.45 1.2 0.75-1.91 15 40.0 3.91 1.34-11.44
No regular partner 2,044 30.9 1 1 371 14.6 1
Never had sexγ 825 11.2 0.28 0.22-0.36 * * - - - -
Don't knowγ - - - - - - 98 11.2 0.74 0.37-1.48
Community outreach HTC (CO-HTC)$ Walk-in HTC (WI-HTC)+
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Table 4.3 Risk factors for community outreach HTC or walk-in HTC among women attending Sero6 in 2010¶ 
 
¶ All characteristics as reported at Sero6 in 2010, $ Cross sectional analysis, + Case-control analysis, cOR crude OR, CI confidence interval, aOR adjusted OR 
N
% 
using cOR 95% CI aOR 95% CI N
% 
using cOR 95% CI aOR 95% CI
Total 4,877 25.2 502 22.3
Age 15-24 1,689 23.3 1 1 78 37.2 1 1
25-34 1,132 32.6 1.59 1.35-1.89 0.98 0.79-1.22 58 58.6 2.39 1.19-4.80 1.76 0.64-4.84
35-44 819 31.3 1.5 1.25-1.81 0.99 0.77-1.25 52 55.8 2.13 1.04-4.35 2.5 0.87-7.21
45-54 516 26.7 1.2 0.96-1.51 0.9 0.67-1.21 59 23.7 0.53 0.25-1.12 0.97 0.32-2.92
≥55 720 9.9 0.36 0.28-0.47 0.34 0.23-0.50 255 2.4 0.04 0.02-0.10 0.43 0.11-1.61
Area of residence Rural 2,493 14.0 1 1 258 20.2 1
Roadside 1,284 34.7 3.27 2.78-3.84 2.96 2.47-3.55 129 27.1 1.48 0.90-2.42
Trading Centre 1,100 39.5 4.02 3.40-4.74 3.81 3.14-4.61 115 21.7 1.1 0.64-1.88
Education None 1,829 17.7 1 1 324 10.5 1 1
Primary 1-4 314 28.3 1.84 1.40-2.41 1.33 0.98-1.80 27 29.6 3.59 1.46-8.83 4.42 1.31-14.95
Primary 5-7 2,214 30.1 2 1.72-2.32 1.4 1.17-1.69 121 49.6 8.39 5.07-13.88 2.83 1.33-6.01
Secondary or higher 510 28.6 1.86 1.49-2.34 1.6 1.18-2.16 30 33.3 4.26 1.84-9.86 2.31 0.74-7.27
Religion Catholic 2,062 26.0 1 1 206 24.3 1
Other Christian 2,433 25.0 0.95 0.83-1.08 1.02 0.88-1.19 207 25.6 1.07 0.69-1.68
Traditional 253 12.3 0.4 0.27-0.58 0.89 0.57-1.39 67 4.5 0.15 0.04-0.49
Muslim 117 42.7 2.12 1.45-3.10 1.57 1.02-2.41 20 25.0 1.04 0.36-3.01
Marital status Never married 1,008 18.3 0.54 0.45-0.64 0.72 0.50-1.04 49 32.7 0.92 0.47-1.81 0.42 0.07-2.44
Married monogamous 2,448 29.4 1 1 180 34.4 1 1
Married polygamous 402 29.6 1.01 0.80-1.27 1.11 0.86-1.44 44 45.5 1.59 0.81-3.09 1.49 0.66-3.36
Widowed 512 13.1 0.36 0.28-0.47 0.57 0.36-0.89 152 2.0 0.04 0.01-0.13 1.71 0.23-12.50
Separated/divorced 464 28.0 0.94 0.75-1.17 0.97 0.67-1.40 74 14.9 0.33 0.16-0.68 4.35 0.75-25.30
HIV Status Negative 4,502 25.5 1 1 474 20.5 1 1
<3 years since first 246 24.0 0.92 0.68-1.24 0.59 0.42-0.82 21 57.1 5.18 2.12-12.65 4.14 1.27-13.52
≥3 years since first 
positive research test 113 14.2 0.48 0.28-0.82 0.26 0.15-0.46 6 50.0 3.89 0.77-19.56 11.6 0.68-198.17
Reported any previous 
HCT No 2,911 17.5 1 1 396 15.2 1 1
Yes 1,894 37.3 2.82 2.47-3.22 1.49 1.27-1.75 103 48.5 5.28 3.29-8.49 1.89 0.95-3.79
Has an HIV positive 
relative No 3,478 22.6 1 1 378 19.8 1
Yes 1,148 34.2 1.79 1.54-2.07 1.22 1.03-1.45 92 33.7 2.05 1.24-3.39
Don't know 199 24.1 1.09 0.78-1.52 0.86 0.59-1.25 32 18.8 0.93 0.37-2.35
Walk-in HTC (WI-HTC)+Community outreach HTC (CO-HTC)$
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Table 4.3 continued¶ 
 
¶ All characteristics as reported at Sero6 in 2010, $ Cross sectional analysis, + Case-control analysis, cOR crude OR, CI confidence interval, aOR adjusted OR 
γ Participants reporting 'never had sex' at Sero6 reassigned to  'don't know' category for WI-HTC analysis, because these testing visits happened after the time of data collection 
* Omitted because of colinearity, β First reported regular partner among those with more than one
N
% 
using cOR 95% CI aOR 95% CI N
% 
using cOR 95% CI aOR 95% CI
Spouse HIV & VCT use 
status at Sero6 No spouse identified 4,180 25.3 1 1 425 21.9 1
Spouse HIV neg no VCT 450 14.0 0.48 0.37-0.63 0.55 0.41-0.75 62 24.2 1.14 0.61-2.13
Spouse HIV pos no VCT 2911 16.2 0.57 0.24-1.38 0.65 0.26-1.65 5 40.0 2.38 0.39-14.45
Spouse HIV neg used VCT 196 49.5 2.9 2.17-3.87 2.17 1.57-3.00 8 25.0 1.19 0.24-5.99
Spouse HIV pos used VCT 9 44.4 2.37 0.63-8.83 2.49 0.59-10.41 - - - -
Age at first sex <15 467 20.6 0.6 0.48-0.77 0.75 0.57-0.97 78 21.8 0.86 0.47-1.55
>=15 3,431 30.0 1 1 318 24.5 1
Never had sexγ 612 8.7 0.22 0.17-0.30 0.25 0.16-0.39 - - - -
Don't knowγ 337 13.9 0.38 0.28-0.52 0.67 0.47-0.95 102 16.7 0.62 0.34-1.10
Number of sexual 
partners in last year None 858 16.6 0.46 0.38-0.56 1.09 0.75-1.58 225 1.8 0.03 0.01-0.07 0.03 0.00-0.22
One 3,261 30.1 1 1 231 40.7 1 1
Two or more 100 44.0 1.83 1.22-2.73 1.81 1.15-2.86 4 50.0 1.46 0.20-10.53 0.2 0.01-4.04
Never had sexγ 612 8.7 0.22 0.16-0.29 * * - - - - - -
Don't knowγ - - - - - - 36 33.3 0.73 0.35-1.53 2.51 0.42-14.95
Had a casual partner in 
last year No 4,007 27.3 1 457 20.4 1 1
Yes 211 33.6 1.35 1.01-1.81 9 77.8 13.7 2.80-67.03 10.3 0.72-146.02
Never had sexγ 612 8.7 0.25 0.19-0.34 - - - - - -
Don't knowγ - - - - 36 33.3 1.96 0.94-4.06 * *
Frequency of condom 
use with spouse Consistent 0 0 - - - - - -
Inconsistent 309 39.5 1.65 1.30-2.11 18 77.8 43 12.81-144.19 3.13 0.88-11.07
Never 2,458 28.3 1 192 35.4 6.73 3.83-11.84 * *
No spouse 1,389 23.8 0.79 0.68-0.92 239 7.5 1 1
Never had sexγ 612 8.7 0.24 0.18-0.32 - - - - - -
Don't knowγ - - - - 36 33.3 6.14 2.64-14.27 * *
Frequency condom use 
with regular partnerβ Consistent 39 33.3 1.38 0.71-2.69 0.93 0.43-1.99 3 33.3 1.94 0.17-21.62
Inconsistent 153 45.8 2.33 1.68-3.22 1.64 1.06-2.55 8 62.5 6.46 1.52-27.55
Never 206 32.0 1.3 0.96-1.76 1.4 0.93-2.12 11 36.4 2.22 0.63-7.74
No regular partner 3,814 26.6 1 1 439 20.5 1
Never had sexγ 612 8.7 0.26 0.20-0.35 * * - - - -
Don't knowγ - - - - 36 33.3 1.94 0.93-4.03
Community outreach HTC (CO-HTC)$ Walk-in HTC (WI-HTC)+
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Table 4.4 Risk factors for ANC-HTC among women attending Sero5 or Sero6 
and reporting pregnancies between 2007-2010 (Sero5 attendees) or 2010-2012 
(Sero6 attendees)¶ + 
 
¶ Pooled analysis - characteristics as reported at either Sero5 (2006/7) or Sero6 (2010) 
+ Case-control analysis 
cOR crude OR, CI confidence interval, aOR adjusted OR 
 
 
N
% 
using cOR 95% CI aOR 95% CI
Total 229 66.8
Age 15-24 58 60.3 1
25-34 117 71.8 1.67 0.86-3.24
35-44 44 68.2 1.41 0.62-3.21
45-54 10 40.0 0.44 0.11-1.72
Area of residence Rural 114 53.5 1 1
Roadside 73 86.3 5.47 2.55-11.73 6.25 2.66-14.58
Trading Centre 42 69.1 1.94 0.91-4.11 2.39 0.97-5.86
Education None 78 65.4 1
Primary 1-4 14 78.6 1.94 0.50-7.56
Primary 5-7 122 68.9 1.17 0.64-2.14
Secondary or higher 14 42.9 0.4 0.12-1.26
Religion Catholic 82 65.9 1
Other Christian 122 68.0 1.1 0.61-2.00
Traditional 17 52.9 0.58 0.20-1.68
Muslim 8 87.5 3.63 0.43-30.99
Marital status Never married 25 48.0 0.35 0.15-0.83
Married monogamous 166 72.3 1
Married polygamous 26 57.7 0.52 0.22-1.22
Widowed 2 0.0 - -
Separated/divorced 10 60.0 0.58 0.16-2.13
HIV Status Negative 220 66.8 1
<3 years since first positive 
research test 5 60.0 0.74 0.12-4.56
≥3 years since first positive research 
test 3 66.7 0.99 0.09-11.13
Reported any 
previous HCT No 162 60.5 1 1
Yes 66 81.8 2.94 1.46-5.92 2.35 1.07-5.13
Spouse HIV & VCT 
use status at Sero6 No spouse identified 167 61.7 1 1
Spouse HIV neg, no VCT 34 82.4 2.9 1.14-7.39 6.58 2.11-20.57
Spouse HIV pos, no VCT 2 50.0 0.62 0.04-10.11 0.53 0.02-11.91
Spouse HIV neg, used VCT 25 80.0 2.49 0.89-6.95 4.08 1.13-14.80
Spouse HIV pos, used VCT - - - - - -
Has an HIV positive 
relative No 166 70.5 1 1
Yes 42 71.4 1.05 0.50-2.21 0.73 0.30-1.78
Don't know 21 28.6 0.17 0.06-0.46 0.18 0.06-0.60
Age at first sex <15 11 63.6 0.79 0.22-2.78
>=15 200 69.0 1
Don't know 18 44.4 0.36 0.14-0.95
Number of sexual 
partners in last year None 6 66.7 0.88 0.16-4.93
One 203 69.5 1
Two or more 10 50.0 0.44 0.12-1.57
Don't know 10 30.0 0.19 0.05-0.75
Had a casual 
partner in last year No 205 67.3 1 1
Yes 14 85.7 2.91 0.63-13.39 3.37 0.59-19.19
Don't know 10 30.0 0.21 0.05-0.83 0.34 0.07-1.51
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4.4.2 HIV prevalence by service type 
HIV prevalence was highest among WI-HTC users (men: 14%, women: 20%) 
compared to CO-HTC users (men: 5.6%, women: 6.1%) or ANC-HTC users (4.9%) 
(Figure 4.1). We were missing substantial proportions of test result data for WI-HTC 
clients (25% of male and 20% of female clients), however even if all of these test-
results had been negative, HIV-prevalence would still have been higher among WI-
HTC users (men: 10.7%, women: 16.1%) compared to the other service types. 
Among HIV-positive individuals, the proportions testing at an early stage of infection 
(<3 years since first positive research test) were similar regardless of testing service 
type (Figure 4.1. Men CO-HTC: 73.3%, WI-HTC: 75%. Women: CO-HTC: 78.7%, 
WI-HTC: 83.3%, ANC-HTC: 71.4). 
 
Figure 4.1 Proportion testing HIV-positive by time since first positive research 
test and HTC service type¶ 
 
¶ Categories ‘Sero6 attendees’ and ‘Pregnant women (Sero5 & 6)’ shown for reference. HIV 
diagnosis based on sero-survey research test results except for WI-HTC and ANC-HTC 
users, where diagnosis based on WI-HTC or ANC-HTC clinic test results. 
*Missing clinic test result data for 19/75 (25%) male WI-HTC users, 22/112 (20%) female WI-
HTC users and 8/153 (5%) ANC-HTC users 
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4.4.3 Trends in the proportion of persons ever tested by HIV status 
The number of HIV-negative individuals receiving their first test at WI-HTC or ANC-
HTC has grown over time, particularly among women and those aged 25-44 (Figure 
4.2a). By Sero6, similar proportions of HIV-negative women had first tested at CO-
HTC (18.6%) or WI-HTC (18.1%), while the greatest proportion of HIV-negative men 
had first tested at CO-HTC (23.9%, versus 7.9% first testing at WI-HTC). HIV 
diagnosis rates were highest at CO-HTC, accounting for 32.9% of all HIV-positive 
men and 24.8% of all HIV-positive women by Sero6 (Figure 4.2b). 
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Figure 4.2 Location of a) first test (HIV-negatives) or b) diagnosis (HIV-
positives) based on actual or reported HTC use among attendees of Seros 4, 5 
and 6 by sex, age-group and area of residence 
a) Location of first test among indviduals testing HIV-negative  
 
 
b) Location of diagnosis among previously undiagnosed HIV-positive individuals*  
 
* Proportions diagnosed at WI-HTC, ANC-HTC or other locations in the study area may be 
under-estimates due to unknown results at time of testing for positive individuals reporting 
HTC use in the past (4% of Sero4 data, 10% of Sero5 data, 35% of Sero6 data) 
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4.5 Discussion 
Our results revealed that WI-HTC was more likely to attract higher risk individuals 
(those with larger numbers of sexual partners) and HIV-positive men and women 
compared to the other testing modalities. This is in agreement with other studies 
which have found that stand-alone or clinic based HTC identified larger proportions 
of HIV-positive patients compared to mobile or outreach testing services (64, 67, 
77). Users of client initiated WI-HTC services may be motivated by recent exposures 
or by suspicions that they are HIV-infected, due to symptoms or death of a partner. 
Conversely, CO-HTC and ANC-HTC represent more passive opportunities to test, 
and therefore seem to attract relatively fewer high-risk individuals. However, the 
aforementioned studies found that outreach testing services were better at 
facilitating earlier HIV diagnosis compared to clinic based services, which tended to 
diagnose patients at a later stage of infection. In this study, we found no substantial 
differences in HIV diagnoses by stage of infection by testing service type, but our 
analyses were limited by small sample sizes, particularly for users of WI-HTC and 
ANC-HTC. 
 
Among sero-survey participants, the largest numbers of HIV-positive men and 
women learned their status via CO-HTC. However this may not be true in the wider 
population, if we had been able to take account of WI-HTC and/or ANC-HTC use 
among individuals who didn’t attend sero-surveys. We may also have 
underestimated the numbers diagnosed at WI-HTC and ANC-HTC, due to low 
linkage sensitivity and reliance on reports of HTC use in the past for which we did 
not know test results (for 4% of HIV-positive individuals at Sero4, 10% of HIV-
positive individuals at Sero5, 35% of HIV-positive individuals at Sero6). 
Nevertheless, CO-HTC is likely to represent an efficient model of service delivery in 
which large numbers of people were reached in a short period of time. Achieving 
high HTC uptake is an important objective of HIV prevention programmes in sub-
Saharan Africa, and a number of studies have found that rates of uptake are highest 
when testing is provided as an outreach service (64, 67, 70, 71). However in terms 
of treatment as prevention it will be important that services can be regularly 
accessed, and to understand which services most effectively link HIV-positive 
individuals to care and treatment (153). 
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The three main HTC services in this setting attracted users with different socio-
demographic profiles. Overall WI-HTC attracted a greater proportion of women than 
men, while the proportions of women and men using CO-HTC were more even 
(Figure 4.2). By Sero6 in 2010, a larger proportion of women had ever tested at any 
HTC service compared to men. These findings concur with other studies which 
found that men were less likely to use health facility based HTC compared to 
women (77, 80) and that larger numbers of women had ever tested overall (41, 56).  
 
In adjusted analyses WI-HTC was less likely to attract individuals aged ≥55 
compared to those aged 15-24, and less likely to recruit women with no education 
compared to those with primary education. While similar patterns for age-group and 
level of education were seen for CO-HTC, the measures of effect were not as 
strong. A number of studies have shown that outreach testing and some types of 
PITC reach proportionately older and less educated clients compared to walk-in 
HTC (76-78), and we similarly found that access to CO-HTC and ANC-HTC 
appeared more equitable in terms of these socio-demographic characteristics 
compared to WI-HTC. However, there were inequities in access by area of 
residence for all testing service types, with the exception of WI-HTC use among 
women. It was somewhat surprising that men and women living in rural areas were 
considerably less likely to use CO-HTC seeing as this service was provided within 
the village. Larger distances to the health centre (where HIV care services are 
available), perceived lack of need, stigma or residual confounding by unmeasured 
socio-economic factors may be some of the reasons explaining this finding. Policies 
which aim to promote and normalise HTC in rural villages may help to increase the 
uptake of testing in these areas. 
 
Unlike many studies relying on data collected at HTC clinics, a key strength of our 
analysis was the linkage of community cohort and clinic data, allowing comparison 
of factors associated with uptake of three different HTC services at the community 
level. Nevertheless, the linkage procedures are likely to have introduced some 
biases which need consideration. WI-HTC clinic records included for analyses were 
less likely to be male compared to records not included (24% versus 29%, p<0.001). 
This may have led us to under-estimate the proportions of men using WI-HTC. 
Linked individuals included in the WI-HTC and ANC-HTC analyses were also more 
likely to be older (p<0.001) and less likely to have secondary education (p=0.002) 
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compared to those not included, which may have led us to under-estimate the 
strength of associations between age and/or educational attainment and WI-HTC or 
ANC-HTC use.  
 
Sensitivity analyses were explored which increased the PPV of the linked WI-HTC 
and ANC-HTC clinic-cohort datasets from 68.9% to 85.0%. These did not change 
the overall direction of any of our findings (see Supplementary Tables 4.5 to 4.7 
below), although in some cases they strengthened associations (as expected given 
that random error should be reduced in higher PPV datasets), giving confidence in 
our findings. An additional strength of our study was the ability to explore 
associations between HIV status and HTC use due to knowledge of HIV status 
among both testers and non-testers. However, small sample sizes may have 
prevented us from detecting weaker effects for some risk factors among WI-HTC 
and ANC-HTC users. 
 
4.6 Conclusions 
Of the three services available, the odds of attracting high-risk or infected individuals 
was greatest at WI-HTC, but the overall proportion of infected persons diagnosed 
was higher at CO-HTC. Further research should compare the effectiveness of the 
three services in influencing sexual behaviour change, and investigate which 
services most effectively link HIV-positive people to treatment services relative to 
the total cost per diagnosis made. 
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Supplementary tables (not included as part of submitted manuscript) 
 
Table 4.5 Sensitivity analyses assessing crude ORs for WI-HTC use among 
men using datasets with PPV 68.9%, 75.0% and 85.0% 
 
α First/main spouse among men with more than one spouse, * Too few data to calculate OR 
β First reported regular partner among those with more than one 
cOR 95% CI cOR 95% CI cOR 95% CI
Age 15-24 1 1 1
25-34 1.5 0.67-3.40 0.67 0.22-2.07 1.2 0.37-3.89
35-44 2.67 1.37-5.21 2.71 1.35-5.42 4.33 1.96-9.55
45-54 0.71 0.28-1.83 0.79 0.31-2.07 1.42 0.51-3.92
≥55 0.29 0.14-0.61 0.32 0.15-0.70 0.52 0.22-1.24
Area of residence Rural 1 1 1
Roadside 2.01 1.13-3.58 1.87 1.01-3.45 2.25 1.14-4.42
Trading Centre 1.92 1.03-3.58 1.67 0.85-3.29 1.88 0.88-4.01
Education None 1 1 1
Primary 1-4 1.02 0.30-3.46 0.99 0.25-3.96 1.15 0.20-6.47
Primary 5-7 4.06 1.92-8.59 4.55 1.98-10.48 6.8 2.36-19.62
Secondary or higher 2.91 1.21-6.97 3.24 1.24-8.47 3.92 1.17-13.18
Religion Catholic 1 1 1
Other Christian 0.97 0.56-1.65 1.14 0.64-2.03 0.92 0.49-1.75
Traditional 0.28 0.12-0.65 0.36 0.15-0.86 0.29 0.11-0.80
Muslim 1.13 0.30-4.24 1.11 0.23-5.32 1.11 0.23-5.32
Marital status Never married 1.41 0.82-2.44 1.51 0.84-2.73 0.92 0.46-1.84
Married monogamous 1 1 1
Married polygamous 3.79 1.56-9.24 4.7 1.90-11.65 4.54 1.77-11.67
Widowed 0.68 0.15-3.05 0.85 0.19-3.82 0.92 0.20-4.17
Separated/divorced 1.43 0.39-5.23 1.18 0.26-5.48 1.29 0.28-5.98
HIV status Negative 1 1 1
<3 years since first positive 
research test 2.32 0.80-6.73 2.78 0.96-8.10 3.62 1.23-10.65
≥3 years since first positive 
research test 4.03 0.66-24.57 4.82 0.79-29.49 6.28 1.20-38.62
Reported any previous HCT No 1 1 1
Yes 6.06 3.60-10.22 5.7 3.28-9.92 8.94 4.75-16.82
Has an HIV positive relative No 1 1 1
Yes 1.52 0.77-3.00 1.65 0.81-3.36 1.78 0.83-3.85
Don't know 0.59 0.29-1.21 0.56 0.25-1.23 0.54 0.22-1.33
Spouse HIV & VCT use status 
at Sero6 No spouse identified 1 1 1
Spouse HIV neg no VCT 0.33 0.14-0.74 0.4 0.18-0.91 0.54 0.24-1.26
Spouse HIV pos no VCT 1.96 0.37-10.34 2.4 0.45-12.72 3.27 0.61-17.46
Spouse HIV neg used VCT 1.36 0.49-3.81 1.67 0.59-4.70 1.81 0.58-5.66
Spouse HIV pos used VCT 2.45 0.22-27.45 3 0.27-33.72 4.08 0.36-46.16
Age at first sex <15 0.82 0.35-1.92 0.82 0.33-2.05 0.79 0.29-2.12
>=15 1 1 1
Don't know 0.43 0.23-0.80 0.43 0.22-0.84 0.21 0.08-0.54
Number of sexual partners in 
last year None 0.85 0.34-2.15 0.86 0.31-2.35 0.82 0.27-2.51
One 1 1 1
Two or more 3.52 1.96-6.32 3.66 1.96-6.86 4.04 2.09-7.84
Don't know 0.95 0.45-1.99 1.04 0.48-2.27 0.38 0.11-1.30
Had a casual partner in last 
year No 1 1 1
Yes 1.83 0.92-3.66 1.84 0.88-3.85 1.94 0.90-4.20
Don't know 0.73 0.37-1.46 0.79 0.38-1.63 0.27 0.08-0.91
Frequency of condom use 
with spouseα Consistent * * * * * *
Inconsistent 6.48 1.97-21.30 6.15 1.76-21.43 6.86 1.96-24.05
Never 1 1 1
No spouse 1.57 0.87-2.84 1.46 0.77-2.76 1.27 0.63-2.54
Don't know 0.82 0.40-1.70 0.85 0.40-1.82 0.28 0.08-0.96
Frequency condom use with 
regular partnerβ Consistent 2.94 0.52-16.42 1.65 0.18-15.08 1.87 0.21-17.28
Inconsistent 3.91 0.64-23.97 4.4 0.72-27.03 2.52 0.26-24.74
Never 3.91 1.34-11.44 2.2 0.58-8.42 2.52 0.66-9.66
No regular partner 1 1 1
Don't know 0.74 0.37-1.48 0.76 0.37-1.56 0.26 0.08-0.86
PPV 68.9% PPV 78.5% PPV 85.0%
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Table 4.6 Sensitivity analyses assessing crude ORs for WI-HTC use among 
women using datasets with PPV 68.9%, 75.0% and 85.0% 
 
* Too few data to calculate OR, β First reported regular partner among those with more than one 
 
cOR 95% CI cOR 95% CI cOR 95% CI
Age 15-24 1 1 1
25-34 2.39 1.19-4.80 2.6 1.24-5.46 3.3 1.41-7.69
35-44 2.13 1.04-4.35 2.71 1.29-5.72 3.28 1.39-7.72
45-54 0.53 0.25-1.12 0.64 0.29-1.43 0.92 0.37-2.26
≥55 0.04 0.02-0.10 0.05 0.02-0.14 0.06 0.02-0.19
Area of residence Rural 1 1 1
Roadside 1.48 0.90-2.42 1.4 0.83-2.35 1.8 0.98-3.29
Trading Centre 1.1 0.64-1.88 0.97 0.55-1.74 1.47 0.77-2.80
Education None 1 1 1
Primary 1-4 3.59 1.46-8.83 3.56 1.38-9.16 3.52 1.29-9.59
Primary 5-7 8.39 5.07-13.88 8.08 4.76-13.71 6.03 3.37-10.81
Secondary or higher 4.26 1.84-9.86 4.35 1.82-10.40 2.23 0.71-7.02
Religion Catholic 1 1 1
Other Christian 1.07 0.69-1.68 1.11 0.69-1.78 1.15 0.67-1.99
Traditional 0.15 0.04-0.49 0.17 0.05-0.58 0.17 0.04-0.73
Muslim 1.04 0.36-3.01 1.24 0.43-3.60 1.43 0.44-4.63
Marital status Never married 0.92 0.47-1.81 1.01 0.51-2.02 0.55 0.21-1.41
Married monogamous 1 1 1
Married polygamous 1.59 0.81-3.09 1.58 0.78-3.18 1.64 0.76-3.53
Widowed 0.04 0.01-0.13 0.03 0.01-0.13 0.04 0.01-0.17
Separated/divorced 0.33 0.16-0.68 0.35 0.17-0.74 0.43 0.20-0.95
HIV status Negative 1 1 1
<3 years since first positive 
research test 5.18 2.12-12.65 5.55 2.23-13.83 7.48 2.91-19.21
≥3 years since first positive 
research test 3.89 0.77-19.56 4.54 0.90-22.90 6.73 1.33-34.20
Reported any previous HCT No 1 1 1
Yes 5.28 3.29-8.49 4.73 2.87-7.77 5.98 3.43-10.43
Has an HIV positive relative No 1 1 1
Yes 2.05 1.24-3.39 2.17 1.29-3.66 2.54 1.42-4.55
Don't know 0.93 0.37-2.35 0.91 0.34-2.46 1.08 0.36-3.26
Spouse HIV & VCT use status 
at Sero6 No spouse identified 1 1 1
Spouse HIV neg no VCT 1.14 0.61-2.13 1.36 0.72-2.55 1.28 0.61-2.69
Spouse HIV pos no VCT 2.38 0.39-14.45 2.84 0.47-17.27 4.02 0.66-24.63
Spouse HIV neg used VCT 1.19 0.24-5.99 1.42 0.28-7.16 2.01 0.40-10.22
Spouse HIV pos used VCT - - - - - -
Age at first sex <15 0.86 0.47-1.55 1.01 0.55-1.85 1.23 0.65-2.34
>=15 1 1 1
Don't know 0.62 0.34-1.10 0.6 0.32-1.12 0.35 0.15-0.85
Number of sexual partners in 
last year None 0.03 0.01-0.07 0.02 0.01-0.07 0.02 0.00-0.08
One 1 1 1
Two or more 1.46 0.20-10.53 1.69 0.23-12.24 2.21 0.30-16.05
Don't know 0.73 0.35-1.53 0.78 0.36-1.67 0.28 0.08-0.95
Had a casual partner in last 
year No 1 1 1
Yes 13.7 2.80-67.03 13.65 2.71-68.87 14.92 2.83-78.62
Don't know 1.96 0.94-4.06 2.09 0.98-4.43 0.75 0.22-2.55
Frequency of condom use 
with spouse Consistent * * * * * *
Inconsistent 42.97 12.81-144.19 31.08 8.62-112.05 31.57 8.47-117.73
Never 6.73 3.83-11.84 6.79 3.76-12.29 5.6 2.95-10.63
No spouse 1 1 1
Don't know 6.14 2.64-14.27 6.33 2.64-15.20 1.97 0.53-7.36
Frequency condom use with 
regular partnerβ Consistent 1.94 0.17-21.62 2.27 0.20-25.31 3.06 0.27-34.32
Inconsistent 6.46 1.52-27.55 6.04 1.33-27.55 8.16 1.78-37.44
Never 2.22 0.63-7.74 2.59 0.74-9.07 3.5 0.99-12.33
No regular partner 1 1 1
Don't know 1.94 0.93-4.03 2.08 0.98-4.42 0.77 0.22-2.62
PPV 68.9% PPV 78.5% PPV 85.0%
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Table 4.7 Sensitivity analyses assessing crude ORs for ANC-HTC use among 
women using datasets with PPV 68.9%, 75.0% and 85.0% 
 
* Too few data to calculate OR 
  
cOR 95% CI cOR 95% CI cOR 95% CI
Age 15-24 1 1 1
25-34 1.67 0.86-3.24 1.62 0.83-3.16 1.9 0.89-4.05
35-44 1.41 0.62-3.21 1.45 0.63-3.31 1.73 0.69-4.38
45-54 0.44 0.11-1.72 0.45 0.11-1.78 0.64 0.14-2.91
Area of residence Rural 1 1 1
Roadside 5.47 2.55-11.73 5.48 2.55-11.77 7.95 3.51-18.02
Trading Centre 1.94 0.91-4.11 1.87 0.87-3.98 1.9 0.79-4.58
Education None 1 1 1
Primary 1-4 1.94 0.50-7.56 1.84 0.47-7.25 1.09 0.22-5.30
Primary 5-7 1.17 0.64-2.14 1.17 0.64-2.16 1.01 0.52-1.97
Secondary or higher 0.4 0.12-1.26 0.41 0.13-1.32 0.41 0.11-1.51
Religion Catholic 1 1 1
Other Christian 1.1 0.61-2.00 1.13 0.62-2.05 1.07 0.55-2.05
Traditional 0.58 0.20-1.68 0.62 0.21-1.78 0.42 0.12-1.56
Muslim 3.63 0.43-30.99 3.84 0.45-32.84 2.55 0.25-25.86
Marital status Never married 0.35 0.15-0.83 0.37 0.16-0.87 0.26 0.09-0.78
Married monogamous 1 1 1
Married polygamous 0.52 0.22-1.22 0.55 0.23-1.28 0.68 0.27-1.69
Widowed - - - - - -
Separated/divorced 0.58 0.16-2.13 0.5 0.13-1.95 0.85 0.22-3.32
HIV status Negative 1 1 1
<3 years since first positive 
research test 0.74 0.12-4.56 0.78 0.13-4.75 0.87 0.12-6.33
≥3 years since first positive 
research test 0.99 0.09-11.13 1.04 0.09-11.61 1.74 0.15-19.56
Reported any previous HCT No 1 1 1
Yes 2.94 1.46-5.92 3.13 1.55-6.32 3.05 1.43-6.48
Spouse HIV & VCT use 
status at Sero6 No spouse identified 1 1 1
Spouse HIV neg no VCT 2.9 1.14-7.39 2.8 1.09-7.18 3.62 1.35-9.70
Spouse HIV pos no VCT 0.62 0.04-10.11 0.65 0.04-10.52 - -
Spouse HIV neg used VCT 2.49 0.89-6.95 2.59 0.92-7.24 3.2 1.08-9.44
Spouse HIV pos used VCT * * * * * *
Has an HIV positive relative No 1 1 1
Yes 1.05 0.50-2.21 1.05 0.49-2.22 1.22 0.54-2.73
Don't know 0.17 0.06-0.46 0.14 0.05-0.42 0.1 0.02-0.45
Age at first sex <15 0.79 0.22-2.78 0.82 0.23-2.91 0.77 0.18-3.18
>=15 1 1 1
Don't know 0.36 0.14-0.95 0.38 0.14-1.00 0.31 0.09-1.02
Number of sexual partners in 
last year None 0.88 0.16-4.93 0.92 0.16-5.15 1.57 0.28-8.85
One 1 1 1
Two or more 0.44 0.12-1.57 0.46 0.13-1.64 0.78 0.22-2.83
Don't know 0.19 0.05-0.75 0.2 0.05-0.79 0.11 0.01-0.94
Had a casual partner in last 
year No 1 1 1
Yes 2.91 0.63-13.39 3.05 0.66-14.00 2.45 0.48-12.54
Don't know 0.21 0.05-0.83 0.22 0.05-0.87 0.12 0.01-0.97
PPV 68.9% PPV 78.5% PPV 85.0%
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5 Paper B. Low rates of repeat HIV testing despite 
increased availability of antiretroviral therapy in 
rural Tanzania: findings from 2003-2010 
 
Introduction to the paper 
TasP strategies advocate regular repeat testing among high-risk HIV-negative 
individuals in order to identify new HIV infections soon after sero-conversion (30, 
82). Paper A showed that in Kisesa, walk-in facility-based HTC (WI-HTC) seemed 
most likely to attract high-risk individuals compared to community outreach HTC 
(CO-HTC) or antenatal testing of pregnant women (ANC-HTC). Paper B (published 
in PLOS ONE) builds on these analyses by exploring rates of repeat CO-HTC use1 
among individuals attending sero-surveys between 2003 and 2010, and compares 
these to rates of repeat testing when reported HTC use outside of sero-surveys is 
taken into account. Risk factors for repeat CO-HTC use are also investigated among 
individuals who attended both Sero5 in 2006-2007 and Sero6 in 2010 and who used 
the CO-HTC service at Sero5 (i.e. were at risk of using CO-HTC again at Sero6). 
This denominator was chosen in order to ensure a comparable time period during 
which participants might have repeat tested, due to availability of HIV-status at the 
time of testing for all participants (HIV-status at time of testing unknown for some 
participants with reported prior HTC use) and due to variability in the accuracy of 
reporting of previous HTC use. The socio-demographic, behavioural and clinical risk 
factors for repeat CO-HTC use are investigated based on risk factors previously 
found to be associated with HTC use in Kisesa (42, 43) as well as factors known to 
be associated with the risk of HIV acquisition, such as greater numbers of sexual 
partners (37) and unprotected sex (38). The association between HIV sero-
conversion and repeat testing is also explored, as this is important to understand 
given that repeat testing is advocated as a mechanism to enable timely diagnosis of 
HIV. 
 
  
                                               
1 Referred to in the paper as the sero-survey VCT service 
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5.1 Abstract 
 
Background: HIV testing and counselling (HTC) services can play an important role 
in HIV prevention by encouraging safe sexual behaviours and linking HIV-infected 
clients to antiretroviral therapy (ART). However, regular repeat testing by high-risk 
HIV-negative individuals is important for timely initiation of ART as part of the 
‘treatment as prevention’ approach. 
 
Aim: To investigate HTC use during a round of HIV serological surveillance in 
northwest Tanzania in 2010, and to explore rates of repeat testing between 2003 
and 2010. 
 
Methods: HTC services were provided during the fourth, fifth and sixth rounds of 
serological surveillance in 2003-2004 (Sero4), 2006-2007 (Sero5) and 2010 (Sero6). 
HTC services have also been available at a government-run health centre and at 
other clinics in the study area since 2005. Questionnaires administered during sero-
surveys collected information on socio-demographic characteristics, sexual 
behaviour and reported previous use of HTC services.  
 
Results: The proportion of participants using HTC increased from 9.4% at Sero4 to 
16.6% at Sero5 and 25.5% at Sero6. Among participants attending all three sero-
survey rounds (n=2,010), the proportions using HTC twice or more were low, with 
11.1% using the HTC service offered at sero-surveys twice or more, and 25.3% 
having tested twice or more if reported use of HTC outside of sero-surveys was 
taken into account. In multivariable analyses, individuals testing HIV-positive were 
less likely to repeat test than individuals testing HIV-negative (aOR 0.17, 95% CI 
0.006-0.52). 
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Discussion/Conclusions: Although HTC service use increased over time, it was 
disappointing that the proportions ever testing and ever repeat-testing were not even 
larger, considering the increasing availability of HTC and ART in the study area. 
There was some evidence that HIV-negative people with higher risk sexual 
behaviours were most likely to repeat test, which was encouraging in terms of the 
potential to pick-up those at greatest risk of HIV-infection. 
 
  
112 
 
5.2 Introduction 
HIV testing and counselling (HTC) services have recently expanded rapidly in sub-
Saharan Africa in order to facilitate access to HIV treatment and care (148). It has 
also been widely assumed that HTC services play an important role in HIV 
prevention, by motivating both HIV-negative and HIV-positive individuals to reduce 
sexual risk taking and adopt preventive behaviours (20, 154). The contribution of 
HTC to HIV prevention may potentially acquire a further role in light of the treatment 
as prevention (TasP) approach, which suggests that widespread use of antiretroviral 
therapy (ART) could have a substantial impact in reducing rates of HIV transmission 
as a result of reduced viral loads in treated patients (30, 155, 156). One modelling 
study suggested that regular testing for all adults aged 15 and over once per year, 
followed by immediate access to treatment for those testing positive, could result in 
the near elimination of HIV in generalised epidemic settings within 50 years (30). 
However, this assertion has been challenged by other authors (157). 
 
Despite increases in the numbers of individuals accessing HIV testing and treatment 
services, the World Health Organisation reported in 2011 that knowledge of HIV 
status remains broadly inadequate. In six countries with results from population-
based surveys conducted in 2007-2009, the proportion of respondents unaware of 
their HIV-positive status ranged from about 30% in Kenya to almost 70% in the 
Congo (148). Only a few studies have investigated rates of repeat testing in sub-
Saharan Africa (83-85, 88), with just two of these being carried out since ART has 
become more widely and freely available (85, 88). In terms of eventual TasP 
implementation, it would be particularly important that individuals initially testing HIV-
negative but who are at high risk of sero-conversion (for example as a result of high 
risk sexual behaviour) come back to test on a regular basis. 
 
This paper reports on the uptake of HTC services during the latest round of HIV 
serological surveillance carried out in 2010 as part of an on-going community cohort 
study in Kisesa in northwest Tanzania. It also reports on repeat use of HTC services 
over consecutive rounds of serological surveillance carried out between 2003 and 
2010; a period of time which saw a number of changes in terms of the availability of 
HIV services, including the commencement of a national ART programme at the 
start of 2005, and the opening of a permanent HTC clinic in the study area later that 
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year. We explore how these changes affected rates of first time and repeat HTC 
over time. 
 
5.3 Methods 
5.3.1 Ethical statement 
Ethical approval for each survey round of the Kisesa cohort study has been granted 
by the Tanzanian Medical Research Coordinating Committee and the Ethics 
Committee of the London School of Hygiene and Tropical Medicine. During the 
2003-2004 survey, verbal consent was obtained directly from all study participants 
including those aged 15-17, due to low literacy rates among the study population. 
Consent was witnessed and documented for each study participant on their survey 
questionnaire, by a member of the sero-survey team. During serological surveys in 
2006-2007 and 2010, consent was again obtained directly from all study participants 
including those aged 15-17, however the option of written consent was introduced, 
for those who were able to provide this. Although data from the subsequent 
serological survey in 2012-2013 are not used in this paper, it was recommended by 
the review committee that additional written consent be obtained from parents or 
guardians for participants aged 15-17 for this round, and this was implemented 
accordingly. 
 
5.3.2 Study setting 
The study setting in Mwanza region has been described in detail by Mwaluko et al 
(142). Briefly, the study area lies approximately 20km to the east of Mwanza city and 
consists of six villages which make up the administrative ward of Kisesa, with a 
combined population of approximately 32,000 people. Some sub-villages lie along 
the main tarmac road which cuts through the study area and leads to the border with 
Kenya, while other sub-villages are located further away from the road in rural 
areas. The largest village in the study area, Kisesa trading centre, lies directly along 
the main road. 
 
Since 1994, 27 rounds of demographic surveillance and six HIV serological surveys 
have been completed. Demographic surveillance took place approximately once 
every six months, collecting information on residence and survival status of all 
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household members, pregnancy among women of reproductive age, and births and 
migration. Eligibility and invitations for the serological surveys (sero-surveys) were 
prepared based on having been resident at the last round of demographic 
surveillance and being aged 15 or older at the time of the sero-survey. Venous 
blood was collected from all consenting participants during the first sero-survey in 
1994/1995, while finger prick blood was collected during all subsequent sero-
surveys. Samples were tested for HIV anonymously at the National Institute for 
Medical Research (NIMR) in Mwanza.  
 
A separate and confidential HTC service was provided in temporary village based 
facilities during the fourth, fifth and sixth rounds of serological surveillance in 2003-
2004 (Sero4), 2006-2007 (Sero5) and 2010 (Sero6), for those wishing to know their 
HIV status (see below for further details). Height and weight measurements were 
taken during sero-surveys, accompanied by a detailed questionnaire. The 
questionnaire was administered by same sex interviewers and included items on 
socio-demographic characteristics, sexual behaviour, health status and previous 
HTC service use. All study participants were additionally offered free medical 
treatment for any health problems present at the time of the sero-survey. 
 
5.3.3 HIV testing and counselling and other health services  
The study population is served by a government-run health centre located in Kisesa 
trading centre, by three small government-run dispensaries located in the rural 
villages, and by a number of private clinics located mainly in the trading centre. HTC 
services are distinguished as those provided at stand-alone voluntary counselling 
and testing (VCT) clinics, or via other clinics within a hospital or health centre 
(usually at antenatal, sexually transmitted infection or tuberculosis clinics), referred 
to as provider initiated testing and counselling (PITC). A stand-alone VCT clinic 
opened at Kisesa health centre in 2005, while PITC has been offered to all pregnant 
women attending the health centre antenatal clinic (ANC) since the end of 2008. 
PITC has also been available at the out-patients department since 2010, where 
testing may be offered to patients attending the sexually transmitted infection and 
tuberculosis clinics. Since mid-2009, antenatal PITC is usually offered at the small 
rural dispensaries, dependant on the availability of test-kit supplies.  
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When HTC services were first provided in Kisesa in 2005, patients testing HIV-
positive were referred to Mwanza city hospitals, where free care and treatment 
services have been available under the national ART programme since the 
beginning of 2005. At the end of 2008, ART services became available locally at a 
Care and Treatment Centre (CTC) at Kisesa health centre. At this point, individuals 
testing HIV-positive were referred to Kisesa CTC for care, while patients already 
attending Mwanza city hospitals were given the option of transferring to Kisesa CTC 
if they wished. 
 
Since the fourth sero-survey round in 2003-2004, a separate and temporary VCT 
clinic has been available to all sero-survey participants wishing to know their HIV 
status. After their questionnaire interview, individuals expressing desire for VCT 
were directed to a separate purpose-constructed hut for pre-test counselling with a 
trained counsellor. At Sero4 venous blood was collected and transported to the 
NIMR laboratory for HIV testing, and clients were asked to return for their test 
results and post-test counselling one week later (42). During Seros 5 and 6, venous 
blood was again collected but rapid HIV screening tests were used; results and 
post-test counselling were usually delivered within 45 minutes of the test being 
performed (43). Individuals testing HIV-positive at Sero4 were informed that 
treatment would become available in the near future through the national ART 
programme. With their prior agreement, these individuals were subsequently traced 
by the VCT counsellors and referred to the zonal referral hospital in Mwanza. 
Individuals testing HIV-positive at Sero5 were referred directly to Mwanza city 
hospitals, while those testing positive at Sero6 were referred to the local Kisesa 
CTC. 
 
5.3.4 Data and analysis 
All survey data were double entered. Linking of demographic data, sero-survey 
interview data, HIV research tests and sero-survey VCT attendance was carried out 
anonymously using study identification numbers. Sexual behaviour variables 
collected during sero-survey interviews included age at first sex, number of sexual 
partners and frequency of condom use with different partner types. Marital change 
and spouse identification variables were obtained from the demographic data, after 
which spouses’ HIV-status was anonymously linked in from the serological data. 
The percentage change in body mass index (BMI) at each sero-survey was 
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calculated using height and weight data collected at the previous sero round, for 
those who had attended the previous sero-survey.  
 
At Seros 4, 5 and 6, the survey questionnaire also captured information on 
participants’ self-reported prior use of HTC services, including VCT use at various 
other clinics within and outside the study area (e.g. Kisesa health centre VCT, 
‘Angaza’ VCT clinics run by the African Medical Research Foundation, other 
temporary mobile VCT clinics provided occasionally in the study area by non-
governmental organisations or regional hospitals), and via PITC at antenatal clinics 
and/or hospital outpatient departments. At Seros 5 and 6, it was possible to 
additionally identify those with known prior use of VCT at an earlier sero-survey 
round, for those who had attended an earlier round.  
 
All statistical analyses were done using Stata 12 (StataCorp LP, Texas, USA). In 
order to ensure that all individuals had an equal period of time during which they 
might have repeat tested, a repeat tester was defined as somebody who attended 
both Sero5 and Sero6 and who used the VCT service available at each of these 
rounds. Univariable analyses were used to describe associations between all 
variables of interest and i) uptake of VCT at the Sero6 round, ii) repeat use of VCT 
at the Sero5 and Sero6 rounds. Logistic regression models were fitted to identify 
characteristics independently associated with VCT uptake using a forward-fitting 
approach and including all variables significant in univariable analyses at the p≤0.10 
level. Likelihood ratio tests were used to assess the inclusion of variables in 
multivariable models. 
 
 
5.4 Results 
5.4.1 Factors associated with VCT use at Sero6 
Altogether 8,008 individuals attended the Sero6 round, of whom 60.9% were 
women. In total 31.7% of men and 30.5% of women gave consent to use VCT, while 
25.9% of men and 25.2% of women subsequently went for VCT. This represents 
approximately a doubling in the proportion of men using VCT since Sero4, and a 
threefold increase amongst women (Table 5.1). 
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Table 5.1 shows trends in the factors most strongly associated with uptake of VCT 
at Seros 4, 5 and 6 in univariable analyses. (Previous analyses of factors associated 
with VCT uptake at Seros 4 and 5 have been published by Wringe et al (42) and by 
Isingo et al (43). The analyses were updated and provided in Table 5.1 for context). 
These included having previously used an HTC service, having a spouse who used 
VCT during that sero-survey round, area of residence (those living in roadside 
villages or in the trading centre being more likely to use VCT compared to those 
living in rural villages) and level of education (those with most education being most 
likely to use VCT). In addition, those who were HIV-positive were more likely to test 
compared to HIV-negatives, except at Sero6, when HIV-positive women were less 
likely to test than HIV-negative women (odds ratio [OR] 0.77, 95% confidence 
intervals [CI] 0.59-1.00). 
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Table 5.1 Selected factors associated with uptake of VCT at Seros 4, 5 and 6 among men and women 
 
¤ Figures for VCT uptake at Seros 4 and 5 reflect an update on previous figures presented by Wringe et al (42) and Isingo et al (43). The figures are provided here for context 
*p≤0.05, ¶p≤0.1 
α Reported or documented (at an earlier sero-survey round) previous HTC use 
∆ Spouse's HIV status & VCT use at current sero-survey round 
No.
% using 
VCT OR (95% CI) No.
% using 
VCT OR (95% CI) No.
% using 
VCT OR (95% CI)
MEN - Total 3,978 12.1 3,633 18.3 3,131 25.9
Area of residence Rural 2,109 10.3 1 2,052 16.7 1 1,772 15.8 1
Roadside 991 11.9 1.18 (0.93-1.49) 940 20.7 1.31 (1.08-1.59)* 763 36.3 3.04 (2.50-3.69)*
Trading Centre 878 16.7 1.75 (1.40-2.20)* 641 19.8 1.24 (0.99-1.55)¶ 596 42.8 3.98 (3.24-4.90)*
Education None 623 4.0 0.26 (0.17-0.39)* 670 13.0 0.62 (0.48-0.80)* 453 18.1 0.61 (0.47-0.79)*
Primary 1-4 years 794 9.2 0.62 (0.48-0.81)* 445 14.8 0.73 (0.55-0.97)* 324 25.3 0.93 (0.71-1.23)
Primary 5-7 years 2,216 14.0 1 1,966 19.3 1 1,563 26.7 1
Secondary or higher 344 21.1 1.63 (1.23-2.17)* 546 24.0 1.32 (1.05-1.65)* 777 29.1 1.13 (0.93-1.36)
HIV status Negative 3,709 11.8 1 3,445 17.8 1 2,947 25.9 1
Positive 213 17.8 1.63 (1.13-2.35)* 173 28.3 1.83 (1.30-2.58)* 161 28.0 1.11 (0.78-1.58)
Previous HTC useα No 3,893 11.5 1 3,077 15.2 1 2,215 18.2 1
Yes 85 38.8 4.87 (3.11-7.62)* 552 35.7 3.1 (2.54-3.79)* 916 44.7 3.63 (3.06-4.30)*
Spouse HIV status & VCT use∆ No spouse identified 2,792 11.8 1 2,580 16.4 1 2,444 24.9 1
HIV neg, no VCT 1,064 9.9 0.81 (0.65-1.03)¶ 829 17.6 1.09 (0.89-1.34) 484 19.4 0.73 (0.57-0.93)*
HIV pos, no VCT 37 13.5 1.16 (0.45-3.00) 41 24.4 1.64 (0.80-3.38) 29 31.0 1.36 (0.62-3.00)
HIV neg, used VCT 70 48.6 7.03 (4.34-11.38)* 162 49.4 4.97 (3.59-6.89)* 163 58.3 4.22 (3.05-5.84)*
HIV pos, used VCT 6 83.3 37.2 (4.33-319.36)* 13 30.8 2.27 (0.69-7.39) 10 60.0 4.53 (1.27-16.10)*
WOMEN - Total 4,982 7.4 5,063 15.3 4,877 25.2
Area of residence Rural 2,404 5.0 1 2,631 12.4 1 2,493 14.0 1
Roadside 1,312 9.1 1.91 (1.47-2.49)* 1,303 19.3 1.69 (1.41-2.02)* 1,284 34.7 3.27 (2.78-3.84)*
Trading Centre 1,266 10.2 2.17 (1.68-2.82)* 1,128 17.6 1.5 (1.24-1.82)* 1,100 39.5 4.02 (3.40-4.74)*
Education None 1,661 2.4 0.21 (0.15-0.30)* 1,972 10.6 0.53 (0.44-0.63)* 1,831 17.7 0.5 (0.43-0.58)*
Primary 1-4 years 786 7.1 0.68 (0.50-0.92)* 425 15.8 0.83 (0.62-1.10) 314 28.3 0.92 (0.71-1.20)
Primary 5-7 years 2,338 10.1 1 2,288 18.4 1 2,212 30.1 1
Secondary or higher 196 18.4 2 (1.36-2.94)* 370 20.5 1.14 (0.87-1.50) 510 28.6 0.93 (0.75-1.15)
HIV status Negative 4,653 7.1 1 4,690 15.0 1 4,502 25.5 1
Positive 277 11.6 1.7 (1.15-2.49)* 341 20.8 1.49 (1.13-1.96)* 359 20.9 0.77 (0.59-1.00)¶
Previous HTC useα No 4,919 7.2 1 4,467 13.4 1 2,921 17.3 1
Yes 63 22.2 3.69 (2.02-6.74)* 592 30.4 2.83 (2.33-3.44)* 1,956 36.9 2.8 (2.45-3.20)*
Spouse HIV status & VCT use∆ No spouse identified 3,769 7.6 1 3,971 15.0 1 4,180 25.3 1
HIV neg, no VCT 994 3.9 0.5 (0.35-0.70)* 782 10.9 0.69 (0.54-0.88)* 450 14.0 0.48 (0.37-0.63)*
HIV pos, no VCT 48 6.3 0.81 (0.25-2.62) 56 14.3 0.94 (0.44-2.00) 37 16.2 0.57 (0.24-1.38)
HIV neg, used VCT 140 25.0 4.05 (2.71-6.05)* 227 34.8 3.02 (2.26-4.02)* 196 49.5 2.9 (2.17-3.87)
HIV pos, used VCT 15 26.7 4.42 (1.40-13.96)* 22 36.4 3.23 (1.35-7.73)* 9 44.4 2.37 (0.63-8.83)
Sero 4 Sero 5 Sero 6
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A full analysis of the associations between socio-demographic, clinical and 
behavioural characteristics and VCT use at Sero6 can be seen in Table 5.2 and 
Table 5.3. Similar factors to those mentioned above persisted as independent 
predictors of VCT use at the Sero6 round. Among men, these included previous 
HTC use (adjusted odds ratio [aOR]: 2.30, 95% CI 1.88-2.81), having a spouse who 
used VCT at Sero6 (aOR HIV-negative spouse using VCT: 2.90, 95% CI 1.93-4.36; 
aOR HIV-positive spouse using VCT: 4.31, 95% CI 1.08-17.26), and area of 
residence (aOR those living in trading centre compared to rural villages: 3.24, 95% 
CI 2.55-4.12; aOR those living in roadside compared to rural villages: 2.57, 95% CI 
2.07-3.19). Similar factors were independently associated with VCT use among 
women (Table 5.2 and Table 5.3) with the addition of level of education; women with 
no education were significantly less likely to use VCT compared to those with 5-7 
years of primary education (aOR 0.67, 95% CI 0.55-0.80).  
 
In contrast to earlier rounds, women who were HIV-positive at Sero6 were 
significantly less likely to use VCT compared to HIV-negative women (Table 5.3: 
aOR 0.46, 95% CI 0.34-0.61). A similar trend was seen among men, although the 
result was not statistically significant (aOR 0.72 95% CI 0.47-1.09). A closer 
investigation revealed an interaction between HIV status and previous HTC use. 
HIV-positive individuals were more likely to use VCT if they had not previously used 
any HTC service (OR men: 1.62, 95% CI 0.99-2.64; OR women: 1.16, 95% CI 0.77-
1.75) but not if they had previously used HTC (OR men: 0.51, 95% CI 0.30-0.85; OR 
women: 0.45, 95% CI 0.32-0.63). 
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Table 5.2 Crude and adjusted odds ratios for socio-demographic factors associated with VCT uptake at Sero6 
 
*p≤0.05, ¶p≤0.1 
ɣ Adjusted for all socio-demographic, clinical & behavioural factors associated with VCT use in univariable analyses (p≤0.10) and remaining significant in multivariable analyses 
No.
% using 
VCT No.
% using 
VCT
Total 3,131 25.9 4,877 25.2
Age 15-24 1,503 19.8 1,722 23.5
25-34 464 37.1 1,125 32.4
35-44 412 35.9 811 31.2
>=45 751 26.0 1,219 16.8
Area of residence Rural 1,772 15.8 2,493 14.0
Roadside 763 36.3 1,284 34.7
Trading Centre 596 42.8 1,100 39.5
Ethnicity Sukuma 2,961 24.7 4,564 24.4
Non Sukuma 168 47.6 306 37.3
Education None 453 18.1 1,831 17.7
Primary 1-4 years 324 25.3 314 28.3
Primary 5-7 years 1,563 26.7 2,212 30.1
Secondary & higher 777 29.1 510 28.6
Religion Catholic 1,107 28.2 2,062 26.0
Other Christian 1,416 27.0 2,433 25.0
Traditional 530 15.8 253 12.3
Muslim 75 44.0 117 42.7
Marital status Never Married 1,466 20.1 1,008 18.3
Married monogamous 1,325 31.5 2,448 29.4
Marries polygamous 128 37.5 402 29.6
Widowed 46 13.0 512 13.1
Separated/Divorced 97 33.0 464 28.0
Marital status change No 2,479 23.5 3,142 22.7
Yes 266 31.2 741 26.7
Don't know 386 38.1 994 31.7
OR (95% CI)
1
2.39 (1.91-3.00)*
2.28 (1.79-2.89)*
1.42 (1.16-1.75)*
1
3.04 (2.50-3.69)*
0.94 (0.79-1.13)
0.48 (0.37-0.63)*
3.98 (3.24-4.90)*
1
2.77 (2.02-3.79)*
0.61 (0.47-0.79)*
0.93 (0.71-1.23)
1.13 (0.93-1.36)
1
1
1.56 (1.32-1.84)*
1.47 (1.22-1.78)*
0.66 (0.55-0.79)*
Males Females
1.95 (1.26-3.04)*
1
1.48 (1.12-1.95)*
2 (1.60-2.51)*
1
1.09 (0.75-1.59)
1.17 (0.76-1.80)
0.83 (0.54-1.27)
1
2.57 (2.07-3.19)*
3.24 (2.55-4.12)*
1
1.67 (1.16-2.40)*
1
0.69 (0.44-1.08)
2 (1.25-3.22)*
1
1.83 (1.54-2.17)*
2.38 (1.63-3.48)*
0.6 (0.25-1.42)
1
1.7 (1.21-2.39)*
0.97 (0.51-1.85)
0.43 (0.16-1.18)¶
0.99 (0.53-1.88)
1
1.1 (0.77-1.57)
0.5 (0.43-0.58)*
0.92 (0.71-1.20)
1
0.93 (0.75-1.15)
1
1
3.27 (2.78-3.84)*
4.02 (3.40-4.74)*
1
1.84 (1.45-2.35)*
0.88 (0.66-1.19)
1
1.00 (0.74-1.34)
1.88 (1.44-2.46)*
0.67 (0.50-0.91)*
1.74 (1.35-2.26)*
1
1.24 (1.03-1.49)*
0.95 (0.83-1.08)
0.4 (0.27-0.58)*
2.12 (1.45-3.10)*
1
1.86 (1.55-2.23)*
1.03 (0.83-1.29)
1.15 (0.90-1.47)
0.83 (0.62-1.11)
1
2.95 (2.45-3.54)*
3.39 (2.78-4.15)*
0.67 (0.55-0.80)*
aOR (95% CI)ɣ OR (95% CI) aOR (95% CI)ɣ
1.07 (0.72-1.58)
0.66 (0.42-1.04)¶
1.2 (0.81-1.78)
1
0.96 (0.70-1.32)
1.58 (1.35-1.85)*
1
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Table 5.3 Crude and adjusted odds ratios for clinical and behavioural factors associated with VCT uptake at Sero6 
 
*p≤0.05, ¶p≤0.1 
ɣ Adjusted for all socio-demographic, clinical & behavioural factors associated with VCT use in univariable analyses (p≤0.10) and remaining significant in multivariable analyses 
α Reported or documented (at an earlier sero-survey round) previous HTC use, ∆ Spouse's HIV status & VCT use at current sero-survey round 
Ω Frequency of condom use in last 12 months considering three most recent partners 
No.
% using 
VCT No.
% using 
VCT
HIV status Negative 2,947 25.9 4,502 25.5
Positive 161 28.0 359 20.9
BMI loss None 931 26.9 1,506 21.8
<5% 240 28.7 347 21.3
>= 5% 144 18.1 350 20.9
Unknown 1,816 25.7 2,674 28.1
Previous HTC useα No 2,215 18.2 2,921 17.3
Yes 916 44.7 1,956 36.9
Spouse HIV status & VCT use∆ No spouse identified 2,444 24.9 4,180 25.3
HIV neg, no VCT 484 19.4 450 14.0
HIV pos, no VCT 29 31.0 37 16.2
HIV neg, used VCT 163 58.3 196 49.5
HIV pos, used VCT 10 60.0 9 44.4
Age at first sex ≥15 1,782 33.5 3,431 30.0
<15 256 21.5 467 20.6
Never had sex 825 11.2 612 8.7
Don't know 237 27.4 337 13.9
No. of sex partners last year None or one 1,650 29.5 4,130 27.2
Two 398 36.2 76 46.1
Three or more 247 36.4 24 37.5
Frequency of condom useΩ Never use 1,348 30.9 2,719 28.5
Inconsistent 304 43.8 532 41.9
Consistent 86 36.0 48 31.3
Never had sex 825 11.2 612 8.7
Don't know 568 24.6 966 16.8
Has a relative who is HIV 
positive No 2,133 24.3 3,478 22.6
Yes 479 38.8 1,148 34.2
Don't know 274 29.2 199 24.1
Knows somebody taking ART No 1,523 23.4 3,029 22.0
Yes 935 35.4 1,515 34.5
Don't know 423 22.5 269 13.8
Males Females
1
1.1 (0.80-1.51)
0.6 (0.38-0.94)*
OR (95% CI) aOR (95% CI)ɣ OR (95% CI) aOR (95% CI)ɣ
4.22 (3.05-5.84)*
2.37 (0.63-8.83)4.53 (1.27-16.10)*
11
0.57 (0.24-1.38)1.36 (0.62-3.00)
1
0.77 (0.59-1.00)¶
1
0.97 (0.73-1.29)
0.94 (0.71-1.25)
1.4 (1.20-1.62)*
1
2.8 (2.45-3.20)*
1
0.94 (0.79-1.13)
1
3.63 (3.06-4.30)*
1
0.48 (0.37-0.63)*0.73 (0.57-0.93)*
1
1.11 (0.78-1.58)
1
2.28 (1.44-3.60)*1.36 (1.08-1.71)*
1.6 (0.70-3.67)1.37 (1.04-1.82)*
0.6 (0.48-0.77)*0.54 (0.40-0.74)*
0.22 (0.17-0.30)*0.25 (0.20-0.32)*
0.38 (0.28-0.52)*0.75 (0.55-1.01)¶
0.73 (0.59-0.92)*
11
11
1.81 (1.50-2.20)*1.74 (1.35-2.25)*
1.14 (0.62-2.11)1.26 (0.80-1.99)
1.79 (1.50-2.14)*
0.57 (0.40-0.81)*0.95 (0.73-1.22)
11
0.46 (0.34-0.61)*0.72 (0.47-1.09)
11
1.1 (0.81-1.51)1.01 (0.70-1.45)
1.07 (0.78-1.47)0.55 (0.34-0.91)*
1.64 (1.37-1.96)*1.09 (0.88-1.35)
1.79 (1.54-2.07)*1.97 (1.60-2.43)*
1.09 (0.78-1.52)1.28 (0.97-1.69)¶
11
0.24 (0.18-0.32)*0.28 (0.22-0.36)*
0.51 (0.42-0.61)*
0.55 (0.40-0.74)*0.71 (0.51-0.98)*
0.69 (0.28-1.74)1.09 (0.44-2.73)
2.17 (1.57-3.00)*2.90 (1.93-4.36)*
11
1.57 (1.33-1.85)*2.30 (1.88-2.81)*
11
2.9 (2.17-3.87)*
0.51 (0.10-2.68)0.25 (0.17-0.36)*
0.59 (0.41-0.83)*0.78 (0.55-1.10)
1
2.7 (0.66-11.07)4.31 (1.08-17.26)*
11
0.73 (0.56-0.95)*0.66 (0.47-0.94)*
1
1.17 (0.93-1.47)1.21 (0.91-1.63)
0.67 (0.34-1.35)0.84 (0.49-1.45)
--
1.99 (1.19-3.31)*
1.21 (0.47-3.13)
11
1.15 (0.96-1.37)*
0.66 (0.44-0.99)*
0.85 (0.57-1.26)
1
0.71 (0.52-0.98)*0.72 (0.53-0.98)*
1
1.19 (0.98-1.42)¶
1.87 (1.63-2.14)*
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5.4.2 Lifetime use of HTC services among those attending Sero4, 5 
and/or 6 
In total over the period 2003-2010, 17,483 individuals attended at least one of Seros 
4, 5 and/or 6. Figure 5.1 shows the number of individuals attending one or more 
sero-surveys and the number of times A) VCT was used at a sero-survey; B) an 
HTC service was ever used (i.e. at sero-survey and/or reported use of HTC outside 
sero-surveys). Considering VCT use at sero-surveys only (Figure 5.1A), of those 
attending all 3 seros (n=2,010) 64.0% never used VCT, 24.9% used VCT once and 
11.1% used VCT either two or three times. Taking into account reported use of HTC 
services elsewhere (Figure 5.1B), of those attending all 3 seros, 48.0% never used 
HTC, 26.8% used HTC once and 25.3% used HTC two or more times. In total, of all 
participants attending at least one sero-survey (n=17,483) and considering HTC use 
at sero-surveys and/or elsewhere, just 11.2% had ever tested twice or more. 
 
Figure 5.1 Number of individuals attending one or more of Sero4, 5 and/or 6 
and the number of times HTC was used.  
Panel A) number of times HTC used during sero-surveys; panel B) number of times 
HTC ever used (i.e. during sero-surveys and/or reported use of HTC outside sero-
surveys). 
 
The proportion of participants who had never used any HTC service declined more 
rapidly over time among HIV-positive participants compared to HIV-negative. Figure 
5.2 shows the proportions of men and women who had ever used HTC at sero-
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surveys and/or elsewhere by the end of each sero-survey round by HIV-status, with 
HIV-status reflecting status at the sero-round in question rather than at any earlier 
test. By 2010 (Sero6), 60.2% of HIV-positive men and 65.2% of HIV-positive women 
had tested at least once, compared to 41.8% of HIV-negative men and 49.3% of 
HIV-negative women. Overall, 16.7% of men and 22.9% of women attending Sero6 
had ever repeat tested (i.e. tested twice or more).  
 
Figure 5.2 Number of times HTC was ever used (i.e. at sero-surveys and/or 
elsewhere) by the end of each sero-survey round by HIV status. 
Panel A) men; panel B) women. (NB: HIV status reflects status at the sero-survey 
round in question, rather than at any earlier test). 
 
 
When interpreting data which includes reported as well as known or documented 
use of HTC services, it should be noted that there is a tendency to both over and 
under report previous HTC service use. Table 5.4 shows that among HIV-negative 
individuals, of 7,015 instances where participants attended two consecutive sero-
survey rounds (either Seros 4 and 5 and//or Seros 5 and 6), in 823 instances 
participants reported that they had used VCT at the earlier sero-survey round. 
However, comparison against earlier records revealed that in only 57.6% of cases 
(474/823) these participants had actually used VCT at the earlier round, with 42.4% 
(349/823) giving incorrect reports. Furthermore, of 822 instances where HIV-
negative individuals had known use of VCT an earlier sero-survey round, in 42.3% 
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of cases (348/822) these individuals failed to report this VCT use when asked at the 
later sero-survey round. Similar trends were seen among HIV-positive individuals, 
although in an even larger proportion of cases (49/89 or 55.1%) participants 
incorrectly reported VCT use at an earlier sero-survey round that did not actually 
occur. Of 67 instances where HIV-positive individuals had known use of VCT at an 
earlier sero-survey, in 40.3% of cases (27/67) participants failed to report this VCT 
use at the later round. 
 
Table 5.4 By HIV status: number of times individuals reported using VCT at an 
earlier sero-survey round, versus number of times VCT was actually used at 
the earlier round 
 
 
Figure 5.3 shows the proportion of men and women attending Sero6 who had used 
different HTC services. Outside of sero-surveys, the largest numbers of tests were 
carried out at the VCT and ANC clinics at Kisesa health centre. These clinics were 
used by a larger proportion of women than men. However, it is expected that only a 
small number of men would be tested at the ANC while attending with their partners. 
Smaller numbers of individuals tested at Angaza clinics in Mwanza city or 
elsewhere, at mobile VCT clinics and at other locations, where the proportionate use 
by men and women was more equal. 
 
 
 
 
HIV negative at later sero-survey round
Actually used VCT at Sero 4 or 5 No Yes Total
No 5844 (94.4) 349 (42.4) 6,193
Yes 348 (5.6) 474 (57.6) 822
Total 6192 (100) 823 (100) 7,015
HIV positive at later sero-survey round
Actually used VCT at Sero 4 or 5 No Yes Total
No 328 (92.4) 49 (55.1) 377
Yes 27 (7.6) 40 (44.9) 67
Total 355 (100) 89 (100) 444
Reported at Sero 5 or 6 that used VCT at 
Sero 4 or 5, N (%)
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Figure 5.3 Among those who attended Sero 6, proportions of men (n=3,131) 
and women (n=4,877) using different HTC services. 
 
 
5.4.3 Factors associated with repeat use of VCT 
Table 5.5 shows the characteristics of individuals who attended Sero5 and used 
VCT at this round, and who also attended Sero6 (n=564; 234 men, 330 women). In 
total 321/564 participants (56.9%) used VCT at Sero5 only, while 243/564 (43.1%) 
used VCT again at Sero6 (i.e. repeat tested). Significantly fewer individuals who 
were HIV-positive at Sero5 used VCT again at Sero6 (n=5/28, 17.9%) compared to 
those who were HIV-negative at Sero5 (n=238/534, 44.6%). However, a smaller 
proportion of individuals who sero-converted between sero-surveys (i.e. HIV-
negative at Sero5, HIV-positive at Sero6) used VCT again at Sero6 (n=2/7, 28.6%) 
compared to those who did not sero-convert (n= 240/553, 43.4%). The proportions 
of individuals repeat testing increased with higher risk sexual behaviours (those 
married polygamously, those with higher numbers of sexual partners in their lifetime 
or in the last 12 months, and those using condoms inconsistently), although not all 
of these associations were statistically significant in univariable and multivariable 
analyses (Table 5.5). 
 
The factors most strongly associated with repeat testing in multivariable analyses 
included area of residence (aOR for trading centre compared to rural villages: 2.34, 
95% CI 1.35-4.04; aOR for roadside villages compared to rural villages: 2.67, 95% 
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CI 1.73-4.12), being of Islamic faith (aOR for muslims compared to catholics: 9.14, 
95% CI 1.88-44.47), testing HIV-negative at Sero5 (aOR for testing HIV-positive 
compared to HIV-negative: 0.17, 95% CI 0.006-0.52), reporting using condoms 
inconsistently (aOR for using condoms inconsistently compared to never using 
condoms: 1.78, 95% CI 1.06-3.00) and being married polygamously (aOR for those 
married polygamously compared to those never married: 1.73, 95% CI 0.97-3.08). 
Those with no education were also significantly less likely to repeat test than those 
with a primary level of education (aOR 0.58, 95% CI0.34-0.98). 
 
Table 5.5 Characteristics of individuals attending both Sero5 and Sero6 and 
factors associated with repeat use of VCT at each round# 
 
#Characteristics and behavioural variables are those reported at Sero6, unless otherwise stated 
*p≤0.05, ¶p≤0.1 
 
  
No.
% Repeat 
Testing OR (95% CI) aOR (95% CI)
Total 564 43.1
Sex Male 234 45.7 1.2 (0.86-1.69) 1.6 (1.03-2.47)*
Female 330 41.2 1 1
Age 15-24 99 42.4 1.25 (0.76-2.08)
25-34 150 45.3 1.41 (0.90-2.21)
35-44 142 48.6 1.61 (1.03-2.53)*
≥45 173 37.0 1
Area of residence Rural 294 32.7 1 1
Roadside 176 53.4 2.36 (1.61-3.47)* 2.67 (1.73-4.12)*
Trading Centre 94 56.4 2.67 (1.66-4.29)* 2.34 (1.35-4.04)*
Ethnicity Sukuma 537 43.0 1
non Sukuma 27 44.4 1.06 (0.49-2.31)
Education None 114 29.8 0.48 (0.30-0.75)* 0.58 (0.34-0.98)*
Primary 1-4 yrs 44 36.4 0.64 (0.33-1.23)* 0.59 (0.27-1.25)
Primary 5-7 yrs 312 47.1 1 1
Secondary or higher 93 49.5 1.1 (0.69-1.75) 1.24 (0.67-2.27)
Religion Catholic 256 41.4 1 1
Other Christian 253 43.5 1.09 (0.77-1.55) 1.35 (0.91-2.01)
Traditional 39 33.3 0.71 (0.35-1.44) 0.71 (0.31-1.65)
Muslim 16 87.5 9.91 (2.21-44.50)* 9.14 (1.88-44.47)
Marital status Never married 66 45.5 1.14 (0.67-1.93)  0.72 (0.30-1.70)
Married monogamous 348 42.2 1 1
Married polygamous 67 52.2 1.5 (0.89-2.53) 1.73 (0.97-3.08)¶
Widowed 24 20.8 0.36 (0.13-0.99)* 0.45 (0.13-1.57)
Separated/Divorced 50 44.0 1.07 (0.59-1.95) 1.45 (0.64-3.27)
Marital status change No 373 42.1 1
Yes 91 39.6 0.9 (0.56-1.44)
Don't know 100 50.0 1.38 (0.88-2.14)
HIV status Sero 5 Negative 534 44.6 1 1
Positive 28 17.9 0.27 (0.10-0.72)* 0.17 (0.06-0.52)*
Seroconverted Sero 5-
Sero6 No 553 43.4 1
Yes 7 28.6 0.52 (0.10-2.71)
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Table 5.5 continued# 
 
#Characteristics and behavioural variables are those reported at Sero6, unless otherwise stated 
*p≤0.05, ¶p≤0.1, ∆ Spouse HIV status and VCT use at Sero6,  
Ω Frequency of condom use in last 12 months considering three most recent partners 
 
  
No.
% Repeat 
Testing OR (95% CI) aOR (95% CI)
BMI loss None 363 44.6 1
<5% 106 40.6 0.85 (0.55-1.31)
≥5% 94 40.4 0.84 (0.53-1.34)
Sero 4 VCT use Didn't attend Sero4 219 44.3 1.22 (0.85-1.75)
Attended Sero4 no VCT 263 39.5 1
Attended Sero4 used VCT 82 51.2 1.61 (0.97-2.64)¶
Spouse HIV & VCT 
use∆ No spouse identified 391 45.0 1 1
Spouse HIV neg, no VCT 117 30.8 0.54 (0.35-0.84)* 0.53 (0.31-0.91)*
Spouse HIV pos, no VCT 5 40.0 0.81 (0.13-4.93) 5.87 (0.68-50.52)
Spouse HIV neg, used VCT 49 59.2 1.77 (0.97-3.24)¶ 1.27 (0.64-2.55)
Spouse HIV pos, used VCT 1 0.0 - -
Age at first sex ≥15 492 45.7 1 1
<15 40 25.0 0.4 (0.19-0.83)* 0.44 (0.19-1.02)¶
Never had sex 13 23.1 0.36 (0.10-1.31) -
Don't know 18 27.8 0.46 (0.16-1.30) 0.57 (0.17-1.88)
Number of sex 
partners in last year None or one 450 41.6 1
Two 69 49.3 1.37 (0.82-2.27)
Three or more 33 54.5 1.69 (0.83-3.43)
Lifetime number of  
sex partners None or one 157 36.9 0.7 (0.45-1.08)
Two 99 43.4 0.92 (0.56-1.50)
Three or more 182 45.6 1
Don't know 122 47.5 1.08 (0.68-1.71)
Frequency of condom 
useΩ Never use 361 42.4 1 1
Inconsistent 98 57.1 1.81 (1.15-2.85)* 1.78 (1.06-3.00)*
Consistent 14 50.0 1.36 (0.47-3.96) 1.04 (0.29-3.68)
Never had sex 13 23.1 0.41 (0.11-1.51) 0.39 (0.08-1.77)
Don't know 78 30.8 0.6 (0.36-1.02) 0.55 (0.25-1.20)
Has a relative who is 
HIV positive No 355 40.6 1
Yes 171 51.5 1.55 (1.08-2.24)*
Don't know 31 35.5 0.81 (0.37-1.73)
Knows somebody 
taking ART No 248 37.5 0.64 (0.45-0.90)*
Yes 276 48.6 1
Don't know 32 50.0 1.06 (0.51-2.20)
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5.5 Discussion 
The uptake of HTC services increased steadily in Kisesa between 2003 and 2010, 
with 9.4% of all participants using VCT at Sero4, 16.6% at Sero5 and 25.5% at 
Sero6. In spite of this, by the end of the Sero6 round (n=8,008), a substantial 
proportion of participants had never used any HTC service – approximately 36% of 
all HIV-positive individuals and 54% of all HIV-negative individuals. Furthermore, 
among participants who attended all three sero-survey rounds (n=2,010), almost 
half (48.0%) had never used any HTC service (at sero-survey and/or elsewhere). 
This figure rose to almost two-thirds (64.0%) if considering VCT use during sero-
survey rounds only. 
 
Considering the rapid expansion of HIV testing and treatment services within the 
study area over the time period in question, it is disappointing that the proportions of 
individuals who had used an HTC service at least once were not even larger. 
Previous research has identified numerous barriers to the uptake of HIV testing 
services in sub-Saharan Africa including prohibitive costs associated with travelling 
to health clinics, shortages of test-kit supplies, high levels of stigma and 
discrimination and concerns about confidentiality (19, 24, 65, 158-161). It is likely 
that stigma formed the greatest barrier to VCT use during sero-surveys in this study, 
as transport was provided free of charge, test-kits were adequately supplied, and 
previous research has found trust in sero-survey counsellors to be high (43). 
However, previous qualitative studies have found high levels of HIV-related stigma 
in Kisesa, which results in fear and a reluctance to test (16, 162). Outside of sero-
surveys, it is likely that a combination of the factors mentioned above contributed to 
the low rates of uptake of testing seen.  
 
At each sero-survey round, those who had previously used an HTC service were 
significantly more likely to use the VCT service offered than those who had never 
used HTC before. However, among participants who attended all three sero-survey 
rounds (n=2,010), the proportions repeat testing (i.e. using HTC twice or more) were 
low, with 11.1% using the VCT service offered at sero twice or more, and 25.3% 
having tested twice or more if reported use of HTC outside of sero-surveys was 
taken into account. As the latter estimate includes data on reported use of HTC 
services, we expect some error around it. However, the numbers of participants over 
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and under reporting previous VCT use were very similar, with 399/917 (43.5%) of all 
individuals over-reporting previous VCT use that did not occur, and 378/896 (42.2%) 
under-reporting previous VCT use that did occur. As a result, the estimate is likely to 
provide a fairly accurate measure of the proportion of individuals who repeat tested 
among those who attended all three sero-survey rounds. While repeat HTC use did 
increase over time, the proportions testing more than once were still low by the end 
of the Sero6 round, when 16.7% of all men and 22.9% of all women had ever repeat 
tested.  
 
The proportions of participants repeat testing in Kisesa are somewhat lower than 
has been reported elsewhere in sub-Saharan Africa, where estimates ranged from 
24.2% in a community cohort study in Uganda (83) to 73.4% in another cohort study 
in Malawi (84). HTC services were provided in the home in both of these studies, 
which may have contributed to the higher rates of uptake seen. One recent 
systematic review found that home-based HTC may be one way in which to 
substantially increase the numbers of people undergoing HIV testing in sub-Saharan 
Africa (70), although such a service would likely place significant financial and 
logistical demands on the local health service infrastructure. In Kisesa, it is clear that 
HIV testing rates are currently well below the one test per adult per year required by 
Granich et al in their model (30), and further dramatic increases in the rate of uptake 
would be required if TasP were to be implemented.  
 
In the analysis of factors associated with repeat VCT use (among those attending 
Seros 5 and 6), there was some evidence that HIV-negative people with higher risk 
sexual behaviours were among those who were most likely to repeat test. This is 
encouraging in terms of the potential to pick up those who are most at risk of HIV-
infection. However, sero-converters were not significantly more likely to repeat test 
than those who did not sero-convert. Only 7 individuals sero-converted between the 
two rounds in this analysis, and so our sample size may have been too small to 
detect any meaningful difference. Other characteristics which were significantly 
associated with repeat VCT use included area of residence and level of education, 
highlighting a persistent inequity among those gaining access to HTC which was 
first seen in 2003-2004 (42). 
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Outside of sero-surveys, most participants reported having used HTC services at 
Kisesa health centre, where the VCT clinic was favoured disproportionately by 
women. This may reflect women who were offered PITC at the antenatal clinic but 
who were subsequently referred to the VCT clinic for testing (possibly due to 
shortages of staff or other resources at the antenatal clinic). However, it may also 
reflect a disinclination among men to use the health centre, which may be viewed as 
a place for women to receive services. Other HTC services such as mobile VCT 
clinics and the Angaza VCT clinic in Mwanza were used more equally by men and 
by women, but by smaller numbers of individuals overall, likely as a result of their 
temporary availability (mobile VCT clinics) or distance from the study area (Angaza 
clinic). With ever larger numbers of women being tested for HIV antenatally in sub-
Saharan Africa (56), men may increasingly represent an under-served group in 
some settings. 
  
This study has a number of strengths including a wealth of data covering an 
important period of time in terms of the development and increasing availability of 
HIV testing and treatment services in Kisesa. The study made use of data on both 
reported and actual use of HTC services, allowing for comparison of rates of testing 
using the two different data sources. It also allowed for comparison of the accuracy 
of reported versus actual HTC use, which was seen to be variable. This may have 
been caused by confusion when answering questions relating to previous HTC use 
and the exact location of any testing, and/or as a result of reporting biases.  
 
We have seen declining participation rates in the Kisesa cohort study over time, 
particularly among younger men living in urban areas (Urassa et al, unpublished 
data), which may have affected our results. HIV-positive individuals may have been 
disproportionately represented among those not participating (163), which may have 
biased estimates of repeat testing upwards, as HIV-positive participants were seen 
to be less likely to repeat test in multivariable analyses. However, the main group of 
interest in terms of repeat testing is HIV-negative individuals. In contrast, estimates 
of repeat testing may have been biased downwards as a result of lesser 
participation among men living in urban areas, where people were significantly more 
likely to use HTC. 
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5.6 Conclusions 
Although the proportion of individuals using HTC services increased in Kisesa over 
time, further increases in the rates of first time and repeat HTC use would be 
required if TasP were to be implemented. Programmes and interventions designed 
to address the persistence of HIV-related stigma and discrimination are urgently 
needed, as are interventions designed to increase the uptake of HTC among those 
living in rural areas and those with least education. 
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6 Paper C. The impact of voluntary counselling and 
testing services on sexual behaviour change and 
HIV incidence: observations from a cohort study in 
rural Tanzania 
 
Introduction to the paper 
Although there is great interest in increasing HTC uptake in sub-Saharan Africa due 
to greater availability of ART and as a means to achieve the potential of TasP 
approaches, one of the original premises of HTC service provision is that it can 
contribute to HIV-prevention by encouraging sexual risk reduction among both HIV-
negative and HIV-positive individuals (4, 5). Paper C (published in BMC Infectious 
Diseases) moves on to explore this topic, investigating the impact of the CO-HTC 
service provided during sero-surveys2 on changes in reported sexual behaviour and 
HIV incidence. Previous studies assessing the impact of HTC on sexual risk 
behaviour or HIV incidence have not investigated trends before and after greater 
availability of ART. In this paper, we explore the impact of HTC first between 2003-
2004 and 2006-2007, when ART was available in Mwanza city 20 kilometres away 
(from the start of 2005) but not within the study area itself, and then between 2006-
2007 and 2010, when ART was available at Kisesa Health Centre. Results for the 
analyses of the impact of HTC on sexual behaviour outcomes are stratified by HIV 
status, in order to detect possible differences between individuals testing HIV-
negative and those testing HIV-positive. 
 
  
                                               
2 Referred to in the paper as the sero-survey VCT service 
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6.1 Abstract 
 
Background: It is widely assumed that voluntary counselling and testing (VCT) 
services contribute to HIV prevention by motivating clients to reduce sexual risk-
taking. However, findings from sub-Saharan Africa have been mixed, particularly 
among HIV-negative persons. We explored associations between VCT use and 
changes in sexual risk behaviours and HIV incidence using data from a community 
HIV cohort study in northwest Tanzania. 
 
Methods: Data on VCT use, sexual behaviour and HIV status were available from 
three HIV serological surveillance rounds undertaken in 2003–4 (Sero4), 2006–7 
(Sero5) and 2010 (Sero6). We used multinomial logistic regression to assess 
changes in sexual risk behaviours between rounds, and Poisson regression to 
estimate HIV incidence. 
 
Results: The analyses included 3,613 participants attending Sero4 and Sero5 
(3,474 HIV-negative and 139 HIV-positive at earlier round) and 2,998 attending 
Sero5 and Sero6 (2,858 HIV-negative and 140 HIV-positive at earlier round). Among 
HIV-negative individuals VCT use was associated with reductions in the number of 
sexual partners in the last year (aRR Seros 4–5: 1.42, 95% CI 1.07-1.88; aRR Seros 
5–6: 1.68, 95% CI 1.25-2.26) and in the likelihood of having a non-cohabiting 
partner in the last year (aRR Seros 4–5: 1.57, 95% CI 1.10-2.25; aRR Seros 5–6: 
1.48, 95% CI 1.07-2.04) or a high-risk partner in the last year (aRR Seros 5–6 1.57, 
95% CI 1.06-2.31). However, VCT was also associated with stopping using 
condoms with non-cohabiting partners between Seros 4–5 (aRR 4.88, 95% CI 1.39-
17.16). There were no statistically significant associations between VCT use and 
changes in HIV incidence, nor changes in sexual behaviour among HIV-positive 
individuals, possibly due to small sample sizes. 
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Conclusions: We found moderate associations between VCT use and reductions in 
some sexual risk behaviours among HIV-negative participants, but no impacts 
among HIV-positive individuals in the context of low overall VCT uptake. 
Furthermore, there were no significant changes in HIV incidence associated with 
VCT use, although declining background incidence and small sample sizes may 
have prevented us from detecting this. The impact of VCT services will ultimately 
depend upon rates of uptake, with further research required to better understand 
processes of behaviour change following VCT use. 
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6.2 Background 
Voluntary counselling and testing (VCT) for HIV has been promoted as a gateway 
for access to HIV treatment and care. Concurrently, the services’ potential 
contribution to HIV prevention has been emphasized; it is hypothesized that 
knowledge of HIV sero-status, accompanied by tailored and targeted risk reduction 
counselling, will assist both HIV-negative and HIV-positive individuals to reduce 
sexual risk-taking and protect themselves and their partners from HIV (20, 154). 
Previous studies have found mixed results with regard to the impact of VCT on 
reductions in sexual risk behaviour. These have generally found greater impact 
among individuals testing HIV-positive compared to those testing negative (22, 23, 
96).  However, some studies have found no association between VCT use and 
changes in sexual behaviour (99, 102), while others have found increases in sexual 
risk taking among individuals testing HIV-negative (24). Few studies have assessed 
the impact of VCT on HIV incidence, however overall, these have found no 
significant differences between participants who received and did not receive VCT 
(23). 
 
The measurement and comparison of indicators of sexual risk behaviour over time 
and between populations is difficult for a number of reasons, possibly explaining 
previous ambiguous findings regarding the impact of VCT on sexual behaviour 
change. Firstly, self-reported sexual behaviour data are often subject to recall and 
social desirability biases, the levels of which may vary depending on the behaviour 
in question, the amount of time that has passed since the event, and past exposure 
to HIV prevention messages (164). Secondly, developing measures or indicators of 
sexual risk behaviour which are specific enough to accurately capture information on 
an individual’s sexual risk profile, yet general enough to be comparable across 
populations or over time, is difficult (165). Nevertheless, while measures of sexual 
behaviour have not always correlated well with rates of HIV incidence or prevalence 
(166-168), trends in these indicators have aided our understanding of the HIV 
epidemic and its relationship with sexual risk behaviour (169).  
 
In this paper, we assess the impact of VCT use on changes in reported sexual risk 
behaviours and HIV incidence using data from consecutive rounds of HIV 
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serological surveillance (sero-surveys) which have been carried out as part of an on-
going community cohort study in northwest Tanzania since 1994. VCT services 
were provided during three sero-surveys in 2003-4, 2006-7 and 2010. 
 
6.3 Methods 
6.3.1 Study setting 
The study setting in Mwanza region has been described in detail by Mwaluko et al 
(142). Briefly, the study area lies approximately 20km to the east of Mwanza city and 
consists of six villages which make up the administrative ward of Kisesa, with a 
combined population of approximately 32,000 people, roughly half of whom are 
adults. The cohort consists of rounds of demographic surveillance taking place 
approximately once every six months since 1994, and rounds of HIV serological 
surveillance among adults aged 15 or older once every two to three years. HIV 
prevalence in the study area rose from 6.0% (95% CI 5.3% to 6.4%) in 1994-5 to 
8.2% (95% CI 7.7% to 8.8%) in 2003-4 (170), before falling to 6.5% (95% CI 6.0% to 
7.0%) in 2010 (R. Isingo, personal communication). This pattern may be explained 
by net in-migration of HIV infected individuals into the study area in the 1990’s, and 
a falling HIV incidence in the study area since the late 1990s (140). 
 
Sero-surveys take place at a central point in each village, with dry-blood spot 
samples taken for ascertainment of HIV-status using a protocol based on informed 
consent without disclosure. HIV diagnosis is based on two ELIZAs (Uniform 2, 
Enzygnost HIV1/HIV2). A detailed questionnaire is administered by same sex 
interviewers, covering topics on socio-demographic characteristics, sexual 
behaviour and participants’ previous use of VCT services including the place and 
circumstances of testing, e.g. whether at a previous sero-survey or elsewhere (and if 
so, where).  
 
Since the fourth sero-survey round in 2003-4 (Sero4), a separate VCT service 
following Tanzanian national guidelines and including pre- and post-test counselling 
(6) has been available to all study participants. Individuals wishing to know their HIV 
status are directed to a purpose-constructed hut for VCT with a trained counsellor 
directly after completing their questionnaire interview. At Sero4, venous blood was 
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collected and transported to the National Institute for Medical Research (NIMR) in 
Mwanza, with diagnosis based on two ELIZAs as for research tests, and clients 
asked to return for their test results and post-test counselling one week later. During 
the fifth and sixth sero-survey rounds in 2006-7 (Sero5) and 2010 (Sero6) venous 
blood was again collected but rapid HIV screening tests were used (preliminary test 
using Capillus, confirmatory test using Determine. Discrepant results resolved using 
two ELIZAs as for research tests). Quality control was performed at the NIMR 
laboratory on a 5% sub-sample using two ELIZAs. During Sero5 and Sero6, HIV 
results and post-test counselling were usually available within 45 minutes of the 
rapid test being performed. Data on the uptake of VCT at sero-surveys are 
anonymously linked to the main sero-survey questionnaire using unique, numerical 
participant identifiers.  
 
Although free antiretroviral therapy (ART) was not available in 2003-4, individuals 
with an HIV-positive result after using VCT at Sero4 were informed that treatment 
would become available in the region in the near future through the national ART 
programme, which started at the beginning of 2005. With their prior agreement, 
these individuals were subsequently traced by the VCT counsellors and referred to 
the zonal referral hospital in Mwanza city for follow-up care. Individuals using VCT 
and testing HIV-positive at Sero5 were referred directly to Mwanza city hospitals. By 
Sero6 in 2010, a care and treatment centre (CTC) was available locally at the health 
centre in Kisesa and so HIV-positive patients were referred here. 
 
6.3.2 Other health services in the study area 
The study population is served by a government-run health centre located in Kisesa 
trading centre, by three small government-run dispensaries located in the rural 
villages, and by a number of private clinics located mainly in the trading centre. A 
stand-alone VCT clinic has been available at Kisesa health centre since 2005, while 
provider initiated testing and counselling (PITC) has been offered to all pregnant 
women attending the health centre for antenatal care since the end of 2008. PITC 
has also been available at the out-patients department since 2010, where testing 
may be offered to patients attending the sexually transmitted infections or 
tuberculosis clinics. Since mid-2009, antenatal PITC is sometimes offered to women 
attending the small rural dispensaries, dependant on the availability of test-kit 
supplies. 
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6.3.3 Ethical statement 
Ethical approval for the Kisesa cohort study has been granted by the Tanzanian 
Medical Research Coordinating Committee and the Ethics Committee of the London 
School of Hygiene and Tropical Medicine. Participation is based on informed 
consent without disclosure of HIV-research test results, however since Sero4 (just 
prior to the introduction of ART), participants are additionally offered a free VCT 
service as detailed above. During Sero4 verbal consent was obtained, due to low 
literacy rates among the study population. This was witnessed and documented for 
each participant on their study questionnaire, by a member of the sero-survey team. 
During Sero5 and Sero6 written consent was introduced (either a signature or a 
thumb-print, depending on the participant’s writing ability). 
 
6.3.4 Data and analysis 
Nine indices of sexual behaviour were used: the number of sex partners in the last 
year, the acquisition or loss of spouse, regular non-cohabiting sexual partner, or 
high risk sex partner in the last year, whether a condom was used with spouse, 
regular non-cohabiting sexual partner, or high risk partner at last sex, and the coital 
frequency with spouse or regular non-cohabiting sexual partner in the last week. 
Changes in sexual behaviour were determined by comparing behaviours reported at 
one round with those reported at the next, in order to determine whether there had 
been an increase, decrease or no change in behaviour. For quantitative variables 
(number of sexual partners, coital frequency), differences in the constructed 
behaviour change variables greater than zero indicated an increase in sexual risk 
behaviour while values less than zero indicated a decrease and a value of zero 
indicated no change. For changes in binary variables (condom use at last sex), the 
indices represented the direction of change in behaviour, with 1 representing 
increased risk, 0 no change and -1 decreased risk. Multinomial logistic regression 
was used to assess the association between VCT and each of the nine indices of 
sexual behaviour change. Crude associations were adjusted for socio-demographic 
variables (age, sex, marital status, area of residence, level of education and 
reported previous use of VCT) in multivariable analyses. 
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In order to explore any potential differences over time, analyses were carried out 
separately for those a) attending both Sero4 and Sero5 and using the VCT service 
at Sero4, b) attending both Sero5 and Sero6 and using the VCT service at Sero5. 
Analyses were restricted to the non-virgin population (those who reported having 
ever had sex) and considered separately for individuals testing HIV-negative and 
HIV-positive at the time of going for VCT. 
 
HIV incidence was estimated based on the number of initially HIV-negative 
respondents who seroconverted between Seros 4 and 5, and Seros 5 and 6, 
respectively. Dates of sero-conversion were assigned based on the midpoint 
between sero-survey interview dates. Poisson regression models were used to 
calculate crude and adjusted HIV incidence rates comparing VCT users and non-
users. 
 
6.4 Results 
6.4.1 Descriptive characteristics 
In total 8,961 participants attended Sero4 (participation rate of 66% (170)), of whom 
3,923 (43.8%) also attended Sero5. Of these, 3,613/3,923 (92.1%) reported that 
they had ever had sex. 933/3,613 (25.8%) individuals expressed a desire for VCT 
while 324/3,613 (9.0%) actually returned to receive their results and complete VCT. 
In total 8,696 participants attended Sero5 (participation rate of 61% (140)), of whom 
3,509 also attended Sero6 (40.3%), with 2,998/3,509 (85.4%) reporting having ever 
had sex. Of these, 525/2,998 (17.5%) individuals expressed a desire for VCT while 
532/2,998 (17.7%) actually completed VCT. The descriptive characteristics of the 
non-virgin population attending the two sets of sero-survey rounds are shown in 
Table 6.1. The largest proportions of attendees were female and fell in the ≥45 age-
group. Of those attending Sero4 and Sero5, 139/3,613 participants (3.8%) were 
HIV-positive, while 23/324 (7.1%) of those who used VCT at Sero4 were HIV-
positive. Of those attending Sero5 and Sero6, 140/2,998 (4.7%) were HIV-positive 
and 29/532 (5.4%) of those who used VCT at Sero5 were HIV-positive. 
 
Across both sets of rounds, approximately 60% of attendees were married 
monogamously with a further 10% being in polygamous marriages. Most 
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participants reported having one sexual partner (in the last year), and not having any 
regular non-cohabiting or high risk partners (also in the last year - Table 6.1). 
Condom use was rare, with just 7.4% reporting ever using a condom at Sero4, and 
9.2% reporting ever using a condom with the three most recent sexual partners at 
Sero5. 
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Table 6.1 Characteristics (at earlier round) of individuals attending i) Sero4 and Sero5, ii) Sero5 and Sero6, by VCT use at earlier 
round 
 
$Small numbers of missing data (<3%) 
*Previous VCT use as reported at the later round (to account for any VCT use in the inter sero-survey period)  
β Data on widowed/separated not broken down at Sero4 
# At Sero5 this variable related to ever use of condoms with spouse or regular non-cohabiting partners only (N=2,403)
  No VCT                 
N (%)
Had VCT                
N (%) Total
  No VCT                 
N (%)
Had VCT                
N (%) Total
Total 3289 (91.0) 324 (9.0) 3613 (100) 2466 (82.3) 532 (17.7) 2998 (100)
Sex Male 1228 (87.1) 182 (12.9) 1420 (100) 795 (78.5) 218 (21.5) 1013 (100)
Female 2061 (93.6) 142 (6.4) 2203 (100) 1671 (84.2) 314 (15.8) 1985 (100)
Age 15-24 815 (92.1) 70 (7.9) 885 (100) 480 (80.8) 114 (19.2) 594 (100)
25-34 731 (86.7) 112 (13.3) 843 (100) 549 (78.1) 154 (21.9) 703 (100)
35-44 673 (89.4) 80 (10.6) 753 (100) 471 (77.2) 139 (22.8) 610 (100)
>=45 1070 (94.5) 62 (5.5) 1132 (100) 966 (88.5) 125 (11.5) 1091 (100)
HIV status Negative 3173 (91.3) 301 (8.7) 3474  (100) 2355 (82.4) 503 (17.6) 2858 (100)
Positive 116 (83.5) 23 (16.5) 139  (100) 111 (79.3) 29 (20.7) 140 (100)
Reported previous use of VCT$* No 3046 (92.2) 258 (7.8) 3304  (100) 1667 (88.9) 208 (11.1) 1875 (100)
Yes 243 (78.6) 66 (21.4) 309  (100) 728 (69.7) 317 (30.3) 1045 (100)
Number of sexual partners in last year None 392 (97.5) 10 (2.5) 402 (100) 490 (92.3) 41 (7.7) 531 (100)
One 2195 (91.8) 195 (8.2) 2390 (100) 1755 (81.8) 390 (18.2) 2145 (100)
Two or more 702 (85.5) 119 (14.5) 821 (100) 221 (68.6) 101 (31.4) 322 (100)
Marital status$β Never married 435 (88.8) 55 (11.2) 490 (100) 294 (81.4) 67 (18.6) 361 (100)
Marr monogamous 1946 (90.9) 195 (9.1) 2141 (100) 1392 (80.7) 332 (19.3) 1724 (100)
Marr polygamous 303 (91.0) 30 (9.0) 333 (100) 268 (81.2) 62 (18.8) 330 (100)
Widowed 276 (92.9) 21 (7.1) 297 (100)
Separated/divorced 236 (82.5) 50 (17.5) 286 (100)
Widowed/Separated 568 (93.4) 40 (6.6) 608 (100)
Regular non-cohabiting partner in last year$ No 2776 (92.0) 242 (8.0) 3018 (100) 2130 (83.7) 415 (16.3) 2545 (100)
Yes 513 (86.2) 82 (13.8) 595 (100) 331 (74.2) 115 (25.8) 446 (100)
High risk partner in last year$ No 3185 (91.3) 302 (8.7) 3487 (100) 2297 (83.0) 471 (17.0) 2768 (100)
Yes 104 (82.5) 22 (17.5) 126 (100) 157 (73.7) 56 (26.3) 213 (100)
Ever used a condom$# No 2907 (92.6) 231 (7.4) 3138 (100) 1778 (81.9) 393 (18.1) 2171 (100)
Yes 380 (80.3) 93 (19.7) 473 (100) 133 (64.3) 74 (35.7) 207 (100)
Attended Sero4 and Sero5 Attended Sero5 and Sero6
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6.4.2 Impact of VCT on sexual behaviour change among HIV-negative 
individuals 
Among HIV-negative individuals, VCT use was associated with some changes in 
sexual behaviour in terms of the number and type of partnerships formed, but less 
so in terms of condom use or coital frequency (see Table 6.2 and Table 6.3). 
Between Sero4 and Sero5, compared to those who did not have VCT, VCT users 
had an increased likelihood of reducing their number of sexual partners in the last 
year (Table 6.2: adjusted risk ratio [aRR] 1.42, 95% confidence interval [CI] 1.07-
1.88). A similar pattern was seen in terms of reduction in the number of sexual 
partners between Sero5 and Sero6 (Table 6.3: aRR 1.68, 95% CI 1.25-2.26). 
 
Among HIV negative individuals, there was evidence that VCT use at Sero4 was 
associated with both acquiring (aRR 1.88, 95% CI 1.29-2.74) and losing (aRR 1.56, 
95% CI 0.95-2.55) a spouse by Sero5 (Table 6.2). While similar trends were seen 
between Sero5 and Sero6, the results were not statistically significant (Table 6.3: 
aRR for acquiring a spouse: 1.19, 95% CI 0.82-1.73; aRR for losing a spouse: 1.12, 
95% CI 0.74-1.70). Between Seros 4 and 5 and also between Seros 5 and 6, VCT 
use at the earlier round was also significantly associated with losing a regular non-
cohabiting partner by the later round (aRR Seros 4-5: 1.57, 95% CI 1.10-2.25, aRR 
Seros 5-6: 1.48, 95% CI 1.07-2.04). Further investigation revealed that 
approximately half of those who acquired a spouse by the later round were the 
same people who had lost a regular non-cohabiting partner (144/298 or 48.3% of 
those acquiring a spouse between Sero4 and Sero5, and 106/202 or 52.5% of those 
acquiring a spouse between Sero5 and Sero6). As a result, at least some of the 
spousal acquisition between rounds is likely as a result of people marrying their 
regular partners. Between Seros 5 and 6, VCT use was also associated with losing 
a high-risk or casual partner (aRR 1.57, 95% CI 1.06-2.31). 
 
In general there was no significant impact of VCT on condom use behaviour, 
although VCT at Sero4 was associated with an increased likelihood of stopping 
using condoms with regular non-cohabiting partners by Sero5 (aRR 4.88, 95% CI 
1.39-17.16).Coital frequency information was not available at Sero4, but between 
Sero5 and Sero6, there was no evidence for an impact of VCT on changes in coital 
frequency with spouses or regular non-cohabiting partners in the last week (Table 
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6.3). In addition, there was no evidence to suggest any interaction between VCT use 
and gender in terms of any of the sexual behaviour change outcomes. 
 
In total 2,010 participants attended all three sero-surveys, of whom 1,876 (93.3%) 
reported having ever had sex. Among these, 82/1,876 (4.4%) used VCT twice (at 
both Sero4 and Sero5) and 1,828/1,876 (97.4%) were HIV-negative at Sero4. In 
crude analyses among HIV negative individuals, those using VCT twice (at Sero4 
and Sero5) were more likely to report increasing their number of sexual partners 
(RR 2.10, 95% CI 1.06-4.14) and acquiring a high-risk partner (RR 2.13, 95% CI 
1.03-4.38) between Sero4 and Sero6, compared to those who did not use VCT 
twice. However there were no significant impacts of VCT on any of the sexual 
behaviour change outcomes in adjusted analyses. 
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Table 6.2 Change in sexual behaviour between Sero4 and Sero5 associated 
with VCT use at Sero4, HIV-negative individuals 
 
¶ All outcomes adjusted for age, sex, marital status, area of residence, level of education 
and previous VCT use as reported at the later sero-survey round 
*p≤0.1, **p≤0.05, ***p≤0.001 
α ‘Acquired or lost spouse' was not adjusted for marital status (as this was the outcome)  
# Analyses conduced among those with relevant partner type at both rounds only 
 
  
Crude Risk Ratio 
(95% CI)
Adjusted Risk Ratio 
(95% CI)¶
Number of sex partners in last year
3173 % 301 %
No change 2060 64.9 169 56.1 1
Increase 306 9.6 25 8.3 1 (0.64-1.54) 0.82 (0.52-1.30)
Decrease 807 25.4 107 35.5 1.62 (1.25-2.09)*** 1.42 (1.07-1.88)**
Acquired or lost a spouseα
3136 % 297 %
No change 2701 86.1 233 78.5 1 1
Acquired 255 8.1 43 14.5 1.95 (1.38-2.77)*** 1.88 (1.29-2.74)***
Lost 180 5.7 21 7.1 1.35 (0.84-2.17) 1.56 (0.95-2.55)*
Acquired or lost a regular non-cohabiting partner
3168 % 301 %
No change 2601 82.1 226 75.1 1 1
Acquired 251 7.9 27 9.0 1.24 (0.81-1.88) 0.88 (0.55-1.43)
Lost 316 10.0 48 15.9 1.75 (1.25-2.44)*** 1.57 (1.10-2.25)**
Acquired or lost a high risk partner
3156 % 299 %
No change 2879 91.2 267 89.3 1 1
Acquired 193 6.1 19 6.4 1.06 (0.65-1.73) 0.97 (0.58-1.62)
Lost 84 2.7 13 4.3 1.67 (0.92-3.03) 1.41 (0.75-2.65)
Condom use at last sex with spouse#
2000 % 190 %
No change 1951 97.6 184 96.8 1 1
Stopped using 31 1.6 2 1.1 0.68 (0.16-2.88) 0.45 (0.10-1.93)
Started using 18 0.9 4 2.1 2.36 (0.79-7.04) 1.79 (0.56-5.67)
Condom use at last sex with regular non-cohabiting partner#
179 % 31 %
No change 147 82.1 17 54.8 1 1
Stopped using 12 6.7 8 25.8 5.76 (2.07-16.08)*** 4.88 (1.39-17.16)**
Started using 20 11.2 6 19.4 2.59 (0.92-7.35) 2.21 (0.60-8.14)
Condom use at last sex with high risk partner#
12 % 5 %
No change 8 66.7 3 60.0 1 -
Stopped using 1 8.3 1 20.0 2.67 (0.12-57.62) -
Started using 3 25.0 1 20.0 0.89 (0.06-12.25) -
No VCT Had VCT
N with outcome (%)
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Table 6.3 Change in sexual behaviour between Sero5 and Sero6 associated 
with VCT use at Sero5, HIV-negative individuals 
 
¶ All outcomes adjusted for age, sex, marital status, area of residence, level of education and previous 
VCT use as reported at the later sero-survey round 
*p≤0.1, **p≤0.05, ***p≤0.001 
α Acquired or lost spouse' was not adjusted for marital status (as this was the outcome) 
Ω Questions related to 'casual' rather than 'high risk' partners at Sero6, however, the two categories 
were considered comparable 
# Analyses conduced among those with relevant partner type at both rounds only 
Crude Risk Ratio 
(95% CI)
Adjusted Risk Ratio 
(95% CI)¶
Number of sex partners in last year
2336 % 502 %
No change 1732 74.1 338 67.3 1 1
Increase 272 11.6 74 14.7 1.39 (1.05,1.85)** 1.13 (0.82,1.55)
Decrease 332 14.2 90 17.9 1.39 (1.07,1.80)** 1.68 (1.25,2.26)***
Acquired or lost a spouseα
2346 % 500 %
No change 2043 87.1 423 84.6 1 1
Acquired 158 6.7 44 8.8 1.35 (0.95,1.91)* 1.19 (0.82,1.73)
Lost 145 6.2 33 6.6 1.1 (0.74,1.63) 1.12 (0.74,1.70)
Acquired or lost a regular non-cohabiting partner
2350 % 501 %
No change 2017 85.8 399 79.6 1 1
Acquired 90 3.8 23 4.6 1.29 (0.81,2.07) 1.23 (0.73,2.07)
Lost 243 10.3 79 15.8 1.64 (1.25,2.16)*** 1.48 (1.07,2.04)**
Acquired or lost a high risk or casual partnerΩ
2344 % 498 %
No change 2062 88.0 406 81.5 1 1
Acquired 153 6.5 48 9.6 1.59 (1.13,2.24)** 1.28 (0.84,1.95)
Lost 129 5.5 44 8.8 1.73 (1.21,2.48)** 1.57 (1.06,2.31)**
Condom use at last sex with spouse#
1379 % 332 %
No change 1345 97.5 326 98.2 1 1
Stopped using 18 1.3 3 0.9 0.69 (0.20,2.35) 0.64 (0.18,2.28)
Started using 16 1.2 3 0.9 0.77 (0.22,2.67) 0.62 (0.17,2.29)
Condom use at last sex with regular non-cohabiting partner#
75 % 29 %
No change 51 68.0 20 69.0 1 1
Stopped using 12 16.0 5 17.2 1.06 (0.33,3.40) 0.70 (0.14,3.54)
Started using 12 16.0 4 13.8 0.85 (0.24,2.95) 0.32 (0.06,1.63)
Condom use at last sex with high risk or casual partner#Ω
18 % 10 %
No change 10 55.6 6 60.0 1 1
Stopped using 1 5.6 2 20.0 3.33 (0.25,45.11) -
Started using 7 38.9 2 20.0 0.48 (0.07,3.09) -
Number of times sex with spouse in last week#
1388 % 335 %
No change 384 27.7 81 24.2 1 1
Increase 296 21.3 68 20.3 1.09 (0.76,1.56) 1.03 (0.71,1.51)
Decrease 708 51.0 186 55.5 1.25 (0.93,1.66) 1.3 (0.96,1.77)
Number of times sex with regular non-cohabiting partner in last week#
75 % 29 %
No change 27 36.0 11 37.9 1 1
Increase 19 25.3 7 24.1 0.9 (0.30,2.76) 0.83 (0.21,3.32)
Decrease 29 38.7 11 37.9 0.93 (0.35,2.50) 0.92 (0.27,3.14)
No VCT Had VCT
N with outcome (%)
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6.4.3 Impact of VCT on HIV incidence 
Between Sero4 and Sero5, HIV incidence among those who did not use VCT at 
Sero4 was 0.86 per 100 person years (95% CI 0.70-1.06), while it was 1.04 per 100 
person years (95% CI 0.56-1.94) among those who used VCT. The corresponding 
incidence between Sero5 and Sero6 was 0.66 per 100 person years (95% CI 0.46-
0.93) among those who did not use VCT at Sero5 and 0.48 per 100 person years 
(95% CI 0.20-1.16) among those used VCT. In crude and adjusted analyses, VCT 
was not significantly associated with changes in HIV-incidence between either set of 
sero-survey rounds (Table 6.4). 
 
Table 6.4 HIV incidence among initially HIV-negative participants, by VCT use 
at the earlier sero-survey round 
 
*Adjusted for age, sex and previous VCT use as at reported at the later sero-survey round 
 
6.4.4 Impact of VCT on sexual behaviour change among HIV-positive 
individuals 
Fewer indicators of sexual behaviour change could be assessed among HIV-
positive individuals due to small sample sizes, and VCT use was not significantly 
associated with changes in any of these in crude or adjusted analyses (Table 6.5 
and Table 6.6).  
 
However, for some indicators, the measures of effect seemed to go in opposite 
directions between Seros 4 and 5 and Seros 5 and 6. For example, a larger 
proportion of HIV-positive individuals using VCT at Sero4 lost a spouse by Sero5 
(13.0% versus 11.4%, aRR 2.65, 95% CI 0.46-15.23) and acquired a regular non-
cohabiting partner by Sero5 (30.4% versus 17.5%, aRR 3.46, 95% CI 0.71-16.83) 
compared to those not using VCT. The opposite effect was seen between Seros 5 
and 6. Compared to those not using VCT, HIV-positive individuals using VCT at 
N Person years Seroconversions Incidence per 100PY
Crude Rate Ratio 
(95% CI)
Adjusted Rate 
Ratio (95% CI)*
Attended Sero4 and Sero5
No VCT 3160 10133.8 87 0.86 (0.70-1.06) 1 1
VCT 299 959.1 10 1.04 (0.56-1.94) 1.21 (0.63-2.34) 1.13 (0.58-2.22)
Attended Sero5 and Sero6
No VCT 2343 4880.1 32 0.66 (0.46-0.93) 1 1
VCT 501 1031.0 5 0.48 (0.20-1.16) 0.74 (0.29-1.90) 0.69 (0.26-1.82)
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Sero5 were more likely to acquire a spouse (10.3% versus 2.7%, aRR 4.35, 95% CI 
0.68-27.93) and to lose a non-cohabiting partner (20.7% versus 11.7%, aRR 1.59, 
95% CI 0.45-5.64) by Sero6. However, the confidence intervals around all of these 
estimates are very wide. 
 
In crude analyses, VCT use at both Sero4 and Sero5 seemed to be associated with 
an increased likelihood of both stopping and starting using condoms at last sex with 
spouse by the next round (Table 6.5 and Table 6.6). However, the numbers 
contributing to these analyses were very small (six participants between Seros 4 
and 5, eight participants between Seros 5 and 6). As a result, the results were not 
statistically significant, nor was it possible to adjust for or investigate the effect of 
possible confounders. 
 
Pooling the data for both sets of rounds (taking account of clustering for those who 
attended all three rounds) did reveal some evidence for an association between 
VCT use and a reduction in some sexual risk behaviours between rounds (results 
not shown). In these analyses, HIV-positive individuals using VCT at the earlier 
round seemed less likely to increase their number of sexual partners in the last year 
by the next round as compared to those not using VCT (aRR 0.22, 95% CI 0.05-
1.01, p=0.05). 
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Table 6.5 Change in sexual behaviour between Sero4 and Sero5 associated 
with VCT use at Sero4, HIV-positive individuals 
 
¶ All outcomes adjusted for age, sex, marital status, area of residence, level of education 
and previous VCT use as reported at the later sero-survey round 
α Acquired or lost spouse' was not adjusted for marital status (as this was the outcome)  
# Analyses conducted among those with a spouse at both rounds only 
 
 
  
Crude Risk Ratio 
(95% CI)
Adjusted Risk Ratio 
(95% CI)¶
Number of sex partners in last year
115 % 23 %
No change 64 55.7 13 56.5 1 1
Increase 16 13.9 0 0.0 - -
Decrease 35 30.4 10 43.5 1.41 (0.56,3.54) 0.88 (0.25,3.02)
Acquired or lost a spouseα
114 % 23 %
No change 93 81.6 19 82.6 1 1
Acquired 8 7.0 1 4.3 0.61 (0.07,5.18) 0.64 (0.06,7.13)
Lost 13 11.4 3 13.0 1.13 (0.29,4.35) 2.65 (0.46,15.23)
Acquired or lost a regular non-cohabiting partner
114 % 23 %
No change 79 69.3 15 65.2 1 1
Acquired 20 17.5 7 30.4 1.84 (0.66,5.12) 3.46 (0.71,16.83)
Lost 15 13.2 1 4.3 0.35 (0.04,2.86) 0.26 (0.02,2.85)
Acquired or lost a high risk partner
115 % 22 %
No change 98 85.2 17 77.3 1 1
Acquired 10 8.7 1 4.5 0.58 (0.07,4.80) 0.63 (0.05,8.02)
Lost 7 6.1 4 18.2 3.29 (0.87,12.48) 3.10 (0.50,19.31)
Condom use at last sex with spouse#
68 % 12 %
No change 64 94.1 10 83.3 1 1
Stopped using 2 2.9 1 8.3 3.2 (0.26,38.64) 0.99 (0.03,34.27)
Started using 2 2.9 1 8.3 3.2 (0.26,38.64) -
No VCT Had VCT
N with outcome (%)
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Table 6.6 Change in sexual behaviour between Sero5 and Sero6 associated 
with VCT use at the Sero5, HIV-positive individuals 
 
¶ All outcomes adjusted for age, sex, marital status, area of residence, level of education 
and previous VCT use as reported at the later sero-survey round 
α Acquired or lost spouse' was not adjusted for marital status (as this was the outcome) 
Ω Questions related to 'casual' rather than 'high risk' partners at Sero6, however, the two 
categories were considered comparable 
# Analyses conducted among those with a spouse at both rounds only 
 
  
Crude Risk Ratio (95% 
CI)
Adjusted Risk Ratio 
(95% CI)¶
Number of sex partners in last year
110 % 29 %
No change 72 65.5 21 72.4 1 1
Increase 14 12.7 3 10.3 0.73 (0.19,2.80) 0.41 (0.08,2.12)
Decrease 24 21.8 5 17.2 0.71 (0.24,2.10) 0.56 (0.13,2.38)
Acquired or lost a spouseα
111 % 29 %
No change 88 79.3 23 79.3 1 1
Acquired 3 2.7 3 10.3 3.83 (0.72,20.22) 4.35 (0.68,27.93)
Lost 20 18.0 3 10.3 0.57 (0.16,2.10) 0.68 (0.17,2.63)
Acquired or lost a regular non-cohabiting partner
111 % 29 %
No change 90 81.1 22 75.9 1 1
Acquired 8 7.2 1 3.4 0.51 (0.06,4.31) 0.21 (0.01,3.25)
Lost 13 11.7 6 20.7 1.89 (0.65,5.53) 1.59 (0.45,5.63)
Acquired or lost a high risk or casual partnerΩ
110 % 29 %
No change 90 81.8 25 86.2 1 1
Acquired 11 10.0 3 10.3 0.98 (0.25,3.79) 0.53 (0.10,2.98)
Lost 9 8.2 1 3.4 0.4 (0.05,3.31) 0.32 (0.02,4.35)
Condom use at last sex with spouse#
61 % 18 %
No change 56 91.8 15 83.3 1 1
Stopped using 2 3.3 1 5.6 1.87 (0.16,22.01) -
Started using 3 4.9 2 11.1 2.49 (0.38,16.27) -
Number of times sex with spouse in last week#
62 % 19 %
No change 18 29.0 2 10.5 1 1
Increase 14 22.6 3 15.8 1.93 (0.28,13.16) 3.37 (0.26,44.11)
Decrease 30 48.4 14 73.7 4.2 (0.85,20.65) 7.55 (0.84,67.63)
No VCT Had VCT
N with outcome (%)
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6.5 Discussion 
In this study, the overall uptake of VCT at the first two sero-surveys during which it 
was offered was low (10% and 17% at Seros 4 and 5 respectively (43)). A recent 
estimate of ART coverage among those in need in Kisesa (based on individuals 
HIV-positive at Sero5) was also low (just 2% - (171)). As in previous studies, our 
findings with regard to the impact of VCT on sexual behaviour change were mixed, 
with service use associated with changes in some behaviours but not others. 
However, it was encouraging that reductions in the numbers and types of 
partnerships formed persisted across both sets of sero-survey rounds.  
 
We found no evidence for an impact of VCT on changes in HIV incidence. While it is 
possible that a declining incidence in the study area overall and a small number of 
sero-conversions may have prevented us from detecting this, a number of other 
studies have similarly found no impact of VCT on changes in HIV incidence (99, 
172). 
 
It was perhaps unsurprising that HIV-negative individuals were more likely to acquire 
a spouse after going for VCT, as young couples in sub-Saharan African are 
frequently advised to go for VCT before marriage. The interpretation or significance 
of the acquisition or loss of a spouse is somewhat different to the acquisition or loss 
of a high-risk partner. While acquisition of the latter may clearly be interpreted as a 
transition to higher risk behaviour, the acquisition of a spouse may be viewed as a 
shift to lower-risk behaviour as people theoretically move from a ‘sexually active but 
single’ state to a more stable, settled relationship. Conversely, the loss of a spouse 
(which might not be volitional, for example if it occurred as a result of widowhood) 
could be viewed as a transition to higher-risk behaviour as people leave settled 
relationships and return to a phase during which they may seek out new sexual 
partners.  
 
It was somewhat more surprising that HIV-negative individuals using VCT at Sero4 
were more likely to lose a spouse by Sero5 than those not using VCT. However, of 
the 201 HIV-negative individuals who lost a spouse between Sero4 and Sero5, 75 of 
these cases (37.3%) were as a result of widowhood. The observed association 
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between VCT use and spousal loss between Seros 4-5 may be linked to widowhood 
through reverse causality, as individuals with sick partners may have been more 
likely to go and test than individuals with healthy partners. Further qualitative 
research may help to elucidate the reasons why people go (or don’t go) for VCT, the 
types of information that clients receive and the perceived importance of this 
information in helping people to change their sexual behaviour. 
 
Condom use among study participants was low overall and VCT use was generally 
associated with little change in this behaviour. The finding that VCT use at Sero4 
was associated with an increased likelihood of stopping using condoms at last sex 
with regular non-cohabiting partners by Sero5 is difficult to interpret, but may relate 
to the specific risk-profile of these non-cohabiting partners and/or whether they had 
also been for VCT and tested HIV-negative. A number of studies have found VCT 
use to be associated with increases in condom use (22, 92, 96) and so it was 
disappointing that we did not find similar results in this study. Condom use has 
previously been reported to be low in this part of Tanzania (173, 174), and it is 
possible that negative attitudes towards their use persist in spite of messages 
shared during VCT. Low levels of condom use could also relate to anecdotal 
evidence of problems relating to their availability or supply. 
 
There were no statistically significant changes in sexual behaviour associated with 
VCT use among HIV-positive individuals, except for a reduced likelihood of 
increasing the number of sexual partners in the last year in the pooled analysis. In 
the analyses done separately by rounds, for some indicators the measures of effect 
seemed to go in opposite directions between the two sets of rounds. For example, 
between Seros 4-5, individuals using VCT and testing HIV-positive seemed more 
likely to lose a spouse but to acquire a regular non-cohabiting partner by Sero5 
compared to those not using VCT. Conversely between Seros 5-6, those testing 
HIV-positive seemed more likely to acquire a spouse but to lose a regular partner by 
Sero6. These results may have arisen simply as a result of the small sample sizes 
which yielded non-statistically significant results, but other factors could also have 
been at play. For example, antiretroviral therapy was more widely available in the 
study area between Sero5 and Sero6, and this may have assisted participants in 
regaining health and acquiring more permanent spousal partners. Sero-sorting could 
also have been taking place, with more people aware of their HIV-status by the later 
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sero-survey rounds, allowing them to seek out other HIV-positive individuals with 
whom to form more permanent partnerships.  
 
The limitations of this study relate to the observational nature of the data and to the 
pitfalls of working with self-reported sexual behaviour data, which are subject to 
recall and social desirability biases. We have previously shown that in Kisesa, VCT 
tends to attract individuals with higher risk sexual behaviours (43), and so as VCT 
uptake increases, the associations between VCT use and reductions in sexual risk 
behaviour among the general population may be weaker. In addition, we may have 
overstated the impacts of VCT if those who used the service were more likely to 
report declines in their risk behaviour compared to those who didn’t. However, the 
community in Kisesa has been exposed to various HIV information and education 
campaigns over a number of years, and so all study participants are likely to have 
had some degree of exposure to HIV prevention messages. 
 
Our ability to detect changes in levels of risk behaviour was limited by lack of 
knowledge of the sexual risk profile and HIV-status of partners. Take for example an 
individual who reported one sexual partner at both rounds, but who had an HIV-
negative partner at the earlier round and an HIV-positive one at the later round. In 
this scenario, there would have been an increase in the level of risk between rounds 
which our behaviour change index would have been incapable of detecting. Further 
analyses among the subset of married and co-habiting couples for whom partner 
HIV-status are available may warrant investigation. 
 
The strengths of this study relate to the fact that our VCT use data were 
documented rather than self-reported, and we were able to adjust for reported use 
of HIV counselling and testing services outside of sero-surveys, which should have 
helped to reduce levels of measurement error and residual confounding. 
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6.6 Conclusions 
We found moderate but encouraging associations between VCT use and reductions 
in some sexual risk behaviours among HIV-negative participants, including 
reductions in the number of sexual partners in the last year, and a move to safer 
types of partnership. However, the overall uptake of VCT was low and we found no 
impacts of VCT on changes in HIV incidence. There were also no significant or 
consistent impacts of VCT on changes in sexual behaviour among HIV-positive 
individuals, but small sample sizes may have prevented us from discovering these. 
The impact of VCT services on sexual behaviour change and HIV prevention will 
ultimately depend upon rates of uptake, with further research required to better 
understand processes of behaviour change following VCT use. 
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7 Qualitative research methods 
 
This chapter describes the overall aims of the qualitative research and the methods 
used, including the design and development of data collection tools, training of 
fieldworkers, sampling strategy and recruitment, and collection and analysis of data. 
 
7.1 Aims and overview 
The overall aims of the qualitative research were to explore perceptions of HTC 
services, and to understand how HIV prevention counselling messages might 
influence attitudes and intentions regarding sexual risk reduction. These data were 
expected to complement quantitative findings from the analyses presented in 
Chapter 6, by shedding light on factors influencing sexual behaviour change 
following HTC use. A period of qualitative fieldwork was undertaken in Kisesa 
between January and April 2012, using a variety of data collection tools in order to 
maximise learning from different methodologies and perspectives. Participatory 
learning and action (PLA) activities were conducted with community members 
including those who had and had not used HTC services, while in-depth interviews 
(IDIs) were carried out with HIV-negative and HIV-positive clients completing HTC. 
IDIs were also conducted with healthcare workers offering HTC, in order to explore 
provider perspectives. 
 
7.2 Design and development of data collection tools 
7.2.1 PLA activities 
The objectives of the PLA activities were to 1) elicit general community perceptions 
and views about HTC services (regardless of the HIV or HTC use status of 
participants), 2) raise awareness and encourage support for HTC, 3) recruit HIV-
negative and HIV-positive users of HTC services for IDIs (the recruitment 
procedures for IDIs are explained in Section 7.5.2 below). PLA activities were used 
as they can help to encourage processes of dialogue and change amongst study 
participants, by encouraging them to share knowledge with one another and to 
analyse situations or problems together (175, 176). Such activities can also help to 
encourage an exchange of information between researchers and study participants, 
which can in turn mobilise participants’ support around the subject under 
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investigation (175, 176). The original guideline that was developed for the study 
contained two PLA activities. The first of these consisted of a brainstorming activity 
using flip-chart paper to allow participants to visually express ideas and opinions 
relating to HTC services, and to stimulate discussion between group members. The 
second activity involved sketching out steps along the pathway to eventual HTC use 
by an imagined typical community member, followed by a discussion of potential 
barriers at each step or stage along the pathway, as well as possible ways to avoid 
or reduce the magnitude of each barrier. Following piloting however (see Section 7.4 
below), only the first brainstorming PLA activity was included in the discussion 
guide, in order to reduce the length and complexity of the group activities.  
 
During the brainstorming activity, participants were divided into groups and 
encouraged to draw symbols or pictures on pieces of flipchart paper which 
represented their views or perceptions of HTC services. Themes explored included 
the perceived usefulness of HTC services, positive and negative aspects of service 
provision, and opinions relating to counsellors (see activity guideline in Appendix 
11.2.6). All participants were then encouraged to discuss the ideas identified by 
each of the different groups, including whether they agreed or disagreed with the 
ideas expressed, whether the information provided was accurate, and whether they 
had any further information to add. At the end of the activity, facilitators addressed 
each of the topics explored in turn, elaborating on any additional information and 
sensitively correcting any misconceptions regarding availability or protocols for HTC 
service provision in Kisesa. 
 
7.2.2 In-depth interviews 
The aim of the IDIs with clients who had accessed HTC was to allow a detailed and 
confidential discussion of individual experiences of using services, with a view to 
understanding how HTC might influence changes in sexual risk behaviour. The 
discussion guide incorporated topics on motivations for going for HTC, location of 
testing, the relationship between client and counsellor during sessions, information 
and advice shared with and received from counsellors, attitudes and feelings 
regarding the counselling advice received and regarding sexual risk reduction, and 
experiences of disclosing HTC use to partners or other family members (see 
discussion guide in Appendix 11.2.7).  
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The IDIs with healthcare workers aimed to understand provider perspectives 
including counsellors’ experiences of providing HTC and whether they felt services 
met clients’ needs and/or helped to influence or encourage sexual behaviour 
change. The discussion guides varied depending on the role of the counsellor in 
question (whether s/he provided VCT or antenatal PITC), however in general they 
covered topics relating to length of time and experience providing HTC, the content 
and information shared during pre and post-test counselling sessions, community 
perceptions of HTC, and levels of training and support received. One IDI was 
conducted with an individual providing training for counsellors in order to understand 
the content of training programmes and ongoing professional development, support 
and supervision for counsellors. (See healthcare worker discussion guides in 
Appendices 11.2.8, 11.2.9 and 11.2.10).  
 
All of the study tools were reviewed by social scientists with prior experience of 
conducting qualitative research in Kisesa, and were piloted prior to the start of data 
collection (see Section 7.4 below). 
 
7.3 Recruitment and training of fieldworkers  
Four Tanzanian fieldworkers (two men and two women) were recruited to assist with 
data collection activities, including one lead research assistant. All research 
assistants had some experience of qualitative data collection in Kisesa or elsewhere 
in Tanzania, including conducting focus group discussions and IDIs, however they 
had less experience facilitating PLAs. In preparation for the study, I designed and 
delivered a one-week training programme in collaboration with a senior social 
scientist based at NIMR Mwanza (Joyce Wamoyi). I prepared all of the training 
materials (background literature and information sheets, PowerPoint slides), and 
delivered most of the training sessions with the exception of the sessions on 
facilitating PLAs and the refresher session on IDIs, which were delivered in 
conjunction with Joyce Wamoyi. 
 
The training activities introduced research assistants to the aims and objectives of 
the study, provided relevant background literature, covered ethical aspects relating 
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to confidentiality and informed consent, covered the theory and practical aspects 
relating to the use and facilitation of PLA activities, and offered a refresher session 
on facilitating IDIs. Time was devoted to familiarisation with the drafted PLA 
activities and IDI guidelines. Research assistants translated the data collection tools 
from English into Swahili in pairs. The study documents were then exchanged 
between pairs in order to verify translations and make sure the language used was 
appropriate. The training week also enabled a discussion of best practices for 
planning the study schedule and recruitment procedures, based on previous 
experience in Kisesa. 
 
7.4 Piloting 
The training week included an opportunity for research assistants to facilitate the 
planned PLA activities using the rest of the research team as proxy participants. 
Based on this exercise and on feedback from the research assistants as well as the 
senior social scientist, amendments to the activity guide were made including 
reducing the number of PLA activities from two to one. This was primarily because 
the second PLA activity appeared prohibitively complex to implement within a single 
two to three hour session, as had been allocated for each group activity.   
 
Research assistants were also given the opportunity to pilot the HTC-user IDI guide 
with volunteer participants (other colleagues working on unrelated projects at NIMR 
Mwanza) in Swahili. I held de-briefing sessions with the research assistants during 
which they highlighted any challenges or issues they encountered while piloting the 
IDIs, and refinements to the wording of the topic guide were made accordingly. 
 
7.5 Sampling strategy and recruitment 
7.5.1 PLA activities 
A combination of purposive sampling and snowball techniques were used to recruit 
participants for the group activities. First, individuals were purposively selected from 
a sampling frame which was constructed from the demographic, sero-surveillance 
and linked HTC clinic-cohort datasets. This allowed inclusion of individuals who 
were known or reported to have used HTC services during sero-surveys or at 
Kisesa Health Centre, as well some individuals who had not used HTC. This 
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‘seeded’ focus group approach (177) allowed us to include HTC clients in the group 
activities without inadvertently revealing their HTC-use status to other study 
participants. Some ‘seeded’ HTC users were HIV-positive, however field workers 
were unaware of the HIV status of any participants. Next, each purposively sampled 
individual who agreed to participate was asked to invite a neighbour or friend from 
their village and from the same age group to take part in the activity.   
 
I prepared the recruitment lists for each of the group activities based on the 
sampling frame, and provided them to the lead fieldworker who made home-visits to 
those listed. The aim was to recruit a total of between eight and twelve participants 
for each activity. An excess of purposively sampled participants was included on the 
recruitment lists in order to account for participants declining to participate, being 
away from home or having moved out of the study area at the time of invitation. 
Invitations were delivered verbally; the aims of the group activities were explained, 
and the time, date and location for the session were provided, with sessions usually 
occurring within two days of the day of invitation. In total 48 purposively sampled 
men and women were invited to participate. Of these, 40 attended and 32 brought a 
friend or neighbour who also participated, giving a total of 72 participants (41 men 
and 31 women). 
 
7.5.2 IDIs with HTC users 
The majority of HTC users participating in IDIs were recruited via the group 
activities. At the end of the activity, each participant was seen individually in order 
compensate them for their time (5,000 Tanzanian shillings, approximately 3 US 
dollars) and give them the opportunity to ask any questions confidentially. In 
addition, those individuals who had been included as ‘seeded’ HTC users were 
asked whether they were willing to disclose whether they had previously been for 
HTC. If the participant agreed and disclosed previous HTC use, s/he was asked 
whether s/he would like to participate in an IDI on experiences of going for HTC. 
Interviews were usually held the next day at a location of the participants choosing 
(often the same location where PLA activity had been conducted). In total 25 
participants (13 women and 12 men) were invited to take part via the group activities 
and all attended for interview.  
 
160 
 
Due to small numbers of seeded HIV-positive HTC users, some HIV-positive 
individuals were recruited for IDIs via the HIV care and treatment clinic (CTC) at 
Kisesa Health Centre. Clinical staff were briefed on the aims and objectives of the 
study, and invited patients attending routine clinic appointments to participate. In 
total six HIV-positive individuals (three men and three women) were invited and 
agreed to be interviewed. A time, date and location for the interview was agreed and 
these details were passed to the research team. All but one individual (a woman) 
recruited via the CTC subsequently attended for interview. 
 
7.5.3 IDIs with healthcare workers 
Healthcare workers involved in the provision of HTC were sampled purposively in 
order to obtain perspectives from individuals offering different types of services. This 
included two counsellors working at the walk-in HTC or VCT clinic at Kisesa Health 
Centre, two healthcare workers offering PITC at the health centre’s antenatal clinic, 
and one member of the District Health Management Team who provided training, 
supervision and support for HTC counsellors. These individuals were approached by 
the lead research assistant, informed about the aims of the study and invited to 
participate in an IDI relating to their experiences of providing HTC or of offering 
training for counsellors. All interviews were conducted by the research assistants in 
Swahili, and were held at Kisesa Health Centre, NIMR Mwanza or in the case of the 
HTC trainer, at Magu District Hospital.  
 
7.6 Data collection 
A total of nine participatory group activities with 6 to 12 participants each were 
carried out, stratified by gender (four with women – stratified by age group (18-34 or 
35-60 years) and rural or urban area of residence. Five with men – similarly stratified 
by age group and area of residence. Two group activities were carried out with men 
from urban villages in the older age-group, due to low attendance (five participants) 
and limited contributions during the first activity).  
 
Following informed consent, group activities were audio-recorded; recordings were 
later transcribed and translated into English. Activities were facilitated by same sex 
researchers in Swahili, and a note-taker (also matched on gender) kept detailed 
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notes which were subsequently typed up in English and shared with the research 
team. The group activities were conducted at NIMR field offices near Kisesa Health 
Centre for community members from urban villages, and in an empty cotton storage 
barn in Ihayabugaya for participants from rural villages. I sat in as an observer 
during all of the group activities, and conducted de-briefing sessions with the 
research assistants at the end of each activity. 
 
In total 30 IDIs were conducted with users of HTC services (15 men – 10 HIV-
negative and five HIV-positive, 15 women –10 HIV-negative and five HIV-positive) 
while five IDIs with healthcare providers were completed. Research assistants were 
matched to study participants on gender in all cases with the exception of the IDI 
with the HTC trainer (a woman who was interviewed by a man. This was not 
expected to affect data collection as topics covered during interviews with 
healthcare workers were not of a private or personal nature). Interviews were 
conducted in Swahili, audio-recorded and subsequently transcribed and translated 
into English. I did not observe the IDIs with HTC users or healthcare workers due to 
the private nature of the information shared during IDIs with HTC users, and 
because it was felt that the presence of a foreign researcher in the context of a one-
on-one interview may have resulted in social desirability or other biases (for 
interviews with both HTC users and healthcare workers). However, I carried out de-
briefing sessions with research assistants at the end of all IDIs. This allowed 
additional probes around important topics to be included in IDI discussion guides, in 
order to improve the depth and quality of the data collected. 
 
7.7 Ethical considerations 
Ethical approval for this qualitative study was obtained from the ethics committee of 
the LSHTM and from the Tanzanian Medical Research Coordinating Committee 
(see Appendix 11.1.3). Prior to starting each study activity, the session’s aims and 
content were explained by the research assistants in full. Verbal consent was 
obtained for participation and audio-recording of the group activities. Written or 
verbal consent was obtained during IDIs, dependant on the writing ability of 
participants.  
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Study participants were informed that they could decline to answer any question 
during the group activities or IDIs, or that they could leave the group discussion or 
terminate individual interviews at any time. All participants were compensated for 
their time (5,000 Tanzanian shillings (approximately 3 US dollars) for group activity 
participants or IDIs with HTC-users, 10,000 shillings (approximately 6 US dollars) for 
healthcare workers, in line with other qualitative studies conducted in Kisesa). 
During the group activities, participants were informed that the discussions would be 
general and that they were not expected to share any personal information 
regarding prior use of HTC services. Participants chose fictitious names (such as 
the name of an animal or fruit) to use during the group discussions in order to 
protect their anonymity. All study documentation was labelled with codes; names 
were not recorded on audio-files or interview transcripts, nor referred to in 
quotations. Digital files were stored on my personal laptop or a secure server at the 
LSHTM, with password restricted access. 
 
During group activities, the seeded focus group approach allowed me to include 
both users and non-users of HTC, while concealing the HTC-use and HIV status of 
participants from both research assistants and other study participants, and 
providing a convenient sampling frame for the recruitment of HTC users for IDIs. At 
the point of recruitment for IDIs (i.e. when group participants were seen individually 
at the end of each activity), research assistants became aware of the HTC use 
status of participants. However, research assistants were unaware of the HIV-status 
of HTC-users recruited for IDIs via the group activities unless participants chose to 
disclose this during the interview. Before agreeing to participate, HIV-positive 
individuals recruited for IDIs at Kisesa Health Centre were informed that research 
assistants would be aware of their HIV-status by nature of the fact that they were 
recruited at the CTC, but were free to decline participation.  
 
7.8 Data analysis 
Data analysis was guided by a framework approach, drawing on a priori concepts 
drawn from theories of behaviour change and from existing literature, but also 
reflecting the accounts and observations of study participants (178). After 
transcription and translation, the first stage of analysis involved familiarisation with 
the data by reading through transcripts and creating summary notes for each group 
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activity and IDI. I also referred to study notes taken during fieldwork, including notes 
written up by myself and by the research assistants after each group activity, and 
the detailed de-briefing notes taken after IDIs. These summaries were synthesized 
in charts in Excel, which I used to compare emerging themes across cases (i.e. 
comparing views on similar topics expressed by different PLA groups or IDI 
participants). Analytical memos were also used to explore emerging concepts by 
identifying prominent themes among sub-groups of participants by age-group and 
gender.  
 
Coding was carried out in Nvivo10, guided by a theoretical framework which was 
adapted from an individual level model of behaviour change (128). Codes were also 
generated inductively, grounded in the accounts of study participants. The initial 
coding frame developed after coding the first five transcripts was reviewed by study 
co-authors (Alison Wringe, Joyce Wamoyi, Shelley Lees). The codes were then 
refined according to emerging concepts, and grouped under overarching themes. 
The refined coding frame was then applied to all transcripts. Data were then 
synthesized, distilling the coding to explore the emerging patterns and meanings in 
terms of sexual behaviour change and HIV-prevention, and to provide explanations 
for findings 
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8 Paper D. ‘It is just the way it was in the past before 
I went to test’: responses to HIV prevention 
counselling messages in rural Tanzania. 
 
Introduction to the paper 
To contextualise and complement the quantitative analyses presented in Chapter 6, 
which assessed the impact of the sero-survey VCT service on reported changes in 
sexual risk behaviour and HIV-incidence, a qualitative study was conducted in order 
to understand perceptions of HTC services, and how HIV prevention counselling 
messages might influence attitudes and intentions regarding sexual risk reduction. It 
was expected that these data might shed light on the factors shaping sexual 
behaviour change following HTC use, and thus provide possible explanations for 
quantitative findings. While a number of qualitative studies have explored responses 
to HIV-prevention counselling messages among individuals testing HIV-positive in 
sub-Saharan Africa (26-29, 131), few have included clients testing HIV-negative, 
and this was a strength of the data presented in this paper. The findings from the 
quantitative and qualitative analyses of the impact of HTC on sexual behaviour 
change are synthesised and compared in the thesis discussion (Chapter 9).  
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Submitted manuscript 
 
8.1 Abstract 
This qualitative study explored the nature and content of HIV testing and counselling 
sessions with a view to understanding their potential role in reducing sexual risk-
taking. Nine sex-specific participatory group activities were completed, in addition to 
30 in-depth interviews (IDIs) with HTC clients and five IDIs with healthcare workers. 
Data collection activities were conducted in Swahili, audio-recorded, transcribed, 
and translated into English. Nvivo10 was used to code and analyse transcripts, 
guided by a framework approach. Emerging themes included structural and socio-
cultural factors, including poverty, sexual decision-making and relationship 
dynamics, which constrained the extent to which HIV-negative individuals, but 
particularly HIV-negative women, felt that they could control their HIV-risk, which 
was seen as inherently linked to their partners’ sexual relationships. The findings 
also suggested that counselling messages were perceived by clients as dictated 
‘instructions’ which were rarely tailored to their circumstances, while providers 
reported feeling ill-equipped to deliver effective prevention messages. HIV 
prevention counselling is unlikely to significantly contribute to risk reduction unless 
counselling messages are generated through more equitable client-counsellor 
interactions which acknowledge prevailing socio-cultural norms. 
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8.2 Introduction 
Counselling is assumed to form a critical component of the HIV testing and 
counselling (HTC) process, being performed both before and after testing, and 
giving clients an opportunity to consider their sexual behaviour and discuss an 
individualised risk-reduction plan with counsellors (45). Essential to this is the 
sharing of personal information by the client with the counsellor, and the joint 
identification of potential risks and possible strategies to reduce them (4-6). 
 
There has been a widespread assumption that in African settings, counselling in the 
context of undergoing an HIV test can encourage reductions in sexual risk 
behaviours such as multiple concurrent partnerships (179) or low levels of condom 
use (173). However, quantitative evidence to support the role of HTC in sexual 
behaviour change in sub-Saharan Africa is mixed, particularly among HIV negative 
individuals (22, 23). To date, much of the body of qualitative research around HTC 
use in African settings has focussed on barriers or facilitating factors to the uptake of 
services (180), rather than how counselling messages might be perceived, 
understood or acted upon by clients. Some qualitative studies have explored sexual 
risk reduction among HIV-positive individuals or sero-discordant couples following 
HTC (28, 129, 181), however few have focussed on HIV-negative individuals (130).  
 
In order to better understand the processes through which HTC may contribute to 
sexual behaviour change and HIV prevention, we conducted a qualitative study to 
explore community perceptions of HTC services as well as HIV-negative and HIV-
positive clients’ understandings of counselling messages following either voluntary 
counselling and testing (VCT) or antenatal provider-initiated testing and counselling 
(PITC) in a rural area of northwest Tanzania. 
 
Theoretical perspectives 
HTC is an intervention targeted at the level of the individual (or within the unit of a 
couple, where couple counselling is offered), however there is a paucity of evidence 
to guide the theoretical constructs upon which HIV prevention counselling is 
expected to act in African settings. Many models of behaviour change were 
developed in Western settings, focusing on individual attributes such as individual 
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intentions, attitudes and feelings of self-efficacy, generally paying little attention to 
broader social or environmental determinants of behaviour (113). However, social 
and cultural norms and expectations as well as structural factors such as poverty 
are likely to shape behaviour in African settings, where identity is strongly influenced 
by family, community and other social factors (115). In Tanzania, VCT training 
manuals highlight a variety of approaches which may encourage individual-level 
behaviour change, such as approaches based on behavioural or cognitive theory 
(182), although the constructs within these theories, and particularly how they might 
translate into HIV-prevention counselling advice, are not well described. 
 
8.3 Methods 
8.3.1 Study design and setting 
This study was carried out within the context of a community HIV cohort study in 
Kisesa in rural northwest Tanzania, where regular rounds of demographic and HIV 
serological surveillance have been ongoing since 1994 (150). HIV prevalence in the 
study area was estimated at 6.5% in 2010, with most participant’s revenue coming 
from small-scale subsistence farming. HTC services were first provided in the study 
area as part of serological surveillance during 2003-2004, with further provision of 
HTC during three additional rounds of serological surveillance between 2006 and 
2013. A permanent VCT clinic opened within the study area’s main health centre in 
2005, with PITC services offered routinely to pregnant women from the end of 2008. 
Temporary outreach VCT services are occasionally provided in the study area by 
government hospitals or non-governmental organisations. Although they have 
improved over time, rates of HTC uptake in Kisesa remain low, with lifetime 
coverage of testing being approximately 40% among men and 50% among women 
by 2010 (152). 
 
Qualitative data collection took place between February and April 2012, and 
different methods were used in order to maximise learning from different 
perspectives. Nine group activities were conducted incorporating participatory 
learning and action (PLA) activities, which integrate data collection with an 
exchange of information between researchers and participants and can help to 
mobilise support around relevant issues (175, 176). Thirty in-depth interviews (IDIs) 
with HIV-negative and HIV-positive service users explored individual experiences of 
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completing HTC, while five IDIs were carried out with nurses or counsellors offering 
HTC. 
 
8.3.2 Sampling, recruitment and data collection 
PLA activities were carried out with four female and five male groups of six to twelve 
participants, stratified by rural or urban residence and age-group (18-34 or 35-60 
years). A combination of purposive sampling and snowball techniques were used to 
recruit participants. First, four to six individuals were purposively selected from a 
sampling frame constructed from the demographic and sero-surveillance datasets, 
which included some individuals who were known or reported to have used HTC 
services as well as some who had not used HTC. This ‘seeded’ focus group 
approach (177) allowed us to include HTC clients in the group activities without 
inadvertently revealing their HTC-use status to other study participants. Next, each 
purposively sampled individual was asked to invite a neighbour or friend from their 
village and from the same age group to participate. In total 48 purposively sampled 
men and women were invited to participate, of whom 40 attended and 32 brought a 
friend or neighbour, resulting in a total of 72 participants (41 men and 31 women). 
The PLA activities included brainstorming activities using flip-chart paper to express 
ideas and opinions relating to the perceived usefulness of HTC services, positive 
and negative aspects of service provision, and opinions relating to counsellors. 
 
IDIs were carried out with 15 men and 15 women who had used HTC services, 10 of 
whom were HIV-positive (five men and five women). The majority of interviewees 
(n=25) were recruited via the group activities. At the end of the activity, each 
participant was asked privately whether s/he was willing to discuss previous use of 
HTC. If the participant agreed and was an HTC user, s/he was invited to participate 
in an IDI on experiences of going for HTC. The discussion guide included topics on 
motivations for going for HTC, impressions of counsellors, information and advice 
shared with and received from counsellors, attitudes and feelings regarding the 
counselling advice received and regarding sexual risk reduction, and experiences of 
disclosing HTC use to partners or other family members. Five HIV-positive 
individuals were recruited for IDIs via the HIV care and treatment clinic (CTC) at 
Kisesa health centre, due to small numbers of seeded HIV-positive HTC users. 
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The characteristics of the 30 HTC clients who completed IDIs are shown in Table 
8.1. Most clients had received their most recent HTC at the walk-in VCT clinic at 
Kisesa Health Centre, and had tested within the last year. In total 18 were HIV-
negative, 10 were HIV-positive and two were of unknown HIV status. 
 
Five IDIs were carried out with healthcare workers, purposively sampled to include 
individuals providing VCT (n=2), PITC at the ANC (n=2), and one member of the 
District Health Management Team who provided training, supervision and support 
for counsellors. Topic guides for healthcare workers providing HTC services 
included length of time and experience providing HTC, the content and information 
shared during pre and post-test counselling sessions, community perceptions of 
HTC, and levels of training and support received. The IDI with the HTC trainer 
covered issues relating to the content of counsellor training programmes, as well as 
ongoing professional development, support and supervision for counsellors. 
 
All group activities and IDIs were conducted in Swahili by same gender researchers, 
with the exception of the IDI with the HTC trainer (a woman who was interviewed by 
a man). Study activities were audio-recorded following consent from participants, 
and then transcribed and translated into English. Debriefing interviews were held in 
English with field workers after each group activity and IDI in order to discuss 
preliminary findings. 
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Table 8.1 Characteristics of HTC users participating in IDIs 
  Male (n=15) Female (n=15) 
Age group 
  18-24 4 (26.7%) 3 (20%) 
25-34 2 (13.3%) 4 (26.7%) 
35-44 4 (26.7%) 4 (26.7%) 
≥45 5 (33.3%) 4 (26.7%) 
Location of most recent HTC 
  Community outreach-VCT (during 
sero-survey) 1 (6.7%) - 
Walk-in VCT clinic (Kisesa health 
centre) 8 (53.3%) 9 (60%) 
Other VCT* 4 (26.7%) 3 (20%) 
Antenatal PITC - 3 (20%) 
Unknown 2 (13.3%) - 
Time since most recent HTC 
  ≤1 year 9 (60%) 7 (46.7%) 
2-4 years 4 (26.7%) 3 (20%) 
>4 years - 4 (26.7%) 
Unknown 2 (13.3%) 1 (6.7%) 
HIV Status 
  Negative 9 (60%) 9 (60%) 
Positive 5 (33.3%) 5 (33.3%) 
Unknown 1 (6.7%) 1 (6.7%) 
Area of residence 
  Rural 7 (46.7%) 9 (60%) 
Trading centre (urban) 8 (53.3%) 6 (40%) 
Level of education 
  None 1 (6.7%) - 
Primary 7 (46.7%) 13 (86.7%) 
Secondary or higher 7 (46.7%) 2 (13.3%) 
Unknown - - 
Marital status 
  Married monogamous 7 (46.7%) 9 (60%) 
Married polygamous 1 (6.7%) - 
Separated/divorced 2 (13.3%) 2 (13.3%) 
Widowed 2 (13.3%) 3 (20%) 
Single (never married) 3 (20%) 1 (6.7%) 
*Other outreach VCT service within Kisesa, or VCT service outside Kisesa ward 
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8.3.3 Ethical considerations 
This study was approved by the ethics committees of the Tanzanian Medical 
Research Coordinating Committee and the London School of Hygiene and Tropical 
Medicine. During group activities verbal consent was obtained, while for IDIs the 
option of verbal or written consent was offered. Fictitious names were used during 
group activities to safeguard anonymity, and participants were advised that they 
were not expected to share personal information, particularly with regard to HIV-
status or prior HTC use. Recruitment procedures for IDIs using the seeded focus 
group approach were designed to maximise confidentiality and avoid any 
inadvertent disclosure of HTC use status. Some ‘seeded’ HTC users were HIV-
positive, however field workers were unaware of the HIV status of any participants 
unless they chose to disclose this during IDIs. For HTC-users recruited via the CTC, 
prior to agreeing to participate patients were informed that interviewers would be 
aware of their HIV-status, due to the nature of their recruitment. 
 
8.3.4 Data and analysis 
Coding and analysis of transcripts was carried out in Nvivo10, guided by a 
framework approach (178). After familiarisation with the data, an initial coding frame 
was developed, drawing on concepts derived from the theories of behaviour change. 
As it paid some attention to socio-cultural and environmental influences on 
behaviour, an adapted version of an integrated model of individual level behaviour 
change (128) was used to guide data analysis (Figure 8.1). Codes were also 
generated inductively, grounded in the accounts of study participants. The initial 
coding frame developed by the lead author (CC) was reviewed by co-authors (AW, 
SL and JW) and revised according to emerging concepts, which were grouped 
under overarching themes. The refined coding-frame was then applied to all 
transcripts. Data were then synthesized, distilling the coding to explore the emerging 
patterns and meanings in terms of sexual behaviour change and HIV-prevention, 
and to provide explanations for findings. 
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Figure 8.1 Conceptual framework for understanding responses to HIV 
prevention counselling messages in rural Tanzania 
 
 
8.4 Results 
Two major themes emerged in understanding responses to HIV prevention 
counselling messages in Kisesa. These revolved around socio-cultural and 
structural factors, including sexual decision making and relationship dynamics, and 
the nature of client-counsellor interactions, both set against a general background of 
poverty and economic insecurity. We found only moderate evidence that individual 
attributes such as intentions and feelings of self-efficacy had an impact on 
behavioural change following HTC, as their influence was consistently affected by 
the broader social contextual factors that shaped participants’ lives. Findings are 
presented below in each of the two key thematic areas which emerged. 
 
8.4.1 Sexual decision making and relationship dynamics 
Both men and women were appreciative of HTC and reported feeling supported 
after using the service, regardless of whether they tested HIV-negative or HIV-
positive. In IDIs, participants tended to report that they were already implementing, 
or planned to implement in the future, the advice they had received from 
counsellors. However, suspicions of partner infidelity were reported by both men 
and women, and many participants reported feeling at risk of HIV as a result of their 
partner’s rather than their own behaviour. This implied a certain futility in attempting 
to change behaviour without the support and commitment of one’s partner.  
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 There was time my wife travelled...I didn’t see any reason for her to stay 
there for a month. So that issue made me to be very worried that why should 
she stay there for a whole month…what is she doing? (IDI 11, HIV-negative 
man 35-60 years). 
 
  Now he was always travelling because he was a driver. Yeah, whenever he 
came home he could stay only for a week then leave, He could leave for 
almost two months, you see. So it wasn’t easy to get information about him. 
Perhaps he was doing things from there. (IDI 23, HIV-positive woman 35-60 
years). 
 
In particular, women reported that it was expected or accepted that men could have 
multiple partners, and seemed to imply there was a certain inevitability to their 
partners’ infidelity. Women also reported difficulties getting their partners to commit 
to or engage in discussions about sexual risk reduction. 
You should get home and start telling your partner. He listens to you during 
that time but after some time he forgets about it. He starts doing the same 
thing. (IDI 3, HIV-negative woman 18-34 years). 
 
For women, partnerships commonly represented a source of financial support upon 
which they were dependant, particularly where there were children to care for. They 
seemed to deal with competing risks – that of potential exposure to HIV-risk on one 
hand, or loss of economic support on the other. This seemed to limit their choices in 
terms of sexual risk reduction. 
 Even if you move out here and go to another man you will face the same 
problem. You have children too. Where will you go around with the children 
up to? You must stay by persevering. (IDI 3, HIV-negative woman 18-34 
years). 
 
HTC clients were consistent in reporting that they had received ‘ABC’ messages 
from counsellors (abstain from sex, be faithful to one partner and/or use condoms). 
However, most participants were already married or in a sexual partnership, and 
abstinence was not generally perceived as a realistic or desirable option. In addition, 
the desire to have children was occasionally reported as interfering with clients’ 
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abilities to follow counselling advice. Abstinence seemed most likely among HIV-
positive individuals, many of whom reported having reduced their frequency of sex, 
or were not sexually active anymore, mainly because they had separated from their 
partners after diagnosis, or had chosen not to re-marry after a partner had died.  
I have never touched any woman ever since my wife died. Many people were 
advising me that why don’t you marry another woman, but I refused. The 
problem might bring up more problems to my health. It is better if I go on with 
the treatment. (IDI 29, HIV-positive man 35-60 years). 
 
Only a small number of clients reported that they had ever used condoms, which 
were often perceived as relevant for use outside but not within marriage. Women 
and female counsellors also reported that condoms were disliked by men. One 
woman recounted that she did not use condoms with her husband, instead placing 
her faith in God to protect her from HIV, again suggesting limited choices for women 
in terms of reducing their exposure to risk.  
 Now if it is your husband will you again use protection, why should you use 
protection with your husband? That is you have to leave it to God 
now…When you decide to get married to him it is like you trust him. (Female 
group activity participant, age-group 18-34, rural residence). 
 
 He [the client] might say ... I am not used to that kind of protection. Ever 
since I married I have never used it. … Many people especially the men 
don’t want to use the condom. (IDI 33, healthcare worker number 3). 
 
One HIV-negative woman cited multiple reasons why she had never used condoms, 
including that she was afraid to use them because they might be second-hand or re-
used, although it seemed that a greater barrier to condom use may have been 
men’s reluctance to use them.  
 He [the counsellor] asked if I have ever used the condom, then I replied that I 
hadn’t…. There was not enough elaboration because some of us can’t use 
protection. It is because some people say it is bad. There are some that are 
already used; now you also just fear to use protection too…. Some men also 
don’t want to use the condoms. When you give him the condom he receives 
it but pricks it at the end. (IDI 8, HIV-negative female, 18-34 years).  
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Participants sometimes reported positive attitudes and intentions regarding sexual 
risk reduction following HTC, but that despite this, temptations could lead one to 
engage in high risk behaviours. This was sometimes linked to the consumption of 
alcohol, but also cited as normal behaviour, with desire sometimes overriding 
‘rational’ decisions. It was also given as a reason to go for HTC often, in order to be 
reminded and motivated to avoid high risk behaviours.  
It is because there are many temptations if you consider the fact that you 
were guided and counselled once...Going once doesn’t help, you can forget 
and you might have done something that is not worth to be done. (IDI18, 
HIV-negative man 18-34 years).  
 
Several HIV-negative participants reported disclosing their use of HTC and HIV-
status to their partners, with some participants reporting having taken home a test 
card or certificate in order to prove this. However, this rarely seemed to lead to 
further discussions within the couple about potential exposure to HIV-infection, or 
joint plans for sexual risk reduction. Only a small number of participants reported 
that they had gone for couples HTC. These participants generally reported positive 
experiences and suggested that joint counselling might help to obtain commitment 
to behaviour change by both members of the couple (although in all cases both 
partners had tested HIV-negative).  
Maybe that is where we get enlightened and be able to say that, we are both 
mobilised. It is not that I get motivated alone. (IDI 3, HIV-negative female 18-
34 years). 
 
8.4.2 Dynamics of client-counsellor interactions  
There were apparent barriers to clients sharing details of their private sexual lives 
with counsellors. This limited the potential contribution of HTC in terms of clients and 
counsellors being able to jointly identify and discuss possible risk reduction 
strategies. The barriers seemed to at least partly relate to the hierarchical nature of 
the relationship between client and healthcare provider. Counsellors were frequently 
referred to as ‘experts’ who should lead and direct conversations, with clients 
listening or adhering to ‘instructions’ which were received. However, it was also 
177 
 
expressed that it was difficult to share private and personal information with 
counsellors due to the sensitive nature of the subject matter, particularly in the case 
of one woman who was counselled by a man:  
Interviewer: What did you talk to him [the counsellor] about?  
 Respondent: It is him who was asking as I answer…Actually I never thought 
in my mind to ask him any question... in general it was hard to tell a man. We 
could talk about other things but for…mmm it is difficult. It is just fear to tell 
the male counsellor, because all men are… they are of the same calibre. If it 
were a female I would have told her. (IDI 8, HIV-negative female, 18-34 
years).  
 
 In the risk assessment she [the client] talked but she was not able to put it 
open that she had intercourse contrary to the way it was supposed to be 
done. (IDI 31, healthcare worker number 1). 
 
Counsellors recounted their efforts to build rapport with clients and to help them 
identify possible solutions to their problems, although one counsellor acknowledged 
the limitations of counselling, inferring that sexual behaviour was complex and that 
some issues were difficult to ‘solve’.  
The client should be the main speaker, the counsellor should be the listener, 
she should direct the client to be able to realize his problem, and know how 
to solve it. If it is not a problem that can be solved then he should know how 
he will continue to live with it, because not all problems can be solved, there 
are some problems that are difficult to solve. (IDI 31, healthcare worker 
number 1). 
 
However, there was also evidence that healthcare workers tended to be 
authoritative and directive in their counselling, instructing clients to behave in certain 
preferred or ‘correct’ ways (usually being faithful to one partner, or using condoms). 
You have to ensure that somebody has understood….It is until he repeats 
everything that you have said…. and then if you realize that it is correct, then 
he would have understood…. You continue to advise him that it is supposed 
to be like this and this (IDI 33, healthcare worker number 3). 
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Several participants implied that it was the testing aspect of the service, rather than 
the counselling offered, which was most useful. One young woman described that 
not much had changed in her relationship after going for HTC, despite the fact that 
she suspected her husband of being unfaithful, but that she planned to test again 
the next month, and found the testing process reassuring as a way to check up on 
her HIV status.  
It is just the way it was in the past before I went to test… I just encouraged 
myself for the next month to come to go and test to be able to check my 
health status so as to continue protecting myself. (IDI 1, HIV-negative 
woman 18-34 years). 
 
In general counsellors were viewed by clients in a positive light, however 
occasionally concerns were raised that the services provided were poor or that 
healthcare workers were ‘harsh’ or ‘impatient’. During one group activity, male 
participants referred to rumours that some counsellors did not respect privacy and 
‘gossiped’ about patients, and this may have affected client willingness to share 
personal information with counsellors. Other participants stated that they felt 
counsellors were professional and confidential, but that a client’s HIV status could 
sometimes be deduced by other patients in the waiting room, if an individual spent a 
long time with the counsellor (assumed to be HIV-positive). This may make clients 
reluctant to spend lengthy periods with the counsellor, for fear others might suspect 
them of being HIV-positive.  
 
During PLAs, several participants raised concerns that the counselling rooms at the 
health centre were not sufficiently private and that conversations between 
counsellors and clients might be overheard by other patients or staff. This inhibited 
communication and was particularly a problem at the ANC, where HTC sessions 
were conducted in an only partially private area.  
Now right there even if somebody [a pregnant woman] is being guided and 
counselled the one beside her will hear it. So it would have been better if she 
was given her own room as the counsellor. (Female group activity 
participant, age-group 18-34, urban residence).  
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If the nurse and the patient talk loudly, the other people might hear. But if we 
had a room that was covered like this one, you could talk to the mother 
inside here very well. (IDI 32, healthcare worker number 2).  
 
Only a few clients reported their experiences receiving antenatal PITC. Their 
accounts of the types of counselling messages they received did not differ greatly 
from women who attended the VCT clinic, except for one woman who reported that 
she was tested with very little pre or post-test counselling. This is concerning in 
terms of missed opportunities to provide counselling on sexual risk reduction and on 
reducing the risk of mother-to-child transmission of HIV, as well as in terms of 
compliance with procedures for informed consent.  
 
Counsellors reported that a significant challenge they faced was an insufficient level 
of training, including training courses which were too short, and refresher trainings 
which were rarely given. Counsellors intimated that more extensive training sessions 
might have helped them to better grasp the content of training sessions.  
That time was not enough… There were many things to be learnt in two 
weeks... So they should have made it to be one month. It will have been 
better because we could learn slowly. And put all the things straight. Or the 
refresher courses should be there, so that people can be reminded. (IDI 33, 
healthcare worker number 3).  
 
Another challenge highlighted by counsellors related to shortages of HIV test-kit 
supplies, meaning that counsellors sometimes had to close the VCT clinic or turn 
away clients wishing to test at the VCT or ANC. This was a source of stress to 
counsellors, and compromised clients’ trust in healthcare services, which may 
negatively affect perceptions of the quality of the counselling advice received. 
The level of mobilization is very low, I say it is small because the services 
provided here are seasonal, even though there is a centre here every day 
but you get that they are never there. (IDI 20, HIV-negative man 18-34 
years). 
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8.5 Discussion 
Initial approaches to HTC were developed in Western contexts, where individual 
attributes, such as individual intentions and feelings of self-efficacy, are relatively 
more important determinants of health behaviours than in non-Western cultures 
(115). In a rural Tanzanian setting, we found that while clients tended to report 
positive intentions regarding sexual risk reduction following HTC, socio-cultural and 
structural barriers were of greater significance in influencing behavioural outcomes.  
 
In particular, sexual decision-making and relationship dynamics were important in 
shaping responses to HIV counselling messages. HIV-positive individuals generally 
expressed greater self-efficacy in reducing sexual risk behaviour following HTC, at 
least in terms of the reported frequency of sex, while HIV-negative individuals 
implied that they were at risk of HIV as a result of their partners’ rather than their 
own behaviour. Women appeared particularly constrained in their ability to control 
their exposure to HIV-related risk, being economically dependent on male partners 
who were not always willing to engage in discussions regarding sexual risk 
reduction. A number of studies in northwest Tanzania have highlighted the dominant 
role of men in sexual decision making within relationships (174) and the significance 
of male multiple partnerships in determining masculinity and social status (183, 
184). We similarly found that women appeared limited in their ability to enact sexual 
behaviour change without getting the agreement or support of their partner, and that 
women reported that it was expected or accepted for men to have multiple partners. 
Some women reported testing frequently in order to learn whether they had become 
infected, demonstrating a certain level of self-efficacy, at least in terms of the choice 
to attend for testing, however this seemed unlikely to affect sexual behaviour 
change or women’s level of exposure to risk. 
 
Condoms were perceived by women and by female counsellors as being disliked by 
men, and were viewed by both male and female IDI participants as appropriate for 
use with short term or casual partners, but not within marriage. Other studies in East 
Africa have found that condoms were only used during the initial stages of 
relationships (26), that suggesting their use in more stable or committed 
partnerships could raise suspicions of infidelity (27), and that as a male controlled 
technology, women often found it difficult to negotiate their use (185). Other studies 
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in Tanzania have reported male preferences for sex without condoms (173, 174), 
and in our study their use was reportedly limited, at least within steady or committed 
partnerships. As a result, their effectiveness as an HIV prevention intervention 
seems somewhat limited in this setting. 
 
Only a few clients reported having gone for testing together with their partner, 
however some expressed a desire to do so. The few individuals who reported 
having gone for couples-HTC reported positive experiences, including that couples 
might get ‘motivated’ together. In support of this, one Zambian study reported that 
although couple testing did not always lead to safe sex, it helped to renew 
commitment to the relationship and aided women in negotiating safe sex, as 
discussions were mediated by a counsellor (132).  
 
In their accounts of interactions with counsellors, participants referred to counselling 
advice as ‘instructions’ to be followed, challenging the notion of counselling as a 
two-way process during which detailed personal information was shared and 
potential HIV-prevention strategies were jointly identified and discussed. Similar 
findings were reported in another study in Uganda, where clients reported complying 
with ‘rules’ rather than sharing more intimate thoughts with counsellors (186), and 
one study in South Africa noted that counsellors tended to use one of two main 
strategies when delivering counselling advice, which included either ‘making 
appeals’ to clients or ‘prescribing rules for living’ (187). The authors noted that the 
former strategy seemed more effective in encouraging clients to consider their own 
behaviour by engaging them more fully in discussions. In this study, some 
counsellors recounted their efforts to help clients identify possible solutions to their 
own problems, although counsellors were also directive and authoritative, 
demonstrating an imbalanced client-counsellor relationship which has previously 
been noted in Kisesa (58). The limited extent and availability of training may have 
limited counsellors’ abilities in engendering more engaged discussions with clients. 
 
A few clients reported that counsellors were sometimes ‘harsh’, and this may have 
affected client willingness to share personal information, while client-counsellor 
interactions may also have been constrained by the sensitive nature of the subject 
matter and/or client concerns about confidentiality. Several clients reported finding 
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the process of learning their HIV status reassuring in itself, regardless of counselling 
messages received, however this knowledge alone seemed unlikely to lead to 
changes in sexual risk behaviour. Previous studies have suggested that ‘de-linking’ 
testing and counselling service provision might help clients to focus on counselling 
messages and thus more effectively support behaviour change (130, 137), but this 
hypothesis remains untested. 
 
Airhihenbuwa & Obregon propose that in non-Western cultures, family and 
community are more central to the construction of health and well-being than the 
individual (115). In support of this, one study reported that HIV-positive Ugandan 
men and women’s main motivations in preventing HIV transmission were altruistic 
wishes to protect sexual partners and to avoid orphaning children (29). In African 
settings, counselling messages which include broader culturally relevant altruistic 
messages relating to partners, children and the wider community, for example 
emphasising the benefits of protecting unborn children from HIV, or of maintaining 
the integrity and health of the family unit, may be more successful than ones which 
focus solely on self-interest (29). 
 
A limitation of this study was that HTC users may have been reluctant to share 
details of what was discussed with counsellors with study researchers, due to the 
sensitive nature of the topic and due a similar hierarchical relationship between 
participants and researchers to that observed between clients and counsellors. 
However, interviewing techniques to build rapport and trust with participants were 
addressed during fieldworker training. In order to maximise confidentiality, all IDIs 
were conducted either in private rooms near Kisesa Health Centre, or in the case of 
rural residents, in private locations near rural dispensaries, and researchers were 
matched to study participants on gender.  
 
In conclusion, in the face of broader socio-cultural and socio-economic constraints, 
HIV prevention counselling alone based on a Western model of individual level 
agency is unlikely to make a significant contribution to sexual behaviour change in a 
rural setting such as Kisesa. More culturally relevant counselling messages and 
infrastructural improvements, such as additional training for counsellors and 
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counselling rooms which ensure privacy and confidentiality, may lead to better 
outcomes in terms of sexual risk reduction. 
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9 Discussion 
 
This chapter includes a synthesis of the research that was undertaken in relation to 
each of the study objectives, combining the contributions from both quantitative and 
qualitative methods to give an overall presentation of key findings. It also highlights 
the strengths and limitations of the research, and discusses how policy and 
programme recommendations based on the findings will be conveyed to Tanzanian 
policymakers. Recommendations for future research are also highlighted, while the 
efforts taken to date to disseminate the research findings are summarised. 
 
9.1 Synthesis of findings 
In understanding the role of HTC services in HIV prevention in rural Tanzania, the 
study objectives fell under two broad areas of research. The first of these related to 
describing HTC uptake and coverage, with uptake being defined as usage of testing 
services, while coverage refers to the proportion of the population who have ever 
accessed testing services. The second area of research involved investigating the 
role of HTC in sexual behaviour change. The ultimate aim of the research conducted 
under both areas is to understand how to maximise the contribution of HTC to HIV 
prevention efforts in rural Tanzania and other similar settings in sub-Saharan Africa.  
 
An adapted conceptual framework for the study based on the findings which 
emerged is shown in Figure 9.1. Quantitative methods were used to investigate the 
outcomes under the first area of research, which included describing the uptake and 
coverage of different types of HTC services, and identifying the proportions of 
individuals, and risk factors associated with, repeat testing. A mixed methods 
approach was used to investigate the outcomes under the second area of research, 
which included quantitatively assessing the evidence for an association between 
HTC use and reductions in sexual risk behaviour, and using qualitative methods to 
explore perceptions of HTC services and how HIV prevention counselling messages 
might influence or shape sexual behaviour change. While it had been expected that 
the qualitative study would contribute mainly to an understanding of the factors 
influencing sexual behaviour following HTC use, the findings from the qualitative 
research also highlighted factors which were important in understanding access to 
HTC services overall. Evidence for some factors influencing HTC uptake and 
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coverage, as well as sexual behaviour following HTC use, was found from both 
quantitative and qualitative analyses.  
 
In the adapted conceptual framework shown in Figure 9.1, factors which were found 
to most strongly influence HTC uptake or sexual behaviour outcomes following HTC 
use are highlighted in bold, while those which were originally hypothesized to be 
important, but for which evidence was not found, are represented by text which has 
been struck-through. The colours signify whether evidence was found from 
quantitative (identified influences highlighted in blue) or qualitative research 
(identified influences highlighted in green), or from both (identified influences 
highlighted in purple). 
 
The main findings from the study are summarised in Table 9.1 and synthesized 
under the two main areas of research in Section 9.1.1 and Section 9.1.2. 
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Figure 9.1 Adapted conceptual framework for understanding the role of HTC in HIV prevention in rural Tanzania 
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Table 9.1 Summary of main findings presented in the thesis 
 
Chapter/Paper Journal & date Methods
Time frame of 
data collection Main findings
Chapter 2 - Systematic review of the impact 
of HTC on sexual behaviour change and HIV 
incidence in sub-Saharan Africa
N/A Systematic review 
of quantitative 
literature
2000-2014 HTC associated with increases in condom use and reductions in 
numbers of sexual partners among HIV-positive individuals.                                                                
Impact among HIV-negative individuals less clear, with some 
studies reporting no statistically significant reductions (or 
increases) in sexual risk behaviour among this group.                                             
Only one study reported a statistically significant reduction in HIV 
incidence associated with HTC use
Chapter 4 (Paper A) - Risk factors for service 
use and trends in coverage of different HIV 
testing and counselling models in northwest 
Tanzania between 2003 and 2010
Submitted to TMIH 
March 2015
Quantitative 
analysis
2003-2010 Odds of attracting high-risk or infected individuals greatest at WI-
HTC compared to CO-HTC or ANC-HTC.                                                                       
Overall proportion of infected persons diagnosed highest at CO-
HTC.
Chapter 5 (Paper B) - Low rates of repeat HIV 
testing despite increased availability of 
antiretroviral therapy in rural Tanzania: 
findings from 2003-2010
Published in 
PLOS ONE April 
2013
Quantitative 
analysis
2003-2010 Proportions of individuals using CO-HTC twice or more low (11%) 
among attendees of 3 sero-survey rounds.                                                                         
Age at first sex <15, polygyny and inconsistent condom use 
associated with repeat CO-HTC use                                                                                                                      
No association between HIV seroconversion and repeat CO-HTC 
but analysis restricted by small sample size
Chapter 6 (Paper C) - The impact of voluntary 
counselling and testing services on sexual 
behaviour change and HIV incidence: 
observations from a cohort study in rural 
Tanzania
Published in BMC 
Infectious 
Diseases March 
2014
Quantitative 
analysis
2003-2010 CO-HTC associated with reductions in number of sexual partners 
and loss of non-cohabiting partners among HIV-negative 
individuals.                                                                                            
No statistically significant associations between CO-HTC and 
changes in sexual behaviour among HIV-positive individuals, or 
changes in HIV incidence, possibly due to small sample sizes.
Chapter 8 (Paper D) - ‘It is just the way it was 
in the past before I went to test’: responses to 
HIV prevention counselling messages in rural 
Tanzania
Submitted to AIDS 
& Behavior April 
2015
Qualitative 
analysis
2012 Responses to HIV-prevention counselling messages shaped by 
relationship dynamics which constrained the extent to which 
which HIV-negative women felt able to control their HIV-risk. 
Imbalanced client-counsellor interactions limited communication 
during counselling sessions.
188 
 
9.1.1 Uptake and coverage of HTC services 
Increasing the uptake of HTC and identifying HIV-positive and high-risk 
individuals  
Although there is an ongoing debate regarding the feasibility, acceptability and 
ethical aspects of potential TasP approaches in sub-Saharan Africa (147, 157, 188), 
the weight of the evidence and opinion among international public health 
organisations such as the WHO and UNAIDS is shifting in support of earlier access 
to ART for HIV-positive individuals, both for their own health and as an HIV 
prevention intervention (33, 35, 82). Critical to this will be considerable increases in 
the number of individuals accessing HTC services (and doing so regularly if they are 
sexually active and HIV-negative), as the point of diagnosis and entry into care.  
 
In Tanzania, AIDS Indicator Surveys (AIS) have shown that despite considerable 
progress, rates of HTC uptake remain suboptimal. Nationally 47% of men and 62% 
of women reported ever having tested for HIV in the 2011-2012 AIS, while the 
corresponding averages for rural areas were 44% for men and 60% for women (15). 
In Kisesa, as shown in Chapters 4 and 5, although HTC use increased over time, by 
the Sero6 round in 2010, only 41% (1,269/3,108) of male participants and 52% 
(2,507/4,861) of female participants had ever tested for HIV, either at the community 
outreach (CO-HTC) service offered during sero-surveys or elsewhere within or 
outside the study area. This shows a somewhat lower uptake of services in Kisesa 
compared to the national average as well as the average for rural areas, despite the 
additional opportunities to test afforded by the research activities. The 2011-2012 
AIS showed a lower overall uptake of HTC in rural as compared to urban areas in 
Tanzania (15), and this likely relates to greater barriers to the uptake of HIV services 
in rural communities, possibly as a result of differences in levels of HIV-related 
stigma and discrimination, higher levels of poverty and economic insecurity in rural 
areas, shortages of human and other resources, and poorer health system 
infrastructures.  
 
The analyses presented in Chapter 4 revealed that compared to community 
outreach HTC (CO-HTC) and antenatal testing of pregnant women (ANC-HTC), the 
walk-in (WI-HTC) clinic at Kisesa Health Centre was more likely to attract higher risk 
individuals (those with larger numbers of sexual partners) and HIV-positive men and 
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women. However, because of the large numbers testing overall, the greatest 
numbers of HIV-positive individuals learned their status via CO-HTC (although we 
may have underestimated the overall numbers diagnosed at WI-HTC and ANC-
HTC, due to low linkage sensitivity of the final matched clinic-cohort dataset, and the 
presence of reports of previous HTC use for which we did not know test results. The 
likelihood of underestimating HIV-diagnoses at WI-HTC or ANC-HTC was greatest 
at the Sero6 round, when 35% (185/520) of HIV-positive individuals reported 
previous HTC use for which we did not know HIV-status at the time of the test, 
although we were also unable to ascertain the location of possible diagnosis for 10% 
(53/514) of HIV-positive individuals at Sero5). This notwithstanding, CO-HTC is 
likely to have represented an efficient model of service delivery in which large 
numbers of people were reached in a short period of time, and several studies have 
reported that compared to facility-based services, community-based HTC 
approaches have been associated with substantial increases in the uptake of HIV 
testing by reducing logistical, financial and other barriers to service use (65, 66). 
Some studies have also found that compared to facility-based HTC, different types 
of outreach testing services, including mobile testing units, home-based testing, 
index testing (offering HTC to household members of people with HIV) and school or 
workplace-based testing programmes, have reached significantly larger proportions 
of first-time testers as well as HIV-positive individuals at early stages of infection 
(11). In this study, there were no substantial differences in HIV diagnoses by stage 
of infection by testing service type, but our analyses were limited by small sample 
sizes, particularly for users of WI-HTC and ANC-HTC. 
 
In Kisesa and elsewhere in Tanzania, a holistic approach incorporating a variety of 
different service delivery options is likely to be most effective in increasing the 
overall uptake and coverage of testing. While there have been increases in the 
number of women tested via ANC-HTC over time (with the estimated proportions of 
female sero-survey participants first testing HIV-negative or being diagnosed HIV-
positive at ANC-HTC increasing from 1.2% at Sero5 to 8.2% at Sero6), other PITC 
services were only introduced at the health centre’s outpatients department in 2010, 
and to date very small proportions individuals have been tested here. Anecdotal 
evidence from conversations with staff at Kisesa Health Centre suggested that this 
related to a lack of time and training among clinicians working at the outpatients 
department. However, shortages of HIV test kit supplies were also highlighted as a 
critical issue, and it was reported that while clinicians were likely to refer patients 
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with symptoms suggestive of HIV to the WI-HTC, a routine offer of PITC was 
generally not made to asymptomatic patients at the outpatients department. (Denna 
Michael, personal communication August 2014). Furthermore, while in theory ANC-
HTC is available to pregnant women attending the three rural dispensaries (located 
in the villages of Igekemaja, Welamasonga and Ihayabuyaga), other research in 
Kisesa has shown that the service is not always available due to shortages of staff 
or stock-outs of HIV test kits (141), and HTC services for the general population are 
not available at these clinics. There is a need for further expansion of HTC services 
within Kisesa, however a substantial investment of resources will be required, 
including investments in human resources and provision of HTC skills training for 
healthcare workers, ensuring a reliable supply-chain of HIV test kits, and developing 
robust systems for linkage of HIV-positive individuals to care and treatment services. 
 
As the uptake of HTC services increases in Kisesa, there is a need to provide 
appropriate levels of supervision, training, monitoring and support for service 
providers. During qualitative interviews, HTC counsellors expressed a need for 
greater levels of mentoring and supervision as well as access to regular training 
sessions to update and renew their skills. Shortages of HIV-test kits were also 
highlighted as a particular challenge faced by counsellors, resulting in them having 
to turn away clients who wished to test, or having to make difficult ethical choices 
about who to test, both of which were an emotional burden and a considerable 
source of stress to counsellors. Although counsellors were generally viewed by 
clients in a positive light, during the qualitative study a few participants referred to 
rumours about breaches of confidentiality, and the counselling room at the ANC was 
considered insufficiently private. Other research in Kisesa has shown that pre-test 
counselling is not always provided as part of ANC-HTC, and that pregnant women 
were sometimes unaware of the right to decline testing (58). Ongoing training and 
support is required within HTC settings in Kisesa in order to ensure compliance with 
the ‘five C’s’ of HTC (consent, confidentiality, counselling, correct test results, link to 
care) (189). 
 
Linkage to care among individuals testing HIV-positive is an area of research that 
was beyond the scope of this PhD, yet is critical to understanding the relative 
success of different HTC services in contributing to universal access goals. Previous 
research in Africa has demonstrated poor rates of linkage between HTC and HIV 
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care services, with dropout at several stages along the pathway from diagnosis to 
care, including between diagnosis and measurement of CD4 count or clinical 
staging, between staging and assessment of ART eligibility, and between ART 
eligibility and treatment initiation (153, 190). In one systematic review, factors 
reported to facilitate completion of CD4 count measurements among individuals 
testing positive included the collection of blood samples at the time of diagnosis (to 
reduce the requirement for return appointments), the availability of point-of-care 
CD4 diagnostics, and workplace-based HTC programmes which had regular contact 
with clients (11). However, the data on linkage between HTC and HIV care services 
are sparse and further studies are needed in order to understand the relative 
success of different HTC strategies in facilitating linkage to care among HIV-positive 
individuals, such as investigating time to CD4 count measurement or ART eligibility 
assessment by HTC modality.  
 
Socio-demographic differentials in HTC service use 
In Kisesa, while smaller proportions of women than men had ever tested for HIV by 
the Sero4 round in 2003-2004 (8.8% versus 13.4%, respectively), over time 
coverage increased among women such that by Sero6 in 2010, larger proportions of 
women had ever tested compared to men (52% versus 41%, respectively). This was 
partially as a result of increases in the proportions of women using CO-HTC 
services over time, but also greater use of the WI-HTC at Kisesa Health Centre by 
women as compared to men, and the initiation of a routine offer of ANC-HTC to 
pregnant women from the end of 2008 onwards. Other studies in sub-Saharan 
Africa have noted that men represent an underserved group in terms of HTC 
coverage (41, 56), and that ways should be found to make services more accessible 
and acceptable to men, who may be disinclined to use health facilities more 
commonly frequented by women as a result of attendance at antenatal or maternal 
and child health clinic appointments. Men may also be restricted by work 
commitments in terms of the hours during which they can attend for testing, which 
calls for more flexible HTC service provision options such as late opening of clinics 
or options for home or workplace-based HTC.  
 
Despite the fact that we found more women in Kisesa had ever tested compared to 
men, estimates of the proportions of HIV-positive individuals who had learned of 
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their positive status by Sero6 were lower among women (39%, 142/359) compared 
to men (46%, 75/161). Possible explanations for this include that we may have 
underestimated the proportions of women diagnosed via WI-HTC, which was used 
by more women than men, due to low linkage sensitivity between the WI-HTC and 
cohort dataset and the presence of reports of previous HTC use for which we did not 
know the test results. Other possible explanations include that increasing numbers 
of women have been tested via ANC-HTC over time, yet this service was not 
significantly more likely to attract HIV-positive compared to HIV-negative women in 
the logistic regression analyses presented in Chapter 4 (OR for ANC-HTC among 
women HIV positive <3 years since first positive research test compared to HIV-
negative women: 0.74, 95% CI 0.12-4.56. OR for ANC-HTC among women HIV 
positive ≥3 years since first positive research test compared to HIV-negative 
women: 0.99, 95% CI 0.09-11.13). In addition, Chapter 5 showed that there was 
some evidence that CO-HTC services were significantly more likely to attract HIV-
positive compared to HIV-negative men if they had never used HTC before, but the 
strength of this association among women was weak (OR at Sero6 for CO-HTC use 
among HIV-positive men who reported no prior HTC use compared to HIV-negative 
men: 1.62, 95% CI 0.99-2.64. Equivalent OR for women: 1.16, 95% CI 0.77-1.75).  
 
Disparities in HTC service coverage by other socio-demographic characteristics 
persisted or increased in the study area over time. We found that men and women 
living in rural areas had significantly lower odds of using the CO-HTC service offered 
at Sero6, and similar findings were reported at earlier sero-survey rounds (42, 43). 
Similar associations between area of residence and uptake of testing were observed 
among users of WI-HTC (men only) and ANC-HTC. However, surprisingly, the 
measures of effect were greater for CO-HTC compared to the other service types, 
despite the fact that CO-HTC is offered locally within each village during sero-
surveys, and so the distances required to access this service are smaller compared 
to WI-HTC and ANC-HTC (both of which are offered centrally at Kisesa Health 
Centre). Previous research has found high levels of HIV-related stigma in rural 
populations in sub-Saharan Africa (16, 191), and during the qualitative component of 
this research, participants highlighted concerns about being seen or recognised by a 
friend or neighbour at the WI-HTC clinic, as this was assumed to identify oneself as 
being at high-risk of HIV infection. During sero-surveys, it is possible that fears of 
being seen attending for HTC were greater in rural villages, due to higher levels of 
stigma and because clients were afraid of being recognised by friends or relatives 
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living within the same village. Greater distances to the health centre, in terms of 
access to the care and treatment centre (CTC), may also act as a deterrent to the 
uptake of HTC among residents of rural villages. 
 
HTC services in Kisesa were disproportionately used by younger individuals, with 
men and women aged ≥55 being less likely to use CO-HTC and WI-HTC compared 
to those aged 15-24. The proportions using all types of HTC services were generally 
highest among those aged 25-44, although statistically significant associations were 
not always found in adjusted analyses. A higher level of education was an 
independent predictor of WI-HTC use among women, but not men. A similar finding 
was revealed for CO-HTC use among women, but the measure of effect was not as 
strong as for WI-HTC use, and level of education was not associated with uptake of 
ANC-HTC. In Kisesa and other similar settings, PITC and community-based HTC 
approaches are likely to increase the uptake of HTC by different socio-demographic 
groups by making a routine offer of testing to all individuals, thus eliminating some of 
the self-selection associated with traditional client-initiated VCT use. 
 
Repeat testing 
TasP approaches advocate regular repeat testing among high-risk HIV-negative 
individuals in order to facilitate diagnosis at early stages of infection (30, 82). In 
2010, the WHO recommended at least annual testing of all HIV-negative individuals 
with sexual risk behaviours, regardless of epidemic setting (192). The analyses 
presented in Chapter 5 revealed that in Kisesa, rates of repeat testing were 
disappointingly low. By the Sero6 round in 2010, an estimated 16% (475/2,947) of 
HIV-negative men and 28% (45/161) of HIV-positive men had ever tested more than 
once (taking both known and reported HTC use into account, and with HIV-status 
reflecting that at Sero6 rather than at any earlier point in time). The corresponding 
figures for repeat testing among women were 22% (1,009/4,502) for HIV-negative 
individuals and 28% (102/359) for HIV-positive individuals. Other studies in Uganda 
and Malawi offering home-based HTC (83, 84) have shown higher rates of repeat 
testing compared to those seen in Kisesa. Furthermore, in one of these studies (84), 
there were no differences in the socio-demographic characteristics of those 
accepting and not accepting repeat HTC, demonstrating that home-based testing 
helped to reach an equitable distribution of service users by age-group and gender.  
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Among individuals who attended all three sero-survey rounds between 2003 and 
2010 (n=2,010), just 11% of participants used the CO-HTC service twice or more, 
even when transport to the sero-survey site was provided free of charge, test-kits 
were adequately supplied and trust in counsellors was reported to be high (43). This 
demonstrates that the lower rates of repeat HTC seen in Kisesa compared to other 
sites are likely to be only partially explained by problems relating to the quality of 
service provision or HIV test kit supplies. Furthermore, at the later two sero-survey 
rounds in 2006-2007 and 2010, ART was available either in Mwanza town (with a 
transportation allowance for HIV-positive patients travelling to CTC sites there), or 
from the end of 2008 onwards, at the health centre within Kisesa itself. High levels 
of stigma and discrimination, and possibly the time and cost associated with 
potentially having to access the CTC at Kisesa Health Centre, may persist as 
significant barriers to the uptake of HTC in the study area.  
 
The risk factor analyses presented in Chapters 4 and 5 revealed that although the 
numbers of individuals reporting previous HTC use were sometimes small 
(particularly at Sero4 and Sero5), when reported, this factor was strongly associated 
with testing again (for all service types). This suggests that modes of HTC service 
provision which reach large proportions of first time testers (such as CO-HTC in our 
setting) may confer considerable benefits in terms of encouraging subsequent HTC 
use. Adjusted analyses of risk factors for repeat testing among individuals attending 
both Sero5 and Sero6 found that men and women with higher risk sexual 
behaviours (those aged less than 15 at first sex, practising polygyny, or reporting 
inconsistent condom use) were more likely to have used the CO-HTC service at 
both rounds compared to those with lower risk behaviours. However, although 
individuals testing HIV-positive at Sero5 were less likely to use CO-HTC again at 
Sero6 than those who tested HIV-negative at Sero5 (aOR 0.17, 95% CI 0.06-0.52), 
sero-conversion between the two survey rounds was not associated with repeat CO-
HTC use (OR 0.52, 95% CI 0.10-2.71). However, our sample size of sero-converters 
was small (just seven individuals) and so we were likely underpowered in testing this 
association. Overall, our findings provided some evidence for higher rates of repeat 
testing among high-risk HIV-negative individuals. Spousal HIV and HTC use status 
was also an independent predictor of repeat CO-HTC use (as well as of CO-HTC 
use overall and of ANC-HTC use, although not of WI-HTC use), suggesting that 
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couple counselling or the offer of partner testing could help to increase the uptake of 
HTC in Kisesa. 
 
9.1.2 Impact of HTC on sexual risk behaviour 
Increasing the overall uptake and coverage of HTC services in Kisesa may 
contribute to HIV-prevention by encouraging sexual risk reduction among individuals 
testing HIV-negative and HIV-positive. However, despite widespread assumptions in 
international policy documents that this is the case (4, 5), the systematic review 
presented in Chapter 2 revealed that quantitative evidence in support of this 
hypothesis is mixed, particularly among individuals testing HIV-negative. In Kisesa, 
quantitative and qualitative methods were used in order to explore the impact of 
HTC on sexual risk behaviours.  
 
The quantitative analyses presented in Chapter 6 revealed moderate associations 
between CO-HTC use and reductions in some sexual risk behaviours among HIV-
negative participants. For example, compared to those who had not used CO-HTC, 
HIV-negative men and women using CO-HTC at Sero4 or Sero5 were significantly 
more likely to report reductions in the number of sexual partners in the last year by 
the next sero-survey round (by Sero5: aOR 1.42, 95% CI 1.07-1.88, or by Sero6: 
aOR 1.68, 95% CI 1.25-2.26, respectively). Furthermore, there was no evidence for 
a lesser impact of HTC on reductions in the number of sexual partners (or on the 
observed association between CO-HTC use and loss of a non-cohabiting partner) at 
the later set of sero-survey rounds (between Sero5 in 2006-2007 and Sero6 in 
2010) when ART was available within the study area (offered at Kisesa CTC from 
the end of 2008) compared to the earlier set of sero-survey rounds (between Sero4 
in 2003-2004 and Sero5 in 2006-2007) when ART was only available in Mwanza city 
(from the start of 2005). These results are encouraging and do not provide evidence 
for sexual dis-inhibition associated with greater treatment availability, although 
further analyses should explore this topic using data from additional sero-survey 
rounds. 
 
The qualitative research provided insights into possible reasons for some of the 
quantitative findings. For example, several barriers to sexual risk reduction with 
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primary partners were highlighted, including that condoms were rarely used. 
Accordingly, the quantitative analyses revealed few changes in condom use 
behaviour associated with CO-HTC use (except for an increased likelihood of 
stopping using condoms with regular non-cohabiting partners at last sex among 
HIV-negative individuals between Seros 4 and 5, aOR 4.88, 95% CI 1.39-17.16. Our 
interpretation of the meaning of this finding would be enhanced by knowledge of the 
HIV and HTC use status of partners). Furthermore, while HTC users tended to 
report positive attitudes and intentions regarding sexual risk reduction during IDIs, 
there were a number of barriers which appeared to limit behavioural change, 
including imbalanced client-counsellor interactions which limited communication 
during counselling sessions and the individual tailoring of counselling advice. 
 
During the qualitative study, women reported that it was expected or accepted that 
men could have multiple partners, and women seemed unlikely to separate from 
primary partners upon whom they were economically dependent, even if infidelity 
was suspected. Women also reported difficulty talking to their partners about 
information or advice they had received during HTC. Previous qualitative research in 
north-western Tanzania and elsewhere in sub-Saharan Africa has reported the 
dominant role of men within relationships (183, 193, 194), and that women are often 
of lower status, linked to traditional systems of kinship and marriage (183). Such 
research has also highlighted that men’s sexual respectability is often linked to 
greater sexual activity and the conquest of multiple partners (183, 193, 194), in 
contrast to women’s sexual respectability which is characterised by obedience, 
faithfulness and subservience to male partners (183, 194). Similarly, in our 
qualitative study, women appeared limited in their capacity to be the instigators or 
initiators of behaviour change within their relationships. In quantitative analyses, we 
did not find evidence for a differing impact of CO-HTC on sexual risk behaviour by 
gender, however, we may have been limited in our ability to detect this by small 
sample sizes.  
 
The WHO has recently recommended more widespread implementation of couples-
based HTC (195), and some studies have found this mode of testing helped women 
to negotiate safer sex, and helped to strengthen communication and commitment to 
the relationship by both members of the couple (132, 134). However, a trial of the 
uptake and impact of couples-based versus individual VCT among ANC attendees 
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in Dar es Salaam found that only 33% (254/760) of women randomised to receive 
couples VCT at their next ANC appointment returned for testing with their partner, 
and of these, only 47% (119/254) agreed to counsel, test and receive their results 
together (196). In unadjusted analyses, women who completed couples VCT were 
significantly younger, of lower parity and were less likely to have ever experienced 
domestic violence compared to those who were randomised to couples VCT but did 
not complete it. Further research should explore the relative success of different 
HTC strategies in increasing the uptake of couples HTC, the factors which influence 
uptake, possible positive and negative outcomes of couples testing, and whether 
couples HTC helps to encourage greater reductions in sexual risk behaviour relative 
to individual HTC. 
 
In quantitative analyses, we found no impact of CO-HTC on reductions in HIV 
incidence, or on reductions in sexual risk behaviour among individuals testing HIV-
positive, but we were limited by small sample sizes as well as a declining 
background incidence in the study area over time (140). However, the systematic 
literature review presented in Chapter 2, as well as previous meta-analyses 
assessing the impact of HTC on sexual behaviour change and HIV incidence in 
developing countries (22, 23), found declines in sexual risk behaviour among 
individuals testing HIV-positive. In our qualitative study, HIV-positive individuals 
tended to report having reduced their levels of risk behaviour since diagnosis, in 
many cases because they had separated from their partners after diagnosis, or had 
chosen not to re-marry after a partner had died.  
 
To date, five studies have investigated the impact of HTC interventions on HIV 
incidence in sub-Saharan Africa, including three cohort studies (83, 99, 101) and 
two RCTs (61, 97). The two RCTs found no overall impact of HTC on HIV incidence 
(although only one was powered to investigate incidence (97)). Of the three cohort 
studies, two reported no impact of HTC on HIV incidence (83, 99), while one found 
that the hazard of HIV acquisition was significantly lower among young people aged 
15-24 in South Africa who reported previous HTC use compared to those reporting 
no prior HTC (0.59, 95% CI 0.45-0.78) (101). The differences in study findings may 
be partly due to study design, but Rosenberg et al hypothesize that HTC 
interventions may have a different impact among young people who are less likely to 
have formed behavioural habits, and are more likely to be in less stable non-
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cohabiting partnerships, which may facilitate better adoption of HIV prevention 
counselling messages among this group. It is worth noting that one study exploring 
the impact of nine different types of behavioural interventions (including 
interventions other than HTC) on HIV incidence found that none of these RCTs 
showed statistically significant decreases (or increases) in HIV incidence. Three 
possible explanations were offered for this, including that the behavioural 
interventions were ineffective, that they were inadequately implemented, or there 
were problems with measuring effectiveness (197).  
 
In Kisesa, the combined quantitative and qualitative evidence points towards a 
limited impact of HTC in terms of sexual risk reduction, likely due to a variety of 
socio-cultural and structural factors including sexual decision making and 
relationship dynamics, as well as limited client-counsellor interactions and an 
apparent lack of tailoring of individual risk reduction plans during counselling 
sessions. However, HTC services were highly valued by study participants, who 
mentioned that the service helped motivate them to try and avoid high risk 
behaviours. Of interest, one recent RCT in Uganda reported no significant 
differences in unprotected sex with partners of unknown or sero-discordant status 
associated with an abbreviated counselling session (based on PITC protocols – 
median duration of counselling was 16 minutes) when compared to standard VCT 
counselling (median duration of counselling 47 minutes), suggesting that briefer 
counselling sessions may be as effective as longer ones (198). In addition, in 
African settings, more culturally relevant counselling messages which acknowledge 
the importance of family and community in constructions of health and well-being 
may be more appropriate than Western models of counselling which tend to focus 
on individual agency and self-efficacy (29).  
 
Ultimately, a combination of approaches to HIV prevention incorporating elements of 
biomedical, behavioural and structural interventions are likely to be most successful 
(197, 199). While the efficacy of different biomedical HIV-prevention strategies has 
been proven in the context of clinical trials (31, 200, 201), many challenges to their 
implementation exist, and behavioural interventions are important in their own right, 
as they may contribute to background levels of HIV-related knowledge and influence 
general population attitudes regarding safe sexual behaviour, as well as adherence 
to biomedical interventions (197). 
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9.2 Strengths and limitations of the research  
9.2.1 Strengths 
One of the main strengths of the research presented in this thesis relates to its 
context within a long-term demographic and HIV surveillance site, providing a wealth 
of data on demographic, clinical and behavioural factors, as well as on HTC use, 
since 2003. There have been considerable changes in the provision of HIV services 
in the study area during this period, with increasing availability of HTC during sero-
survey rounds since 2003, the opening of the WI-HTC clinic at Kisesa Health Centre 
in 2005, and the routine offer of HTC to pregnant women at the ANC from the end of 
2008 onwards. The Tanzanian national ART programme was rolled out at the start 
of 2005, with free treatment initially available at CTC sites in Mwanza city, and since 
the end of 2008 at a local CTC within the study area. These changes allowed for an 
assessment of the effect of increasing availability of different types of HIV services 
on the uptake of testing, as well as an investigation of the impact of HTC on 
changes in sexual risk behaviour before and after greater availability of ART in the 
study area.  
 
The linkage of data from demographic surveys, sero-surveillance rounds and HTC 
services allowed for the investigation of a range of risk factors for HTC service use, 
including duration of HIV infection, due to the availability of information on HIV-
status among both users and non-users of HTC services at the community level. 
Furthermore, the linkage of the health centre HTC clinic dataset to the Kisesa 
research datasets allowed for a comparison of risk factors for service use by HTC 
delivery model. The impact of CO-HTC services on sexual risk behaviours could be 
explored over extended periods of follow-up (two to three years, for subsets of 
individuals attending more than one sero-survey round), while the cohort and 
demographic surveillance datasets provided a useful sampling frame from which 
users and non-users of HTC services could be recruited for the qualitative study. 
 
The HTC services provided in Kisesa and assessed in the analyses presented in 
this thesis are likely to be typical of the types of services that are, or could be, 
provided in similar rural settings, making the research findings generalizable and of 
importance to policy makers more widely in Tanzania as they look for ways to scale 
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up provision of HTC and related HIV services. Although part of a research study, the 
CO-HTC services offered during sero-surveys provide an example of one model or 
option for delivery of community-based HTC, with the counselling and testing 
procedures implemented according to Tanzanian national guidelines (6). The testing 
services offered at the WI-HTC and the ANC at Kisesa Health Centre are also 
expected to be characteristic of services offered at similar clinics in other rural 
settings in Tanzania, as they were part of the routinely-provided district-level health 
services. Due to the observational nature of the study design, recommended 
improvements to service provision can be fed back directly to health officials at 
regional, district and ward levels (see Dissemination in section 9.5). 
 
A further strength of this study relates to the use of mixed methods, drawing on both 
quantitative and qualitative approaches in order to increase the depth of the 
research findings. The qualitative component used a variety of data collection 
methods, including PLA activities and IDIs in order to maximise learning from 
different perspectives, and provided possible elucidations for the modest reductions 
in sexual risk behaviours observed among HIV-negative individuals in the 
quantitative analyses. This included an understanding of the socio-cultural and 
structural factors which shaped sexual behaviour following HTC, and the importance 
of the local context in understanding responses to HIV prevention counselling 
messages. Although it was expected that the qualitative study would contribute 
mainly to understanding perceptions of the content of HTC sessions, during PLAs 
and IDIs participants highlighted issues which were useful in understanding barriers 
to service access such as fears of HIV-related stigma, and issues relating to service 
provision, such as the availability of HIV test-kit supplies. 
 
In terms of the quantitative analyses, few sites in sub-Saharan Africa have made 
use of data linkage procedures to match routinely collected data from health 
facilities to research study datasets. The linkage methods used to match users of 
the WI-HTC and ANC-HTC services to the cohort dataset used novel techniques 
and provided methodological contributions, which will be of use to other sites 
attempting to develop procedures for retrospective or prospective data linkage. The 
methodology developed serves as a starting point for future research in Kisesa 
using existing or new linked HTC clinic-cohort datasets. The output of the analyses 
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using the linked datasets provided new insight into the relative success of different 
HTC services in increasing the overall uptake and coverage of HTC in Kisesa.  
  
9.2.2 Limitations 
One of the main limitations of the research relates to the observational nature of the 
study design and the potential for participation bias, which may have led to over or 
under estimation of some of the effects investigated (202) – for example if subsets 
of sero-survey participants (e.g. those with at least a primary level of education) 
were more or less likely to use HTC services than similar individuals who did not 
participate. We have seen declining participation in sero-surveys over time, from 
approximately 85% in Sero1 in 1994-1995 to approximately 55% in Sero6 in 2010, 
and so the potential effects of participation bias are likely to have grown over time. 
There have been larger decreases in participation among certain sub-groups – 
namely men aged between 25 and 44, likely as a result of migration for work.  
Previous research has shown that migration is associated with a higher risk of HIV 
infection (203), and so this may have resulted in overestimates, or perhaps more 
likely underestimates, of the strength of the associations between HIV-status and/or 
sexual risk behaviours (numbers of sexual partners, condom use, etc) and CO-HTC 
or WI-HTC use among men. Previous research has also shown that HIV-positive 
individuals are less likely to participate in population-based sero-surveillance 
because they may fear others learning their HIV status, and/or as increasing 
numbers of individuals test and thus are already aware of their status (163, 204, 
205). This may have led to particular effects among HIV-positives – for example if 
sero-surveys tended to attract positive individuals with relatively higher (or lower) 
risk behaviours compared to positive individuals who did not participate. Despite the 
possible participation biases, the crude analyses presented in Chapter 5 showed a 
similar range of factors to be associated with CO-HTC use at the three sero-survey 
rounds between 2003 and 2010, and many of the risk factors for HTC use in this 
study (e.g. area of residence, level of education, higher risk sexual behaviours) have 
also been reported in other similar settings in sub-Saharan Africa (40, 80, 81). 
 
There are inherent difficulties in measuring self-reported sexual behaviour, which 
may be subject to recall and social desirability biases (164, 169, 173, 179). Within 
the Kisesa cohort study, the questions on sexual behaviour are reviewed and 
updated for each round of the study, in order to try and maximise the quality of the 
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data collected (for example ‘partner loops’ were introduced during Sero6 so that 
questions on partners and sexual behaviour were clearer and happened in 
chronological order). While it is difficult to remove all potential for recall and/or social 
desirability bias from questioning on sexual behaviour, it is worth noting that 
comparative analyses of data from Kisesa and other cohort sites have found that 
while poor recall or inaccuracies in reporting of some behaviours (e.g. age at first 
sex, age at first marriage) introduced noise, they did not bias results in a systematic 
way (206, 207). In the quantitative analyses presented in Paper C, it is possible that 
recall error may have biased some of our risk ratios towards one, if such noise or 
random error was present. On the other hand, social desirability biases may have 
overstated the associations between CO-HTC use and changes in sexual risk 
behaviour, if those who used the service were more likely to report reductions in 
risky behaviour compared to those who did not. During qualitative data collection, 
participants tended to report compliance with ‘instructions’ regarding safe sexual 
behaviour which were received from counsellors, providing some evidence that 
social desirability biases were present. Some population-based studies have used 
informal confidential voting methods to collect sexual behaviour data (208), and 
such strategies may be useful for consideration in future rounds of the Kisesa cohort 
study.  
 
In quantitative analyses, sample sizes were sometimes small (particularly for the 
analyses assessing risk factors for ANC-HTC use, and the impact of CO-HTC on 
sexual risk behaviours among HIV-positive individuals), which may have limited my 
ability to detect smaller effects for some exposures. Residual confounding by 
unmeasured variables may also have occurred. In particular, for the analyses of the 
impact of CO-HTC on sexual behaviour change, it would have been helpful to have 
accounted for the HIV and HTC use status of partners, and further analyses among 
the subset of married and co-habiting couples for whom this information is available 
are warranted. In addition, data were not available on whether clients were 
counselled as individuals or couples during CO-HTC, and this information would be 
useful in order to allow future analyses of the potential impacts of this mode of 
service delivery on sexual risk reduction. 
 
While the linkage of the data on WI-HTC and ANC-HTC use at the health centre to 
the community cohort dataset was a novel contribution and harnessed the power of 
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the data available from the research dataset, it is worth mentioning that methods for 
retrospective data linkage are still in development and a number of issues were 
encountered during the linkage process which limited the positive predictive value 
(PPV) (i.e. of the gold standard records matched, the proportion which were 
correctly matched) and sensitivity (i.e. the overall proportion of gold standard links 
which were correctly matched) of the final linked clinic-cohort dataset. Firstly, the 
linkage algorithm was ultimately a trade-off between sensitivity and specificity, and 
we obtained large numbers of potential multiple matches for each HTC clinic record. 
Various validation procedures were applied in an attempt to choose a single best 
cohort match for each clinic record. Ultimately, the result of this process was a 
reasonable PPV (69%), which could be further increased to 78% and 85% by 
placing additional restrictions on final matched-pairs accepted, at the expense of 
further losses in sensitivity. Analyses run using the higher PPV datasets did not 
change overall findings, giving confidence in the results obtained using the largest, 
lowest PPV dataset. 
 
Of relatively greater concern was the low estimated sensitivity of the final linked 
dataset, at   just 18%. Although a high linkage rate was initially achieved (94% of 
10,994 Kisesa resident users of the WI-HTC clinic between 2005 and 2012 initially 
matched to the cohort dataset), large proportions of clinic records were dropped 
during the final two validation procedures. This included 32% (3,337/10,289) of the 
initially matched records dropped due to selection of a single best match-pair where 
an identical cohort record had been matched to more than one clinic ID number 
(these match-pairs may have represented either one or more than one person, but 
the extent of this was unknown, due to unreliable systems for linking repeat visits 
together under one ID number at the WI-HTC clinic), and 28% (2,881/10,289) of the 
initially matched records dropped after manual selection of a score threshold, below 
which the accuracy of match-pairs was in doubt.  
 
In comparative analyses, HTC clinic attendees for whom a single best match could 
be found in the cohort dataset were more likely to be female (p<0.001), more likely 
to be older (p<0.001) and less likely to have secondary education (p=0.002) than 
those not included (either because they had not been linked in the first place, or 
more commonly because their record had been dropped during validation 
procedures), and this may have led to biases in our assessment of some of the risk 
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factors associated with WI-HTC and ANC-HTC use. For example, we may have 
underestimated the proportions of men using WI-HTC, or we may have 
underestimated the strength of associations between age and/or educational 
attainment and WI-HTC or ANC-HTC use. However, reassuringly, there were no 
significant differences in the proportions of individuals included in final analyses by 
HIV-status (p=0.9). Records for the final year for which WI-HTC clinic data were 
available (2012) were incomplete, and this may have led to misclassification of the 
outcome (WI-HTC or ANC-HTC use) for a small proportion of individuals, which 
would have biased odds ratios towards one. Despite the limitations of the linkage 
procedures and the low sensitivity achieved, the identified risk factors for WI-HTC 
and ANC-HTC use were not wholly unexpected (e.g. residents in urban areas more 
likely to use WI-HTC (men only) and ANC-HTC compared to those living in rural 
villages, level of education associated with WI-HTC use (women only)), and are 
broadly in line with other studies assessing the uptake of these types of services in 
sub-Saharan Africa (76, 78, 79). Future analyses should build on the record linkage 
methodology developed as part of this thesis, taking advantage of potentially larger, 
improved datasets (in terms of PPV and sensitivity) which may be outputted (see 
Section 9.4 on recommendations for future research below). 
 
During the qualitative component of the research, local facilitators were used in 
order to overcome language barriers as well as to help generate richer, less biased 
data. However, had I been able to conduct the group activities and interviews myself 
I might have gained a deeper insight into the data, some of which may have been 
partially lost during the processes of transcription and translation. Due to limited 
availability of staff, transcription and translation of audio-recordings did not begin 
until data collection was complete. Ideally transcription and translation would have 
happened as the study progressed, in order to explore emerging themes and make 
amendments to the data collection tools as the study proceeded, although 
modifications to the content of the IDI guidelines were made based on debriefing 
sessions held with research assistants after each interview. In retrospect it appears 
as though the sampling frame used to recruit HTC users included too few women 
who had completed ANC-HTC (only three were interviewed), and it would have 
been interesting to have collected a broader range of views from women who had 
used this service. The ability of the research assistants to elicit information from 
HTC users may have been limited by the sensitive nature of the topic, a possible 
hierarchical relationship between participants and research assistants, and/or by 
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social desirability biases, all of which may have inhibited participants from disclosing 
or discussing high-risk sexual behaviours with researchers. 
 
9.3 Reflections on the research 
9.3.1 The research setting 
The Kisesa cohort study is an observational study which does not include HIV 
education or prevention interventions other than those, such as the provision of HTC 
services, which are already part of district level HIV prevention programming. Other 
HIV prevention activities carried out within study area (e.g. school or community-
based HIV education and prevention campaigns, occasional outreach HIV testing 
campaigns) are part of standard HIV prevention efforts coordinated by the District 
AIDS Committee and the Ministry of Health and Social Welfare. As an observational 
research site with minimal additional interventions, the results from the Kisesa 
cohort study are thus generalisable to other similar rural settings elsewhere in 
Tanzania and sub-Saharan Africa. Nevertheless, it is worth considering how 
participation in the research itself (i.e. the rounds of demographic and serological 
surveillance, and any associated research activities such as qualitative studies) may 
have influenced the results obtained.  
 
During the informed consent process, sero-survey participants are provided with 
information on HIV, and are free to ask any questions they may have, which may 
lead to improvements in their levels of HIV-related knowledge and awareness. The 
process of answering the sero-survey questions may also add to participants’ HIV-
related knowledge, and sero-surveys extend the reach and availability of HTC 
services via the temporary CO-HTC clinics which are set-up within each village, 
constituting an additional source of information on HIV. Residents within the study 
area are also invited to periodic community meetings where the results of the 
research are disseminated. As such, and as a result of the extended period of time 
over which sero-surveys have been conducted (since 1994), it is likely that Kisesa 
cohort study participants have better HIV-related knowledge compared to other 
similar but less studied rural populations elsewhere in Mwanza region or in 
Tanzania. This may have led to higher rates of uptake of HTC, or better responses 
to HIV-prevention counselling messages, than might be expected in other settings. 
However, despite this, the proportions of sero-survey participants using CO-HTC 
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were low (as shown in Paper B), as were the proportions of individuals using other 
HTC services in the study area (as shown in Paper A). This suggests that cohort 
study participation did not increase HTC uptake as much as one might have 
expected. 
 
The quantitative and qualitative analyses presented in Papers C and D provided 
only moderate evidence for an association between HTC use and changes in sexual 
risk behaviour. As such, it seems unlikely that the additional HIV-related knowledge 
or awareness imparted as a result of participation in the cohort study led to 
significantly greater reductions in sexual risk behaviour than might have otherwise 
been seen. This is supported by findings from the qualitative research, which 
highlighted various socio-cultural barriers which inhibited sexual behaviour change 
following HTC use, regardless of individual level factors such feelings of self-efficacy 
or levels of HIV-related knowledge. 
 
Although it increased over time, the uptake of CO-HTC offered during sero-surveys 
in Kisesa was low, being just 25% at the Sero6 round in 2010 (despite the fact that a 
routine offer of CO-HTC was made to all study participants, and that ART has been 
freely available at Kisesa health centre since late 2008). The uptake of CO-HTC in 
Kisesa is considerably lower than that reported in a recent meta-analysis of 
community based HTC approaches, which reported that in 14 studies (10 of which 
were conducted in sub-Saharan Africa), overall 87% of participants accepted to use 
mobile community-based outreach HTC services when they were offered (11). 
Differences in the uptake of community-outreach HTC between settings may relate 
to the way in which services are provided, for example whether services are 
provided independently, alongside community mobilisation activities, or as part of a 
research study. In Kisesa, although all study participants may use CO-HTC without 
participating in the sero-survey (i.e. without completing the sero-survey 
questionnaire or providing a blood sample), in practice the proportion of individuals 
who do this is small (<5%). According to study protocol, CO-HTC is completed as 
the last step or stage in study participation (i.e. after completion of the questionnaire 
(for those who choose to complete it), provision of a finger prick blood sample and 
medical consultation with a study clinician (if desired)). As such, sero-survey 
participation may be incorrectly perceived as a requirement or pre-requisite for CO-
HTC use, or study participants may be disinclined to use CO-HTC after they have 
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already spent a reasonably lengthy period of time completing the sero-survey 
questionnaire (approximately 45 minutes to one hour) and participating in other 
elements of the study. The CO-HTC services offered during sero-surveys are 
provided by trained counsellors who come from outside the study area. However, 
some of the counsellors providing HTC during sero-surveys also work at Kisesa 
health centre, and it is possible that fears of being seen or recognised by these 
healthcare workers may make participants disinclined to use the CO-HTC services 
offered during sero-surveys.  
 
The aspects of sero-survey participation described above may have had a negative 
impact on the uptake of CO-HTC in Kisesa, which might have been higher if the 
service had been offered independently of the sero-survey. However, it is worth 
noting that levels of HIV-related stigma and discrimination are high in Kisesa (16, 
162), and this is also likely to have influenced the low uptake of HTC seen. 
Additional factors which may have contributed to low HTC uptake include perceived 
or actual barriers to accessing ART in the case of a positive diagnosis, particularly 
for those living in the rural villages located furthest from the trading centre. 
 
9.3.2 Looking back: lessons learned 
Inevitably a PhD is a learning process and a journey of accomplishments and 
triumphs, as well as of setbacks and moments of uncertainty or difficulty. At the 
point of completion, it is worth reflecting on the work undertaken and taking stock of 
the lessons learned, in order that these might inform and improve future research. 
Some of these lessons and learnings are summarised below. 
 
The probabilistic record linkage work undertaken to match data from the health 
centre HTC clinic to the cohort dataset was perhaps the most challenging technical 
task undertaken as part of my PhD, and involved collaboration with IT experts based 
at NIMR Mwanza. I was thankful to work alongside these data managers during one 
of my periods of fieldwork in Tanzania between January and April 2012. This time 
provided us with an invaluable opportunity to develop the record linkage algorithm, 
working on several different versions of the model, and continually reviewing and 
refining it in order to improve the output. Validation of the final linked dataset that I 
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obtained occurred after I had returned to the UK. At this point it became clear that 
documentation of the steps we had undertaken during development of the linkage 
algorithm was not always clear or detailed enough, and these details were much 
more difficult to ascertain at a later point in time. Future research teams should 
ensure that all methods are recorded in detail at each stage of model development, 
and that these are reviewed by all team members in a timely manner in order to 
ensure their accuracy and to reach consensus where there is uncertainty. This will 
help to improve the utility of the outputted datasets and to resolve queries regarding 
optimal approaches to data analysis. 
 
Inevitably we learned other lessons during development of the probabilistic record 
linkage algorithm and if doing the work again, we might approach some aspects a 
bit differently. We trained and tested our record linkage algorithm using the same 
gold standard dataset (i.e. we developed the scoring scheme, and then assessed 
the performance of the model (in terms of its sensitivity and positive predictive 
value), using the same dataset), because this was the only gold standard dataset 
available to us at the time. Future attempts at probabilistic record linkage would 
benefit from using different gold standards for each of these two steps, as this would 
provide a more robust test of the model’s performance. We also encountered 
difficulties due to the fact that re-visits by the same client at the HTC clinic are often 
given a new client ID number. Thus, whenever the same cohort record had been 
selected as the best match for more than one clinic ID, it was not known whether 
these matches were all correct (because the different clinic ID numbers represented 
the same individual), or whether one or more of the matches were false (because 
the different clinic ID numbers represented different individuals). An alternative 
approach would have been to match the HTC clinic dataset onto itself first (in order 
to identify unique clients) before linking to the cohort dataset. Ultimately this might 
have improved the sensitivity of the final linked dataset we obtained. Further 
suggestions for refining the probabilistic record linkage algorithm and for future 
research on this topic are presented in Section 9.5.4 below. 
 
The qualitative study that I designed and conducted in Kisesa was also a 
challenging yet rewarding part of my PhD research. It presented me with a steep 
learning curve during which I had to familiarise myself with the theory underlying 
approaches to qualitative data collection and analysis. I was required to design my 
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data collection tools, draw up a sampling frame from the cohort study datasets, help 
with training the research assistants, coordinate the logistics of recruitment and data 
collection, and finally collect and analyse the data. As my first experience designing 
and conducting a qualitative study, there are in retrospect some things I might have 
done differently. For example, the research assistants had only limited prior 
experience conducting PLA activities, and this was an element of the study which 
they found particularly challenging. In order to reduce the length and complexity of 
the group sessions, the number of PLA activities was reduced from two to one. 
Alternative options which might have allowed us to get richer data from the group 
sessions would have been to spend some additional time on training, and/or to have 
carried out the sessions over two days in order allow the additional PLA activity to 
be conducted.  
 
The qualitative study went more or less according to schedule, but one of the group 
activities (among men from urban villages) had to be repeated due to poor 
attendance and participation in the first activity. This highlights the importance of 
being flexible and allowing for extra time or changes to the study schedule when 
needed. I used a combination of purposive and snowball sampling techniques to 
recruit participants for the group activities. I achieved a good response rate (40/48 
purposively sampled men and women attended the group activities, 32 of whom 
brought a friend or neighbour to participate). However I might have achieved an 
even better response rate if I had purposively sampled all individuals, which would 
not have been difficult to do, and would have given me access to demographic and 
other information (such as HIV status) on all group activity participants, not just the 
40 who were purposively sampled. 
 
As a private and intimate topic, talking about sexual behaviour is likely to be 
uncomfortable or difficult for many study participants. During IDIs, the development 
of trust and rapport between researcher and research participant is thus particularly 
important. It is possible that additional IDIs with each individual, spaced perhaps a 
few weeks apart, might have helped participants to develop better rapport with 
researcher assistants, and thus to discuss the nature of their sexual partnerships, as 
well as of their relationships with counsellors, in greater detail. This might have 
helped to generate richer data than could be obtained from a single IDI on a 
sensitive topic.  
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Papers B and C (Chapters 4 and 5) were the first papers which I wrote up and 
submitted for publication as part of my PhD. From a personal point of view, I found 
this process extremely helpful as it gave me an opportunity to learn how to distil and 
present the most important findings from my analyses, to develop my writing skills, 
and to gain useful and insightful feedback from co-authors and reviewers. Inevitably 
the analyses presented in each of these papers went through a number of iterations 
before arriving at the final product, which perhaps lengthened the amount of time it 
took to complete them. Nevertheless, I found the process a rewarding and 
invaluable learning experience. 
 
9.4 Programme and policy recommendations 
This section highlights the programme and policy recommendations arising out of 
the research, which will be relevant to policy makers in Kisesa and other similar rural 
settings in Tanzania.  
 
9.4.1 Promoting access to HTC services 
Although there was limited evidence for an impact of HTC on reductions in sexual 
risk behaviour, improvements to service provision may improve their effectiveness, 
and HTC services have a role to play in the biomedical prevention of HIV, as well as 
in improving background levels of HIV-related knowledge within the community. 
Although they have increased over time, the rates of uptake of HTC in Kisesa 
remain low, and additional strategies should be employed in order to encourage 
further increases in the uptake of testing services, such as the provision of additional 
community-based HTC services. This would likely require considerable investment 
in terms of finance and human resources, although community outreach HTC 
services have proven to be cost-effective relative to traditional client-initiated VCT 
services in other settings (64, 67). Successful strategies for implementation might 
require collaboration or partnerships with governmental or non-governmental 
organisations (NGOs) or community groups already offering HIV-related services in 
the study area.  
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Alongside efforts to scale-up HTC service provision, structural and community level 
programmes must be employed in order to tackle HIV-related stigma and 
discrimination, which was highlighted as a barrier to accessing HTC services in the 
qualitative research. These might include social and community mobilisation 
programmes which aim to catalyse social change, or more formal structural 
interventions such as improved education (which was significantly associated with 
HTC use), and permissive legal and policy frameworks which do not discriminate 
against HIV-positive individuals. Where national level policy change is difficult to 
achieve, local leaders and community groups such as village elders, village AIDS 
committees, healthcare workers and NGOs can lobby for local action and change. 
The potential impacts of such interventions are likely to take a lengthy period of time 
before being seen and their effectiveness may be difficult to measure, however they 
represent public goods in their own right. 
 
The qualitative research indicated that awareness of the availability of HTC services 
in the study area was high, nevertheless there was sometimes confusion relating to 
issues to do with service provision, for example the frequency with which CO-HTC 
services were offered. HTC counsellors could help to promote the uptake of HTC 
services via attendance at community meetings, during which they could provide 
clarifications and further information. HTC counsellors could also ensure different 
healthcare providers have relevant information about the provision and availability of 
HTC services, encouraging them to provide information about testing to their 
patients. Clients who have undergone HTC and are willing to provide information on 
the relative advantages of testing could act as peer educators within their 
communities in order to encourage others to consider testing (and at least one 
individual participating in IDIs mentioned that he was interested in taking on such a 
role). 
 
9.4.2 Strengthening HTC service provision at Kisesa Health Centre 
A significant barrier to HTC service provision at Kisesa Health Centre related to 
shortages of HIV test-kit supplies. It was unclear whether this related to systems for 
procurement at the medical stores departments at district or national levels, or 
whether it may have related to problems with procedures for estimating and 
reporting supply requirements at the WI-HTC and ANC. Robust systems should be 
put in place in order to ensure a reliable supply of HIV test kits, thereby avoiding 
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missed opportunities for testing, maintaining community trust and confidence in 
healthcare systems, and avoiding undue stress to healthcare workers. Other 
potential structural improvements at the health centre include the provision of 
dedicated rooms for private counselling of pregnant women, who received their 
post-test counselling in an only partially private area. Although conducted in 
enclosed rooms, clients at the WI-HTC also expressed concerns that their 
counselling sessions might be overheard by staff in a doctor’s clinic located close to 
the WI-HTC building, and measures should be taken to ensure that all HTC 
sessions take place in an environment that is private and confidential. 
 
Strategies for PITC were not fully implemented at Kisesa Health Centre, particularly 
at the outpatients department. Additional training on issues relating to HTC and HIV 
care, as well as additional human resource capacity and systems for referral of HIV-
positive individuals to the CTC, will be required in order to enable healthcare 
workers at the outpatient clinics to routinely offer these services. During qualitative 
interviews, one women mentioned that she received very little pre or post-test 
counselling during antenatal PITC, and other research in Kisesa has shown that pre-
test counselling is not always provided to pregnant women, undermining their ability 
to opt out of testing and resulting in missed opportunities for counselling (58). 
Women at the ANC are sometimes referred for testing at the WI-HTC, dependant on 
staff capacity and the availability of HIV test kits at the ANC. This sometimes 
resulted in duplication of work-load in terms of record keeping and reporting; as 
women were first logged in a test-book at the ANC (in order to report on testing of 
pregnant women), and then logged again in another test-book at the WI-HTC (in 
order report on all testing carried out at the WI-HTC). Systems for gathering and 
reporting data on testing carried out at the various clinics at the health centre should 
be streamlined in order to avoid such duplication. 
 
Improved systems for the collection and management of data on HTC carried out at 
the ANC, WI-HTC and outpatient clinics would improve the utility of these data. A 
standardised TAZAMA logbook should be designed for entry of HIV test results at 
the WI-HTC clinic, in order to improve the linkage between main logbook and test 
results data. Computerised data entry of HTC logbooks may be problematic due to 
frequent power-cuts, however such systems are already in place at the CTC, and 
would be beneficial in terms of improving the quality and reporting of data. For 
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example, client ID numbers could be automatically generated, drop down menus 
would help to standardise data entry, and a search function might help counsellors 
to trace returning clients and record their unique identifier against each visit, 
providing better information on repeat testing. Such systems would also assist with 
reporting on numbers of clients seen and tests completed to District AIDS 
Committees and the medical stores department, as well as with future projects to 
retrospectively or prospectively link data on HTC use at the health centre to the 
Kisesa cohort datasets. 
 
9.4.3 Decentralisation of services and improving HTC service 
provision in rural areas 
Residents of rural villages in Kisesa remain underserved in terms of their access to 
HTC services. Community level programmes should aim to tackle HIV-related 
stigma and discrimination, and to provide information on the benefits of testing to 
residents of rural communities. There are three dispensaries located in rural areas 
of Kisesa. These provide basic outpatient and maternal and child health services, 
and since mid-2009 antenatal PITC is usually offered to pregnant women, however 
this is dependent on staffing and the availability of HIV test-kit supplies. 
Furthermore, HTC services for the general population are not available. Systems for 
HTC service provision at the rural dispensaries should be strengthened in order to 
improve PITC services and make HTC available to the general population. This will 
likely require investments in training for healthcare workers as well as in additional 
human resources and structural capacity (i.e. availability of suitable counselling 
rooms), improved procedures for procurement of HIV test kits, and robust systems 
for referral of HIV-positive patients to treatment and care. 
 
HIV care and treatment services are available centrally within Kisesa at the health 
centre, or further away in Mwanza city for those requiring referral for example 
because of treatment failure. Nevertheless, the distance and cost associated with 
potentially having to travel to the health centre in the case of an HIV-positive 
diagnosis may represent a significant deterrent to testing among those living in rural 
villages. The infrastructural and resource requirements associated with further 
decentralisation of HIV treatment to rural villages may be too significant to enable 
such an expansion of services, however alternative options should be explored such 
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as weekly subsidised transport to the health centre, microfinance initiatives which 
encourage community development, and/or community bicycle or motorbike renting 
or sharing schemes which might assist rural villagers in accessing the trading 
centre. 
 
9.4.4 Enhancements to counselling 
The qualitative research highlighted potential limitations to the types of advice and 
information included as part of HIV-prevention counselling messages, which tended 
to focus on ‘ABC’ (abstain, be faithful, use condoms) messages regardless of the 
fact that abstinence seemed an unrealistic and unlikely option for most participants, 
and condom use was low. Counselling approaches which focus on positive 
outcomes, for example by highlighting opportunities for protecting unborn children 
from HIV, and which incorporate constructs relating to family and community into 
counselling messages, may be more effective than those which focus on 
individualistic and negative perceptions of disease and risk (29, 115, 209). As such, 
a review of the theory and protocols underpinning counsellor training may be 
warranted. 
 
The qualitative research also highlighted limited interactions between clients and 
counsellors during HTC sessions, with clients stating their intentions to comply with 
dictated ‘instructions’ received from counsellors, and little evidence that intimate 
thoughts or behaviours were shared by clients. This may relate partly to the 
sensitive nature of the topic, but also to levels of trust in counsellors and/or the 
hierarchical nature of the relationship between healthcare providers and clients. 
Although existing VCT guidelines encourage the development of individualised and 
actionable risk reduction plans (6), there was little evidence of this occurring. More 
frequent and in-depth counsellor training sessions may help to address some of 
these issues, particularly including modules focussing on methods for engendering 
more engaged and equitable discussions between clients and counsellors, and for 
enabling freer conversations around intimate and private sexual topics.  
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9.4.5 Promotion of couples testing 
In Kisesa, the data indicate that a very small proportion of HTC users are counselled 
as couples (based on testing at the health centre; information on couples-testing not 
currently available from the sero-survey data), and this is in line with trends 
elsewhere in sub-Saharan Africa where HTC programmes have tended to focus on 
individuals (210). However, the WHO have recently recommended greater 
implementation of couples-HTC (195), and this approach has been associated with 
greater rates of HIV sero-status disclosure, reduced levels of risk behaviour 
(particularly among sero-discordant couples – (106-108)), and greater rates of 
uptake of ART and PMTCT services (110, 196, 210, 211).  
 
The quantitative analyses revealed that partner HTC use was positively associated 
with HTC uptake among married men and women, demonstrating that there may be 
unmet potential to increase the overall uptake of testing by providing support for 
partner testing or testing of couples in Kisesa. Because the rates of ever testing are 
currently higher among females compared to males, couples testing also holds the 
potential to reach larger numbers of men by implementing strategies which 
encourage women to attend or return for testing with their partner. Such strategies 
might include priority for couples attending HTC clinics together, more permissive 
opening hours (e.g. afternoon or evening hours) which may allow more men to 
attend for testing, or certain days or times which are reserved specifically for 
couples. Counsellors providing couples-HTC are likely to require additional levels of 
training and support on specific topics such as those relating to mediating sero-
status disclosure (particularly where the couple is sero-discordant), and providing 
explanations for sero-discordance, which has previous proven to be challenging in 
some African settings (181, 212). 
 
9.5 Recommendations for future research  
9.5.1 Monitoring access to HTC services 
As the uptake of HTC services increases over time, data from Sero7 (not used in 
this thesis), as well as additional future sero-surveys and data from the HTC 
services at Kisesa Health Centre should be used to monitor trends in access, for 
example whether community mobilisation activities help in increasing uptake among 
relatively underserved groups, such as those living in rural areas, or whether 
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additional PITC services (for example at sexually transmitted infections or 
tuberculosis clinics) help in reaching more men. If additional HTC strategies (such 
as home-based testing) are implemented in Kisesa, opportunities should be 
explored to forge collaborations between these projects and TAZAMA, with a view to 
anonymously linking these data to the Kisesa cohort, enabling quantitative analyses 
of service use similar to those presented in this thesis to be conducted. The 
analyses conducted among pregnant women undergoing ANC-HTC only included 
women who had received this service after referral to the WI-HTC. Future work 
should build on these analyses by making use of data on testing of pregnant women 
which occurred within the ANC building itself, and also data on testing of pregnant 
women at the rural dispensaries (some of which have already been linked to the 
Kisesa cohort as part of a separate project (141)).  
 
While rates of repeat testing were explored as part of this thesis, future research 
should investigate trends over time and make additional use of data from Kisesa 
Health Centre as data collection and record linkage procedures are optimised, 
making it easier to identify repeat testers within the health centre datasets. The 
ability to investigate the association between HIV sero-conversion and repeat use of 
HTC was limited by a small sample size. Future analyses should explore this 
association making use of additional rounds of sero-surveillance data, pooling data 
across rounds if necessary. Future qualitative research might explore opinions 
regarding repeat testing, reasons for doing so and/or preferences for HTC service 
types, as well as perceived negative and positive outcomes of undergoing HTC.  
 
Future research could also assess the relative cost effectiveness of different HTC 
strategies in Kisesa, gathering data on costs of service provision, and reporting on 
costs per client tested and per HIV-positive individual diagnosed. Similar studies 
elsewhere in sub-Saharan Africa have reported that community-outreach HTC 
models are cost effective in comparison to facility-based services (64, 67), but a 
better understanding of this in the Kisesa context would be useful to Tanzanian 
policy makers as they allocate future funds for HIV treatment and prevention 
programmes. 
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9.5.2 Investigating linkage to care by HTC service type 
Of paramount importance in terms of universal access to HIV care and treatment 
and potential TasP approaches will be an understanding of the relative success of 
different HTC strategies in linking HIV-positive individuals to treatment clinics, yet 
few data on this topic are available, and recording systems are often not kept up to 
date for HIV-positive individuals who have registered in care but are not yet eligible 
for ART (153). The Kisesa cohort study is well suited to investigate this topic, due to 
the existence of a referral system which tracks individuals from the point of testing 
during sero-surveys or at the WI-HTC through to registration at the health centre’s 
CTC or at Bugando Medical Centre CTC in Mwanza city, using custom designed 
referral forms. Referrals of pregnant women testing HIV-positive at the ANC are also 
made using national PMTCT transfer forms. Future analyses should explore overall 
rates of referral uptake by HTC modality, as well as time to CD4 count measurement 
or ART eligibility assessment. Risk factor analyses should be conducted in order to 
identify factors associated with successful referral and to help devise strategies to 
improve referral uptake, while comparative analyses could also explore the relative 
success of referral by CTC location (Kisesa Health Centre or Mwanza CTC sites). 
One study in Uganda reported that an enhanced linkage intervention (including 
counselling about barriers to care, a scheduled appointment at the treatment clinic, 
and reminders by mobile phone or home visits) reduced time to enrolment in HIV-
care compared to ‘standard’ referrals (198), and the potential benefits of such 
approaches could also be explored in Kisesa. Qualitative research should explore 
barriers and enabling factors to registration in care among HIV-positive individuals, 
with a particular focus on the relative ease or difficulty of referral uptake by testing 
service type. 
 
Other potential areas for future research in Kisesa or elsewhere include the linkage 
of HIV-negative individuals to further HIV-prevention services, such as referral of 
HIV-negative men to programmes for medical male circumcision, or referral of high-
risk HIV-negative women to pre-exposure prophylaxis programmes, if these services 
become more widely available in the future. 
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9.5.3 Further analyses of the impact of HTC on sexual behaviour 
change  
The quantitative analyses presented in this thesis explored the impact of CO-HTC 
services offered during sero-surveys on reductions in reported sexual risk 
behaviours. Further analyses should build on this work by making comparisons 
between HTC service types, making use of the linked health centre-cohort dataset, 
which was still under development at the time the sexual behaviour changes 
analyses were completed. This would allow an assessment of the relative success 
of different modes of HTC service delivery in producing reductions in risky sexual 
behaviours. Further analyses should also be conducted among the subset of 
married and co-habiting couples for whom HIV and HTC use status are available, as 
this would provide more detailed information on levels of risk (for example by 
providing information on partner HIV-status), and might help in explaining some of 
the changes seen (for example potential reductions in condom use if both members 
of a couple had undergone HTC and tested HIV-negative). 
 
The investigation of the impact of CO-HTC on sexual behaviour change among HIV-
positive individuals was limited by small sample sizes. Future analyses should make 
use of data from Sero7 and additional sero-surveys (the uptake of CO-HTC is 
expected to be higher at these rounds), and/or pool data from different subsets of 
sero-survey rounds, in order to increase sample sizes. Future sero-surveys should 
also promote, and capture usage of, couples-HTC. This mode of testing has been 
associated with significant reductions in sexual risk behaviour among sero-
discordant couples (106, 107, 211), but its impact among sero-concordant couples 
is less well documented. Future quantitative and qualitative research could explore 
barriers and facilitating factors to the use of couples-HTC services, and the impact 
of couples-HTC on sexual risk behaviour, while qualitative research could explore 
the impact of HTC on reproductive health decisions, in addition to sexual behaviour. 
 
9.5.4 Development of data linkage techniques 
Although the linkage of users of the health centre HTC services to the Kisesa cohort 
dataset represented a significant advancement in terms of the development of the 
methodology, the linkage procedures could be optimised and improved. 
Modifications to the weighting and scoring schemes used might reduce the numbers 
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of multiple research-participant matches for each clinic record, while migration 
reconciliation procedures within the demographic surveillance system (DSS) dataset 
would allow identification of which DSS ID numbers actually represented the same 
person. To deal with sub-optimal systems for recording unique ID numbers for return 
clients at the WI-HTC clinic, the HTC clinic dataset could first be mapped or linked 
onto itself, in order to identify unique clients which were represented by different ID 
numbers within the clinic logbooks.  
 
Analysis methods might be improved by using weighted regression or multiple 
imputation techniques, in order to investigate the effect of selecting different 
potential ‘best’ DSS matches for a unique clinic ID on the outcomes investigated. 
Finally, methods for prospective or ‘real-time’ data linkage could be implemented in 
Kisesa. These could make use of DSS ID cards which are currently being developed 
for all residents in the study area, by recording an individual’s DSS ID card number 
in clinic logbooks at the time of service use, and/or making use of databases 
containing photographs, which are also included on the DSS ID cards. 
 
9.6 Dissemination of research findings  
The research findings have already been, or shortly will be, disseminated to a broad 
audience including the local community in Kisesa, programme managers and policy 
makers in Tanzania, and the wider research and academic community working in 
the field of HIV prevention. 
 
9.6.1 Healthcare workers and community members in Kisesa 
I will communicate key findings from the study to healthcare workers providing 
services during sero-surveys and at Kisesa Health Centre, through preparation of a 
short report. This will summarise the main findings and recommendations from the 
research. Issues relating to aspects of service provision by counsellors and nurses 
will be discussed in a sensitive and constructive way. The key findings from the 
research will also be fed back to healthcare workers through face to face meetings, 
with the assistance of TAZAMA Project staff. 
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In order that community members may see the output and recommendations arising 
out of their participation in the research, and that they may benefit from it, the main 
findings from this study will be fed back to community members through community 
meetings organised by the village AIDS committees. This will be done with the 
assistance of TAZAMA Project staff as well as Tanzanian social scientists and/or the 
fieldworkers who were involved in the qualitative research. Key messages will be 
presented in plain language, and the policy recommendations which have been 
made will also be included. 
 
9.6.2 National and district health authorities 
The findings from this research will be relevant for district and national health 
authorities as they plan and implement HIV treatment and prevention programmes 
around Tanzania. The key findings from the research will be presented to health 
officials within Magu District as well as at the National AIDS Control Programme 
(NACP) in Dar es Salaam through preparation of a report. This will focus on the 
relevance of the lessons learned in Kisesa to other settings in Tanzania, and how 
the policy recommendations might apply. I also expect to travel to Dar es Salaam in 
June 2015, providing an opportunity to disseminate findings to relevant members of 
staff at the NACP through face to face meetings and/or presentations. 
 
9.6.3 Sharing of data, research methods and data collection tools 
The linked WI-HTC clinic-cohort dataset will be stored on secure project servers at 
the London School of Hygiene and Tropical Medicine (LSHTM) and the National 
Institute for Medical Research (NIMR) in Mwanza, and made available for future 
researchers working with the TAZAMA Project, subject to approvals by the principal 
investigators at LSHTM and NIMR. The data linkage methodology will also be 
shared with relevant TAZAMA researchers, or with other researchers working at 
similar demographic surveillance sites across sub-Saharan Africa, where relevant. 
There is already a new PhD project underway in Kisesa, with the aim of piloting and 
implementing a new real-time data linkage system at the WI-HTC and other clinics 
at the health centre, and various documents and project learnings have already 
been shared with this student via email and face-to-face meetings. 
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Subject to permissions, the qualitative dataset will also be made available to future 
researchers exploring the uptake and impact of HTC services in Kisesa, and may be 
used as part of a current study exploring bottlenecks along the HIV diagnosis-to-
care continuum, with a particular focus on barriers at the point of HTC uptake. The 
qualitative data collection tools have already been shared with researchers working 
on this project in order to avoid duplication of efforts, and other project learnings and 
insights in terms of recruitment and study design are also likely to be shared. 
 
9.6.4 Researchers – academic publications and conferences 
Two of the papers presented in this thesis (Papers B and C) have already been 
published in peer reviewed open access journals with a wide international 
readership, while two additional papers (Papers A and D) are currently under 
review. The quantitative analyses presented in Chapter 6 (Paper C – impact of CO-
HTC on sexual behaviour change and HIV incidence) was chosen for inclusion in 
the 4th issue of ‘HIV this month’ 2014 (213), which is a monthly review of articles 
compiled by ‘UNAIDS Science now’ to provide updated scientific information to 
UNAIDS staff and other professionals, with selection from close to a thousand 
articles each month. A further publication is likely to be prepared based on the 
systematic review of the impact of HTC on sexual behaviour change and HIV 
incidence presented in Chapter 2. In addition to the papers arising directly out of the 
research, I have also co-authored on three additional papers, one assessing the 
impact of HIV and ART knowledge on HTC use (214) and two using similar data 
linkage methods to those presented in this thesis to assess the uptake of PMTCT 
services in Kisesa (215, 216). 
 
In addition to the scientific publications prepared, the following presentations were 
made at international conferences (posters or slide sets are included in Appendix 
11.5): 
 
Appendix 11.5.1: Caoimhe Cawley, Alison Wringe, Mark Urassa, Raphael Isingo, 
Jim Todd, Yususfu Kumogola et al. Socio-demographic and clinical factors 
associated with repeat HIV testing and counseling in a community cohort study in 
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north-west Tanzania: Oral presentation; 16th International Conference on AIDS & 
STDS in Africa (ICASA), Addis Ababa, December 2011. 
This was a precursor to the analyses presented in Chapter 5 (Paper B), assessing 
socio-demographic and clinical factors associated with repeat testing among 
individuals attending Sero4 and Sero5. The analyses were later adapted to assess 
repeat testing among individuals attending Sero5 and Sero6, due to greater data 
availability at this subset of rounds. 
 
Appendix 11.5.2: Caoimhe Cawley, Alison Wringe, Rose Manyalla, Yusufu 
Kumogola, Benjamin Clark, Raphael Isingo et al. The role of voluntary counseling 
and testing in HIV prevention and sexual behaviour change: Poster presentation; 
16th ICASA, Addis Ababa, December 2011. 
This was a precursor to the analyses presented in Chapter 6 (Paper C), and 
explored changes in sexual risk behaviour among individuals attending Sero4 and 
Sero5 using logistic regression. Analyses methods were later refined to incorporate 
an additional set of sero-survey rounds (Sero5 and Sero6) using multinomial logistic 
regression, which was better suited to investigate multiple outcomes (decrease, 
increase or no change in sexual risk behaviour). 
 
Appendix 11.5.3: Caoimhe Cawley, Alison Wringe, Benjamin Clark, Clemens 
Masesa, Annabelle Gourlay, Richard Machemba et al. Access to HIV testing and 
counselling services in rural Tanzania by mode of service delivery: Oral 
presentation; HIV/AIDS: Interdisciplinary Perspectives, Bayreuth, Germany, 
September 2014. 
This was a presentation of the main findings from the analyses presented in Chapter 
4 (Paper A). 
 
An additional abstract (included in Appendix 11.5.4) based on the findings arising 
out of the qualitative research has been accepted for a poster presentation at the 8th 
International AIDS Conference on HIV Pathogenesis, Treatment and Prevention in 
Vancouver in July 2015: 
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Caoimhe Cawley, Alison Wringe, Shelley Lees, Joyce Wamoyi, Ray Nsigaye, Mark 
Urassa. It is just the way it was in the past before I went to test’. Exploring the role of 
HIV prevention counselling in sexual behaviour change in rural Tanzania 
 
9.7 Concluding remarks  
Despite encouraging increases over time, the uptake and coverage of HTC services 
remains suboptimal in Kisesa, and ultimately this results in missed opportunities in 
terms of their potential contribution to HIV education and prevention efforts. Groups 
which are particularly underserved include those living in rural villages, those with 
least education, men who are HIV-negative or of unknown status, and HIV-positive 
women. Programmes should be implemented which aim to increase coverage 
among these groups, and future research should monitor whether such programmes 
and interventions have been successful, as well as which services most effectively 
link HIV-positive individuals to treatment and care services. The traditional client 
initiated WI-HTC service was most successful in attracting HIV-positive individuals, 
although the evidence suggests that the largest overall proportions of HIV-positive 
individuals were diagnosed via CO-HTC. However, the relative success of the 
different HTC strategies in attracting HIV-positive individuals at early stages of 
infection was unclear, and future analyses should explore this using larger sample 
sizes. 
 
The findings from the research provided moderate evidence for an impact of HTC on 
reductions in sexual risk behaviour among HIV-negative individuals, but highlighted 
several socio-cultural and structural barriers which inhibited behaviour change. 
These included sexual decision-making and relationship dynamics, which 
constrained the extent to which women in particular felt able to control their 
exposure to HIV risk, which was seen as inherently linked to their partners’ 
behaviour. Counselling techniques and approaches which help counsellors to 
encourage an exchange of information during counselling sessions, and which 
include more culturally relevant counselling messages, may help to improve the 
effectiveness of HTC as an HIV-prevention intervention in a rural African setting 
such as  Kisesa.  
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TAZAMA study, NIMR  Sero 6    1234567 
Sero6 English Questionnaire Final 1.0 249 
Registration and consent sheet 
     
Today’s Date  └─┴─┘ └─┴─┘ └─┴─┴─┴─┘ 
       Day      Month        Year 
 
Informed consent for general survey participation 
  Please print names staff ID code 
r1  Name of person reading information sheet  
 
………  ……………… 
 
└─┴─┴─┴─┴─┴─┘ 
r2  Who will sign informed consent?  
circle response 
 
Respondent 1        Witness 2 
Respondent → ic1 
r3  Name of witness for informed consent  
 
……………  ……………… 
 
└─┴─┴─┴─┴─┴─┘ 
 
Read first side of information sheet down to first consent question, sign next to yes or no box: 
ic1 Do you agree to register at the clinic and answer questions in our survey? 
circle response 
 
Yes 1         No 2 
Signature 
 
…………….…… 
 
If ic1 is NO stop here, attach all stickers to back of form so they cannot be used elsewhere. 
 
Informed consent for HIV tests: sign to confirm yes or no response 
ic2 
Do you agree to provide us with a blood spot for 
our HIV research tests and for us to store the blood 
spot for further tests, without telling you the result? 
circle response 
 
Yes 1         No 2 
Signature 
 
…………….…… 
ic3 
Do you want to have a VCT test for HIV so you can 
find out your HIV status today? 
If no, sign, fill r4 and then go to r11 
circle response 
 
Yes 1         No 2 
Signature 
 
…………….…… 
ic4 
If yes, can we store the VCT blood sample to carry 
out further research tests in the future, for which 
you will not receive individual results? 
circle response 
 
Yes 1         No 2 
Signature 
 
…………….…… 
 
Which sections of the sero-survey clinic did the person visit? 
 Section Write your staff ID code below if this person visits your section 
 
r4  
 
Identification desk 
 
└─┴─┴─┴─┴─┴─┘ 
 
r5  
 
Questionnaire hut 
 
└─┴─┴─┴─┴─┴─┘ r5a 
 
QC  └─┴─┴─┴─┴─┴─┘ 
 
r6  
 
DBS research sample 
 
└─┴─┴─┴─┴─┴─┘ 
 
do not go here if ic2 is No  
r7  
 
Clinician consultation 
 
└─┴─┴─┴─┴─┴─┘ 
 
r8  
 
Laboratory 
diagnostics 
 
└─┴─┴─┴─┴─┴─┘ 
 
r9  
 
Drug dispensary 
 
└─┴─┴─┴─┴─┴─┘ 
 
r10  
 
VCT counsellor 
 
└─┴─┴─┴─┴─┴─┘ 
 
do not go here if ic3 is No 
Sero6 link number 
1234567 
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Identification form  
r11  
Ask: 
What name do you use now? 
 
 
…………………….      …………..……… 
r12  
Ask: 
What name have you used before 
now (if different)? 
 
…………………….      …………..……… 
r13  
Check: 
Was the person recognised by the 
village enumerator or other helper? 
Yes 1   No 2 
Yes - put staff 
code of helper 
No - put 0000   
 
└─┴─┴─┴─┴─┴─┘ 
r14  
Ask: 
Have you got a sero survey 
invitation slip?  
Yes 1  No 2 no → r20 
 
 
Take their invitation slip so you can check the following 
 
r15  
Check: 
Does sex of person match sex on 
the invitation slip? 
Yes 1            No 2  
r16  
Check: 
Does age of person approximately 
match age on the invitation slip? 
Yes 1            No 2  
r17  
Copy the name written on the 
invitation slip 
 
 
…………………….      …………..……… 
r18  
Think carefully 
Is the person using the correct 
invitation slip? 
Yes 1            No 2 no → r20 
r19  Copy the DSS link number only from correct invitation slip  
 
└─┴─┴─┴─┴─┴─┴─┘ 
→ r35 
 
If invitation slip is correct put one of the sero6 linking stickers on it  
If invitation slip is wrong put the slip in the wrong invitation box 
 
 
Identify those with wrong invitation or no invitation by consulting clinic register 
 
 
Current residence name DSS code 
r20  Village  
└─┘ 
r21  Subvillage   
└─┴─┘ 
r22  Balozi (if known)  
└─┴─┘ 
r23  Can you find this person in the clinic register? 
 
Yes 1            No 2 no → r25 
r24  Copy down the DSS link number if it is in the register 
 
└─┴─┴─┴─┴─┴─┴─┘ 
→ r35 
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Check if this person currently lives in a household that is in the clinic register 
 
r25  
Do you know the name of any other 
invited person from same household? 
Write NONE if no-one else invited 
 
…………………..      ………..……….. 
r26  Was the household found in the clinic register? Yes 1            No 2 no → r28 
r27  Write down the household DSS number  
 
└─┘└─┴─┘└─┴─┘└─┴─┴─┘ 
 
r28  Fill new member DSS visit request form └─┴─┴─┴─┴─┴─┘DSS visit request form no.  
r29  Were you previously resident in a different household in Kisesa ward? Yes 1            No 2 no → r38 
 
 
Consult clinic register for place of previous residence 
 
 Previous residence name DSS code 
r30  Village  
└─┘ 
r31  Subvillage   
└─┴─┘ 
r32  Balozi (if known)  
└─┴─┘ 
r33  Can you find the previous residence in the clinic register? Yes 1            No 2 no → r38 
r34  
Write down the DSS link 
number if shown for previous 
residence  
 
└─┴─┴─┴─┴─┴─┴─┘ 
 
 
 
Check past sero-survey attendance for those with clinic register entry 
 
r35  Is the person’s old study number available from invitation slip or clinic register entry? 
 
Yes 1           No 2 no → r38 
r36  Copy old study number from invitation slip or clinic register 
 
└─┴─┴─┴─┴─┴─┴─┴─┘ 
 
r37  Ask: Have you ever attended a sero survey before this one? 
Yes 1           No 2 yes → q1 
 
If person answers no, they have never been to sero-survey before, probe carefully and 
check that you have found the correct line in the clinic register.   
 
Make any corrections necessary above in RED ink, remember to cross out incorrect 
study number on this form if there is no study number for this person in the register. 
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If past sero-survey number not available from invitation slip or clinic register entry 
 
r38  
Ask:  
Have you ever attended a sero survey before 
this one? 
Yes 1           No 2 no → q1 
r39  
Ask:  
Were you old enough to be interviewed last time 
you came to a sero survey? 
Yes 1           No 2 no → q1 
r40  
Ask:  
Were you resident in Kisesa last time you came 
to a sero survey? 
Yes 1           No 2 no → q1 
 
 
Consult clinic register for village of residence at latest sero-survey 
 
 Residence at last sero 
survey attended Name DSS code 
r41  Village  
└─┘ 
r42  Subvillage  
└─┴─┘ 
r43  Balozi (if known) 
 
└─┴─┘ 
r44  
Check: 
Is the person’s previous 
residence in the clinic register? 
 
Yes 1           No 2 no → q1 
r45  
Write down the DSS link 
number for previous residence 
if one is shown. 
 
└─┴─┴─┴─┴─┴─┴─┘ 
 
r46  Is the old study number shown in clinic register? 
 
Yes 1            No 2 no → q1 
r47  Copy old study number from clinic register 
 
└─┴─┴─┴─┴─┴─┴─┴─┘ 
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 Label page 
 
 
 
 
 
 
              
This label for invitation slip   1234567 
This label for DSS visit request form   1234567 
This label for DBS submission form   1234567 
This label for clinician diagnosis record   1234567 
This label for pharmacy dispensing record   1234567 
This label for VCT attendance record   1234567 
This label for green VCT to CTC referral form   1234567 
This label for plasma submission form   1234567 
This is a spare label   1234567 
 
 
 
 
 
Stickers supplied by NIMR lab 
Put DBS lab sticker here 
 
Put plasma lab sticker here 
 
Sero Link Number 
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This blank page represents reverse side of label page
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Main questionnaire 
Note to interviewers: q1 to q5 filled at identification desk before going to interview hut 
q1 Sex   (circle one) Male 1  Female 2 
 
q2 
Date of birth    
(write 99 if day or month not known, 
9999 if year not known) 
 
└─┴─┘└─┴─┘└─┴─┴─┴─┘ 
  dd     mm  yyyy 
 
q3 Age or approximate age  (refer to calendar of events if needed) 
 
└─┴─┘years 
 
q4 Height 
 
└─┴─┴─┘cms 
 
q5 Weight 
 
└─┴─┴─┘kgs 
 
  
Private interview starts here Education & literacy 
q6 Can you read? (circle one) Yes 1    No 2  
q7 Can you write? Yes 1    No 2  
q8 Have you had a formal education? Yes 1    No 2 no → q10 
q9 How many years of education did you have? number of years completed at each level 
q9a Primary └─┴─┘years 
q9b Secondary └─┴─┘years 
q9c College └─┴─┘years 
q9d University └─┴─┘years 
q9e Adult institute └─┴─┘years 
q9f Religious education └─┴─┘years 
q9g Other (specify below) └─┴─┘years 
q9h  …………………………… 
 
Economic activity 
q10 Do you perform any work that helps you or 
your household earn money? 
Yes 
No, I am still a student 
No, I just look after the house 
No, I am too ill to work 
No, I am too old to work 
No, other reason (specify below) 
Circle only one response  
 
1 
2 
3 
4 
5 
6 
 
 
for all “No, …” 
responses 
→ q13 
q10a  
 ……………………… 
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q11 What is the main way in which you earn money? 
 
Farming 
Tending livestock 
Small business 
Large business 
Professional 
Driver 
Skilled manual worker 
Unskilled labourer 
Fishing 
Bar Work 
Other (specify below) 
Circle only one response 
 
01 
02 
03 
04 
05 
06 
07 
08 
09 
10 
11 
q11a  
 ……………………… 
 
q12 
In which other ways do you earn money? 
Do not read out the list below, but after 
each response ask if there are other ways 
Write 01 for the way mentioned first, 02 for 
the second, etc.  When respondent runs 
out of answers write 00 in all unused lines 
q12a Farming 
└─┴─┘ 
q12b Tending livestock 
└─┴─┘ 
q12c Small business 
└─┴─┘ 
q12d Large business 
└─┴─┘ 
q12e Professional 
└─┴─┘ 
q12f Driver 
└─┴─┘ 
q12g Skilled manual worker 
└─┴─┘ 
q12h Unskilled labourer 
└─┴─┘ 
q12i Fishing 
└─┴─┘ 
q12j Bar Work 
└─┴─┘ 
q12k Other (specify below) 
└─┴─┘ 
q12l   ……………………… 
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Religion and Ethnicity 
q13 What is your ethnic group? 
 
Sukuma 
Other (specify below) 
Circle only one response 
 
1 
2 
q13a   ……………………… 
q14 What is your religion?  
Muslim 
Catholic 
Other established Christian 
Other evangelical Christian 
Traditional 
None 
Other (specify below) 
Circle only one response 
1 
2 
3 
4 
5 
6 
7 
q14a   ……………………… 
 
Residence and mobility  
q15 Were you born in the village that you now live in? Yes 1    No 2 yes → q19 
q16 Have you lived in this same village for 1 year or more? Yes 1    No 2 no  → q16b 
q16a How many years have you lived in this village? 
└─┴─┘  years  
→ q17 
q16b How many months have you lived in this village? 
└─┴─┘  months  
 
q17 Where did you live before moving here? 
 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Circle only one response 
 
1 
2 
3 
4 
5 
6 
q18 What type of place was it? 
 
Rural – remote 
Rural – on main road 
Urban  
Circle only one response 
 
1 
2 
3 
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Condom knowledge 
q19 Have you ever heard of condoms? Yes 1          No 2 no →q22 
q20 Is it possible to get condoms in this village? Yes 1         No 2   DK 9 no or DK → q22 
q21 
Where can you get condoms in this village? 
Do not read out the list, but after each 
response ask if there are other places 
Write 1 for place mentioned first, 2 for the 
second, etc.  If respondent doesn’t know any, 
or any more places, write 0 in all unused lines 
q21a Village dispensary └─┘ 
q21b Family planning clinic └─┘ 
q21c Pharmacy └─┘ 
q21d Shop └─┘ 
q21e Community distribution scheme └─┘ 
q21f TANESA / TAZAMA / PSI └─┘ 
q21g Other (specify below) └─┘ 
q21h  …………………………… 
 
Family planning 
q22 Have you ever heard about family planning? Yes 1      No 2 no → r29 
q23 
What was the source of your information? 
Do not read out the list, but after each 
response ask if there were other sources 
Write 1 for source mentioned first, 2 for the 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q23a Radio └─┘ 
q23b Television └─┘ 
q23c Posters └─┘ 
q23d Newspapers / Magazines └─┘ 
q23e Health facility └─┘ 
q23f TANESA / UMATI └─┘ 
q23g Family member or friend └─┘ 
q23h Other (specify below) └─┘ 
q23i  …………………………… 
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q24 Have you ever used family planning ? Yes 1      No 2 no → q28 
q25 
Which methods did you use? 
Do not read out the list, but after each 
response ask if there were other methods 
Write 01 for method mentioned first, 02 for 
the second, etc.  When respondent runs out 
of answers write 00 in all unused lines 
q25a Pills └─┴─┘ 
q25b IUD/loop └─┴─┘ 
q25c Injection └─┴─┘ 
q25d Female condom or cap └─┴─┘ 
q25e Male condom └─┴─┘ 
q25f Female sterilisation └─┴─┘ 
q25g Male sterilisation / vasectomy └─┴─┘ 
q25h Norplant └─┴─┘ 
q25i Abstinence └─┴─┘ 
q25j Calendar / rhythm └─┴─┘ 
q25k Traditional methods └─┴─┘ 
q25l Other (specify below) └─┴─┘ 
q25m  …………………………… 
 
q26 Are you currently using family planning? Yes 1      No 2 no → q28 
q27 Which is the main method that you use now? Circle only one response 
 Pills 
IUD/loop 
Injection 
Female condom or cap 
Male condom 
Female sterilisation 
Male sterilisation / vasectomy 
Norplant 
Abstinence 
Calendar / rhythm 
Traditional methods 
Other (specify below) 
01 
02 
03 
04 
05 
06 
07 
08 
09 
10 
11 
12 
q27a  ……………………… 
q28 Do you intend to use family planning in the future? Yes 1     No 2     DK 9 
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Pregnancy and childbirth 
q29 Checkq1  and q3 :  is this person a woman aged 15-49? Yes 1       No 2 no → q42 
 
q30 Have you ever been pregnant? Yes 1       No 2 no → q42 
q31 Have you ever given birth?  Yes 1       No 2 no → q37 
 
  write 00 if none in q32a to q32f 
q32 How many of your own biological children: Boys Girls 
 live with you in your home? q32a └─┴─┘ q32b └─┴─┘ 
 live somewhere else? q32c └─┴─┘ q32d └─┴─┘ 
 have died? q32e └─┴─┘ q32f └─┴─┘ 
 
Check: add together responses to q32a, q32b, q32c, q32d, q32e and q32f and enter at q33 
q33 
Say:  
I want to check, altogether you have given birth to └─┴─┘ 
 
children? 
If mother disagrees with your total estimate check responses to q32a, q32b, q32c, q32d, 
q32e and q32f and check your addition.  
If total children = 01 → q35 
 
q34 Do all your children have the same father? Yes 1        No 2 
q35 
When did you last give birth?    
(write 99 if day or month not known,  
9999 if year not known)   
└─┴─┘└─┴─┘└─┴─┴─┴─┘ 
   d      d         m      m         y     y     y     y 
q36 Is your last born child still alive? Yes 1        No 2 
q37 Did you attend an Ante Natal Clinic (ANC) during your last pregnancy? Yes 1       No 2 no → q39 
q38 Which blood tests did you have at any ANC you attended during your last pregnancy? Ask about each one in turn 
q38a HIV test for PMTCT Yes 1          No 2         DK 9 
q38b Syphilis test Yes 1          No 2         DK 9 
q38c Test for anaemia Yes 1          No 2         DK 9 
q38d Other blood test (specify below)    Yes 1            No 2         
q38e  …………………………… 
 
q39 Are you pregnant now? Yes 1          No 2         DK 9 
q40 How many of your pregnancies have ended in a still birth? (write 99 if not known) └─┴─┘  number 
q41 How many pregnancies have you had in which you lost a baby before it was fully formed? (write 99 if not known) └─┴─┘  number 
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Current marriage or cohabitation: men and women 
q42 What is your current marital status? 
Never married or been in cohabiting union 
Monogamously married or cohabiting  
Polygamously married or cohabiting  
Widowed 
Separated or divorced 
Circle only one response 
1 never married → q51 
2 
3 
4 
5 
q43 If polygamously married, how many co-wives are there in this marriage? (including person being interviewed, if woman) 
 
└─┴─┘  number 
 
First marriage or cohabitation 
q44 How old were you when you first married or lived with a sexual partner? (write 99 if not known) 
 
└─┴─┘  years old  
q45 Are you still married to or living with that same person? Yes 1   No 2 if yes, → q51 
q46 Is that first spouse / partner still alive? Alive 1     Dead 2     DK 9 if alive or DK → q49 
q47 Were you living together when he/she died? Yes 1   No 2  
q48 Did he / she die in Kisesa ward? Yes 1   No 2 → q51 
q49 Did you live together in Kisesa ward? Yes 1   No 2 if no, → q51 
q50 Does he / she still live in Kisesa ward? Yes 1     No 2     DK 9  
 
First sex 
q51 How old were you when you first had sex? (never = 99, don’t know = 88, when married = 77) └─┴─┘  years if 99 → q57 
q52 Why did you have sex at that time? 
I got married 
I wanted to have sex 
I was tricked into having sex 
I had sex because I needed money 
I was forced to have sex 
Can’t remember, too long ago 
Other (specify below) 
Circle only one response 
1 
2 
3 
4 
5 
6 
7 
q52a  ……………………… 
q53 Did you use a condom when you first had sex? (if can’t remember code don’t know) Yes 1   No 2   DK 9 
  
All sexual partners: probe carefully and explain all partners must be reported, including 
spouses and partners who died long ago 
q54 How many different sexual partners altogether in your whole lifetime? (including spouse(s), regular & casual partners) 
 
└─┴─┘   
q55 How many different sexual partners altogether in the last 12 months?  (including spouse(s), regular & casual partners) └─┴─┘  if 00 → q57 
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ALL SEXUAL PARTNERS IN LAST 12 MONTHS 
  A) FIRST, MOST RECENT PARTNER B) SECOND PARTNER C) THIRD PARTNER 
pp1 How would you describe 
your relationship to this 
person? 
 
Circle only one 
Spouse or cohabiting partner 
Regular partner  
Casual partner 
Other friend or visitor 
1 
2 
3 
4 
Spouse or cohabiting partner 
Regular partner  
Casual partner 
Other friend or visitor 
1 
2 
3 
4 
Spouse or cohabiting partner 
Regular partner  
Casual partner 
Other friend or visitor 
1 
2 
3 
4 
pp2 Do you live in the same 
house as this partner? Yes 1       No 2 yes → pp4 Yes 1       No 2 yes → pp4 Yes 1       No 2 yes → pp4 
pp3 Where does this partner 
live now? 
 
Circle only one 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Dead 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Dead 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Dead 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
pp4 Is this partner older or 
younger than you? 
 
Circle only one 
more than 10 years older 
around 5 years older 
about same age 
around 5 years younger 
more than 10 years younger 
1 
2 
3 
4 
5 
more than 10 years older 
around 5 years older 
about same age 
around 5 years younger 
more than 10 years younger 
1 
2 
3 
4 
5 
more than 10 years older 
around 5 years older 
about same age 
around 5 years younger 
more than 10 years younger 
1 
2 
3 
4 
5 
 
Last sex with this partner 
pp5 When did you last have 
sex with this partner? 
 
One line each partner 
last week 
last month  
last year 
1 → 
2 → 
3 → 
How 
many 
times: 
in last week? └─┘ 
in last month?└─┴─┘ 
in last year?└─┴─┴─┘ 
last week 
last month  
last year 
1 → 
2 → 
3 → 
How 
many 
times: 
in last week? └─┘ 
in last month?└─┴─┘ 
in last year?└─┴─┴─┘ 
last week 
last month  
last year 
1 → 
2 → 
3 → 
How 
many 
times: 
in last week? └─┘ 
in last month?└─┴─┘ 
in last year?└─┴─┴─┘ 
pp6 Did you use a condom 
last time you had sex? Yes 1       No 2 Yes 1       No 2 Yes 1       No 2 
pp7 Had either you or your 
partner drunk alcohol last 
time you had sex? 
Yes 1       No 2 Yes 1       No 2 Yes 1       No 2 
pp8 Do you think in the future 
you will have sex with this 
partner again?  
Yes 1       No 2 Yes 1       No 2 Yes 1       No 2 
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Most recent partners continued 
  A) FIRST, MOST RECENT PARTNER B) SECOND PARTNER C) THIRD PARTNER 
 Check: is this spouse 
or regular partner ? → pp10 → pp10 → pp10 
 Check: is pp5 how 
many times > 01 ? → pp10 → pp10 → pp10 
pp9 Was this the only time 
you ever had sex with 
this partner? 
Yes 1       No 2 yes → pp13 Yes 1       No 2 yes → pp13 Yes 1       No 2 yes → pp13 
pp10 How frequently did you 
use a condom with this 
partner? 
 
Circle only one 
Always 
Most of the time / often 
Occasionally 
Only at the start of the relationship 
Never 
Don’t know 
1 
2 
3 
4 
5 
6 
Always 
Most of the time / often 
Occasionally 
Only at the start of the relationship 
Never 
Don’t know 
1 
2 
3 
4 
5 
6 
Always 
Most of the time / often 
Occasionally 
Only at the start of the relationship 
Never 
Don’t know 
1 
2 
3 
4 
5 
6 
 
First sex with this partner 
pp11 When did you first have 
sex with this partner? 
 
Circle only one 
last week 
last month  
last year 
more than a year ago 
1 
2 
3 
4 
last week 
last month  
last year 
more than a year ago 
1 
2 
3 
4 
last week 
last month  
last year 
more than a year ago 
1 
2 
3 
4 
pp12 Did you use a condom 
first time you had sex 
with this partner? 
Yes 1              No 2       DK 9  Yes 1              No 2       DK 9  Yes 1              No 2       DK 9  
pp13 Before you first had sex 
with this partner how long 
had you known him/her? 
 
Circle only one 
less than a week 
less than a month 
less than a year 
more than a year  
1 
2 
3 
4 
less than a week 
less than a month 
less than a year 
more than a year  
1 
2 
3 
4 
less than a week 
less than a month 
less than a year 
more than a year  
1 
2 
3 
4 
 
Next partner 
pp14 Did you have sex with 
anyone else in the last 12 
months? 
Yes 1 
 
No 2 
 → pp1 for second partner 
 
→ q56 end of partner columns 
Yes 1 
 
No 2 
 → pp1 for third partner 
 
→ q56 end of partner columns 
Yes 1 
 
No 2 
 → pp1 for fourth partner 
 
→ q56 end of partner columns 
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ALL SEXUAL PARTNERS IN LAST 12 MONTHS 
  D) FOURTH PARTNER E) FIFTH PARTNER F) SIXTH PARTNER 
pp1 How would you describe 
your relationship to this 
person? 
 
Circle only one 
Spouse or cohabiting partner 
Regular partner  
Casual partner 
Other friend or visitor 
1 
2 
3 
4 
Spouse or cohabiting partner 
Regular partner  
Casual partner 
Other friend or visitor 
1 
2 
3 
4 
Spouse or cohabiting partner 
Regular partner  
Casual partner 
Other friend or visitor 
1 
2 
3 
4 
pp2 Do you live in the same 
house as this partner? Yes 1       No 2 yes → pp4 Yes 1       No 2 yes → pp4 Yes 1       No 2 yes → pp4 
pp3 Where does this partner 
live now? 
 
Circle only one 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Dead 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Dead 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
Other part of Kisesa ward 
Another part of Magu district 
Mwanza city 
Another part of Mwanza region 
Another part of Tanzania 
Another country 
Dead 
Don’t know 
1 
2 
3 
4 
5 
6 
7 
8 
pp4 Is this partner older or 
younger than you? 
 
Circle only one 
more than 10 years older 
around 5 years older 
about same age 
around 5 years younger 
more than 10 years younger 
1 
2 
3 
4 
5 
more than 10 years older 
around 5 years older 
about same age 
around 5 years younger 
more than 10 years younger 
1 
2 
3 
4 
5 
more than 10 years older 
around 5 years older 
about same age 
around 5 years younger 
more than 10 years younger 
1 
2 
3 
4 
5 
 
Last sex with this partner 
pp5 When did you last have 
sex with this partner? 
 
One line each partner 
last week 
last month  
last year 
1 → 
2 → 
3 → 
How 
many 
times: 
in last week? └─┘ 
in last month?└─┴─┘ 
in last year?└─┴─┴─┘ 
last week 
last month  
last year 
1 → 
2 → 
3 → 
How 
many 
times: 
in last week? └─┘ 
in last month?└─┴─┘ 
in last year?└─┴─┴─┘ 
last week 
last month  
last year 
1 → 
2 → 
3 → 
How 
many 
times: 
in last week? └─┘ 
in last month?└─┴─┘ 
in last year?└─┴─┴─┘ 
pp6 Did you use a condom 
last time you had sex? Yes 1       No 2 Yes 1       No 2 Yes 1       No 2 
pp7 Had either you or your 
partner drunk alcohol last 
time you had sex? 
Yes 1       No 2 Yes 1       No 2 Yes 1       No 2 
pp8 Do you think in the future 
you will have sex with this 
partner again?  
Yes 1       No 2 Yes 1       No 2 Yes 1       No 2 
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More distant partners continued 
  D) FOURTH PARTNER E) FIFTH PARTNER F) SIXTH PARTNER 
 Check: is this spouse 
or regular partner ? → pp10 → pp10 → pp10 
 Check: is pp5 how 
many times > 01 ? → pp10 → pp10 → pp10 
pp9 Was this the only time 
you ever had sex with 
this partner? 
Yes 1       No 2 yes → pp13 Yes 1       No 2 yes → pp13 Yes 1       No 2 yes → pp13 
pp10 How frequently did you 
use a condom with this 
partner? 
 
Circle only one 
Always 
Most of the time / often 
Occasionally 
Only at the start of the relationship 
Never 
Don’t know 
1 
2 
3 
4 
5 
6 
Always 
Most of the time / often 
Occasionally 
Only at the start of the relationship 
Never 
Don’t know 
1 
2 
3 
4 
5 
6 
Always 
Most of the time / often 
Occasionally 
Only at the start of the relationship 
Never 
Don’t know 
1 
2 
3 
4 
5 
6 
 
First sex with this partner 
pp11 When did you first have 
sex with this partner? 
 
Circle only one 
last week 
last month  
last year 
more than a year ago 
1 
2 
3 
4 
last week 
last month  
last year 
more than a year ago 
1 
2 
3 
4 
last week 
last month  
last year 
more than a year ago 
1 
2 
3 
4 
pp12 Did you use a condom 
first time you had sex 
with this partner? 
Yes 1              No 2       DK 9  Yes 1              No 2       DK 9  Yes 1              No 2       DK 9  
pp13 Before you first had sex 
with this partner how long 
had you known him/her? 
 
Circle only one 
less than a week 
less than a month 
less than a year 
more than a year  
1 
2 
3 
4 
less than a week 
less than a month 
less than a year 
more than a year  
1 
2 
3 
4 
less than a week 
less than a month 
less than a year 
more than a year  
1 
2 
3 
4 
 
Next partner 
pp14 Did you have sex with 
anyone else in the last 12 
months? 
Yes 1 
 
No 2 
 → pp1 for fifth partner 
 
→ q56 end of partner columns 
Yes 1 
 
No 2 
 → pp1 for sixth partner 
 
→ q56 end of partner columns 
Yes 1 
 
No 2 
 → q56 end of partner columns 
 
TAZAMA study, NIMR  Sero 6    1234567 
Sero6 English Questionnaire Final 1.0 266 
Check: Is the number of partner columns filled less than number of partners in last 12 
months reported in q55 (or Less than 6 if q55 is 6 or more)? 
If less, say: I just need to make sure, and repeat question pp14 on last partner column. 
If respondent remembers another partner in last 12 months continue with partner loops 
 
Even if there is an inconsistency, do not ask respondent to change their answer to q55 
partners in last 12 months, but report on consistency here (without asking respondent).  
q56 Summary of partner reporting consistency: 
 Number of columns agrees with partners last year 
Number of columns greater than partners last year 
Number of columns less than partners last year 
Number of columns less than partners last year 
because more than 6 partners last year 
Circle only one response 
1 
2 
3 
4 
 
Partner loops finished → q58 
 
 
 
 
 
If no sexual partners last 12 months 
q57 Why did you abstain from sex in the last 12 months? 
No spouse or other sexual partner 
Previous spouse or partner died 
Quarrelled with spouse or partner 
Divorced from previous spouse 
Spouse / partner travelled away from home 
I travelled away from home 
Spouse / partner was too sick 
I was too sick 
We are abstaining after birth of a child 
Spouse /partner is afraid of HIV 
I am afraid of HIV 
Other (specify below) 
Circle only one response 
01 
02 
03 
04 
05 
06 
07 
08 
09 
10 
11 
12 
q57a  ……………………… 
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Other risk factors 
q58 Have you had a blood transfusion in the last 5 years? Yes 1     No 2  
q59 How many injections did you get in last 12 months? (write 99 if not known) └─┴─┘ number 
 
q60 Have you had body incisions during the last 5 years? Yes 1     No 2 women → q63 
q61 Have you been circumcised ? Yes 1     No 2 no → q63 
q62 How old were you when you were circumcised? (write 99 if not known) └─┴─┘ years 
 
 
 Knowledge of sexually transmitted infections 
q63 Have you ever heard about sexually transmitted infections? Yes 1      No 2 no → q65 
q64 
What are the signs of sexually transmitted 
infections?  Do not read out list, but after 
each response ask if there are other signs 
Write 1 for sign mentioned first, 2 for the 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q64a Discharge or bleeding from genitals 
└─┘ 
q64b Genital ulcers, swelling or irritation 
└─┘ 
q64c Difficulty in urinating 
└─┘ 
q64d Painful intercourse 
└─┘ 
q64e Pain in uterus 
└─┘ 
q64f Don’t know any signs 
└─┘ 
q64g Other (specify below) 
└─┘ 
q64h  …………………………… 
 
Symptoms of sexually transmitted infections 
q65 Have you had painful urination at any time in last 12 months? Yes 1      No 2 
q66 Have you urinated blood at any time in last 12 months? Yes 1      No 2 
q67 Have you had a genital discharge in last 12 months? Yes 1      No 2 
q68 Have you got genital ulcers or swelling in last 12 months? Yes 1      No 2 
 If q65 to q68 all answered No  → q71 
q69 Do you still have any of these symptoms now? 
Yes 1      No 2 
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q70 
What action did you take?   
Do not read out list, but after each 
response ask what else they did 
Write 1 for action mentioned first, 2 for the 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q70a Treated at government health facility 
└─┘ 
q70b Treated at private health facility 
└─┘ 
q70c Self medication with pharmacy drugs  
└─┘ 
q70d Self medication with herbs 
└─┘ 
q70e Consulted traditional healer 
└─┘ 
q70f Got drugs from TANESA / TAZAMA / TUMAINI └─┘ 
q70g No action taken 
└─┘ 
q70h Other (specify below) 
└─┘ 
q70i  …………………………… 
 
Knowledge about HIV 
q71  Have you ever heard / read about HIV, the virus which causes AIDS? Yes 1        No 2 no → q102 
q72  
What was the source of your information? 
Do not read out list, but after each 
response ask if there were other sources 
Write 01 for source mentioned first, 02 for 
the second, etc.  When respondent runs 
out of answers write 00 in all unused lines 
q72a Radio └─┴─┘ 
q72b Television / Video / Cinema └─┴─┘ 
q72c Posters └─┴─┘ 
q72d Magazines / Booklets └─┴─┘ 
q72e Meetings / Campaigns (including TANESA) └─┴─┘ 
q72f At school / from peer counsellors └─┴─┘ 
q72g Church / Mosque └─┴─┘ 
q72h Health facility workers └─┴─┘ 
q72i Home based care / Village health worker  └─┴─┘ 
q72j Family or friend └─┴─┘ 
q72k Other (specify below) └─┴─┘ 
q72l  …………………………… 
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q73  Do you know how HIV/AIDS is transmitted? Yes 1        No 2 no → q75 
q74  
Mention all the ways that you know 
Do not read out list, but after each 
response ask if there are other ways 
Write 1 for way mentioned first, 2 for the 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q74a Having sex with a casual / high risk partner └─┘ 
q74b Having sex without a condom └─┘ 
q74c Unsafe blood transfusion └─┘ 
q74d Unsterile injections └─┘ 
q74e Mother to child transmission └─┘ 
q74f Incisions on the body └─┘ 
q74g Sharing personal items └─┘ 
q74h Other (specify below) └─┘ 
q74i  …………………………… 
 
q75  Is it possible for a healthy looking person to have HIV/AIDS? Yes 1         No 2 DK  9 
q76  Can AIDS be transmitted by mosquito bites? Yes 1         No 2 DK  9 
q77  Can AIDS be transmitted by sharing cups and plates? Yes 1         No 2 DK  9 
q78  Can AIDS be transmitted by kissing? Yes 1         No 2 DK  9 
 
Stigma and personal experience of HIV 
q79  
Where does HIV transmission mainly take 
place?  Do not read out list, but after each 
response ask if there are other places 
Write 1 for place mentioned first, 2 for the 
second, etc.  If respondent doesn’t know 
any or any more write 0 in all unused lines 
q79a Wedding and funeral parties └─┘ 
q79b Pombe shops └─┘ 
q79c Bars and guest houses └─┘ 
q79d Discos / Ngoma dances └─┘ 
q79e At hospitals └─┘ 
q79f At markets └─┘ 
q79g Hair salons └─┘ 
q79h Other (specify below) └─┘ 
q79i  …………………………… 
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q80 
What kinds of people are responsible for 
transmitting HIV?  Do not read out list, but 
after each response ask if there are others 
Write 01 for people mentioned first, 02 for 
the second, etc.  If respondent doesn’t know 
any or any more, write 00 in all unused lines 
q80a Bar workers / Food vendors └─┴─┘ 
q80b Students / Young people └─┴─┘ 
q80c People who travel a lot └─┴─┘ 
q80d Widows and widowers └─┴─┘ 
q80e Refugees and homeless people └─┴─┘ 
q80f Drunks &/or drug users └─┴─┘ 
q80g Teachers and village leaders └─┴─┘ 
q80h Health workers and hospital workers └─┴─┘ 
q80i Homosexuals └─┴─┘ 
q80j Anyone can transmit it └─┴─┘ 
q80k Other (specify below) └─┴─┘ 
q80l  …………………………… 
 
q81 Among your relatives is anyone infected with HIV? Yes 1       No 2 DK  9 
q82 Have any of your relatives died of AIDS? Yes 1       No 2 DK  9 
q83 Is anyone in this village infected with HIV? Yes 1       No 2 DK  9 
q84 Has anyone in this village died of AIDS? Yes 1       No 2 DK  9 
 
Need for services 
q85 
What services are needed to help HIV 
infected people? Do not read out list, but 
after each response ask if there are others 
Write 1 for those mentioned first, 2 for the 
second, etc.  If respondent doesn’t know 
any or any more write 0 in all unused lines 
q85a Drugs to treat HIV └─┘ 
q85b Drugs to treat other infections └─┘ 
q85c Home based care during serious illness └─┘ 
q85d Help to get food └─┘ 
q85e Help to take care of their children └─┘ 
q85f Other (specify below) └─┘ 
q85g  …………………………… 
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q86 
What services are needed to prevent new 
HIV infections?  Do not read out list, but 
after each response ask if there are others 
Write 1 for those mentioned first, 2 for the 
second, etc.  If respondent doesn’t know 
any or any more, write 0 in all unused lines 
q86a Education & information └─┘ 
q86b Condom provision └─┘ 
q86c Rules to enforce good behaviour └─┘ 
q86d PMTCT in ANC clinics └─┘ 
q86e Clean syringes at health centres & dispensaries └─┘ 
q86f Other (specify below) └─┘ 
q86g  …………………………… 
 
Experience of VCT 
q87 Have you ever had VCT ? Yes 1     No 2 no → q99 
q88 When did you last use any of these VCT services? Ask about each 
q88a Sero survey VCT  note: sero5 was in 2006 At sero5  1       At earlier sero-survey 2   Never 3 
q88b Kisesa health centre VCT Last year 1          More than a year ago 2  Never 3 
q88c ANGAZA Last year 1          More than a year ago 2  Never 3 
q88d At ANC clinic Last year 1          More than a year ago 2  Never 3 
q88e Mobile VCT service Last year 1          More than a year ago 2  Never 3 
q88f Other (specify below) Last year 1          More than a year ago 2  Never 3 
q88g  …………………………… 
 
q89 Did you receive pre-test counselling at your last VCT? Yes 1    No 2 
q90 Did you find out your test results after your last VCT? Yes 1    No 2 
q91 Did you receive post-test counselling after your last VCT? Yes 1    No 2 
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q92 Did you tell anyone about your test result? Yes 1    No 2 no → q94 
q93 
Who did you tell? 
Do not read out list, but after each response 
ask if there were other people 
Write 1 for person mentioned first, 2 for 
the second, etc.  When respondent runs 
out of answers write 0 in all unused lines 
q93a Spouse / partner └─┘ 
q93b Parent └─┘ 
q93c Other relative └─┘ 
q93d Friend └─┘ 
q93e Home Based Care Worker └─┘ 
q93f Other (specify below) └─┘ 
q93g  …………………………………………… 
 
q94 Would you recommend a friend to have VCT? Yes 1        No 2          DK  9 
q95 Was your VCT counsellor kind and understanding?   Yes 1         No 2 
q96 Was the VCT interview embarrassing or difficult?   Yes 1         No 2 
q97 Can VCT counsellors be trusted to keep results secret? Yes 1        No 2          DK  9 
q98 If a person is seen going into a VCT centre do people assume he/she is infected? Yes 1        No 2          DK  9 
 
Knowledge about ART 
q99 Is anyone you know taking drugs for HIV infection? Yes 1        No 2          DK  9 
q100 Are drugs for HIV infection available at the following places? Ask about each one 
q100a Village dispensary Yes 1        No 2          DK  9 
q100b Kisesa Health Centre Yes 1        No 2          DK  9 
q100c Magu district hospital Yes 1        No 2          DK  9 
q100d Sekou Toure regional hospital Yes 1        No 2          DK  9 
q100e Bugando referral hospital Yes 1        No 2          DK  9 
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q101 Are the following statements about drugs for HIV treatment true or false 
Ask about each one 
q101a Drugs can only slow down HIV illness, not stop it  True 1  False 2 DK 9 
q101b ART drugs are very dangerous and can kill people True 1  False 2 DK 9 
q101c ART drugs have to be used for life True 1  False 2 DK 9 
q101d ART drugs are available free of charge in Tanzania True 1  False 2 DK 9 
q101e Everyone who is infected with HIV needs drugs  True 1  False 2 DK 9 
 
Use of health services 
q102 In the last 12 months, how many times have you used the following services 
write number for each, 00 if none 
q102a Hospital in patient └─┴─┘  times  
q102b Hospital clinic outpatient └─┴─┘  times  
q102c Health centre / dispensary └─┴─┘  times  
q102d ANC or MCH or vaccination clinic └─┴─┘  times  
q102e Visit from Home Based Care Worker └─┴─┘  times 
q102f Private pharmacy └─┴─┘  times  
q102g Traditional healer └─┴─┘  times  
If zero for each of  q102a to q102g→ q107 
 
q103  Did you have expenses when you used these services? Yes 1       No 2 no → q87 
q104  
What kind of expenses have you had? 
Do not read out list, but after each 
response ask if there were others 
Write 1 for those mentioned first, 2 for the 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q104a Paid for meals / bed in hospital └─┘ 
q104b Paid for transport └─┘ 
q104c Paid to see doctor / nurse └─┘ 
q104d Paid for drugs └─┘ 
q104e Gave gifts to service provider └─┘ 
q104f Gave gifts to helper └─┘ 
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q105  Did you get help from anyone with these expenses? Yes 1       No 2 no → q107 
q106  
What kind of help did you get? 
Do not read out list, but after each 
response ask if there were others 
Write 1 for help mentioned first, 2 for the 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q106a Family and friends helped └─┘ 
q106b I got a loan └─┘ 
q106c The service provider lowered the cost └─┘ 
q106d TUMAINI / TAZAMA / TANESA helped └─┘ 
q106e I got district health insurance └─┘ 
q106f Other (specify below) └─┘ 
q106g   …………………………………………… 
 
Home based care 
q107  Have you ever heard of home based care for people who are too sick to leave home? Yes 1       No 2 
No → end 
interview 
q108  Has your village ever had home based care workers / volunteers? Yes 1      No 2       DK  9 No or DK → q110 
q109  
Who organised this service? 
Do not read out list, but after each 
response ask if there were others 
Write 1 for organiser mentioned first, 2 for 
second, etc.  When respondent runs out of 
answers write 0 in all unused lines 
q109a TUNAJALI / TUMAINI  └─┘ 
q109b TAZAMA / TANESA / NIMR └─┘ 
q109c HUPEMEF └─┘ 
q109d Other (specify below) └─┘ 
q109e   …………………………………………… 
q110  Do people welcome home based care workers to visit them in their house? Yes 1        No 2          DK  9 
q111  Do home based care workers help with household tasks? Yes 1        No 2          DK  9 
q112  Do home based care workers provide medicines?  Yes 1        No 2          DK  9 
q113  Do home based care workers give advice about going to clinics and hospitals?  Yes 1        No 2          DK  9 
 
THANK PARTICIPANT FOR THEIR TIME AND PATIENCE     
 
notes about interview 
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275 
 
11.2.3 TAZAMA WI-HTC (VCT) clinic main registration book 
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11.2.4 TAZAMA WI-HTC (VCT) clinic client ID card 
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11.2.5 TAZAMA WI-HTC (VCT) clinic test results book 
 
 
 
 
 
  
 
Sample number is the field which 
provides the link between the main 
registration and test results data  
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11.2.6 Protocol for PLA activities 
 
HIV Testing and Counselling Study 
Participatory Learning and Action (PLA) Activities 
 
Materials required: flipchart paper, masking tape, marker pens, note-books & pens, 
digital camera (to take pictures of flipcharts), digital recorder & spare batteries 
 
Welcome participants as they arrive. You can greet them in Sukuma, but please 
inform them that we will need to do the focus group in Swahili, as this subject is 
difficult to discuss in Sukuma 
 
Once everyone has arrived, ask people to take a seat 
Once people have sat down, thank and welcome them again 
 
 
 
Introduce yourself and the note taker.   
Give participants a brief overview of the study: 
 Free HIV testing and counselling (HTC) services are offered at the Voluntary 
testing and counselling (VCT) clinic at Kisesa health centre, and also during 
the sero-survey rounds that are conducted in Kisesa ward every 2-3 years.  
 The National Institute for Medical Research (NIMR) is carrying out a study 
about the HIV testing and counselling services in Kisesa.  
 This information can be used to make recommendations about how these 
services could be improved in the future.  
 We would like to know the views of men and women in this community about 
HIV testing and counselling services. 
 We will do our best, but we cannot guarantee that we will be able to provide 
all the needs or suggestions that are identified by study participants today. 
 
Explain to participants the details of how the session will be conducted: 
 Today we will be having discussions and conducting activities together as a 
group. The activity will last about 2 hours. 
 The purpose of the activities will be to exchange information. We will ask you 
to share knowledge and views of HIV testing and counselling services, and 
will try to answer any questions you have. 
 We will be discussing together as a group, learning about HTC in general, 
and discussing possible ways to improve these services. No one needs to 
share any personal experiences of VCT or discuss sensitive topics, as this is 
a general discussion. 
 Each person should now pick a name that they will use for the activity, to 
protect their identity. Real names should not be used. 
Informed Consent and Introductions (20 minutes) 
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 The discussion will be kept confidential by the researchers. Codes, for 
example “female aged 25-30”, will be used for identification in any 
documents or reports, so we will not record your names anywhere. All the 
professionals involved in this project have been trained and are committed to 
keeping the information confidential. 
 At the end of the activities, we would like to take photos of the drawings and 
diagrams we have made, if everybody agrees to this. We do not wish to take 
photos of any people. 
 It is possible that the discussion might bring up issues that are difficult or 
upsetting. Any participant is free to leave at any time or to not participate in 
any part of the activity.   
 
If you have any questions, please feel free to ask me now and I’ll try to clarify the 
information for you.   
 
Does anyone have any questions? 
 
If you have additional questions regarding the study after the discussion, you can 
speak with me or one of the HTC counsellors, or the fieldworker in your village that 
can get in touch with one of the researchers at NIMR Mwanza. 
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Verbal Consent 
 
Ask participants to introduce themselves to the group using their made up 
names, not their real names. Explain to participants that you would like to 
record the discussions. Ask each participant in turn whether they agree to 
recording of the discussions: 
 
Do you agree to the activities and discussions being recorded? (Answer Yes or No) 
 
If participants do not consent to recording: 
 Researchers will explore, in a sensitive way, reasons for non-consent, and 
will re-emphasise that all information will be kept confidential. No names will 
be recorded or used in any quotes in documents, publications or reports. 
 Discuss the purpose of the activity – the activity does not aim to collect 
personal/sensitive information, just to understand people’s views about the 
HTC services provided in this community 
 Tell the group that anyone who does not want to participate can leave at any 
time 
 
If all participants do not agree to recording, notes will be taken instead. 
 
If all participants agree to recording, turn on the tape recorder and READ 
ALOUD:  
“In this group activity we would like to discuss your views of HIV testing and 
counselling services.  Some of the discussions may bring up issues that are difficult 
or upsetting, but you do not have to participate in any parts of the activity that you do 
not want to, and you are free to leave the discussion at any time. In reports or other 
documents, we may use quotes of things you say during the discussions, but these 
will always be anonymous (e.g. “female aged 25-30”, no names will be used). 
 
Ask each participant in turn, using their made-up name: 
“[Name], do you confirm you have understood all of the information that I have given 
you, and agree to continue with this activity?  (Yes/No). 
 
Verbal consent only for group activities.  
 
Consent noted for each participant by note-taker if session is not tape-
recorded. 
 
Before the session starts ensure everyone is comfortable and can see and hear 
each other.  
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Explain to participants that we would like to get their general views about HIV testing 
and counselling services – what they know about HTC services, what they think 
about HTC services, what they have heard about HTC. 
 
On a piece of flipchart paper, draw a symbol representing a HTC/VCT clinic in the 
middle of the page (e.g. picture of clinic building).  
 
Prompt the discussions using the questions below. Remember, discussion is good, 
do not try and cut it short! Probe participants, and ask them to explain what they 
mean if it is not clear. As participants mention or discuss different issues, try to draw 
a picture representing this issue on the flipchart paper. If you cannot think of a 
picture to draw, write words instead. 
 
As you go through the questions, participants may discuss different problems 
relating to HTC (eg they might say something like “There is no HTC clinic near to my 
house” or “counsellors are bad people”. Or anything similar like this). If problems 
like these come up, try to probe other participants what they think about this 
problem, and/or if there are any solutions or ways of overcoming this 
problem. If participants are confused or mention something which is incorrect, 
try to provide correct information to the group in a sensitive way. 
 
If the participants are quiet about some of the questions, you may decide to divide 
them up into smaller groups, to discuss each issue. Then they can report back to 
you. Go around to each group as they are discussing, to prompt the discussions or 
see if they need any help.  
 
 What do you think or what do you know about HIV testing and 
counselling services (In general – e.g. what happens there?) 
 If someone wanted to go for HTC in Kisesa, where would they get this 
from? 
 Do they give information there? What kind of information do they give? 
Does this differ by anything (e.g. whether you are a woman or whether 
you are a woman, or HIV status?) 
 What do you think are some of the advantages of going for HTC? 
 What do you think are some of the disadvantages of going for HTC? 
 What do you think about HTC counsellors? 
 Is it useful to go for HTC more than once, or not? 
 Is there anything else about HTC that you would like to tell us? 
 
At the end of the discussions, when the participants have no more points to add, 
summarise the main points about HTC that were discussed today. Go around 
Activity: Knowledge and Perceptions of HTC services 
- Brainstorming 
- Discussing problems and possible solutions 
 
282 
 
the picture and address each point in turn, explaining whether the information they 
have heard is true or false (or partly true!) and giving more details. It is important to 
do this in a sensitive way – so that you leave the group with accurate information, 
but do not make anyone feel bad for having given a false piece of information. 
 
Ask the participants if they have any questions for you.  
 
Ask the participants if they consent to taking photos of the flipchart paper. 
 
Tell the group that you will now speak to each of them in private, in order to pay 
them some compensation for their time and to offer the opportunity to answer any 
personal questions that they may have. 
 
For each participant, the facilitator will then: 
 
 Pay the participant compensation for their time 
 Ask if there are any questions the participant would like to ask 
 If the participant is a seed (check participant list), tell the participant 
that we are also interested in conducting in-depth interviews with 
people who have used HIV testing and counselling services before, to 
get their views on these services.  
ASK THE PARTICIPANT IF HE/SHE IS WILLING TO DISCUSS WHETHER 
HE/SHE HAS BEEN FOR HTC BEFORE.  
If the participant says yes, ask if he/she would like to participate in an 
IDI about use of HTC services.  
If the participant agrees to an IDI, agree a time and place to do the 
interview 
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11.2.7 IDI discussion guide with users of HTC services 
 
HIV Testing and Counselling Study 
In-depth interviews with users of HIV testing and counselling services 
 
 
 
 
Thank the participant for his/her time and introduce yourself. Give participants a 
brief overview of the study: 
 The National Institute for Medical Research (NIMR) is carrying out a study 
about the HIV testing and counselling services in Kisesa, to explore clients’ 
experiences of using these services. 
 NIMR can use this information to make recommendations about how the 
services could be improved in the future.  
 We will do our best, but we cannot guarantee that we will be able to 
implement all the needs or suggestions that are identified by study 
participants. 
 
Mention the following: 
 I would like to talk to you today about your views of HIV testing and 
counselling services.  
 The interview will take about 1-2 hours and NIMR will compensate you for 
the travel costs to the interview location today.  
 The information you give will be kept completely confidential. Codes for 
example “female aged 25-30” will be used for identification in documents or 
reports, so we will not record your name anywhere.  
 All the professionals involved have been trained and are fully committed to 
keeping your information confidential. However, we would like to record the 
discussion to help with our documentation. Only researchers at NIMR will 
hear this recording. However, if you do not wish to be recorded, I will take 
written notes during the interview instead.   
 During the discussion, I will ask you for some personal information about 
your experiences of going for HIV testing and counselling. Some of the 
questions may bring up issues or emotions that are upsetting or difficult for 
you, but I will try to offer support and answer your questions. You do not 
have to answer any questions that you do not want to, and you can ask to 
stop the interview at any time. 
 If you have additional questions regarding the study after the interview, you 
can speak with me or visit an HTC counsellor, or get in touch with the 
Director of the Tazama Project at NIMR Mwanza, Mr Mark Urassa, Tel 028-
2500399. 
 
If you have any questions about the study, please feel free to ask me now. 
Information and Informed Consent  
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I will now ask you some questions to confirm that you have understood all of the 
information that I have given to you, and that you agree to participate in this study: 
 
1. Do you confirm that you have understood all of the information that I have 
given to you, and that you have had time to consider this information, as well 
as participating in the study?  
 
Yes  No 
 
 
2. Do you understand that your participation is voluntary, that you are free to 
withdraw from the study at any time, without giving any reason, and without 
your rights (e.g. medical, access to clinic or treatment) being affected? 
 
Yes  No 
 
 
3. Do you agree to this interview being recorded? 
 
Yes  No 
 
 
4. Do you agree to anonymous quotes of what you say being used in reports or 
publications? 
 
Yes  No 
 
 
Name of participant                Date        Signature (Or interviewer signature as 
witness)  
 
_______________________    _____      ________________________________ 
 
Name of interviewer                Date        Signature  
 
_______________________    _____      _________________________________ 
 
Signed/Witnessed Consent  
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Turn digital recorder on. 
Ice-breaker, personal details, knowledge about HIV 
 
1. Please can you tell me a bit about you and your household? (eg Where do 
you live? Who do you live with? What is your relationship to them? Do you 
have any children? What is your level of schooling? What type of housing do 
you live in? What facilities do you have (electricity, water)?) 
 
2. Can you describe to me what you do during a typical day (what type of 
activities), or what you do for income?  
 
3. Do you have any partner(s)?  
a. How long have you had your partner? Can you tell me about your 
relationship with this partner?  
b. If married: can you tell me about your relationship history/previous 
partners? 
If not married: can you tell me about any other partners that you have 
– who are they, how long have you had these other partners, etc?  
 
4. Can you tell me what you know about HIV/AIDS? (How is it spread, how can 
it be prevented, etc?) 
 
5. Do you fear that your partner(s) might be at risk of getting HIV or could have 
HIV? 
 
HIV testing and counselling 
When we met after the group activity, you told me you had used HTC services 
before. Now I would like to talk to you about your experience when you used that 
service. 
6. Can you tell me about your most recent visit for HIV testing and 
counselling: 
a. How long ago did you go for HTC? 
b. Where did you go for testing that day (e.g Kisesa health centre – at 
the VCT clinic or the ANC clinic (if female)? Or elsewhere – eg 
Bugando, Secou Toure, somewhere else? Why did you go to this 
place? 
c. Why did you go for testing? (e.g. because felt ill, was worried, 
planning to get married or to have a baby, etc?) 
d. Did anyone go with you? If yes, who went with you? Why did you go 
with this person? 
e. If you went on your own can you tell me why? 
 
7. Can you tell me about what happened when you arrived at the HTC clinic? 
a. Did you have to wait before seeing the counsellor?  
b. If yes, how did you feel or what did you think while you were waiting 
to see the counsellor? 
Start of Interview 
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The next question is a key question, so try to probe about the relationship 
between the counsellor and the participant:  
8. Can you tell me about the counsellor? 
a. How did you find the HTC counsellor (eg his/her attitude or 
behaviour?)  
b. What was the relationship between you and the counsellor like – did 
you feel comfortable with him/her?  
c. How long did the counselling and testing take? How did you feel 
about the time taken? 
 
Experience at HTC and how counselling advice was understood 
These are key questions, so try to probe about what the client discussed with 
the counsellor. What did he/she say to the counsellor - what personal 
information did he/she share with the counsellor? What information did the 
counsellor give to the client in return? Was there a specific risk reduction plan 
for that client, based on what he/she said to the counsellor? 
 
9. Did you receive pre-test counselling? Can you tell me what you said to the 
counsellor during pre-test counselling? Do you feel free to share personal 
information with counsellors? For example, did you tell the counsellor 
about your personal details - about how many partners you have, about your 
sexual practices with these partners (e.g. whether you use condoms or not, 
etc), or about any difficulties you may have with your partners?  
What did the counsellor say back to you, when you told him/her these 
things? Can you tell me if he/she gave you any information that was specific 
to you and your life? What information did he/she give to you? Was it a 
two-way discussion, or was the information general? 
 
10. Did you receive post-test counselling? What did you discuss during post-test 
counselling – can you tell me about what you said to the counsellor, and 
about what the counsellor said to you? Was the information specific or 
was it general – how was it specific or how was it general? 
 
11. Can you tell me how you felt about what the counsellor said to you? Did you 
feel you would be able to implement the advice that he/she gave to 
you? If yes – how did you implement this advice? If not, why could you 
not implement the advice? 
 
12. Can you tell me whether you think one counselling session is enough, to 
help you to protect yourself or your partners from HIV? Or should people go 
for counselling more than once? If yes, why should they go for counselling 
more than once? If not, why not? (Focus should be on counselling as 
opposed to testing). 
 
13. Can you describe how you felt when you left the clinic, after you had been for 
HTC?  
 
14. Did you decide to tell anyone you had been for HTC? If yes, who did you 
tell? Why did you tell this person? If not, why did you decide not to tell 
anyone? 
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15. Did you have any thoughts or feelings which were different after going for 
HTC, compared to before? Eg about your partner, about yourself, about your 
relationships? Can you tell me about these thoughts or feelings? 
 
Other 
 
16. Would you encourage a partner or a friend to go for HTC? Why or why not? 
 
17. Have you been for HTC more than once? If yes, why did you to go for testing 
again? Or if you have been only once, why did you not return for testing? 
 
18. If you have been for HTC more than once, was your experience different the 
next time you went, compared to the first time? Ie did you feel differently 
about attending the clinic, or about the counsellor, or about what he/she said 
to you? 
 
19. What do you think are effective ways for people to protect themselves from 
HIV in this community – can you tell me about this? Are there additional or 
other things that individuals, or communities, can do to help to prevent the 
spread of HIV? 
 
20. Are there any suggestions or improvements that you think could be made to 
HTC services?  
 
21. Is there anything else about your experience(s) of HIV testing and 
counselling that you would like to share with me? 
 
End of interview. Thank the participant for his/her time and contributions, and pay 
the compensation. 
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11.2.8 IDI discussion guide with VCT counsellors 
 
IDIs with VCT Counsellors 
Information Sheet 
 
The National Institute for Medical Research (NIMR) is doing a research study to 
explore the provision of HIV testing and counselling (HTC) services in Kisesa, and 
how clients perceive the counselling advice that they receive. It is important to do this 
as HTC services expand and as the number of clients attending for testing increases. 
 
We are interested in: 
 Understanding the messages and information that are shared with clients 
during HTC, and whether you feel clients understand these messages and/or 
find them useful or helpful. 
 Learning how counselling messages are adapted for different clients, 
according to their individual circumstances or needs. 
 Understanding what training is provided for counsellors, and if you have any 
ideas about how counsellor training sessions could be improved. 
 Learning about any re-fresher trainings or support that is provided for HTC 
counsellors. 
 Hearing any ideas you may have about possible improvements to the design 
and delivery of HTC services in Kisesa and in Tanzania. 
  
Although we will try our best, we cannot guarantee that we will be able to incorporate 
all the suggestions you make during the study.  
 
If you have any questions about the information that I’ve given you, or about the study, 
please feel free to ask, and I’ll do my best to answer. 
 
If you have further questions about the study after this conversation, you can contact 
Mark Urassa (director of the TAZAMA study) at NIMR Mwanza. 
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Consent Form  
 
Thank you very much for taking the time to meet with me today. This interview will 
take about 1.5 hours and will be kept completely confidential. We will be using 
anonymous codes to identify participants - your name will be recorded on this form 
only for the purpose of obtaining informed consent. All the professionals involved in 
the project have been trained and are fully committed to keeping information 
confidential.  
 
We will be producing a report in order to communicate the findings of this research, 
which we will make available once it is finished.  In the report or other published 
documents, we may give examples of some things you say during the interview, but 
we will NOT include your name or any other details:  instead we would write “Health 
Worker number 1”, for example. 
 
We would like to tape record this interview to help with our documentation. Only 
researchers at NIMR will hear this tape. If you do not wish to be recorded, we will take 
written notes during the interview instead. You do not have to answer any questions 
that you do not want to, and you can ask to stop the interview at any time.  
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Please answer yes or no to the questions below: 
 
1. Do you confirm that you have understood all of the information that I have 
given to you, and that you have had time to consider this information, as well 
as participating in the study? 
 
Yes  No 
 
2. Do you understand that your participation is voluntary, that you are free to 
withdraw from the study at any time, without giving any reason? 
 
Yes  No 
 
3. Do you agree to this interview being recorded? 
 
Yes  No 
 
4. Do you agree to anonymous quotes of what you say being used in reports or 
publications? 
 
Yes  No 
 
 
 
Name of participant        Date  Signature  
 
______________________________   ______   ____________________________ 
 
 
Name of Interviewer       Date            Signature  
 
______________________________   ______   ____________________________ 
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Turn digital recorder on 
 
Part 1 – Introduction 
 
1. Can you tell me a bit about yourself and your profession: 
 
a) How long have you been a counsellor? Have you always worked in Kisesa, 
or have you also worked in other places? If so, where? How did your work 
in other places compare to your work in Kisesa - was there anything that 
was similar or anything that was different? 
b) Can you describe a typical day to me, e.g.: 
How many clients do you usually see in one day?  
How long does each counselling session normally take? 
Can you tell me about any positive aspects or things that you enjoy in your 
day-to-day work? 
Can you tell me about any challenges or things that are difficult in your 
day-to-day work? 
 
 
Part 2 – Experiences as a counsellor 
 
2. Can you tell me what you normally discuss with a client during a pre-test 
counselling session? How long does a pre-test counselling session normally 
take? 
 
3. Can you tell me about the testing process – how do you explain this to clients? 
How long does it normally take to do the test(s)? Do clients normally wait in 
the room with you while you do the test, or do they wait outside? 
 
4. Can you tell me about a typical post-test counselling session with someone 
who tests HIV negative? E.g. how long does the post-test counselling normally 
take? What are typical reactions from the client? What issues are covered? 
What is easy or what is difficult about counselling people who test HIV 
negative? 
 
5. Can you tell me about a typical post-test counselling session with someone 
who tests HIV positive? E.g. how long does the post-test counselling normally 
take? What are typical reactions from the client? What issues are covered? 
What are the issues or challenges when counselling people who test HIV 
positive? What referrals or further information do you provide for people who 
test HIV positive? 
A – INTERVIEWS WITH VCT COUNSELLORS 
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6. Do you provide couple counselling services (i.e. counselling for couples who 
come to test together). What different issues do you cover, or what different 
challenges do you face, when providing counselling for couples? 
 
7. Do you provide any other types of counselling services – E.g:  
Group counselling? 
Counselling for young people? 
Ante-natal counselling and testing for pregnant women?   
Can you tell me about anything which is different, or any of the issues, when 
providing counselling for these different types of clients?  
Probe for issues relating to each type of counselling that the participant 
mentions. 
 
8. Do you provide supportive counselling services? If yes, what sort of issues do 
you normally discuss with clients during supportive counselling? How long do 
supportive counselling sessions normally take? What are the positive aspects 
or the challenges of providing supportive counselling? 
 
9. Do you provide any other types of counselling services, apart from those we 
have already discussed? If yes, can you tell me about these other counselling 
services that you provide? 
 
 
Part 3 – How clients receive HTC services 
The next few questions are about how clients receive HTC services. 
 
10. How do you think HTC services are received or perceived by: 
- people in the community in general? 
- clients who have used the service? 
 
11. Without mentioning any names, can you think about a time or a client for whom 
the VCT service seemed helpful? Can you describe this time or example? 
Why was the VCT useful or helpful for this person? How did he or she react to 
counselling, or to you, or to the information he/she received? 
 
12. Without mentioning any names, can you think about a time or a client for whom 
VCT was not helpful? Can you describe this time or example? Why did the 
VCT not seem helpful for this person? How did he or she react to counselling, 
or to you, or to the information he/she received? 
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Part 4 – Training for counsellors 
 
13. Can you tell me about any training that you received to become a counsellor, 
eg: Where did you receive training? Who conducted the training (which 
organisation)? How long was the training for? 
 
14. Can you tell me broadly what topics were covered during the training – i.e. 
what were you taught or what did you learn and discuss? 
 
15. Can you tell me about any counselling theories, methods or approaches that 
were taught during training? What do you think about these different methods 
or approaches? What is good or useful about them and what is bad or not 
useful about them? Do you tend to use similar approaches with all clients, or 
different methods with different clients? Can you tell me about this? 
 
16. What do you think are skills of a good counsellor? 
 
17. What do you think are characteristics of a poor or weak counsellor? 
 
18. Can you tell me how you feel about the training that you received. E.g. did it 
meet your needs or expectations? Has it taught you the skills that you feel you 
need to do your job? Did it cover relevant topics? How did you feel about the 
length of training, or the amount of training received? 
 
19. Can you tell me about any refresher trainings that you receive during the 
course of your work? E.g. who runs this training, how often is it offered or does 
it occur, what topics are covered in refresher training? 
 
 
Part 5 – Support for counsellors and professional development 
 
20. Do you have any other responsibilities or duties, apart from being an HTC 
counsellor? If yes, can you tell me about these responsibilities or duties? How 
do you manage your workload or balance your time to manage these different 
tasks? 
 
21. Can you tell me about any professional support or supervision that you receive 
as a counsellor? How do you feel about the support that you receive (or about 
the lack of support)? 
 
22. Is there any other training or support that you feel would help you to perform 
your job? If yes, can you tell me about this? 
 
 
294 
 
Part 6 - Other 
 
23. Can you identify the biggest challenge that you face in your daily work? Can 
you describe this to me? 
 
24. Can you identify the most satisfying or the most positive aspect of your job? 
Can you describe this to me? 
 
25. Are there any issues that we have discussed today that you’d like to talk about 
further? 
 
26. Do you have any questions or other comments about any of the topics that we 
have discussed today? 
 
 
End of interview – wrap up and thank the respondent 
 
  
295 
 
11.2.9 IDI discussion guide with healthcare workers offering PITC 
 
IDIs with healthcare workers involved in Provider Initiated Testing & 
Counselling 
Information Sheet 
 
The National Institute for Medical Research (NIMR) is doing a research study to 
explore the provision of HIV testing and counselling (HTC) services in Kisesa, and 
how clients perceive the counselling advice that they receive. It is important to do this 
as both Voluntary Counselling and Testing (VCT) and Provider Initiated Testing and 
Counselling (PITC) services expand, and the number of clients receiving these 
services increases. 
 
We are interested in: 
 Understanding how PITC services are provided in Kisesa, and how patients 
perceive or receive the service (e.g. how they understand counselling 
information or messages, whether they find the service useful or not, etc). 
 Understanding your experiences in providing PITC, and how you balance this 
responsibility with other duties or tasks that you have. 
 Understanding what training is provided for staff involved in PITC, and if you 
have any ideas about how the training could be improved. 
 Learning about any re-fresher trainings or support that is provided for 
healthcare workers involved in PITC. 
 Hearing any ideas you may have about possible improvements to the design 
and delivery of VCT or PITC services in Kisesa and in Tanzania. 
  
Although we will try our best, we cannot guarantee that we will be able to incorporate 
all the suggestions you make during the study.  
 
If you have any questions about the information that I’ve given you, or about the study, 
please feel free to ask, and I’ll do my best to answer. 
 
If you have further questions about the study after this conversation, you can contact 
Mark Urassa (director of the TAZAMA study) at NIMR Mwanza, Tel: 028-2500399. 
 
Consent form same as for VCT Counsellors, see Appendix 11.2.8 
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Turn digital recorder on 
 
Part 1 – Introduction 
 
1. Can you tell me a bit about the ante-natal clinic (ANC):  
- What facilities are available there and what services are provided there? 
- How many staff work at the clinic? What are their different responsibilities 
or roles?  
- How many patients are generally seen at the clinic each day? 
 
2. Can you tell me a bit about your job: 
- What duties or tasks are you normally involved in providing?  
- How many patients do you normally see in a typical day? 
 
 
Part 2 – Experiences of PITC 
 
3. Can you tell me about provider initiated testing and counselling (PITC) at the 
ANC clinic: 
- How long has this service been offered? 
- What is the uptake of PITC like – what proportion of women generally 
accept PITC, and how do they react to this service (e.g. are they positive 
or negative about it, nervous or happy, etc)? 
- How often do you refer PITC clients to the VCT clinic (e.g. because you 
are unable to do testing at the ANC - due to time constraints, lack of test-
kits or re-agents, etc)? 
 
4. Can you tell me about your experiences in providing PITC: how long have you 
been involved in providing PITC? How many PITC sessions do you normally 
conduct in a day? Where is the service offered (e.g. is there a separate room 
at the ANC where you can conduct PITC? If not where do you conduct PITC?).  
 
5. Can you tell me about pre-test counselling in PITC – is this done in groups or 
individually? How long does pre-test counselling normally take? Can you tell 
me what you normally discuss with a patient during pre-test counselling? 
 
6. Can you tell me about the testing process – how do you explain this to 
patients? How long does it normally take to do the test(s)? Do the patients wait 
with you in the same room while you do the tests, or do they wait somewhere 
else? 
 
7. Can you tell me about post-test counselling with somebody who tests HIV 
negative? E.g. how long does the post-test counselling normally take? What 
are typical reactions from the patient? What do you normally discuss with the 
INTERVIEWS WITH HEALTHCARE WORKERS INVOLVED IN PITC 
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patient? What is easy or what is difficult about PITC with women who test HIV 
negative? 
 
8. Can you tell me about post-test counselling with somebody who tests HIV 
positive? E.g. how long does the post-test counselling normally take? What 
are typical reactions from the patient? What do you normally discuss with the 
patient? Do you normally provide referrals to other services for patients who 
test HIV positive? If yes can you tell me about these? What is easy or what is 
difficult about PITC with women who test HIV positive? 
 
 
Part 3 – How patients receive PITC 
The next few questions are about how PITC services are received or perceived by 
people in the community in general and by patients. 
 
9. How do you think PITC services are received or perceived by: 
- people in the community in general? 
- women who attend the ANC clinic? 
 
10. Without mentioning any names, can you think about a time or a patient for 
whom the PITC service seemed helpful? Can you describe this time or 
example? Why was the PITC useful or helpful for this person? How did the 
woman react to counselling, or to you, or to the information she received? 
 
11. Without mentioning any names, can you think about a time or a client for whom 
PITC was not helpful? Can you describe this time or example? Why did the 
PITC not seem helpful for this person? How did the woman react to 
counselling, or to you, or to the information she received? 
 
 
Part 4 – Training for PITC 
 
12. Can you tell me about any training that you received for PITC. E.g: Where did 
you receive training? Who conducted the training (which organisation)? How 
long was the training for? 
 
13. Can you tell me broadly what topics were covered during training? (E.g. 
Scientific information about HIV/AIDS? HIV/AIDS testing procedures? 
Principles or methods of counselling? Referral procedures? etc) 
 
14. Can you tell me how you feel about the training that you received - did it meet 
your needs or expectations? Did it give you the skills or information you feel 
you need in order to provide PITC services? 
 
298 
 
15. Can you tell me about any suggestions or recommendations you may have in 
order to improve PITC training? 
 
 
Part 5 – On-going support and professional development 
 
16. Can you tell me about any refresher trainings that you receive in relation to 
PITC? (E.g. who runs the training, how often is it offered or does it occur, what 
topics are covered in refresher training?) 
 
17. Can you tell me about your workload – how do you balance your other tasks 
and responsibilities with provision of PITC? How do you feel about your 
workload - what is it like - e.g. light or heavy? Manageable or not manageable? 
 
18. Can you tell me about any professional support or supervision that you receive 
at work? How do you feel about the support or supervision that you receive 
(or about the lack of support/supervision)? 
 
19. Is there any other training or support that you feel would help you to perform 
your job well? If yes, can you tell me about this? 
 
20. Can you tell me about any positive aspects or things that you enjoy in your 
day to day work? 
 
21. Can you tell me about any difficult things or challenges that you face in your 
day to day work? 
 
 
Part 6 – Other 
 
22. Are there any other suggestions or recommendations you have in relation to 
either the provision of PITC services, or to training and support for healthcare 
workers involved in PITC? 
 
23. Are there any issues that we have discussed today that you’d like to talk about 
further? 
 
24. Do you have any questions or other comments about any of the topics that we 
have discussed today? 
 
End of interview – wrap up and thank the respondent 
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11.2.10 IDI discussion guide with HTC trainer 
 
IDI with HTC Trainer 
Information Sheet 
 
The National Institute for Medical Research (NIMR) is doing a research study to 
explore the provision of HIV testing and counselling (HTC) services in Kisesa, and 
how clients perceive the counselling advice that they receive. It is important to do this 
as HTC services expand and as the number of clients attending for testing increases. 
 
We are interested in: 
 Understanding the messages and information that are shared with clients 
during HTC, and whether you feel clients understand these messages and/or 
find them useful or helpful. 
 Learning how counselling messages are adapted for different clients, 
according to their individual circumstances or needs. 
 Understanding what training is provided for counsellors, and if you have any 
ideas about how counsellor training sessions could be improved. 
 Learning about any re-fresher trainings or support that is provided for HTC 
counsellors. 
 Hearing any ideas you may have about possible improvements to the design 
and delivery of HTC services in Kisesa and in Tanzania. 
  
Although we will try our best, we cannot guarantee that we will be able to incorporate 
all the suggestions you make during the study.  
 
If you have any questions about the information that I’ve given you, or about the study, 
please feel free to ask, and I’ll do my best to answer. 
 
If you have further questions about the study after this conversation, you can contact 
Mark Urassa (director of the TAZAMA study) at NIMR Mwanza. 
 
Consent form same as for VCT Counsellors, see Appendix 11.2.8 
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Turn digital recorder on 
  
Part 1 – Introduction 
 
Explain that we would like to know about training for HIV counsellors in Magu district 
(or Mwanza region, if relevant). 
 
1. Can you tell me a bit about training for HIV counsellors in Magu district or 
Mwanza region: 
 
- Which organisation(s) are responsible for organising and running 
training for HIV counsellors in Magu district/Mwanza region? 
- How often is this training normally offered/run?  
- How many trainers are normally involved in each session or course 
(e.g. one trainer, or more than one?) 
 
2. Can you tell me a bit about yourself and your job: 
 
- How long have you been involved in running training for HIV 
counsellors? Can you tell me about the duties and tasks that you are 
involved in?  
- Were you a counsellor previously? If yes can you tell me about this – 
e.g. how long were you a counsellor for? Where did you work? How 
did you find this job as a counsellor (what were the positive and 
negative aspects of that job?) 
- How did you start to become involved in training for counsellors? How 
do you find this job – what are the positive and negative aspects of 
being a trainer? 
 
 
Part 2 – Training for new VCT counsellors 
 
3. Can you tell me about training courses for people to become new VCT 
counsellors: 
 
- How often are training courses normally offered or run? 
- For somebody to become a new VCT counsellor, how long does the 
training usually take? 
- How many participants usually take part in each course? 
- How many trainers are usually involved in running each course (e.g. 
one? or more than one?) 
B – INTERVIEWS WITH TRAINERS 
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4. Can you give me an overview of the curriculum, or tell me what topics are 
covered, in training for new VCT counsellors? (e.g. basic science? 
Counselling theory? Counselling for different groups or situations? Treatment 
and care services for HIV negative and/or HIV positive people?). 
 
5. Can you tell me about any specific counselling theories, methods or 
approaches which are taught during training? If different methods or 
approaches are taught, how are counsellors taught to adapt these, depending 
on the needs of individual clients? 
 
6. Can you tell me your thoughts about training for new VCT counsellors? E.g. 
does the curriculum meet the needs of VCT counsellors, in order to allow them 
to do their job well? Are there any changes or recommendations you would 
suggest to improve the training for VCT counsellors? 
 
7. What are the challenges when providing training for new VCT counsellors? 
 
8. What are the positive aspects of providing training for new VCT counsellors? 
 
 
Part 3 – Ongoing professional development, support and refresher training for 
VCT counsellors 
 
9. Are on-going or refresher trainings offered for VCT counsellors? If yes, which 
organisation(s) offer or run these courses? How often are they offered, or how 
often do VCT counsellors normally go for refresher training? 
 
10. Can you tell me what topics are normally covered in refresher training? What 
are the goals of these courses, and what content or material do they include?  
 
11. What other supervision or support is available to VCT counsellors? Who is 
responsible for providing this supervision or support (e.g. clinic in charge? 
District medical officer? Regional medical officer?) 
 
12. Can you tell me your opinion about the refresher training or supervision and 
support that is available for VCT counsellors? 
 
 
Part 4 – Training for PITC 
 
13. Can you tell me about training for provider initiated testing and counselling 
(PITC)? Is this different to training for new VCT counsellors? Can you give me 
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an overview of the goals of PITC training, and what topics it covers? How long 
do PITC courses normally take? Which organisation(s) are responsible for 
running PITC courses? 
 
14. Can you tell me about any refresher training or ongoing professional 
development or support that are offered for staff who provide PITC services?  
 
15. Can you tell me your opinion about training for PITC (e.g. how well it meets 
the needs of health-care workers involved in providing PITC, suggestions for 
changes or improvements to the training provided)? 
 
 
Part 5 – Other 
 
16. What do you think are the main challenges that HIV counsellors (VCT or PITC) 
face in their day to day work – can you describe these to me? 
 
17. What are the main challenges you face in your job as a trainer – can you tell 
me about these? 
 
18. What are the positive aspects of your job as a trainer – can you tell me about 
these? 
 
19. Do you have any suggestions as to how training for HIV counsellors could be 
improved in this district or region, or in Tanzania in general? 
 
20. Are there any issues that we have discussed today that you’d like to talk about 
further? 
 
21. Do you have any questions or other comments about any of the topics that we 
have discussed today? 
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11.3 Parameters for the linkage algorithm 
The matching procedure used for the analyses presented in this thesis was based 
on version 1 of the linkage algorithm described in the following document. 
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Introduction 
TAZAMA VCT Auto-Matcher 
1) This is a brief description of the stored procedure that implements the matching of 
the VCT data to the DSS data. There are two stored procedures that implement the 
matching, and they differ in the way that the individual component scores are 
computed and combined. 
2) Unless stated otherwise, all tables and stored procedures mentioned in this 
document are located in the SQL Server database KisesaVCT. 
 
Matching Algorithms 
 
Input Data 
1) For both versions of the algorithm the inputs are the same and are the VCT data, 
and the DSS data to which it is to be matched. The DSS data is taken from 
AbidanceTable, augmented by the Village, Sub Village, and Ten Cell Leader names 
from GeoUnitsTable. The following cases are excluded from the DSS input data: 
• The geography represented by the GeoUnitID is missing or invalid 
• The first name is missing 
• The second name is missing 
• The sex is missing or invalid 
2) The VCT data is taken from three sources: 
• The table valued function [dbo].[tfn_VCTNumberV001_00] that contains 
encrypted VCT data; 
• the join of the tables [dbo].[VCTIdenifiers] and [dbo].[VCTLog]; 
• the table [PostedData].[dbo].[VCTLOGFE_1_01] 
3) Where sex is missing from the VCT data it is estimated by using the gender 
probabilities of the names found in the table [dbo].[NameSexProb], provided that 
the probability found in the table exceeds 0.85. 
4) 
 
Output Data 
1) Data about the matches are stored in the output table VCT_PossibleMatches by 
version V1 of the algorithm, and in VCT_PossibleMatches_V3 by version V3 of the 
algorithm. Apart from the column SourceIdentifier that occurs in the version V3 
output, both tables have the same structure, given in Table 1 below. The primary 
key of the table is indicated by underlining the names of the columns of the key. 
2) The column labeled 'SourceIdentifier' is obtained by concatenating the following 
columns of the tables used to construct the input VCT data, and separating them by 
semi-colons ';': 
• A constant: 
◦ 1 if the input was from [dbo].[tfn_VCTNumberV001_00] 
◦ 2 if the input was from [dbo].[VCTIdenifiers] and [dbo].[VCTLog] 
◦ 3 if the input was from [PostedData].[dbo].[VCTLOGFE_1_01] 
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• The VCT number 
• If the input was from [dbo].[VCTIdenifiers] and [dbo].[VCTLog] 
◦ The RID of the input row from [dbo].[VCTIdenifiers] 
◦ The RID of the input row from [dbo].[VCTLog] 
• If the input was from [PostedData].[dbo].[VCTLOGFE_1_01], the VRID of the 
input row. 
3) The scheme such as this has turned out to be necessary due to the appearance of 
duplicate VCT numbers in the input data, leading to insertion failures in the output 
tables VCT_ PossibleMatches and VCT_ PossibleMatches_V3 as these originally 
had (VCTNumber, AbidanceID, MatchRoutine) as a multi-column primary key. 
 
Name Type Description 
VCTNumber Int The VCT number of the person being matched. 
AbidanceId Int The Abidance ID of the person against whom the 
match is being made. 
TotalScore Float The total score for the match 
FirstNameRawScore Float The raw score of the first name match 
SecondNameRawScore Float The raw score of the matching of trhe second names 
GenderRawScore Float The raw gender matching score 
AgeRawScore Float The raw age matching score 
VillageRawScore Float The raw village name matching score 
SubVillageRawScore Float The raw subvillage name matching score 
TenCellLeaderRawScore Float The raw ten cell leader matching score 
FirstNameScore Float The final first name matching score 
SecondNameScore Float The final second name matching score 
GenderScore Float The final gender matching score 
AgeScore Float The final age matchig score 
VillageScore Float The final village name matching score 
SubVillageScore Float The final sub village name matching score 
TenCellLeaderScore Float The final ten cell leader name matching score 
VCTFirstNameFreq Float The relative frequency of the first name in the VCT 
data 
VCTLastNameFreq Float The relative frequency of the last name in the VCT 
data 
VCTFullNameFreq Float The relative frequency of the full name (first name 
followed by last name) in the VCT data. 
DSSFirstNameFreq Float The relative frequency of the first name in the DSS 
data 
DSSLastNameFreq Float The relative frequency of the last name in the DSS 
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Name Type Description 
    data 
DSSFullNameFreq Float The relative frequency of the full name (first name 
followwed by last name) in the DSS data 
MatchRoutine Text The name given to the parameter set that was used in 
the run of the algorithm 
Verified Int Always zero. Used by other routines. 
SourceIdentifier Text An identifier used to distinguish between input rows 
that have the same VCTNumber 
Table 1: Output Table Columns 
 
Method 
1) The present implementation of the matching algorithm is based on the following 
variables taken from the VCT data (the source) variables: first name, second name, 
gender, year of birth, village name, subvillage name, and ten-cell leader name, and 
a similar set of variables taken from the DSS data (the target): first name, second 
name, gender, year of birth, village name, sub-village name, and ten-cell leader 
name.  For each pair of variables, one from the source and the other being the 
corresponding variable from the target, a score is computed and these are then 
summed to give a total score for the pair of records. A match is declared if the total 
score exceeds a pre-set threshold, which is passed as an input parameter to the 
routine. When a match is declared information about the match is written to the 
output table. 
2) In addition to the total score exceeding the threshold, constraints have been placed 
on some of the individual scores and these must also be satisfied before the source 
and target are declared to be matched. 
3) The similarity Sim(Name1, Name2) between two names, Name1 and Name2 is 
given by the function 
1 – Levenstein(Name1, Name2)/Max(length(Name1), length(Name2)) 
where: 
Levenstein(Name1, Name2) is the Levenstein distance between Name1 and 
Name2. The Levenstein distance between two words  is the minimum 
number of single-character edits (insertion, deletion, substitution) required to 
change one word into the other 
This similarity function lies in the range 0 to 1 inclusive, is 0 if the names are totally 
dissimilar and 1 if the names are identical. 
 
First Name Score 
 
Raw Score 
1)  This is the similarity of the first name of the source and the first name of the target: 
Sim(VCT First Name, DSS First Name), 
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Final Score – Version 1 
1)  This is a cubic polynomial in the raw first name score, R: 
3 
(a ∗R +a 2 ∗R +a ∗R+a )∗w 
13 12 11 10 1 
where a , a 
10 
, a , a 
11 12 13 
, and w 
1 
are constants whose values are given in the 
appendix. 
 
Final Score – Version 3 
1) This is given by the non-linear function: 
⎿R/c 
1 
⏌g +f 
1 1 
where R is the raw score, c 
1 
(the cutoff), g 
1 
(the gap), and f 
1 
(the offset) are 
constants whose values are given in the appendix. 
2) The effect of the floor function, ⎿	⏌is to turn the final score, as a function of the 
raw score R, into a series of discrete steps with a constant value between each 
step. 
 
Second Name Score 
 
Raw Score 
1) This is the maximum of the similarities of the second name of the source and the 
first and second names of the target: 
Max(Sim(VCT Second Name, DSS First Name), Sim(VCT Second Name, DSS Second Name)) 
2) The constraint on the second name score is that it must exceed 0.6 
 
Final Score – Version 1 
1)  This is a cubic polynomial in the raw second name score, R: 
3 
(a ∗R +a 2 ∗R +a ∗R+a )∗w 
23 22 21 20 2 
where a , a 
20 
, a , a 
21 22 23 
and w 
2 
are constants whose values are given in the 
appendix. 
 
Final Score – Version 3 
1) This is given by the non-linear function: 
⎿R/c 
2 
⏌g +f 
2 2 
where R is the raw score, c 
2 
(the cutoff), g 
2 
(the gap), and f 
2 
(the offset) are 
constants whose values are given in the appendix. 
2) The effect of the floor function, ⎿	⏌is to turn the final score, as a function of the 
raw score R, into a series of discrete steps with a constant value between each 
step.s 
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Gender Score 
 
Raw Score – Version 1 
1) This is given by the formula: 
• 5 if DSS Gender = VCT Gender 
• -5 otherwise. 
 
Final Score – Version 1 
1)  This is simply the weighted value of the raw score: 
R ∗w 
where w 
13 
13 
is the gender weight whose value is given in the appendix. 
 
Raw Score – Version 3 
1) This is given by the formula: 
• 1 if DSS Gender = VCT Gender 
• 0 otherwise 
 
Final Score – Version 3 
1)  This is given by the formula: 
•  5∗w 
23 
•  -5∗w 
23 
if DSS Gender = VCT Gender 
otherwise 
where w 
23 
is the gender weight whose value is given in the appendix 
 
Year of Birth Score 
 
Raw Score 
1) The year of birth raw score is given by the absolute value of the difference between 
the two ages: 
|VCT Year of Birth – DSS Year of Birth| 
2) The constraint on Year of Birth is that the source and target must not differ by more 
than 10 years, i.e. 
|VCT Year of Birth – DSS Year of Birth| ≤ 10 
 
Final Score – Version 1 
1)  This is given by the formula: 
R∗b11 
(−e +b )b 
12 13 
where R is the Year of Birth raw score, and b 
11 
, b , and b 
12 13 
are constants whose 
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values are given in the appendix. 
 
Final Score – Version 3 
1)  This is given by the formula: 
b21 
(−R b +b )b 
22 23 24 
where R is the Year of Birth score, and b , b  , b , and b are constants whose 
values are given in the appendix. 
 
Village Score 
21 22 23 24 
 
Raw Score 
1) The village raw score is the similarity between the VCT village name and the DSS 
village name: 
Sim(VCT Village Name, DSS Village Name). 
2) There are no additional constraints on the village raw score. 
 
Final Score – Version 1 
1)  This is simply the weighted village raw score 
Rv 
1 
where R is the raw village score and v 
1 
value is given in the appendix. 
(the village weight) is a constant whose 
 
Final Score – Version 3 
1)  This is given by the non-linear function: 
⎿	R/c 
3 
⏌g +f 
3 3 
where R is the village raw score, and c 
3 
(the cutoff), g 
3 
(the gap), and f 
3 
(the offset) 
are constants whose values are given in the appendix. 
1) The effect of the floor function, ⎿	⏌is to turn the final score, as a function of the 
village raw score R, into a series of discrete steps with a constant value between 
each step. 
 
Subvillage Score 
 
Raw Score 
1) The subvillage raw score is the similarity between the VCT subvillage name and the 
DSS subvillage name: 
Sim(VCT Subvillage Name, DSS Subvillage Name). 
2) There are no additional constraints on the subvillage raw score. 
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Final Score – Version 1 
1)  This is simply the weighted subvillage raw score 
Rv 
2 
where R is the raw subvillage score and v 
2 
whose value is given in the appendix. 
 
Final Score – Version 3 
1) This is given by the non-linear function: 
(the subvillage weight) is a constant 
⎿	R/c 
4 
⏌g +f 
4 4 
where R is the subvillage raw score, and c 
4 
(the cutoff), g 
4 
(the gap), and f 
4 
(the 
offset) are constants whose values are given in the appendix. 
2) The effect of the floor function, ⎿	⏌is to turn the final score, as a function of the 
subvillage raw score R, into a series of discrete steps with a constant value 
between each step. 
 
Ten-Cell Leader Score 
 
Raw Score 
1) The ten-cell leader raw score is the similarity between the VCT ten-cell leader name 
and the DSS ten-cell leader name: 
Sim(VCT Ten-cell Leader Name, DSS Ten-cell Leader Name). 
2) There are no additional constraints on the ten-cell leader raw score. 
 
Final Score – Version 1 
1)  This is simply the weighted ten-cell leader raw score 
Rv 
3 
where R is the raw ten-cell leader score and v 
3 
(the ten-cell leader weight) is a 
constant whose value is given in the appendix. 
 
Final Score – Version 3 
1)  This is simply the weighted ten-cell leader raw score 
Rv 
4 
where R is the raw ten-cell leader score and v 
4 
(the ten-cell leader weight) is a 
constant whose value is given in the appendix. 
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Appendix 
 
Values of the Constants 
Version 1 
  Parameter Name Value Notes 
a 
10 
Name0Order1 -3 First Name Parameters 
a 
11 
Name1Order1 -0.6 
a 
12 
Name2Order1 4.0 
a 
13 
Name3Order1 8.0 
w 
1 
FirstNameWt 3.217200725477540000E+119 
a 
20 
Name0Order2 -3 Second Name Parameters 
a 
21 
Name0Order2 -0.6 
a 
22 
Name0Order2 4.0 
a 
23 
Name0Order2 8.0 
w 
2 
SecondNameWt 1.785129198009530000E+119 
w 
13 
GenderWt 2.11E+118 Gender Parameter 
b 
11 
Age3rdExpondent 0.6 Year of Birth Parameter 
b 
12 
  1.28402541669000 
b 
13 
AgeWt 1.524010308350720000E+116 
v 
1 
VillageWt 0 Village Parameter 
v 
2 
SubVillageWt 3.34E+119 Subvillage Parameter 
v 
3 
TenCellLeaderWt 0 TenCell Parameter 
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Version 3 
 
  Parameter Name Value Notes 
c 
1 
NameCutOff1 0.6 First Name Parameters 
g 
1 
NameGap1 100 
f 
1 
NameOffset1 40 
c 
2 
NameCutOff2 0.6 Second Name Parameters 
g 
2 
NameGap2 60 
f 
2 
NameOffset2 10 
w 
23 
GenderWt 1 Gender Parameter 
b 
21 
AgePower 5 Year of Birth Parameters 
b 
22 
AgeCurve 0.1 
b 
23 
AgeOffset 250 
b 
24 
AgeWt 1 
c 
3 
VillageCutOff2 0.6 Village Parameters 
g 
3 
VillageGap2 60 
f 
3 
VillageOffset2 15 
c 
4 
SubVillageCutOff2 0.6 Subvillage Parameters 
g 
4 
SubVillageGap2 60 
f 
4 
SubVillageOffset2 15 
v 
4 
TenCellLeaderWt 0 TenCell Parameter 
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11.4 Evidence of retention of copyright 
 
11.4.1 PLOS ONE  
 
See: http://www.plosone.org/static/license 
 
Open-Access License 
No Permission Required 
 
PLOS applies the Creative Commons Attribution (CC BY) license to all works we publish (read 
the human-readable summary or the full license legal code). Under the CC BY license, authors 
retain ownership of the copyright for their article, but authors allow anyone to download, 
reuse, reprint, modify, distribute, and/or copy articles in PLOS journals, so long as the 
original authors and source are cited. No permission is required from the authors or the 
publishers. 
In most cases, appropriate attribution can be provided by simply citing the original article 
(e.g., Kaltenbach LS et al. (2007) Huntingtin Interacting Proteins Are Genetic Modifiers of 
Neurodegeneration. PLOS Genet 3(5): e82. doi:10.1371/journal.pgen.0030082). If the item 
you plan to reuse is not part of a published article (e.g., a featured issue image), then please 
indicate the originator of the work, and the volume, issue, and date of the journal in which the 
item appeared. For any reuse or redistribution of a work, you must also make clear the 
license terms under which the work was published. 
This broad license was developed to facilitate open access to, and free use of, original works 
of all types. Applying this standard license to your own work will ensure your right to make 
your work freely and openly available. Learn more about open access. For queries about the 
license, please contact us. 
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11.4.2 BMC Infectious Diseases 
 
See: http://www.biomedcentral.com/bmcinfectdis/about 
 
About BMC Infectious Diseases 
Aims and scope | Editorial team | Open access | Article-processing charges | Indexing services |Publication and peer 
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policies, open access and article-processing charges, the peer review process and other 
information. For details of how to prepare and submit a manuscript through the online submission 
system, please see the instructions for authors. 
 
Scope 
BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all 
aspects of the prevention, diagnosis and management of infectious and sexually 
transmitted diseases in humans, as well as related molecular genetics, pathophysiology, 
and epidemiology. 
BMC Infectious Diseases is part of the BMC series which publishes subject-specific journals 
focused on the needs of individual research communities across all areas of biology and 
medicine. We offer an efficient, fair and friendly peer review service, and are committed 
to publishing all sound science, provided that there is some advance in knowledge 
presented by the work. 
BMC series - open, inclusive and trusted. 
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Open access 
All articles published by BMC Infectious Diseases are made freely and permanently accessible 
online immediately upon publication, without subscription charges or registration barriers. 
Further information about open access can be found here. 
Authors of articles published in BMC Infectious Diseases are the copyright holders of their 
articles and have granted to any third party, in advance and in perpetuity, the right to 
use, reproduce or disseminate the article, according to the BioMed Central copyright and license 
agreement. 
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11.5 Conference presentations and posters 
 
11.5.1 ICASA 2011 presentation slides 
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Socio-demographic and clinical factors associated 
with repeat HIV counseling and testing in a 
community cohort study in Tanzania
Caoimhe Cawley, Alison Wringe, Mark Urassa, Raphael Isingo, 
Jim Todd, Yusufu Kumogola, Rose Manyalla, Benjamin Clark, 
John Changalucha, Basia Zaba
Timing of Kisesa study activities
0
ART clinic
VCT service
ANC surveillance
HIV Serology
Demography
Methods
• Analyses included those who attended both
Sero 4 (2003-4) and Sero 5 (2006-7), and who
used the VCT service at both rounds
• Statistical methods: logistic regression
Numbers attending and using VCT at 
Sero 4 and Sero 5, by sex
M F Total M F Total
Sero 4 3951 5012 8963 480 (12.2) 370 (7.4) 850 (9.5)
Sero 5 3612 5051 8663 663 (18.4) 777 (15.4) 1440 (16.6)
Sero 4 AND Sero 5 1562 2271 3833 89 (5.7) 64 (2.8) 153 (4.0)
Number using VCT (%)Number Attending
Socio-demographic factors associated with repeat use of VCT among 
individuals who were HIV negative at Sero 4
§ As recorded at Sero5
*p≤0.05, **p≤0.01, ***p≤0.001
Variable
§
N (% Repeat 
Testing) Crude OR (95% CI) Adjusted OR (95% CI)
Sex
   Male 1503 (5.5) 1 1
   Female 2198 (2.9) 0.5  (0.4-0.7)*** 0.7  (0.5-1.0)*
Age
   ≥45 1331 (2.9) 1
 15-24 802 (1.9) 0.6  (0.4-1.1)
 25-34 874 (5.4) 1.9  (1.2-2.9)**
 35-44 694 (6.3) 2.2  (1.4-3.5)***
Area of residence
   Rural 2077 (3.8) 1
   Roadside 961 (5.0) 1.3  (0.9-1.9)
   Trading centre 663 (2.9) 0.8  (0.4-1.3)
Education
   None 1382 (1.4) 1 1
   Primary 1-4 yrs 391 (3.6) 2.5  (1.3-5.0)** 1.8  (0.9-3.7)
   Primary 5-7 yrs 1623 (6.0) 4.3  (2.7-7.0)*** 3.2  (1.9-5.3)***
   Secondary + 303 (4.6) 3.3  (1.6-6.6)*** 2.4  (1.2-4.9)*
N= 3701
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Association between marital status change and repeat 
use of VCT among men
† Adjusted for sex and education
*p≤0.05, **p≤0.01, ***p≤0.001
Marital status Sero 4 - Sero 5
N (% Repeat 
Testing) Crude OR (95% CI) Adjusted OR (95% CI)
†
   Married monog-married monog 710 (5.6) 1 1
   Never married-Never married 346 (1.4) 0.2  (0.1-0.6)** 0.2  (0.1-0.6)**
   Married polyg-married polyg 30 (10.0) 1.9  (0.5-6.4) 2.1  (0.6-7.6)
   Widowed/separated-Widowed/separated 40 (7.5) 1.4  (0.4-4.6) 2.1  (0.6-7.4)
   Not married-married 153 (10.5) 2.0  (1.1-3.6)* 1.9  (1.0-3.5)*
   Married monog-married polyg 41 (14.6) 2.9  (1.1-7.2)* 2.5  (0.9-6.9)
   Married polyg-married monog 32 (12.5) 2.4  (0.8-7.1) 2.2  (0.7-6.8)
   Married-Widowed/Separated 36 (13.9) 2.7  (1.0-7.3)* 3.5  (1.2-10.1)*
   Never married-Widowed/separated 19 (0) - -
Males (N=1503)
Association between marital status change and repeat 
use of VCT among women
† Adjusted for sex and education
*p≤0.05, **p≤0.01, ***p≤0.001
Marital status Sero 4 - Sero 5
N (% Repeat 
Testing) Crude OR (95% CI) Adjusted OR (95% CI)
†
   Married monog-married monog 967 (2.9) 1 1
   Never married-Never married 97 (3.1) 1.1  (0.3-3.6) 0.9  (0.3-3.2)
   Married polyg-married polyg 140 (2.9) 1.0  (0.3-2.8) 1.1  (0.4-3.1)
   Widowed/separated-Widowed/separated 396 (1.3) 0.4  (0.2-1.1) 1.1  (0.4-3.2)
   Not married-married 196 (2.0) 0.7  (0.2-2.0) 0.7  (0.2-2.0)
   Married monog-married polyg 116 (6.9) 2.5  (1.1-5.6)* 2.5  (1.1-5.7)*
   Married polyg-married monog 75 (2.7) 0.9  (0.2-3.9) 1.1  (0.2-4.8)
   Married-Widowed/Separated 141 (2.8) 1.0  (0.3-2.8) 1.6  (0.5-5.0)
   Never married-Widowed/separated 23 (17.4) 7.1  (2.2-22.1)** 8.0  (2.4-26.3)***
Females (N=2198)
Association between HIV status at Sero
4 and Sero 5 and repeat use of VCT
Males (n=1554)
N (% Repeat 
Testing) Crude OR (95% CI)
N (% Repeat 
Testing) Crude OR (95% CI)
Negative, negative 1462 (5.3) 1 2127 (3.0) 1
Negative, positive 37 (10.8) 2.18 (0.75-6.31) 57 (0) -
Positive, positive 55 (12.7) 2.62 (1.15-5.99)* 71 (1.4) 0.47 (0.06-3.42)
Females (n=2255)
Discussion
• Uptake of VCT and rates of repeat testing low
overall (data are from 2003/4 and 2006/7)
• Repeat uptake of VCT lower among women
and those with least education
• No association between sero-conversion and
likelihood of repeat testing
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Access to HIV counselling and 
testing services in rural Tanzania
Caoimhe Cawley, Alison Wringe, Jim Todd, Annabelle Gourlay, Benjamin 
Clark, Clemens Masesa, Richard Machemba, Georges Reniers, Mark 
Urassa, Basia Zaba
Overview
• Background
• Study site and methods
• Results
• Conclusions
HIV in Tanzania
• Estimated 1.4 million people living with HIV in 2013 (range 1.3‐1.5 
million)
• Prevalence of 5.0% (range 4.6%‐5.3%) in adults aged 15‐49
• Estimated 72,000 adults and children newly infected in 2013 (range 
59,000‐87,000)
*Source: UNAIDS. http://www.unaids.org/en/dataanalysis/
HIV counselling and testing services
• Voluntary counselling and testing (VCT) ‐ traditional model 
• Provider initiated testing and counselling (PITC)
• Home based testing
• Outreach/mobile testing
• Self‐testing
TAZAMA Project
• Demographic 
surveillance site
• HIV serological 
surveillance
• Kisesa Health
Centre
Study objective
• Identify factors associated with VCT use during Sero6 or at Kisesa Health
Centre 
Data sources:
• Outreach VCT service provided during Sero6 in 2010
• Permanent VCT clinic at the health centre (client visits between 2010‐2012) 
– linked to cohort dataset
Statistical analyses:
• Logistic regression models (Stata v12)
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VCT at Kisesa Health Centre 
• Linkage rate for clinic records was low (17.8%) 
• Case‐control analysis among Sero6 participants with a link to the 
permanent VCT clinic (fewer numbers than analysis of VCT use at
sero‐survey)
• However positive predictive value was reasonable (69%)
VCT at Sero6
0%
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Used VCT No VCT
N=3,131 N=4,877
Location of first test by sex, all Sero6 attendees
0%
20%
40%
60%
80%
100%
Men Women
Sero‐survey Kisesa VCT Kisesa ANC
Other Never tested
N=3,096 N=4,859
Age: older men and women had lower odds 
of testing
aOR = adjusted odds ratio
95% CI = 95% confidence interval
Men Women
VCT Sero6 VCT Health Centre VCT Sero6 VCT Health Centre
Year of birth N (% using 
VCT)
aOR (95% CI) N (% using VCT) aOR (95% CI) N (% using VCT) aOR (95% CI) N (% using VCT) aOR (95% CI)
1986‐1995 1,494 (19.7) 1 167 (16.8) 1 1,689 (23.3) 1 78 (37.2) 1
1976‐1985 458 (37.6) 1.14 (0.84,1.54) 43 (23.3) 0.55 (0.19,1.56) 1,132 (32.6) 0.98 (0.79,1.22) 58 (58.6) 1.74 (0.62,4.86)
1966‐1975 417 (35.7) 1.14 (0.83,1.58) 60 (35.0) 1.00 (0.40,2.49) 819 (31.3) 0.96 (0.76,1.23) 52 (55.8) 2.25 (0.77,6.56)
1956‐1965 313 (32.6) 1.03 (0.73,1.47) 48 (12.5) 0.31 (0.10,1.00) 516 (26.7) 0.88 (0.66,1.19) 59 (23.7) 0.8 (0.26,2.47)
1905‐1955 447 (21.3) 0.67 (0.48,0.94) 182 (5.5) 0.24 (0.10,0.58) 720 (9.9) 0.34 (0.23,0.50) 255 (2.4) 0.41 (0.11,1.57)
Area: those living in roadside villages or 
trading centre had higher odds of testing
Men Women
VCT Sero6 VCT Health Centre VCT Sero6 VCT Health Centre
Area of 
residence
aOR (95% CI) aOR (95% CI) aOR (95% CI) aOR (95% CI)
Rural  1,772 (15.8) 1 278 (11.2) 1 2,493 (14.0) 1 258 (20.2) *
Roadside 763 (36.3) 2.61 (2.09,3.26) 124 (20.2) 2.11 (1.09,4.10) 1,284 (34.7) 2.97 (2.48,3.56) 129 (27.1) *
Trading
centre
596 (42.8) 3.43 (2.72,4.33) 98 (19.4) 1.30 (0.63,2.68) 1,100 (39.5) 3.83 (3.16,4.64) 115 (21.7) *
aOR = adjusted odds ratio
95% CI = 95% confidence interval
*Not significant for inclusion in multivariable model
HIV positive individuals had higher odds of 
using VCT at health centre
aOR = adjusted odds ratio
95% CI = 95% confidence interval
*Too few data to calculate OR
Men Women
HIV Status N (% using VCT) aOR (95% CI) N (% using VCT) aOR (95% CI)
Negative 472 (14.2) 1 474 (20.5) 1
Positive <3 years 3 (0) * 6 (16.7) 0.4 (0.03,5.20)
Positive ≥3 years 20 (35.0) 4.52 (1.36,15.03) 21 (66.7) 10.7 (2.53,44.97)
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HIV status and VCT use during Sero6
• Men HIV positive ≥3 years had higher odds of using VCT if they had
never used any HCT before, OR 1.96 (1.15‐3.32)
‐ But not if they had used HCT before, OR 0.57 (0.32‐1.00)
• Women HIV positive ≥3 years had lower odds of using VCT if they had
used any HCT before, OR 0.38 (0.26‐0.57).
Those with more sexual partners had higher 
odds of testing
Men Women
VCT Sero6 VCT Health Centre VCT Sero6 VCT Health Centre
Number of 
sex partners
N (% using VCT) aOR (95% CI) N (% using VCT) aOR (95% CI) N (% using VCT) aOR (95% CI) N (% using VCT) aOR (95% CI)
None 322 (21.1) 0.65 (0.46,0.91) 59 (10.2) 1.25 (0.43,3.61) 858 (16.6) 1.06 (0.73,1.54) 225 (1.8) 0.03 (0.00,0.20)
One 1,315 (31.6) 1 247 (11.7) 1 3,261 (30.1) 1 231 (40.7) 1
Two or 
more
640 (36.2) 1.12 (0.89,1.42) 91 (31.9) 2.92 (1.45,5.87) 100 (44.0) 1.84 (1.16,2.90) 4 (50.0) 0.2 (0.01,4.15)
aOR = adjusted odds ratio
95% CI = 95% confidence interval
Location of first test, trends over time
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N=3,096 N=4,859
Sero 6 (2010)
N=3,978 N=4,982
Sero 4 (2003/2004)
N=3,633 N=5,063
Sero 5 (2006/2007)
Conclusions
• By 2010, still only 50% of women and 40% of men who had ever tested (low
considering this is a high prevalence area)
• Different VCT services attracted different individuals – women more likely to use 
clinic compared to men. Clinic more ‘selective’ (measures of effect stronger), VCT
during sero‐survey more ‘inclusive’
• Both services attracted those with higher risk sexual behaviours and HIV‐positive
individuals.
• However, for treatment as prevention to be effective, services need to reach as 
many people as possible. Important underserved groups include men and those
living in rural areas
Policy implications
• Decentralisation of services may help to increase rates of testing in
rural areas
• Different models of delivery help to make services more equitable
• Need to understand which testing services are most effective at
linking positive individuals to treatment and care 
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11.5.4 IAS 2015 Abstract (upcoming poster presentation) 
 
Title: ‘It is just the way it was in the past before I went to test’. Exploring the role 
of HIV prevention counselling in sexual behaviour change in rural Tanzania 
 
Authors: Caoimhe Cawley, Alison Wringe, Shelley Lees, Joyce Wamoyi, Mark 
Urassa 
 
Track C: Prevention Science (C50 – HIV testing) 
 
Background: HIV counselling in the context of undergoing an HIV test is assumed to 
play an important role in preventing new infections by encouraging clients to develop 
and apply individualised risk-reduction plans. However, few qualitative studies have 
explored the processes through which clients in sub-Saharan Africa might modify their 
behaviour. We conducted a qualitative study to explore HIV-negative and HIV-positive 
individuals’ attitudes towards this advice and their perceived ability to implement it 
following HIV testing in rural Tanzania. 
 
Methods: Nine sex-specific participatory group activities gathered community 
perceptions of HIV testing and counselling (HTC). Thirty in-depth interviews (IDIs) 
with HIV-negative and HIV-positive service users explored individual experiences of 
HTC including testing motivations, the client-counsellor relationship, and attitudes 
towards advice on sexual risk reduction. Five IDIs were conducted with HTC providers 
to understand their perspectives. Study activities were conducted in KiSwahili, 
recorded and transcribed, and then translated into English. Nvivo10 was used for 
coding and analysis of transcripts, guided by a framework approach. 
 
Results: We identified several individual-level, related attributes including skills, 
perceived self-efficacy, attitudes and intentions which influenced how counselling 
messages were interpreted and acted upon (Figure 1). However, individual level 
attributes were strongly mediated by socio-cultural norms such as expectations of 
multiple partnerships, a perceived inability for women to communicate about safer sex 
with partners, or beliefs that condoms were associated with promiscuous behaviour. 
Advice was often referred to as ‘instructions’ systematically covering ‘ABC’ prevention 
messages, reflecting imbalanced client-counsellor power relations, with little tailoring 
to clients’ circumstances. Clients’ perceived abilities to act upon counselling advice 
was also constrained by environmental factors such as poverty and economic 
dependency. 
  
Conclusions: HIV prevention counselling is unlikely to significantly contribute to 
sexual behaviour change unless counselling messages are generated through a truly 
open client-provider discussion. Counselling messages should also be tailored to 
individual circumstances, taking account of users’ existing skills, attitudes and 
intentions towards risk reduction and acknowledging prevailing socio-cultural norms 
and environmental constraints.  
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Figure 1: Conceptual framework for understanding responses to HIV 
prevention counselling in rural Tanzania 
 
 
 
 
 
 
 
 
 
 
 
